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ABSTRACT 
Individual human beings report highly variable pain experiences following exposure 
to the same noxious stimulus, including noxious heat. A series of missense single 
nucleotide polymorphisms (SNPs) have been found in the human noxious heat 
transducer, transient receptor potential vanilloid type 1 ion channel (hTRPV1), which 
responds to, exogenous, and endogenous, vanilloids, protons, and depolarisation. The 
aim of this project was to examine the effect of SNPs on the sensitivity of hTRPV1 
to certain activators. 
              
The three most frequently occurring SNPs (I315M, T469I, V585I) were used to 
generate 4 haplotypes: hTRPV1112 (V585I); hTRPV1121 (T469I); hTRPV1211 
(I315M); and hTRPV1222 (I315M, T469I, V585I). The responses of these haplotypes 
to these activators were compared to the responses of the “wild type” hTRPV1 
(hTRPV1111, I315, T469, V585) using whole-cell patch-clamp recordings from 
HEK293 cells which transiently-expressed the relevant ion channels. Site-directed 
mutagenesis was used to confirm the role of the SNPs in altering the sensitivity of 
hTRPV1 to the activators applied.  
           
In addition, in control experiments, several important collateral issues were 
investigated, namely: (a) the effect of the solvent, dimethyl sulphoxide (DMSO), on 
untransfected, and transfected, cells, respectively; and (b) the extent to which acid-
sensing ion channels, constitutively-expressed by HEK293 cells, compromised the 
assessment of the proton-evoked responses of hTRPV1. The techniques employed 
included: the co-transfection of the cells with vector carrying the coding region of the 
green fluorescent protein (GFP) gene; the reverse transcriptase polymerase chain 
reaction; immunocytochemistry; the cobalt uptake assay; and whole-cell patch-clamp 
recordings.    
 
The pharmacological and biophysical properties of the DMSO-evoked, and 
capsaicin-evoked, responses were similar. Furthermore, DMSO desensitised TRPV1. 
Acid-sensing ion channels were sensitive to the diuretic, amiloride (30µM).  
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However, amiloride increased hTRPV1-mediated responses evoked by noxious heat 
but not capsaicin.   
 
hTRPV1222 showed a higher sensitivity than hTRPV1111 to capsaicin, and heat.  
Thus, when capsaicin was applied, the EC50 of hTRPV1111 and hTRPV1222 was 817 
nM and 89 nM, respectively. The activation thresholds when heat was applied to 
hTRPV1111 and hTRPV1222 were 44.5±0.31 
o
C, and 42.3±045 
o
C, respectively). 
However, hTRPV1111 was more sensitive to depolarisation than hTRPV1222, with the 
V1/2 at 37
o
C for hTRPV1111 and hTRPV1222 being 42.3 mV and 83.3 mV, 
respectively. Furthermore, no differences were found between the proton-and 
anandamide- sensitivity of hTRPV1111 and hTRPV1222. The sensitivities of 
hTRPV1121 to heat and depolarization were similar to those of hTRPV1222, but 
different from those of hTRPV1111. Furthermore, the sensitivity of hTRPV1112 and 
hTRPV1211 were similar to that of hTRPV1111, but different from that of hTRPV1222 
and hTRPV1121. Charge-neutralising and conserving mutations at position 469 
produced clones with similar sensitivities to hTRPV1121 and hTRPV1111, 
respectively.     
 
The studies undertaken established, first, that DMSO is able to activate TRPV1. 
Second, the non-synonymous SNP at position 469 in hTRPV1 alters the sensitivity of 
the ion channel to vanilloids, heat, and depolarisation. These findings suggest that 
missense SNPs in hTRPV1 may contribute to the development of different pain 
experience in humans in response to the same noxious stimulus. Accordingly, regard 
must be had to SNPs found in hTRPV1 when attempting to develop analgesics for 
pain which depends on TRPV1 activation and in treating that pain. Finally, the 
finding that the T469I mutation increased the sensitivity of the molecule to heat, but 
reduced its sensitivity to depolarisation, suggests that the various sensors in TRPV1 
may be coupled allosterically rather than directly.   
 5 
ACKNOWLEDGEMENT 
      I wish to take this opportunity of thanking all those people who have made 
it possible for me to spend four years discovering that there is more to chillies than is 
apparent in my local curry-house and who have been there to support me and make 
those years as enjoyable as they have been interesting and intellectually rewarding. 
 
My first thanks must go to Dr. Istvan Nagy who has spent these last few years 
putting up with my mad rantings about Jelly Beans, Subway Sandwiches and 
Chinese takeaways but most importantly for giving me this opportunity to work with 
him. His love for science and his constant insistence to aim for the highest standards 
has given me the necessary foundation to be passionate about my own work and to 
believe in my own ability. I am deeply grateful to him.  
 
Thanks to Dr. John White for his friendship and endless supply of warm dinners and 
glasses of wine. His company and his constant presence during the late nights while I 
was recording from cells made it more bearable, especially when I was really sleepy, 
hungry and fed-up.  My pure addiction to "one more" -- one more cell, because one 
more cell will make, or break, it -- will forever haunt me and make me smile. 
 
I wish to express my appreciation to Dr. John B. Davis, for his always valuable 
assistance, his challenging ideas, and generous support of my work. Thanks to Dr. 
Andy Photiou and Dr. Laki Buluwela for allowing me to hang out in their lab and for 
admitting me to their inner circle where I learned the fascinating complexities of site-
directed mutagenesis.    
 
A very big "thank you" is due to all the people in the laboratories at Chelsea and 
Westminster Hospital.  Their laughter, good company, and continuous supply of 
jokes and Starbucks, have always been appreciated.    
 
My deepest debt of gratitude is owed to my nearest and dearest.  Thanks to my 
parents for providing me with endless love, support, and for a roof to sleep under. 
Thanks to my three wonderful sisters, especially to Annabelle, who has kept me 
grounded and sane with words of encouragement during the very testing time of 
writing this thesis.  Finally, to Gurpreet Singh, without whom I would have been lost; 
just you and I against the world! 
 
Cleoper Paule 
Sensory Processing Group 
Imperial College 
Chelsea and Westminster Hospital Campus 
London 
 6 
CONTENTS 
Abstract 3 
Preface 5 
Table of content 6 
List of figures and tables 11 
List of abbreviations 16 
 
Chapter 1 
 The Capsaicin Receptor: from chillies to pain 
     
1.1 Introduction   20 
 1.1.1 Pain as a blessing and a burden  21  
 1.1.2 Development of acute pain  22 
 1.1.3 Development of prolonged and chronic pain  23 
1.2 Differences in pain perception   25 
 1.2.1 Cultural and social influences  25 
 1.2.2 Biological factors  26 
  1.2.2.1 Sex and Gender 26 
  1.2.2.2 Psychological status 27 
  1.2.2.3 Ethnicity  28 
  1.2.2.4 Genetically-defined factors 28 
  1.2.2.4.1 Polymorphisms 29 
1.3 TRPV1   32 
 1.3.1 Structure of TRPV1  32 
 1.3.2 TRPV1 multimeric structure  33 
 1.3.2a TRPV1 splice variants  35 
 1.3.3 TRPV1 activators  36 
  1.3.3.1 Vanilloids 36 
  1.3.3.2 Anandamide 37 
  1.3.3.3 Protons 37 
  1.3.3.4 Heat 38 
  1.3.3.5 Voltage-dependent activation 39 
  1.3.3.6 Post-translational modification 39 
 1.3.4 Expression and distribution of TRPV1  40 
  1.3.4.1 Expression by primary sensory neurons 40 
  1.3.4.2 Expression in the central nervous system 40 
  1.3.4.3 Expression by non-neuronal cells 41 
 1.3.5 The role of TRPV1 in physiological and pathological 
conditions 
42 
  1.3.5.1 Pain 42 
  1.3.5.2 TRPV1 and inflammatory pain 42 
  1.3.5.3 TRPV1 and neuropathic pain 43 
  1.3.5.4 Visceral hyper-reflexia and pain 44 
  1.3.5.5 Diabetes 44 
 1.3.6 TRPV1 polymorphisms  46 
 7 
1.4 Aims and objectives   52 
 1.4.1 Hypothesis  52 
 1.4.2 Aim  52 
 1.4.3 Objectives  52 
 
Chapter 2 
Experimental techniques and protocols  
 
2.0  Introduction 54 
2.1 Cell Culture 54 
 2.1.1 Cell culture of DRG neurons 57 
  2.1.1.1 Theory of DRG neurons in culture 57 
  2.1.1.2 Culturing DRG neurons 60 
 2.1.2 Cell culture of HEK293 cells 65 
  2.1.2.1 Theory of technique 65 
  2.1.2.2 Culturing HEK293 cells 66 
2.2 Transfection 69 
 2.2.1 Background to the purpose of transfection 69 
  2.2.1.1 Cloning of DNA 69 
  2.2.1.2 Theory of transfection 72 
  2.2.1.3 Transient transfection 75 
2.3 Site-directed mutagenesis 78 
 2.3.1 Theory behind site-directed mutagensis 78 
 2.3.2 Site-directed mutagenesis: practical approach 84 
2.4 Agonist-activated cobalt uptake 91 
 2.4.1 Theory of agonist-activated cobalt uptake 91 
 2.4.2 Practical application of agonist-activated cobalt uptake 96 
  2.4.2.1 Data analysis of agonist-activated cobalt 
uptake 
97 
  2.4.2.2.1 Data analysis for hTRPV1-transfected 
 HEK293 cells 
99  
  2.4.2.2.2 Data analysis for mouse DRG culture 101 
2.5 Whole-cell patch-clamp recordings 103 
 2.5.1 Introduction to whole-cell patch-clamp recording 103 
 2.5.2 Biophysics of whole-cell patch-clamp technique 108 
  2.5.2.1 Ion channels 108 
  2.5.2.2 Lipid bilayer 113 
  2.5.2.2.1 Compensating the capacitive transients 113 
  2.5.2.3 Ionic distribution 114 
  2.5.2.3.1 Compensating for series resistance 117 
 2.5.3 Practical components of whole-cell patch-clamp recordings  119 
  2.5.3.1 Solutions 120 
  2.5.3.2 Patch Electrodes 120 
  2.5.3.3 Perfusion system and drug application 122 
  2.5.3.4 Obtaining whole-cell patch-clamp 
configuration 
126 
 8 
 2.5.4 Recording protocols and data analysis 127 
 2.5.5 Capsaicin-evoked activation 127 
 2.5.6 Anandamide-evoked activation 128 
 2.5.7 Proton-evoked activation 128 
 2.5.8 Heat-evoked activation 129 
  2.5.8.1 Analysis of heat-sensitivity 130 
  2.5.8.2 Biophysics of heat-sensitivity 130 
  2.5.8.3 Analysis of heat-induced response 134 
  2.5.8.4 Comparison of analysing heat-induced 
responses by the two methods  
145 
  2.5.9.1 Current-voltage relationship of the 
TRPV1agonist-evoked responses 
150 
 2.5.10 Voltage-dependence  152 
  2.5.10.1 Biophysics of voltage-dependence 152 
  2.5.10.2 Untransfected HEK293 cells and  voltage-
dependence 
155 
  2.5.10.2.1 Study design and practical application 155 
  2.5.10.2.2 Response of untransfected cell to changing the 
membrane potential 
157 
  2.5.10.3 TRPV1-transfected HEK293 cells and voltage-
dependent acyivity 
158 
  2.5.10.3.1 Study design 158 
  2.5.10.3.2 Practical application  163 
  2.5.10.3.3 Response of TRPV1-transfected cell to 
voltage-dependence 
163 
2.6 Statistical Analysis 171 
 2.6.1 Descriptive statistics 171 
  2.6.1.1 Central tendency 171 
  2.6.1.2 Variability 172 
  2.6.1.3 Distribution 174 
  26.1.4 Sampling distribution of the mean 176 
 2.6.2 Inferential statistics 179 
  2.6.2.1 Estimation statistics 179 
  2.6.2.1.1 Parameter estimation 179 
  2.6.2.1.1.1 Linear regression model 179 
  2.6.2.1.1.1a Correlation coefficient of a linear regression 180 
  2.6.2.1.1.2 Non-linear regression model 181 
  2.6.2.1.1.2a Gaussian distribution 181 
  2.6.2.1.1.2b Sigmoid curve 183 
  2.6.2.1.1.2c Boltzmann curve 184 
  2.6.2.1.1.3 The goodness of fit of nonlinear regression 185 
  2.6.2.1.1.4 Confidence intervals 185 
  2.6.2.2 Hypothesis testing 186 
  2.6.2.2a Statistical errors: type I and type II error 187 
  2.6.2.2b Power analysis 188 
  2.6.2.2.1 Parametric tests 189 
  2.6.2.2.1a Test for normality of the distribution 190 
  2.6.2.2.1b Test for equal variance 191 
 9 
  2.6.2.2.1.1 Comparing the means of data 193 
  2.6.2.2.1.1a Student t-test 193 
  2.6.2.2.1.1b ANOVA 195 
  2.6.2.2.1.1c Post hoc tests 197 
     
 
 
 
Chapter 3 
DMSO activates TRPV1 
     
3.1 Introduction   201 
3.2 Methods   201 
 3.2.1 Whole-cell patch-clamp recordings 
3.2.1.1 Application of  0.2% DMSO 
3.2.1.2 Application of 0.2% DMSO  in the presence of 
capsazepine 
 
201 
203 
203 
 3.2.2 Cobalt-uptake of hTRPV1111-transfected HEK293 cells  204 
  3.2.2.1 0.2% DMSO application 204 
  3.2.2.2 0.2% DMSO application in the presence of 
capsazepine   
205 
  3.2.2.3 Repeated applications of capsaicin and DMSO in the 
presence and absence of calcium ions. 
207 
  3.2.2.4 
 
3.2.2.5 
Application of capsaicin dissolved in varying  
percentages of DMSO 
Cobalt-uptake on cultured DRG neurons  
 
209 
 
209 
 3.2.3 Statistical analysis 
 
 210 
3.3 Results   211 
 3.3.1 Properties of DMSO-evoked hTRPV1-mediated currents   211 
 3.3.2 The effect of DMSO on cobalt-uptake  217 
 3.3.3 DMSO-evoked desensitisation in the presence of calcium ions. 220 
 3.3.4 Effect of  DMSO on the capsaicin-evoked hTRPV1 activation 225 
 3.3.5 DMSO-evoked responses in DRG cultures 227 
3.4 Discussion   230 
 
 
 
 
 
 10 
Chapter 4 
 Constitutive and acid sensitivity of HEK293 cells 
     
4.1 Introduction   236 
4.2 Methods   236 
 4.2.1 Whole-cell patch-clamp recordings of hTRPV1-transfected 
HEK293 cells 
4.2.1.1 Proton application in the absence  
              and presence of amiloride 
4.2.1.2  Capsaicin application in the absence, 
                and presence, of amiloride 
4.2.1.3  Heat  application in the absence and 
presence of amiloride 
236 
 
238 
239 
 
239 
 4.2.2 Statistical analysis  240 
4.3 Results   241 
 4.3.1 Proton-evoked responses in untransfected HEK293 cells   241 
 4.3.2 The effect of amiloride on hTRPV1-mediated responses in 
hTRPV1-tranfected cells  
243 
  4.3.2.1 The effect of amiloride on proton-evoked responses 243 
  4.3.2.2 The effect of amiloride on capsaicin-evoked responses 245 
  4.3.2.3 The effect of amiloride on heat-evoked responses 247 
4.4 Discussion   250 
 
 
Chapter 5 
Naturally occurring polymorphism in human TRPV1 gene  
alters the sensitivity of the ion channel 
  
5.1 Introduction   254 
5.2 Method  255 
5.3 Results  255 
 5.3.1 Comparative analysis of hTRPV1111-, and hTRPV1222 -, 
mediated responses to various activators 
 255 
  5.3.1.1 Comparison of responses to capsaicin 255 
  5.3.1.2 Comparison of responses to anandamide 260 
  5.3.1.3 Comparison of responses to protons 262 
  5.3.1.4 Comparison of responses to heat 266 
  5.3.1.5 Comparison of responses to  
voltage-dependent activation 
 
269 
  5.3.1.6 Summary of comparisons of responses of 
hTRPV1111  
and hTRPV1222 to various to TRPV1 activators 
272 
 5.3.2 The relationship between heat and voltage for hTRPV1111 
and hTRPV1222 
274 
  5.3.2.1 The heat threshold depends on the holding 
potential 
 
274 
 11 
 5.3.3 Comparative analysis of hTRPV1211- , hTRPV1121- and 
 hTRPV1112-, mediated responses 
276 
  5.3.3.1 Responses of TRPV1211, hTRPV1121, and  
hTRPV1112  to heat 
276 
  5.3.3.2 Response of hTRPV1121 to voltage-dependent 
activation 
278 
 5.3.4 Comparative analysis of hTRPV1 121-S  and hTRPV1121-A 
mediated responses 
280 
  5.3.4.1 Responses of mutants to heat 280 
5.4 Discussion  282 
 
 
Chapter 6 
Summary of results and conclusions 
 
6.1 Summary   291 
6.2 DMSO activates TRPV1  291 
6.3 Amiloride affects TRPV1-mediated responses  293 
6.4 Polymorphisms alter the sensitivity of hTRPV1 to various 
activators 
 295 
 
REFERENCES                297 
 
 
FIGURES AND TABLES 
 
Chapter 1: The Capsaicin Receptor: from chillies to pain   
Figure 1.1 Membrane topology of TRPV1 
Figure 1.2 Membrane topology and approximate location of the 7 
missense SNP‟s found in hTRPV1 receptor 
Table 1.1 Seven missense SNPs found in hTRPV1 by Davis and 
colleagues (unpublished data). 
Table 2.2 5 haplotypes of hTRPV1, where isoleucine (I), threonine (T) 
and valine (V) are substituted by a different amino acid 
within a specified position. 
 
 
Chapter 2. Experimental techniques and protocols 
 
Figure 2.1 Cross-section of the spinal cord and surrounding structures 
Figure 2.2 The spinal segments of a mouse. 
Figure 2.3 Map of pcDNA3.1v5-HIs-TOPO vector. 
Figure 2.4 Location of mutagenic primers for site-directed mutagenesis 
of codon 469 on the hTRPV1 gene. 
 
 12 
Figure 2.5 Complementary DNA sequence between bases 1021-1660 of 
the open reading frame of the human TRPV1 and the location 
of the primer pair flanking the region of site directed 
mutation. 
Figure 2.6 Sequencing data of site directed mutation of codon 469 of the 
human TRPV1 gene 
Figure 2.7 General procedure when carrying out cobalt-uptake assay to 
investigate functional TRPV1 activity in TRPV1-expressing 
cells. 
Figure 2.8 Analysis of cobalt-uptake assay on hTRPV1-transfected 
HEK293 cells 
Figure 2.9 Analysis of cobalt-uptake assay on mouse DRG cells. 
Figure 2.10 The main components of a two-electrode voltage-
clamp set-up. 
Figure 2.11 Diagram of the main components of a patch-clamp 
configuration using one electrode 
Figure 2.12 The Ag/AgCl electrode. Currents are able to flow in both 
direction of the electrode. 
Figure 2.13 Four configurations of patch-clamp technique. 
Figure 2.14 Ohm‟s law. Ohm‟s law states that there is a  
linear relationship between current I and voltage V. 
Figure 2.15 Schematic diagram of an idealised single channel recording 
Figure 2.16 Ion channels as a parallel circuit. 
Figure 2.17 A single membrane ion channel as circuit 
Figure 2.18 The main components of a patch-clamp set-up 
Figure 2.19 Schematic diagram of the fabrication of patch electrodes using 
a two-stage vertical puller. 
Figure 2.20 Perfusion system of the electrophysiology set-up. 
Figure 2.21 Thermo-TRP channels respond to a wide range of 
temperatures 
Figure 2.22 Schematic diagram of a typical Arrhenius plot. 
Figure 2.23 Arrhenius plot of heat-induced response in hTRPV1-
transfected cells 
Figure 2.24 Whole-cell membrane current induced by heat ramp and its 
Q10 in an untransfected HEK293 cell. 
Figure 2.25 A whole-cell membrane current induced by a heat ramp and 
its Q10 in TRPV1-transfected HEK293 cell. 
Figure 2.27 Q10 values of untransfected HEK293 cells and hTRPV1-
transfected HEK293 cells between 37-51 
o
C. 
Figure 2.28 Q10 values and activation energy the slow rising phase (37-43 
o
C) and the fast (46-51 
o
C) from hTRPV1-transfected 
HEK293 cells. 
Figure 2.29 Heat activation threshold of first and second analysis of data. 
Figure 2.30 
Figure 2.31 
Voltage-dependent activation of untransfected HEK293 cells. 
 Data analysis of voltage-dependence of hTRPV1-mediated 
response 
Figure 2.32 Typical conductance-voltage relationships of a TRPV1111-
transfected HEK293 cell 
 13 
Figure 2.33 V-G/Gmax relationship of conductances 
Figure 2.34 V-G/Gmax relationship showed on fig 2.32, fitted with two 
Boltzmann functions. 
Figure 2.35  V-G relationship of voltage-activated current in untransfected 
cell and hTRPV1-transfected cell 
Figure 2.36 Average V-G/Gmax relationship of hTRPV1111 and hTRPV222 
Figure 2.37 Normal distribution curve and the Empirical Rule 
Figure 2.38 The spread of the sampling distribution of the mean 
Figure 2.39 Sigmoidal dose response curve. 
Figure 2.40 Boltzmann curve 
Figure 2.41 Types of statistical errors associated with hypothesis testing. 
Table 2.1 Seven haplotypes of hTRPV1. Haplotypes 1-5 were made by 
Davis and co-workers. 
Table 2.2 TRP channels and their Q10 values as found in various studies. 
 
Chapter 3. DMSO activates TRPV1 
Figure 3.1 Sequence of treatment steps performed to investigate 
capsazepine on capsaicin-evoked, and DMSO-evoked, 
capsaicin-evoked cobalt-labelling. 
Figure 3.2 Sequence of treatments steps investigates the effect of 
successive applications of capsaicin and DMSO. 
Figure 3.3 DMSO-evoked responses in untransfected cells and hTRPV1-
transfected cells using whole-cell patch-clamp recordings. 
Figure 3.4 The effect of capsazepine on capsaicin-evoked activation of 
hTRPV1-transfected cells using whole-cell recordings. 
Figure 3.5 The effect of capsazepine on 0.2% DMSO-evoked currents in 
hTRPV1-transfected cells using whole-cell recordings. 
Figure 3.6 Grey scale images of cells following cobalt-uptake assay of 
untransfected cells in response to 500 nM capsaicin and 0.2% 
DMSO application. 
Figure 3.7 Grey scale images of cells following cobalt-uptake assay 
Cobalt-uptake images of hTRPV1-transfected cells in 
response to 500 nM capsaicin and 0.2% DMSO application. 
Figure 3.8 The effect of capsaicin (500nM), capsazepine (5µM) and 
DMSO (0.2 %) on hTRPV1-transfected cells using cobalt-
uptake 
Figure 3.9 Repeated application of capsaicin and DMSO in hTRPV1-
transfected cells in the presence, and absence, of 2 mM CaCl2 
using the cobalt-uptake assay.   
Figure 3.10 The effect of the percentage of DMSO content in capsaicin on 
hTRPV1-mediated capsaicin responses assessed by the cobalt-
uptake assay 
Table 3.2 Protocols of cobalt-uptake assay to investigate the effect of 
capsazepine (Cpz) on capsaicin-evoked, and DMSO-evoked, 
cobalt-labelling. 
Table 3.3 Protocols of cobalt-uptake assay to investigate the effect of 
repeated applications of capsaicin and DMSO. 
 14 
 
Chapter 4. Constitutive and acid sensitivity of HEK293 cells 
Figure 4.1 Untransfected HEK293 cells constitutively express proton-
responding ion channels. 
Figure 4.2 Proton-evoked responses of hTRPV1-transfected HEK293 
cells in the absence, and presence, of amiloride. 
Figure 4.3 Proton concentration–response curve of hTRPV1-transfected 
HEK293 cells in the absence, and presence, of amiloride. 
Figure 4.4 Whole-cell patch-clamp recordings of hTRPV1-mediated 
responses to 10 µM capsaicin in the absence and presence of 
amiloride buffer. 
Figure 4.5 
 
Figure 4.6 
 
Figure 4.7 
Figure 4.8 
 
Concentration response curves of hTRPV1 to capsaicin in the 
absence and presence of 30 µM amiloride.  
Heat-evoked responses of hTRPV1-transfected cells in the 
absence, and presence, of amiloride (part I). 
Heat-evoked response of untransfected cell in standard buffer. 
Heat-evoked responses of hTRPV1-transfected cells in the 
absence, and presence, of amiloride part (II) 
  
 
Chapter 5. Naturally occurring polymorphism in human TRPV1 
gene alters the sensitivity of the ion channel 
 
Figure 5.1 Capsaicin-evoked responses of hTRPV1111-transfected, and 
hTRPV1222-transfected, HEK293 cells. 
Figure 5.2 Current-voltage relationship of 1 µM capsaicin-evoked 
current of hTRPV1111 and hTRPV1222 
Figure 5.3 Anandamide-evoked responses in hTRPV1111-transfected, and 
hTRPV1222-transfected, HEK293 cells. 
Figure 5.4 Proton-evoked responses of hTRPV1111-transfected and 
hTRPV1222-transfected, HEK293 cells. 
Figure 5.5 Current-voltage relationship of pH 5-evoked currents of 
hTRPV1111 and hTRPV1222. 
Figure 5.6 Heat-evoked responses of hTRPV1111-transfected and 
hTRPV1222-transfected, 
Figure 5.7 Current-voltage relationship of heat-evoked currents of 
hTRPV1111 and hTRPV1222. 
Figure 5.8 Voltage-evoked response of hTRPV1111-transfected, and 
hTRPV1222-transfected HEK293 cells using symmetrical Na+ 
concentrations (130 mM).  
Figure 5.9 Summary of reversal potential obtained from current-response 
curves of hTRPV1111-transfected and hTRPV1222-transfected, 
HEK293 cells evoked by various TRPV1 activators using 
normal extracellular and intracellular solution. 
Figure 5.10 Heat activation threshold of hTRPV1111 and hTRPV1222 at 
four different holding potentials. 
 
 15 
Figure 5.11 Heat responses of hTRPV1111, hTRPV1222, hTRPV1121, 
hTRPV1211 and hTRPV1112 
Figure 5.12 Voltage-dependent activation of hTRPV1111,  hTRPV1222, and 
hTRPV1121. 
Figure 5.13 Heat-activation threshold of hTRPV1111, hTRPV1222, hTRPV1 
121, hTRPV1121-S, and hTRPV1121-A. 
Figure 5.14 Amplitude of currents at 48
o
C of hTRPV1111, hTRPV1222, 
hTRPV1 121, hTRPV1121-S, and hTRPV1121-A 
Table 5.1 5 haplotypes of hTRPV1, where isoleucine (I), threonine (T) 
and valine (V) are substituted by a different amino acid within 
a specified position. 
Table 5.2 Summary of responses of hTRPV1111-transfected and 
hTRPV1222-transfected, HEK293 cells evoked by various 
TRPV1 activators. 
  
  
 
 16 
 
ABBREVIATIONS 
 
1-ANOVA One way analysis of variance  
Ag/AgCl Silver wire coated with silver-chloride  
AMPA Alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate 
ASIC Acid-Sensing Ion Channel  
ATP Adenosine triphosphate  
BK Bradykinin  
Ca
2+
 Calcium ions 
CaCl2 Calcium chloride 
CB1 Cannabinoid  1 
cDNA Complementary DNA 
CGRP Calcitonin Gene-Related peptide  
CNS Central nervous system 
Co
2+
 Cobalt ions 
CoCl2 Cobalt chloride 
DMSO Dimethyl  
DNA Deoxyribonucleic acid 
D-PBS Dulbecco's Phosphate Buffered Saline 
DRG Dorsal root ganglion 
EC50 Half maximal effective concentration 
ECACC European Collection of Cell Cultures 
EDTA Ethylenediaminetetraacetic acid-tetrasodium 
G6PD Glucose 6-phosphate dehydrogenase 
GAPDH Glyceraldehyde-3-phosphate dehydrogenase 
GDNF Glial cell derived neurotrophic factor 
GFP Green fluorescent protein 
HEK  Human Embryonic Kidney cells 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
hTRPV1 Human Transient Receptor Potential Vanilloid type 1 
IASP International Association for the Study of Pain 
KCl Potassium Chloride 
LSD Least significant difference 
MES 2-(N-Morpholino)ethanesulfonic acid sodium 
MgCl2 Magensium Chloride 
mRNA Messenger RNA 
NaCl, Sodium Chloride 
NADA N-arachidonoyl-dopamine  
NAEs N-acylethanolamines 
NGF Nerve growth factor 
NMDA N-methyl-D-aspartic acid 
OLDA N-oleoyldopamine 
OPRM1 mu-opioid receptor gene 
 17 
PBS Phosphate Buffered Saline 
PGE2 Prostaglandin E2 
pH0.5 Half-maximal pH 
PIP2 or 
PtdIns(4,5)P2 Phosphatidylinositol 4,5-Bisphosphate 
PKA cAMP-dependent protein kinase 
PKC Protein kinase C 
RT-PCR Reverse Transcription-Polymerase Chain Reaction 
rTRPV1 Rat transients Receptor Potential Vanilloid type 1 
RTX Resiniferatoxin 
SDM Site -Directed Mutagenesis 
SEM Stand Error of Mean 
SIC Stretch-inactivated channel 
SNP Single Nucleotide Polymorphism 
TM Transmembrane 
TRPA1 Transient receptor potential subtype A1 
TRPM8 Transient receptor potential cation channel, subfamily M, 
member 8    
TRPV1 Transients Receptor Potential Vanilloid type 1 
TRPV1VAR TRPV1 splice variant 
V1/2 Half activation potential 
VR.5‟sv TRPV1 5‟ splice variant 
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Twenty years from now you will be more disappointed by the things that you didn't 
do than by the ones you did do. So throw off the bowlines. Sail away from the safe 
harbour. Catch the trade winds in your sails. Explore. Dream. Discover. 
Mark Twain 
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Chapter 1 
 
THE CAPSAICIN RECEPTOR: FROM CHILLIES TO PAIN   
 20 
1.1  Introduction 
 
The capsaicin receptor, the transient receptor potential vanilloid type-1 
receptor (TRPV1), is a non-selective cationic channel (Caterina et al., 1997).  
TRPV1 is expressed by the great majority of nociceptive primary sensory neurons 
within the dorsal root, and trigeminal ganglia predominately in small diameter cells 
(Caterina et al., 1997; Tominaga et al., 1998). Intense TRPV1 immunoreactivity has 
also been observed in both the peripheral, and central, terminals of primary sensory 
neurons (Szallasi and Blumberg, 1999; Tominaga and Caterina, 2004). In addition to 
small diameter primary sensory neurons, TRPV1 is also expressed in neurons in 
various areas in the brain including the cortex, hypothalamus, and hippocampus 
(Starowicz et al., 2007; Cristino et al., 2006; Sasamura et al., 1998; Mezey et al., 
2000; Roberts et al., 2004). Non-neuronal tissues expressing TRPV1 include 
epithelial cells of the skin, urinary bladder, kidney and mast cells (Denda et al., 2001; 
Birder et al., 2002; Sanchez et al., 2001; Stander et al., 2004).  
 
TRPV1 belongs to a unique group of ion channels which can be activated by 
multiple stimuli. TRPV1 responds to at least 5 groups of activators which include: 
ligands, such as capsaicin, the pungent agent of chilli pepper; acidification; heat 
above 43ºC; post-translational modification, such as phosphorylation; and 
depolarisation (Caterina et al., 1997; Tominaga et al., 1998; Voets et al., 2004; 
Zygmunt et al., 1999). TRPV1 is regarded as a noxious heat transducer in primary 
sensory neurons because many of its activators, including capsaicin, heat above 43
o
C 
and protons, evoke a burning pain sensation when they activate TRPV1 expressed in 
these cells. TRPV1 is expressed in various neurons other than primary sensory 
neurons, as well in non-neuronal cells, which suggests that TRPV1 may be involved 
in a series of physiological and pathological processes. However, initiating, and 
maintaining pain sensation is still regarded as the main function of TRPV1. 
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1.1.1  Pain as a blessing and a burden 
 
The International Association for the Study of Pain (IASP: 1979), defines 
“pain” as an unpleasant sensory and emotional experience associated with actual, or 
potential, tissue damage, or described in terms of such damage. The pain experience 
develops in a process called nociception which exists in the entire animal kingdom. 
Nociception involves the processing of signals arising from the inner, or outer, 
environment of the organism and their interpretation by the nervous system as 
presenting a threat to the integrity of the tissues, and ultimately, the integrity of the 
whole organism. Nociception leads to the experience of pain in humans while 
animals exhibit “pain-related behaviour”. Nociception serves as a warning signal to 
the organism of an impending danger and, therefore, it is biologically beneficial and 
absolutely essential for survival. However, both in humans and in animals, 
nociception may sometimes have no biological function and may not serve as a 
survival tool. On the contrary, in those circumstances, it may ruin the quality of life. 
Thus, while pain with a biological function is called “physiological pain”, pain 
without that function is called “pathological pain”.  
 
Physiological pain develops in two circumstances: (1) when the thermal, 
mechanical, or chemical, characteristics of the environment change in a way which 
threatens the integrity of tissues; or (2) when changes in these characteristics results 
in actual tissue damage. While the first type of pain is called “acute pain” and can 
last for seconds, the second type is called “prolonged pain” and can last for days, or 
even weeks. On the one hand, the obvious function of acute pain is to generate a 
warning signal or a flight reaction, while, on the other hand, the function of 
prolonged pain is to promote healing through quiescence, by promoting avoidance of 
contact and use of the injured tissue. 
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Pathological pain or chronic pain is usually associated with injury which 
cannot heal. Such pain is found in rheumatoid arthritis, nerve injury, osteoarthritis or 
cancer-induced tissue damage. Pathological pain can also develop after successful 
healing of the original injury and may last for years. The IASP defines chronic pain 
as "pain which has persisted beyond normal tissue healing time", which is taken, in 
the absence of other criteria, to be three months. The great majority of prolonged and 
chronic, pain is associated with peripheral events and can be of either inflammatory, 
or neuropathic, origin. As the names imply, inflammatory pain is related with 
inflammation of tissues, while neuropathic pain is associated with physical, 
metabolic injury, or infection of neurons in the peripheral nervous system. In 
addition, chronic pain may also have a central (central nervous system) origin. 
 
1.1.2 Development of acute pain 
 
Acute pain develops as a consequence of activation of specialised molecules 
called transducers which are expressed by nociceptive primary sensory neurons. 
These transducers respond to changes in the thermal, mechanical and/or chemical 
characteristics of the environment which have the potential of damaging the integrity 
of the tissues. The known transducers, including TRPV1, are cationic channels. As a 
result of the effect of changes in the thermal, mechanical, and chemical, 
characteristics of the environment, the open probability of transducers is increased 
which results in depolarising inward currents due to the influx of cations.  These 
inward currents produce a generator potential which leads to the generation of action 
potentials, if and when the membrane depolarisation reaches the threshold for 
activation of voltage-sensitive sodium channels. The action potentials are propagated 
along thinly myelinated Aδ (conduction velocity within the range of 5-25 m/s), or 
unmyelinated C (conduction velocity within the range of 0.5-2 m/s), primary sensory 
fibers into the dorsal horn of the spinal cord. The action potentials induce the release 
of neurotransmitters, such as glutamate, from the spinal terminals of these 
nociceptive primary sensory neurons. Glutamate acts mainly on the ionotropic class 
of glutamate receptors to produce inward currents in secondary sensory neurons. The 
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receptor involved in this process is the alpha-amino-3-hydroxy-5-methyl-4-isoxazole 
propionate (AMPA) type of glutamate receptors. The current flowing through the 
AMPA receptor initiates action potential generation in the secondary sensory 
neurons, which have ascending axons. These axons project from laminae I and IV via 
the spinothalamic tract and the spinal lemniscal tract where they terminate at the 
ventral posterior nuclei of the thalamus and release transmitters to generate action 
potentials in tertiary sensory neurons (Warren et al., 2006). These tertiary sensory 
neurons project to the somatosensory cortex, where the information is processed and 
that processing results in the perception of acute pain sensation.  
 
1.1.3 Development of prolonged and chronic pain 
 
Prolonged, and chronic, pain develops in a „re-tuned‟ nervous system. This 
re-tuning is the result of plastic changes induced by pathological processes and 
includes so-called peripheral sensitisation and central sensitisation. These 
sensitisations result in an increased excitability of nociceptive neurons. In addition, 
sensitisation also induces the recruitment of otherwise silent nociceptive-specific 
neurons, some non-nociceptive neurons, and glial cells (Schmidt et al., 1995; Xu et 
al., 2000). Thus, prolonged and chronic pain is not a simple repetition of acute pain. 
Consequently, the prolonged, and chronic, pain experiences are qualitatively 
different from the acute pain experience. Since the great majority of prolonged, and 
chronic, pain has a peripheral origin, it is reasonable to assume that central 
sensitisation and the recruitment of silent nociceptive, non-nociceptive neurons, and 
glial cells in the central nervous system, are initiated and maintained by increased 
activity and excitability of primary sensory neurons (Woolf and Costigan, 1999).  
 
 Two major types of pathological pain sensations are experienced in 
prolonged, and chronic pain, namely: hyperalgesia where there is an increase in pain 
responses to noxious stimuli; and allodynia where pain responses are evoked by 
normally innoxious stimuli. The modalities of both hyperalgesia and allodynia may 
be either mechanical or thermal. Since the great majority of prolonged, and chronic, 
pain diseases have a peripheral origin, it is reasonable to assume that the transducers, 
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which result in the development of acute mechanical, or thermal, pain sensations, are 
also involved in the development of mechanical, and thermal, pathological pain 
sensations, respectively. Indeed, it has been shown, for example that TRPV1 -the 
acute activation of which results in burning pain sensation- is necessary for the 
development of heat hyperalgesia in certain pathological conditions (Davis et al., 
2000; Caterina et al., 2000) 
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1.2 Differences in pain perception 
 
The extent and nature of the pain experienced following noxious stimuli 
varies greatly between individuals. Human beings show large differences in their 
pain thresholds and individual tolerance to pain. Individuals also exhibit differences 
in their response to analgesic drugs and their susceptibility to clinical pain 
syndromes. Pain perception is a personal experience and is influenced by many 
factors, including cultural and social factors, and biological factors. These factors are 
able to interact, making pain perception a complex mechanism. Understanding the 
mechanisms that influence pain perception is especially important to comprehend the 
development of various types of pain and to develop novel analgesic regimes which 
are more efficacious then the currently available treatments.  
 
1.2.1  Cultural and social influences 
 
The extent to which the subjective experience of pain by individuals is 
affected by cultural and social influences has been the subject of considerable study 
in recent years. Cultural influences refer to values, beliefs and practices of a 
particular group which are learned and shared and which guide thinking and 
decisions of action in a given society (Chang et al., 2006). According to classical 
studies by Zborowski and Herzog (1952), each culture has its own language of 
distress which is expressed both verbally and non-verbally. For example, cultural 
attitudes of pain in childbearing women have been reported to affect perception, 
expression and treatment to pain (Callister et al., 2003; Cheung, 1994; Lee and 
Essoka, 1998). Higher pain ratings and more pain-like behaviours were seen in 
women living in the Middle East than women living in Western Europe. However 
there was no difference in coping style of labour pain (Weisenberg and Caspi, 1989). 
Moreover, labour pain perception was rated more highly by Anglo women, followed 
by East Indian women, next Hutterite (Amish or Mennonites) women and finally, 
among Ukraine women (Morse and Park., 1988)   
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 The religious orientation of an individual also influences pain perception 
(Low, 1997). In a chronic pain sufferer, religious belief can positively impact upon 
health, longevity and recovery from physical illness (Carone and Barone, 2001; 
Rippentrop et al., 2005).  
 
 
1.2.2   Biological factors 
 
 Biological factors can be subdivided into several categorises: sex and gender; 
psychological status; ethnicity; and genetically-defined factors. 
 
1.2.2.1   Sex and Gender 
 
The term „sex‟ relates to the biology and medicine of male and female, 
whereas the term „gender‟ is used in a social and cultural context (Diamond, 2002). 
While sex is primarily a biological fact, sex in the context of the gender role of a man 
or a woman in culture and in society is different. Gender role modelling is the 
process in which individuals are socialised into masculine and feminine models of 
behaviour (Moore et al., 2005). Furthermore, gender roles are based on a stereotype 
which refers to socially shared beliefs that sex determines certain qualities (Chang et 
al., 2006). These definitions of “sex” and “gender” are terms of art employed in the 
context of these studies.  
 
Gender differences in pain perception may arise from a variety of differences 
in cognitive and emotional ways of dealing with pain and in social or occupational 
roles (Miller and Newton, 2006). Females have lower pain thresholds, greater 
abilities to discriminate pain and are less tolerant to noxious stimuli than males 
(Feine et al., 1991; Lautenbacher and Rollman, 1993; Wise et al., 2002; Riley et al., 
1998). Women have also been shown to experience a variety of more recurrent pain 
then men (Unruh, 1996).  
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Sex differences in response to opoid analgesia in clinical and experimental 
findings have also been studied (Fillingim and Gear, 2002). In rodent studies, greater 
opioid analgesia was found in males when compared to females (Kest et al., 2000; 
Craft, 2003). This difference may be explained by genetic factors which control sex 
differences in antinociceptive responses in rodents (Barret et al., 2002; Mogil et al., 
2000). Conversely, human studies show that females exhibit greater opioid analgesic 
responses (Sarton et al., 2000; Dahan et al., 1998). Sex hormones and their respective 
receptors are widely disturbed in the central nervous system (CNS) and have been 
shown to modulate pain sensitivity (McEwen et al., 1998; Aloisi and Bonifazi, 
2006).  
 
Overall, there is a general consensus amongst scientists that sex and gender 
differences in pain warrant greater attention in pain research and in the development 
of analgesics. 
 
1.2.2.2    Psychological status 
 
 Pain perception can be greatly influenced by psychological aspects such as 
situational and emotional factors.  For example, major depression and impaired 
functional status has been recently shown to contribute independently to poorer 
quality of life in cancer patients (Wedding et al., 2008). Furthermore, emotional and 
social functioning were shown to predict depression, whereas, emotional and 
physical functioning were key predictors of anxiety (Lue et al., 2008).  
 
 Medical areas which use psychological assessment significantly aid in the 
diagnosis and treatment of patients suffering from psychiatric and neurological 
disturbances, circulatory diseases (especially hypertension), diabetes, chronic pain, 
sexual dysfunctions, and gastrointestinal problems (Granick, 1983) 
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1.2.2.3    Ethnicity  
  
 Several researchers have shown that ethnic differences influence the clinical 
appearance of pain experience (Riley et al., 2002; Rahim-Williams et al., 2007; 
Hastie et al., 2005). Including the severity of pain associated with medical conditions 
such as arthritis (Creamer et al., 1999), postoperative pain (Faucett et al., 1994), joint 
pain (Rantanen et al., 1998), and the treatment of conditions such as low back pain 
(Taylor et al., 2005). Ethnic differences have also been seen in the responses to 
multiple experimental pain stimuli. For example, African Americans show 
significantly higher ratings in intensity and unpleasantness for supra-threshold heat 
stimuli than Caucasians (Campbell et al., 2005). A recent study has shown that ethnic 
identity predicts experimental pain sensitivity across multiple noxious stimuli 
(Rahim-Williams et al., 2007). The difference in pain perception experienced by 
various ethnic groups indicates that genetic factors may play a major role in the 
development of pain. 
 
1.2.2.4    Genetically-defined factors 
 
 It is likely that environmental factors account for a substantial part of the 
variability in pain perception amongst individuals. However, Mogil and colleagues 
(1999) have shown significant strain differences in basal responses to all nociceptive 
assays in rodents.  This suggests that genetic factors are also likely to influence the 
perception of pain 
 
 Recently there has been a surge in research to elucidate the genetics of pain. 
This will undoubtedly assist in the development of analgesics for individuals. 
However, as there are thousands of genes which have been implicated in pain 
variability in humans, it is essential to prioritise candidate genes. 
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1.2.2.4.1    Polymorphisms 
 
 Naturally occurring mutations (polymorphisms) have also been shown to 
result in different experiences of pain among individuals. „Poly‟ means many. 
‟Morph‟ means form. Hence, „polymorphism‟ refers to a type of genetic variation, 
specifically a discontinuous variation, which occurs within species in which distinct 
forms exist in the same population. Polymorphisms are a result of the evolutionary 
process which are heritable and are adapted by natural selection. Polymorphic genes 
are genes that have different forms of the DNA sequence, which arise through 
mutations. These variants of genes are called alleles and a haplotype is a 
combination of alleles that are inherited together. Although most SNPs are found in 
all human populations, the allelic frequencies (a measure of the relative frequency of 
an allele in a population) differ among continents. 
 
 An example of a genetic polymorphism relevant to opiate sensitivity is the 
cytochrome P450 (CYP) enzyme. The analgesic effect of the opioid codeine depends 
on the metabolic activation by CYP 2D6 enzyme which is known to exhibit genetic 
polymorphisms. These polymorphisms result in allelic variants which may be 
classified on the basis of the level of activity of CYP 2D6 enzyme and, in turn, the 
production of active opioid (Wuttke et al., 2002; Weinshilboum et al., 2003; Evans et 
al., 2003; Bradford, 2002; Gaedigk et al., 2002; Wan et al., 2001). The allelic 
frequencies of CYP 2D6 enzyme varies among ethnic groups. Generally, for 
European Caucasians, the functional group of alleles is predominant, with a 
frequency of 71%. In Asians, functional alleles represent only ~ 50% of the 
frequency of CYP 2D6 alleles (Bradford, 2002). 
                               
 There are different types of genetic mutations, such as: (i) deletions where 
bases are removed; (ii) insertions, were bases are added; (iii) inversions, were a 
nucleotide sequence is reversed; and (iv) substitutions, were bases are replaced with 
another. Not all genetic mutations result in a change to the amino acid sequence of 
the protein. This is either due to the mutation occurring in the intron and is referred 
to as silent or neutral mutations. Or that the mutation appears in the exon but does 
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not alter the translation of the final amino acid sequence. This type of mutation may 
also be described as a silent mutation but more appropriately referred to as a 
synonymous substitution.  
 
It has been estimated that the human genome consist of more than 3 billion base 
pairs. About 99.9% of the human genome is identical in all individuals. Of the 0.1% 
difference between individuals, the most common source of genetic variation in the 
human genome is from single nucleotide polymorphisms (SNPs; pronounced 
„snips‟). A SNP is a single nucleotide substitution of one base for another and is 
usually observed in the general population at a frequency greater than 1%. A 
substitution which results in a codon (three nucleotides which codes for specific 
amino acid) to code for a different amino acid is referred to as missense SNP or 
nonsynonymous substitution. Furthermore, a missense SNP may or may not alter the 
protein function (Human Genome Project, 2008).  
 
An example of a missense SNP which alters the protein function is the A118G SNP 
of the human mu-opioid receptor gene (OPRM1), which occurs in in ~10-20% of the 
population, and is tightly linked with sensitivity to noxious pressure. Missense SNPs 
are usually abbreviated based on the amino acid and the amino acid position, i.e., in 
this particular example glycine is replaced with alanine at codon 118. Individuals 
with this allele variant have significantly higher pressure pain thresholds than those 
with the common allele at position 118 (Fillingim et al., 2005). Furthermore, the 
OPRM1 receptor is the primary site of action for opioids (morphine, heroin, 
methadone and endogenous beta-endorphin). Individuals with this allele show a 
response to opioids which is ~3-fold more potent than the response found in those 
with the common allelic form of the receptor (Bond et al., 1998). Consequently, 
addiction to opioids has also been linked to this rare allele, and it may contribute to 
vulnerability to opioid dependence (Szeto et al., 2001; Ide et al., 2004).  
 
 Polymorphisms can also affect individual‟s susceptibility to both dose-
dependent, and dose-independent, adverse drug reactions. For example, a deficiency 
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in the X-linked gene for glucose 6-phosphate dehydrogenase (G6PD) causes 
haemolysis in response to drugs taken for malaria (Martini et al., 1996).  
 
It is therefore essential that scientists should in the future design studies to further 
elucidate the role of genetic factors in relation to pain perception. Moreover, 
understanding the role of naturally occurring polymorphisms in pain-related genes 
may explain individual variability to pain. This may, in turn, aid in designing better, 
and more specific, analgesics for individuals. 
 
 As discussed above, the screening of genes for molecules which are involved 
in the development of various types of pain has identified several molecules. Some 
of these molecules, such as sodium channels, are involved in action potential 
generation. Others, such as various protein kinases and transcription factors, are 
involved in transcriptional, and post-translation, processes which underlie peripheral 
and central sensitisation. In addition to these molecules, transducers, including 
TRPV1, have been assumed to be the „driving force‟, responsible for the initiation 
and maintenance of sensitisation, and ultimately for the development of the pain 
experience.  
 
 Among the molecules which are regarded as constituting the “driving force”, 
the capsaicin receptor, TRPV1, seems to be one of the most important, because it 
occupies a strategic position in the pain pathways which are responsible for the 
development of pain experience of peripheral origin. TRPV1 is expressed by almost 
all primary sensory neurons which are responsible for the detection of acute noxious 
stimuli and which are sensitised during the development of prolonged and chronic 
pain sensation. Furthermore, studies of genetically engineered mice which are 
deficient in TRPV1 revealed that the development of inflammatory heat hyperalgesia 
depends on this receptor. While the TRPV1 knock-out animals failed to develop 
inflammatory heat hyperalgesia, they retained their ability to respond to acute 
noxious stimuli. Therefore, pharmaceutical companies continue to show great 
interest in TRPV1. 
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1.3  TRPV1 
 
1.3.1  Structure of TRPV1 
 
Caterina and colleagues cloned and identified the TRPV1 in rat (Caterina et 
al., 1997). The rat TRPV1 gene contains an open reading frame of 2,514 nucleotides 
that encodes a protein of 838 (human: 839) amino acids with a predicted relative 
molecular mass of 95,000. TRPV1 has six transmembrane domains with three 
ankyrin repeats present in the N-terminal region. Both the C- and N-terminals are 
located within the cell. The pore loop of TRPV1 is located at the intracellular side of 
the membrane between transmembrane (TM) domains 5 and 6.  
 
 
 
Figure 1.1  Membrane topology of TRPV1. (Taken from Caterina et al., 1997) 
 
 
Ankyrin repeat domains are thought to interact with cytosolic proteins 
(Clapham, 2003). Calmodulin, a calcium binding protein which is involved in 
regulation of channel function, is one such protein which has been shown to bind to 
the ankyrin repeats (Rosenbaum et al., 2004). Mutations in the ankyrin repeat region 
result in rapidly diminishing responses to ligands (Lishko et al. 2007). 
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The N-terminus of the TRPV1 does not exhibit a strong homophilic 
interaction and does not associate with other full-length TRPV1 subunits (Hellwig et 
al., 2005). However, studies on an N-terminal splice variant (VR.5‟sv) have shown 
the importance of this region in the formation of functional receptors because VR.5‟ 
lacks responses to typical TRPV1 stimuli (Schumacher et al., 2000). In addition to 
the possible role of the N-terminus in the formation of functional receptors, recent 
findings suggest that this region may be involved in defining the responsiveness of 
the molecule. Sharif Naeini and co-workers (2006) reported that an N-terminus 
variant of TRPV1 may gain osmosensitivity. Furthermore, Brauchi and colleagues‟ 
(2007) findings suggest that the heat sensor is located in the N-terminal region. The 
N-terminal has also been shown to bind the channel function modulator, calmodulin 
(Rosenbaum et al., 2004).  
 
The C-terminus displays homophilic interactions. Amino acids at position 
E684 and R721 are molecular determinants of the TRPV1 assembly into functional 
channels (Garcia-Sanz et al., 2004). Calmodulin has been shown to bind to this 
region, in a Ca2+-independent manner (Numazaki et al., 2003). Mutations in this 
region result in a Ca
2+
-dependent functional loss of responsiveness to capsaicin (Liu 
et al., 2004). Moreover, a reduced sensitivity to capsaicin, protons and heat responses 
was seen in TRPV1 receptors with a truncated C-terminus (Vlachova et al., 2003). 
 
1.3.2 TRPV1 multimeric structure  
 
The functional TPRV1 channel is a multimer both in dorsal root ganglion 
neurones and in heterologous expression systems, with a tetramer as the predominant 
form. In the tetramer, the TRPV1 monomers appear to assemble with fourfold-
symmetry around a central aqueous pore (Kedei et al., 2001; Kuzhikandathil et al., 
2001). TRPV1 channel subunits do not combine arbitrarily. On the contrary, they 
appear to predominantly assemble through an interaction of protein moieties located 
between transmembrane segments 1-6. Both cytosolic termini and transmembrane 
segments synergistically contribute to the overall affinity between TRPV1 channel 
subunits and control the selectivity of homo- and heteromeric assembly of the pore-
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forming subunits. Thus, inter-subunit interaction between TRPV1 subunits also 
involves the transmembrane portion of the protein. This is consistent with the fact 
that the hexahelical channel subunits that are flanking the pore probably come into 
close contact with their transmembrane segments 5 and 6 and also their pore loops to 
stabilise the closed pore conformation of the inactive channel complex or to maintain 
the selectivity filter upon gating (Hellwig et al., 2005). 
 
As a heteromer TRPV1, in addition to splice variants, could be assembled 
with other TRP molecules. For example, TRPV1 can form heteromer with the 
transient receptor potential vanilloid type 3 (TRPV3) that does not respond to 
capsaicin, but does respond to heat with a threshold of about 39ºC. TRPV3 is co-
expressed in dorsal root ganglion neurones with TPVR1. The association of TRPV1 
to TRPV3 may modulate the responses of the former, because of the different 
sensitivity of the molecules (Smith et al., 2002). Other members of the TRPV family 
may also form heteromers with TRPV1. Indeed Rutter et al. (2005) have reported 
that the high threshold heat-sensitive TRPV channel, TRPV2 may form heteromers 
in a small sub-population of primary sensory neurons. Cheng and colleagues (2007) 
have shown that TRPV1, TRPV2, TRPV3 and TRPV4 form heteromers when co-
transfected and that the responses of the heteromeric channels had properties 
“inherited” from the sub-units. However, others found that TRPV channels prefer to 
form homomers in transfection systems (Hellwig et al., 2005). Nevertheless, the 
probability that TRPV1 forms heteromers with sub-units which modify its responses 
may contribute to functional diversity (Nagy and Rang, 1999). 
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1.3.2a  TRPV1 splice variants 
 
 Several TRPV1 splice variants have been found since it was first cloned.  The 
function of the majority of these variants, remains unknown. Splice variants of the 
same genes are mainly expressed in the same tissue and may act as regulators of each 
other. Moreover, splice variants which lack an important region of the protein can 
function as dominant-negative molecules and inhibit the activity of the full-length 
protein. TRPV1 splice variants include: TRPV1b; the TRPV1 5‟ splice variant; the 
TRPV1VAR channel; and stretch-inactivated channel (SIC) TRPV1 channel. 
 
 The human receptor splice variant, hTRPV1b forms a functional ion channel 
that can be activated by heat (threshold ~ 47 
o
C) but not by capsaicin or protons (Lu 
et al., 2005). However, when rat TRPV1b is co-expressed with rat TRPV1 in 
transfected HEK293 cells, TRPV1b acts as an inhibitory modulator of TRPV1 (Vos 
et al., 2006). 
 
 The TRPV1 5‟ splice variant (VR.5‟sv) has been found to be predominantly 
expressed in the dorsal root ganglia. It is insensitive to noxious heat, capsaicin, the 
ultra potent vanilloid, resiniferatoxin, and protons (Schumacher et al., 2000; Sanchez 
et al., 2001). However, co-expression of VR.5‟sv with TRPV1 results in inhibitory 
modulation of TRPV1 (Eilers et al., 2007) 
 
 The human renal splice variant TRPV1VAR (Tian et al., 2006) has been shown 
to have the capacity to act as either a potentiator, or inhibitor, of rat TRPV1 activity, 
depending on the cell line used for expression. A potentiating effect is seen when 
TRPV1VAR is cotranfected with TRPV1 in HEK293 cells. However, when Cos-7 
epithelial cells are used, a dominant-negative effect is seen. Furthermore, when 
TRPV1VAR is transfected alone in these cells, no response was seen during the 
application of resiniferatoxin (Tian et al., 2006). The mechanism of TRPV1VAR 
inhibitory and potentiating effect on TRPV1 activity has not yet been elucidated.  
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 The SIC TRPV1 is a non-selective, cation, channel, also expressed in the 
kidney, and codes a 563 amino acid protein with the topology of a putative six 
transmembrane segments. The N-terminal sequence of SIC is essentially identical to 
TRPV1. However its C-terminal is similar to TRPV4 (Xue et al., 2001). SIC cannot 
be activated by any classical TRPV1 activators and its activation is blocked by 
mechanical stimuli (Suziki et al., 1999).  
 
 
 
1.3.3  TRPV1 activators 
 
TRPV1 can be activated by a number of endogenous, and exogenous, 
activators, including ligands, protons, heat, voltage, and post-translation 
modification.  
 
1.3.3.1    Vanilloids 
 
Capsaicin is one of the first known natural algogens and is the active 
compound in hot chilli peppers causing a burning pain sensation (Thresh, 1846). It 
belongs to the family of vanilloids, which is characterised by the presence of a 
vanilloid moiety (Nelson, 1919). Before the TRPV1 ion channel was given the name 
by which it is universally known today, it was referred to as the capsaicin receptor 
because capsaicin activates TRPV1 selectively.  
 
Other vanilloids such as resiniferatoxin (RTX), the ultrapotent capsaicin 
analog, derived from the cactus-like Euphorbia resinifera, are also able to activate 
the receptor (Szallasi et al., 1989; Szallasi and Blumberg, 1990a). Moreover RTX, is 
3-4 orders of magnitude more potent than capsaicin (Szallasi and Blumberg, 1990b) . 
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1.3.3.2    Anandamide 
 
A great number of endogenous compounds have been suggested to directly 
open TRPV1. These endogenous agents include: anandamide (Zygmunt et al. 1999); 
N-arachidonoyl-dopamine (NADA: Huang et al., 2002); N-oleoyldopamine (OLDA: 
Chu et al., 2003); lipoxygenase products, such as 12- and 15-(S)-HPETE (Hwang et 
al., 2000); and unsaturated C18 N-acylethanolamines (Movahead et al., 2005).  
 
 
In addition to activation of TRPV1, anandamide is also able to activate the 
CB1 receptor (Schuel et al., 1994; Di Marzo et al., 1994) and it is therefore of major 
interest. Anandamide belongs to a group of bioactive lipids, the long chain C18 N-
acylethanolamines (NAEs). Other members of this group are also able to activate and 
modulate TRPV1 activity (Movahead et al., 2005).  
 
The ability of anandamide to activate TRPV1 in normal physiological 
conditions is very limited. This is essential to prevent unnecessary activation of 
TRPV1 which would result in pain in absence of pain-inducing stimuli (Ross, 2003; 
van der Stelt and Di Marzo, 2004). However, in several pathological conditions, such 
as inflammation and when TRPV1 is activated by other stimuli, the anandamide-
evoked effect is potentiated (Olah et al., 2001; Di Marzo et al., 2002; Singh Tahim et 
al., 2005; Ahluwalia et al., 2003). Furthermore, anandamide-evoked activation of 
TRPV1 has been shown to contribute to the development of bladder hyperreflexia 
and hyperalgesia during cystitis (Dinis et al., 2004)    
 
1.3.3.3    Protons 
 
Protons are able to activate TRPV1 directly at pH below 6.5. In addition, 
proton binding to TRPV1 enhances the apparent binding affinity of capsaicin, and 
lowers the heat threshold for activation (Caterina et al., 1997; Jordt et al., 2000; 
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Tominaga and Julius, 2000; Baumann and Martenson, 2000). Apparently, capsaicin-
binding and protonation of the channel interact allosterically (Ryu et al., 2003).  
 
In addition to protons, excess positive charges carried by various ions seem 
also to be able to activate TRPV1. Ahern and colleagues (2005) showed that 
extracellular Na
+
, Mg
2+
, and Ca
2+
 can open the TPRV1 ion channel. Moreover, these 
extracellular cations can sensitise the ion channel to other activators.  
 
 
1.3.3.4    Heat 
 
Sensitivity to noxious heat is one the most distinctive features of TRPV1 
(Caterina et al., 1997). Heat contributes to TRPV1 activation in two distinct ways. 
First, heat reduces the threshold for the activation of TRPV1 by all other TRPV1 
activators. Second, heat above ~ 43 ºC independently activates TRPV1 (Tominaga et 
al., 1998). At temperatures < 43 ºC, channel openings are few and brief. However, 
raising the ambient temperature rapidly increases the frequency of channel openings 
(Liu et al., 2003). Other activators can reduce the threshold for activation by heat to 
below body temperature (<37 ºC) with the result that body temperature is sufficient 
to activate TRPV1 (Caterina et al., 1997; Jordt et al., 2000; Tominaga and Julius, 
2000; Baumann and Martenson, 2000). This provides an explanation of ongoing 
spontaneous pain. 
 
It has been suggested that the ultimate TRPV1 activator is heat, since protons, 
capsaicin, and indirect activators, such as bradykinin, all reduce the temperature 
threshold of the channel (Jordt et al., 2000; Babes et al., 2002; Sugiura et al., 2002).  
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1.3.3.5    Voltage-dependent activation 
 
 TRPV1 is a voltage-gated ion-channel (Gunthorpe et al., 2000; Voet et al., 
2004; Piper et al., 1998). TRPV1 is activated by depolarisation and changes in the 
temperature results in a graded shift of the receptors voltage-dependent activation 
curve. Hence, a tight link between temperature sensing and voltage-dependent gating 
has been suggested (Voets et al., 2004). However, voltage-dependent activation was 
recently shown to only partially activate TRPV1 (Matta and Ahern, 2007). 
 
1.3.3.6    Post-translational modification  
 
TRPV1 can be activated directly by vanilloids, heat, protons, and 
depolarisation. However, gating of this ion channel can also be evoked indirectly. 
The indirect activators include various inflammatory mediators, which are produced 
and released during inflammation in tissues (Julius and Basbaum, 2001). These 
inflammatory mediators, through activating their own target receptors, which are also 
expressed on nociceptive primary sensory neurons expressing TRPV1, induce 
activity in the neuron's intracellular second messenger system. That, in turn, results 
in post-translational modification of TRPV1. 
 
 Hydrolysis of phosphotidylinositol 4,5-bisphosphate (PtdIns(4,5)P2 or PIP2)  
in the cytoplasmic membrane, cAMP-dependent protein kinase (PKA) and protein 
kinase C (PKC) mediated phosphorylation of the capsaicin receptor, have each been 
shown to induce opening of TRPV1 (Chuang et al., 2001; Premkumer, 2001).  
 
Hydrolysis of PIP2 can be initiated by the activity of either trkA or 
bradykinin B2 receptors. Interestingly, while previous data show that PIP2 binding 
has inhibitory effect on TRPV1 (Chuang et al., 2001), recent data suggest that the 
effect of PIP2 hydrolysis/binding may depend on certain condition (Lukacs et al., 
2007). The PKC-mediated phosphorylation can be induced by activating the 
bradykinin B2 receptor (Chuang et al., 2001; Premkumar and Ahern, 2000: Vellani et 
 40 
al., 2001). Activation of prostaglandin E (PGE2) receptors induces PKA-mediated 
phosphorylation of TRPV1 (Mohapatra and Nau, 2003; Moriyama et al., 2005; 
Rukwied et al., 2007). Furthermore, treatment with PGE2, or activation of PKA, 
transiently sensitises capsaicin-activated currents (Lopshire and Nicol, 1998). 
Similarly, the anandamide-evoked response through TRPV1 is enhanced by PKA 
(De Petrocellis et al., 2001).  TrkA, bradykinin B2 and PGE2 receptors are all 
expressed on capsaicin-sensitive primary sensory neurons (Lee et al., 2002; Michael 
et al., 1999; Dray et al., 1988).  
 
 
1.3.4  Expression and distribution of TRPV1 
 
1.3.4.1   Expression by primary sensory neurons  
 
TRPV1 is predominantly expressed in a sub-population of nociceptive 
primary sensory neurons (Ahluwalia et al., 2000; Guo et al., 1999; Ichikawa and 
Sugimoto, 2004; Michael and Priestley, 1999). In peripheral tissues, TRPV1-
expressing sensory fibres can be found in the dermis, along the epidermal/dermal 
junction, epidermis, and also in Meissner‟s corpuscles (Guo et al., 1999; Pare et al., 
2001). In the viscera, TRPV1 immunopositive fibres are found in the mucous 
membrane, submucous, and muscular layer (Avelino et al., 2002; Ward et al., 2003). 
TRPV1-expressing fibres also innervate the Langerhans islands in the pancreas 
(Gram et al., 2007). The central terminals of TRPV1-expressing primary sensory 
neurons terminate primarily in the superficial dorsal horn of the spinal cord (Guo et 
al., 1999). However, some TRPV1-expressing fibres can also be found in the deep 
dorsal horn and around the central canal (Tominaga et al., 1998). 
 
1.3.4.2    Expression in the central nervous system 
 
Several neurons in the central nervous system also express TRPV1. The 
olfactory nuclei, cerebral and cerebellar cortex, thalamus, hypothalamus, lateral and 
dorsal septal nuclei, periaqueductal gray, locus coeruleus, substantia nigra, inferior 
olive, dentate gyrus, and hippocampus express TRPV1 (Starowicz et al., 2007; 
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Cristino et al., 2006; Sasamura et al., 1998; Mezey et al., 2000; Roberts et al., 2004). 
TRPV1 expressed in neurons of the thermoregulatory nucleus apparently respond to 
capsaicin as evidenced by the failure of thermoregulation in animals injected 
systemically with capsaicin, or when capsaicin is injected directly into the medial 
preoptic hypothalamic nucleus at neonatal age (Jancso-Gabor et al., 1970).  
 
1.3.4.3 Expression by non-neuronal cells 
 
Some non-neuronal cells have also been shown to express TRPV1, but the 
function of these ion channels generally remains unknown. TRPV1-expressing cells 
are found in the inner ear where they include inner and outer hair cells, inner and 
outer pillar cells, Hensen‟s cells, spiral ganglion neurons, Scarpa‟s ganglionic 
neurons and satellite cells (Balaban et al., 2003; Zheng et al., 2003; Takumida et al., 
2005). Both capsaicin and resiniferatoxin increase the threshold for auditory nerve 
compound action potential generation and reduce the magnitude of cochlear 
microphonic and electrically evoked oto-acoustic emissions suggesting that capsaicin 
receptors are functional in the inner ear (Zheng et al., 2003). A sub-population of 
keratinocytes also expresses TRPV1 which appear to be functional (Ioue et al., 2002; 
Southall et al., 2003).   
 
A sub-population, at least, of cultured rat gastric epithelial cells express 
TRPV1, but these ion channels are peculiar in that they are not desensitised or 
damaged by exposure to capsaicin (Kato et al., 2003). TRPV1 is also found in the 
basal and superficial layers of the urothelium. These cells are functional as they 
respond to capsaicin and resiniferatoxin application with a TRPV1-mediated increase 
in intracellular calcium concentration (Birder et al., 2001).  
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1.3.5  The role of TRPV1 in physiological and pathological conditions 
 
1.3.5.1    Pain 
 
TRPV1 is well established as a mediator of the pain sensation which results 
from inflammation. This was demonstrated in behavioural experiments by Davis and 
colleagues (2000) and Caterina and colleagues (2000) in which TRPV1 knock-mice 
appear normal in a wide range of behavioural tests, including responses to acute 
noxious thermal stimuli but lack the ability to develop thermal hyperalgesia after 
inflammation. Moreover, TRPV1 is required for inflammatory sensitisation to 
noxious thermal stimuli but not required for normal sensation of noxious heat (Davis 
et al., 2000).  
 
1.3.5.2     TRPV1 and inflammatory pain 
 
Tissue injury is normally associated with inflammation and inflammatory 
pain. Inflammatory pain is induced by inflammatory mediators released in the 
injured tissue, such as PGE2, nerve growth factor (NGF), and bradykinin, acting on 
nociceptors in peripheral nerve terminals. Another prominent chemical generated in 
injured tissue is protons which result in tissue acidosis.  
 
The development of hyperalgesia following inflammation involves an 
increased level of TRPV1 expression as well as the sensitisation of existing TRPV1 
channels (Tominaga, 2000). Inflammatory mediators, such as ATP, bradykinin, and 
NGF, increase the temperature and proton sensitivity of TRPV1 and contribute to 
enhanced TRPV1 activity (Kwak et al., 2000; Liu et al., 2005; Amaya et al., 2004; 
Zhang et al., 2005; Cesare et al., 1996; Chuang et al., 2001). Intracellular adenosine 
triphosphate (ATP) sensitises TRPV1, although there is controversy about whether it 
is through a direct interaction (Kwak et al., 2000) or, indirectly, through PIP2 
synthesis (Liu et al., 2005). 
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Levels of both NGF and glial cell derived neurotrophic factor (GDNF) 
increase following inflammation and contribute to inflammatory hyperalgesia via an 
increase in TRPV1 expression (Amaya et al., 2004). Chuang and colleagues (2001) 
injected wild-type and TRPV1 knock-mice with bradykinin or NGF and measured 
paw withdrawal latencies from a radiant heat source before, and after, treatment. 
Each agent produced substantial sensitisation in wild-type animals but not in the 
knockout mice, demonstrating that TRPV1 is essential for the development of 
bradykinin-induced, or NGF-induced, thermal hypersensitivity in vivo.  
 
1.3.5.3 TRPV1 and neuropathic pain 
 
Although the role of TRPV1 in mediating inflammatory pain conditions is 
well-established, the extent of the involvement of TRPV1 in neuropathic pain 
conditions remains unknown. There is, however, evidence that, in relation to 
neuropathic pain, the contribution made by TRPV1 depends on the context of origin 
of the neuropathic pain condition and, perhaps, even on the species of animal.  
 
Caterina and colleagues (2000) found that in a model of partial spinal nerve 
ligation, there was no difference between the level of mechanical and thermal 
nociceptive responses of TRPV1 knock-mice as opposed to wild-type mice. On the 
other hand, after nerve injury a distinct difference in the regulation of TRPV1 
expression is observed (Hudson et al., 2002; Fukuoka et al., 2002; Kanai et al., 
2005). After sciatic nerve ligation and intrathecal application of capsazepine, a 
TRPV1 antagonist, blocks A-delta fibre-evoked responses in the dorsal horn 
neurones of rats (Kelly et al., 2002).  
 
There is also evidence that the contribution made by TRPV1 to neuropathic 
pain conditions may even be species dependent. Capsazepine reverses mechanical 
hyperalgesia in a guinea pig model of partial sciatic nerve ligation, but has no effect 
in either rat or mouse models of neuropathic pain (Walker et al., 2003). Recently, 
Christoph and colleagues (2007) reported that in an in vivo rat model of spinal nerve 
ligation, both intravenous application of the TRPV1 antagonist, thioxo-BCTC, and 
 44 
intrathecal administration of the antisense oligonucleotide against TRPV1, reduce 
mechanical hypersensitivity in a similar manner, proving the involvement of TRPV1 
in such neuropathic pain conditions in rat (Christoph et al., 2007).  
 
1.3.5.4 Visceral hyper-reflexia and pain 
 
Capsaicin-sensitive sensory fibres are known to have a role in the micturition 
reflex, because capsaicin instillation first induces contraction, then desensitisation of 
the urinary bladder (Maggi et al., 1984; Holzer-Petshe and Lembeck; Cheng et al., 
1999). Moreover, capsaicin instillation also evokes the expression of the early gene, 
c-Fos in the dorsal spinal cord, which indicates that nociceptive input reaches second 
order neurons (Wang and Hassouna, 2000). Recently, Charrua and colleagues (2007) 
demonstrated that TRPV1 is responsible for both the pain sensation associated with 
overfilled bladder and the hyper-reflexia associated with inflammation, because 
bladder distension-evoked spinal c-Fos, expression, and inflammation-evoked hyper-
reflexia failed to occur in TRPV1 knock-out mice. However, the extent of the 
contribution from TRPV1 which is expressed by bladder afferents and by TRPV1 
expressed by urothelial cells, to the development of pain and hyper-reflexia, remains 
to be established. 
 
1.3.5.5 Diabetes 
 
One of the most unexpected putative roles for TRPV1 has been suggested to 
be in diabetes. Razavi and co-workers (2006) have reported that TRPV1-expressing 
nerve fibres invade the Langerhans islets in the pancreas. Furthermore, TRPV1 in 
non-obese diabetic mice, a model for type 1 diabetes, shows polymorphism (P322A 
and D734E), which results in reduced sensitivity of the molecule to capsaicin. Razavi 
and colleagues argue that there is a negative feed-back between TRPV1-expressing 
primary sensory terminals and beta-cells, in which insulin, by increasing the activity 
of TRPV1 induces the release of neuropeptides, such as substance P and calcitonin 
gene related peptide (CGRP), which inhibit insulin secretion. Once this regulatory 
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mechanism is unbalanced due to reduced TRPV1 responsiveness, the anti-
inflammatory effect of SP is diminished and insulinitis develops. 
 
 Gram and colleagues (2007) have reported recently that systemic injection of 
capsaicin prevents the development of hyperglycaemia and reduced insulin secretion 
in Zucker Diabetic Fatty rats, which are regarded as a model of human type 2 
diabetes mellitus in certain aspects. The preventive effects of systemic capsaicin 
injection were accompanied by complete loss of CGRP-, and TRPV1-coexpressing 
islet-innervating fibers. The authors hypothesise that enhanced release of CGRP that 
reduces insulin secretion from β cells (Kozlova and Jansson, 2005) from sensitised 
TRPV1-expressing peptidegic fibres innervating the islets, reduces insulin secretion. 
The sensitisation could be produced by increased release of inflammatory cytokines 
from the enhanced amount of adipose tissues (Sopasakis et al., 2005), and/or 
hyperglycaemia-induced NGF release from the beta cells. Whether TRPV1 itself has 
any role in the putative enhanced activity of the islet-innervating fibres awaits 
elucidation.  
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1.3.6  TRPV1 polymorphisms 
  
 The human TRPV1 (hTRPV1) ion channel expresses several naturally 
occurring polymorphisms. I315M and V585I are missense SNPs which result in a 
change in the amino acid coded (Hayes et al., 2000: Kim et al., 2004). Similar non-
synonymous SNPs are found in hTRPV1 at: P91S, I315M, T469I, T505A and V585I 
(Xu et al., 2007). The I315M and P91S variants elicit a greater response to capsaicin 
than wild-type hTRPV1 receptors (Xu et al., 2007).  In addition to these human 
TRPV1 SNPs, rat TRPV1 also show polymorphisms. Recently, two SNPs in the rat 
TRPV1 have been identified (Razavi et al., 2007). P322A and D734E SNPs have 
been found in non-obese diabetic mice and these have been shown to underlie the 
development of insulinitis in these animals (Razavi et al., 2007).  
 
 There are many projects involved in identifying SNPs. In 1999, the SNP 
Consortium (TSC) was established to identify as many individual SNPs in the human 
genome. Within two years of collaborative efforts of several companies and 
academic institutions of TSC, ~1.4 million SNPs were published, which exceeded 
their initial goal of 300,000 SNPs (Sachidanandam et al., 2001). 
 
 Dr John Davis and colleagues, at GlaxoSmithKline, have also investigated 
polymorphisms in TRPV1 on the assumption that mutations in this receptor may 
result in altered pain sensitivity in humans. For this purpose, these investigators 
assessed the genetic variations within 94 human DNA samples (62 Caucasians, 16 
Asians and 16 African Americans) using double stranded sequencing. 
 
In order to identify SNP in hTRPV1 from these human DNA samples, 
oligonucleotide specific primers had to be design to anneal with the flanking 
sequences of the gene. Primers were designed on the genomic accession number of 
hTRPV1 (AJ272063, AF168787, AC027796 and AC027040), to scan all the coding 
sequences of the 15 exons for naturally occurring variations in the DNA sequence.  
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The hTRPV1 contained about 100 bp of intronic sequence flanking each exon: from 
0 kb of the promoter sequence to 0.6 kb sequence beyond the stop codon. A total of 
20 fragments of ~ 500 bp of each sequence were screened. In total 10 kb was 
screened.  
 
As a result of this analysis, a total of 48 SNPs within the hTRPV1 gene were 
observed. Although non-coding SNPs may be involved or effect important 
mechanisms such as transcription, translation and splicing, coding SNPs are easier to 
study and are potentially more damaging (Werner, 2003). Davis and colleagues 
showed that 14 SNPs originated from the coding regions of the gene, of which only 7 
were found to be missense SNPs (a change in the amino acid coded) (table.1.1). The 
7 missense SNPs identified are as follows (see Fig 1.1): two SNPs in exon 2 were 
located at the N-terminus of the protein, hTRPV1Q85R and hTRPV1P91S. hTRPV1I315M 
is encoded by a codon located on exon 6 and localised in the region of the ankyrin 
repeat domains. hTRPV1T469I is encoded by a codon found on exon 9 and is situated 
on the extracellular loop between TM1 and TM2. hTRPV1T505A is encoded by a 
codon found on exon 10 and is localised on the intracellular loop between 
transmembrane 1 and 2. hTRPV1V585I and  hTRPV1N738Y are encoded by codons 
located on exon 12 and exon 14, respectively, and localised on TM5 and the C-
terminus of the receptor, respectively. However, due to the small sample size, the 
observed frequencies are not representative of those that one might expect to find in 
the population as a whole. SNPs occurring in the population at a minor allele 
frequency of less than 20% are not likely to be represented. Only three non-
synonymous SNP mutations were found in Caucasians and African Americans to 
produce a frequency of more than 20% which indicates that these SNPs are major 
alleles. The three most frequently occurring missense SNPs in hTRPV1 in 
Caucasians and African Americans were found to be: I315M (hTRPV1211); T469I 
(hTRPV1121); and V585I (hTRPV1112).  
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Table 1.1 Seven missense SNPs found in hTRPV1 by Davis and colleagues (unpublished data). Data were obtained from a sample of 98 
humans made up of 62 Caucasians, 16 Asians and 16 African Americans. Bold prints represent the most frequently occurring missense 
SNPs in hTRPV1. 
1
 Due to small sample sizes, the observed frequencies are not representative of those which one would expect to find 
in the population as a whole. SNPs occurring in the population at a minor allele frequency of less than 20% are not likely to be 
represented in the population. *Appears as a major allele frequency in this population as it is more than 20% and is likely to be present 
in the population. 
2
 The 16 Asians were made up of 8 Japanese and 8 Chinese. (Db)- database SNP verified by GlaxoSmithKline 
sequencing. Number in brackets represents the number of samples with that particular mutation, out of the total sampled population. For 
example, I315M SNP has a allele frequency of 0.28, which represent 17.4 samples out of the 62 total Caucasians population.  
Gene 
Region 
Base 
Change Position 
Amino acid 
Change 
 
Minor allele freq. in 
62 Caucasians  
 
Minor allele freq. in 16 
African Americans
1
 
 
Minor allele freq. in 
16 Asians
1,2
 
          
Exon 2 A > G 254 bp Q85R 0.04  0 0.03 
Exon 2 (Db) C > T 271 bp P91S 0.06 0.19 0.03 
Exon 6 (Db) C > G 945 bp I315M 0.28* (17.4) 0.53* (8.5) 0.16  (2.6) 
Exon 9 (Db) C > T 1406 bp T469I 0.43* (26.6) 0.66* (10.6) 0.19  (3.0 
Exon 10 A > G 1513 bp T505A 0.01 0 0 
Exon 12 G > A 1753 bp V585I 0.31* (19.2) 0.59* (9.4) 0.19  (3.0) 
Exon 14 G > T 2212 bp N738Y 0.01 0 0 
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Figure 1.2 Membrane topology and approximate location of the 7 missense SNP‟s 
found in hTRPV1 receptor. Key: (A) Alanine; (I) Isoleucine;  (M) Methionine; (N) 
Asparagine; (P) Proline; (Q) Glutamate; (R) Arginine; (S) Serine; (T) Threonine; (V) 
Valine; (Y) Tyrosine; (O) Outer plasma membrane; and (I) inner plasma membrane. 
Amino acid position of the SNPs in relation to ion channel membrane also shown. 
The amino acids are arranged in 6 transmembrane domains (cylinders) which are 
linked by intra- and extra-cytosolic loops with an additional short hydrophobic loop 
which connects the 5
th
 and 6
th
 transmembrane domains. Both the N- and C-terminals 
of TRPV1 are intracellular. The N-terminal is rich in proline and has three ankyrin 
repeat domains (ovals). * represent the most frequently occurring polymorphs in 
hTRPV1. 
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Several polymorphisms were found while cloning the hTRPV1 receptor. 
Davis and colleagues accordingly searched for hTRPV1 missense SNPs in three 
ethnic groups (Caucasians, African-Americans, and Asians) to investigate whether 
the ethnic differences in heat-sensitivity in these groups were due to mutations in 
their TRPV1. In total, only three non-synonymous SNPs in the hTRPV1 gene in 
Caucasians and African Americans were found to produce a frequency of more than 
20%. Five clones were made; three clones contained single missense SNPs (see table 
5.1). These were hTRPV1211 (I315M), hTRPV1121 (T469I) and hTRPV1112 (V585I). 
Clone hTRPV1111 (I315/T469/V585) represented “wild-type”, whereas hTRPV1222 
(I315M/T469I/ V585I) had the combination of all three missense SNPs of hTRPV1 
in one clone.  
  
 To ascertain whether these mutations produce any functional differences, 
whole-cell patch-clamp recordings were done during application of each of 
capsaicin, anandamide, protons and heat, and voltage-dependent activation. 
hTRPV1111 and hTRPV1222 were chosen for the first comparison because any 
differences in the responses, it would be apparent in these two haplotypes, because 
they show the greatest genetic variability. 
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Amino Acid 
Code name. 
Position  
315 
Position  
469 
Position  
585 
hTRPV1111  I T V 
hTRPV1211 M T V 
hTRPV1121 I I V 
hTRPV1112 I T I 
hTRPV1222 M I I 
 
Table 1.2 Five haplotypes of hTRPV1, where isoleucine (I), threonine (T) and 
valine (V) are substituted by a different amino acid within a specified position. 
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1.4 Aims and objectives 
 
1.4.1 Hypothesis 
Missense single nucleotide polymorphisms (SNPs) in the human noxious heat 
transducer and transient receptor potential vanilloid type 1 (TRPV1) ion channel are 
associated with differences in the sensitivity of this ion channel to several of its 
activators. 
 
1.4.2 Aim 
To study the responses of the human TRPV1 polymorphs which appear as major 
alleles to various TRPV1 activators. 
 
1.4.3  Objectives 
1. To compare the responses of wild-type hTRPV1111 and hTRPV1222 (I315M, 
T469I and V585I mutations) to: capsaicin; anandamide; heat; protons and 
voltage-dependent activation, respectively. 
2. To identify the SNP, or SNPs, which are responsible for altered sensitivity of 
hTRPV1222 when compared to the responses of hTRPV1111. 
3. To study the effect of altering the polarity of the amino acids in the positions 
which are likely to be involved in mediating the differences in responses of 
hTRPV1111 and hTRPV1222 to heat-evoked, and voltage-dependent, 
activation, respectively. 
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Chapter 2 
 
EXPERIMENTAL TECHNIQUES  
AND PROTOCOLS 
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Introduction 
 
     The experimental work required for this PhD project was based on various 
techniques in molecular biology, extending over the areas of: cell culture; agonist-
activated cobalt uptake and imaging; electrophysiology; and the use of transgenic 
animals. Here, the theoretical basis of these techniques is described, as are the 
protocols which were employed. 
 
2.1 Cell culture  
 
 Cell culture is a technique used when cells are grown under controlled 
conditions. Several different types of cell cultures are routinely performed and can be 
divided into two groups: primary cell culture and secondary cell culture. 
 
 Primary cell cultures can consist of the culture of a complex organ or tissue 
slice or a defined mixture of cells or highly purified cells isolated directly from the 
organism. I have used dorsal root ganglia neurons harvested from mice to investigate 
the effect of DMSO in TRPV1-expressing cells. The isolation of a specific 
population, or populations, of cells requires several biochemical procedures. The 
required cells must be dissociated from their parent tissues and from other cell types. 
Disruption of the extracellular matrix and intercellular junctions that hold the cells 
together is typically achieved by the use of proteolytic enzymes, such as trypsin and 
collagenase, or with agents, such as EDTA, that bind, or chelate, the Ca
2+
 on which 
cell-to-cell adhesion depends. Large cells can be separated from small cells, and 
dense cells from light cells, by centrifugation (Alberts et al., 2002). Primary cell 
culture has an advantage in that they closely resemble the function of that cell in 
vivo. However, such cultures suffer from several drawbacks, most notably, the 
damage which the cells sustain while being harvested and the effect on their normal 
functioning of their being dissociated from the other tissues with which interact in 
vivo (Mather and Roberts, 1998). 
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 Secondary cell cultures are cultures of established or immortal cell lines. 
Secondary cell cultures describe the cultures obtained from propagating cells derived 
from tumours (e.g. Hela) or from cells transformed in vitro or from normal 
embryonic tissue. Secondary cell cultures use propagation techniques, in which cells 
are propagated in vitro for experimental use, such as to express exogenous ion 
channel proteins.  I have used a human embryonic kidney (HEK293) cell line to 
exogenously express various hTRPV1 haplotypes to investigate their response to 
various activators.  
 
The fundamental aspect of secondary cell culture technique is the process of growing 
cells in a confluent monolayer by providing them with anchorage to pass “start” in 
their cell cycle. Dissociated cells plated on a dish in the presence of appropriate 
media adhere to the surface, spread out, and divide until a confluent monolayer is 
formed in which each cell is attached to the dish and contacts its neighbours on all 
sides. Cells grown in vitro also generally exhibit “anchorage dependence of cell 
division” meaning that they require to be able to adhere to the underlying plate 
surface in order to divide. A suitable surface to which propagating cells may adhere 
is constituted by the plastic surface of the culture-dish or T75 flask. 
 
When cells from normal mammalian tissues are cultured in standard conditions, their 
ability to propagate is confined to a limited number of division cycles – about 50 for 
typical cells derived from humans. After this, they cease dividing in the process 
described as “cell senescence”. Some cells are capable of avoiding cell senescence to 
divide indefinitely as “cell lines.” These cells have undergone a genetic change that 
makes them effectively immortal. They will proliferate indefinitely in appropriate 
conditions and can be propagated as a cell line. Normal cells may similarly be 
“transformed” to constitute “transformed cell lines” by using a chemical or virus to 
alter their genetic make-up. The genetic uniformity of a cell line can be improved by 
cell cloning, in which a single cell is isolated and allowed to proliferate to form a 
large clone. A “clone” is any such collection of cells that are all descendants of a 
single ancestor. Such clones offer standardised cells which are ideal for comparative 
purposes over many experiments (Alberts et al., 2002).  
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The major advantages of these cloned cells reside in the efficiency with which they 
may be produced when compared with primary cultures and the consistency and 
reproducibility of the results which can be obtained from their use. The main 
disadvantage associated with the use of these cells is that these cells are atypical and 
their responses are not indicative of those of any other cell type. Moreover, after 
repeated passaging their characteristics may change and become quite different from 
those found in the starting population. 
 
Most kinds of animal cells are able to survive, proliferate, and even express 
differentiated properties in a tissue culture dish in appropriate conditions. Cells 
require a suitable environment and a medium which contains the necessary nutrients 
to sustain cell life, as well as various other factors, such as growth factors, which 
stimulate cell proliferation, and transferrin, which carries iron into cells. These 
nutrients and other factors were traditionally supplied by constituting a medium 
comprising specified quantities of small molecules such as salts, glucose, amino 
acids, and vitamins, together with a poorly defined mixture of macromolecules in the 
form of animal serum such foetal bovine serum (Alberts et al., 2002). It must also be 
emphasised that the growth of cells in culture requires a sterile and controlled 
environment, especially in terms of temperature, oxygen and carbon dioxide. 
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2.1.1. Cell culture of DRG neurons 
 
2.1.1.1 Theory of DRG neurons in culture 
 
 Different kinds of neurons from the peripheral and central nervous system of 
various kinds of animals have been cultured. These primary neuronal cultures have 
been used to investigate various molecules involved in the function of neurons. The 
selection of a particular type of neuron for culture depends on the purpose of the 
study. In this study, adult mice DRG neurons were chosen because TRPV1 is highly 
expressed in a population of primary sensory neurons (Caterina et al., 1997; 
Ahluwalia et al., 2000; Guo et al., 1999; Ichikawa and Sugimoto, 2004; Michael and 
Priestley, 1999).    
 
Although the term nociceptor is now commomly used to describe nociceptive 
primary sensory neurons, traditionally it refers to the peripheral terminals 
of nociceptive A-delta and C afferents. These terminals express receptors for 
detecting potentially tissue damaging physical and chemical stimuli. However, it is 
impossible to record ionic currents from these terminals as they are too small (1 µm) 
for microelectrode penetration (Passmore, 2004). It is also difficult to control in vivo 
experiments as these do not allow for controlled application of chemical stimuli 
(Kress and Reeh, 1996; Gold et al., 1996). A more practical approach is to identify 
cell bodies of nociceptive neurons (perikarya), which are found in the DRG, under 
the assumption that the somatic membranes of the DRGs are also expressed at the 
nerve terminal at both ends. Furthermore, it is also assumed that the perikarya in 
vitro express all the molecules which are expressed in vivo. 
 
The perikarya of primary sensory neurons are located in the spinal ganglia in the 
vertebral canal before the nerve reaches the spinal cord and are readily dissectible. 
Dissected neurons can be dissociated into single cell suspensions, plated on glass 
coverslips and maintained in culture. Dissociation and culturing of neurons involve 
axotomy close to the cell body. Hence, therefore the predominant phenotype of 
cultured primary neurons is one of regeneration and inflammation. Studies show that 
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following injury, primary sensory neurons become hyperexcitable due to the 
resulting change in the expression of receptors and the release of inflammatory 
mediators (Dickenson, 1995; Millan, 1999, D‟Mello and Dickenson, 2008). In 
addition, DRG neurons in culture express antinociceptive neuropeptide Y, to the 
same extent as axotomised DRG in vivo (Kerekes et al., 2000).  
 
Despite this, it has been shown that there is no significant difference in the 
distribution of cell size or neurochemistry of cells from L4/L5 ganglia in vivo and in 
culture (McMahon et al., 1994; Gavazzi et al., 1999). In addition, many sensory 
neurons in culture are excited by low concentrations of capsaicin and bradykinin, 
sensitised by prostaglandin E2 and display substance P-like immunoreactivity, each 
being a characteristic property of nociceptive neurons in vivo (Baccaglini and Hogan, 
1983; Gold et al., 1996a).  
 
Capsaicin selectively stimulates nociceptors, and sensitises nociceptors. Capsaicin 
selectively activates and sensitises TRPV1 leading to excitation of primary sensory 
neurons expressing TRPV1 (Bevan and Yeats, 1991; Oh et al., 1996; Vlachova´ and 
Vyklicky; 1993). Inflammatory mediators such as ATP and bradykinin greatly 
potentiate TRPV1-mediated responses (Dai Y et al., 2004, Tominaga et al., 2001; 
Sugiura et al., 2002; Steen et al., 1995a, 1996; Kress et al., 1992).  Subsequent 
studies have shown that sensory neurons in culture share other similarities with in 
vivo models. Nociceptive neurons are small diameter neurons both in vivo and in 
vitro (McCarthy & Lawson, 1989, McCarthy & Lawson, 1990; Harper and Lawson, 
1985).  
 
Survival and maintenance of the phenotype of cultured DRG neurons requires the 
addition of nerve growth factor (NGF) to the growth medium. The neurotrophin NGF 
is a molecule that promotes the survival and differentiation of sensory and 
sympathetic neurons. NGF has an important influence on the morphological and 
functional properties of neurons, both in vitro and in vivo.  Whilst DRG cell cultures 
can survive for few days in the absence of NGF, long term survival can be achieved 
only with regular treatment of NGF as it promotes the formation of neuronal 
processes (Levi-Montalcini, 1964; Otten et al., 1983). NGF has been shown to 
59 
increase the number of TRPV1-positive neurons in culture and TRPV1 mRNA and 
protein expression (Anand et al., 2006; Puntambekar et al., 2005; Winston et al., 
2001).  In the absence of NGF, cultured DRG neurons lose their responsiveness to 
capsaicin and proton application (Bevan and Winter, 1995; Winter et al., 1988).  
 
The concentration of NGF used by most laboratories is 50 ng ml−1, which has been 
optimized for ganglion root culture (Levi-Montalcini & Angeletti, 1963). However, 
although, concentrations even up to 200 ng ml
−1 
have also been used to investigate 
changes in cultured DRG neurons responses (Winter, 1988). These concentrations 
are largely in excess of that which is typically present in the extracellular fluid of 
young rats (about 0.6 ng ml−1; Xia et al., 2000),  and thus they more closely 
correspond to the substantial increases in local NGF levels typically found during 
tissue inflammation and injury (Ueda et al., 2002). Thus, even though the level of 
NGF is higher than that found in vivo, the data obtained from these experiments are 
comparative to those in vitro.  
 
The primary advantage of cultured DRG neurons is that they facilitate experimental 
design and enable controlled environment to be established for drug applications as 
well as efficient wash-out system. This allows accurate pharmacological 
characterisation of nociceptors. Furthermore, experimental variations are reduced 
which assists in experimental replication as environmental influences (e.g. 
temperature, CO2 content) and the condition of the animal (e.g. hormones, illness and 
nutrition) are irrelevant (Polikov et al., 2007). In addition, there is an abundance of 
DRG neurons in a rodent. There are 34 pairs of spinal nerves, each attached to its 
own DRG.  
 
The most serious limitation on the use of acutely dissociated DRG cultures is that 
they lack systemic input from the peripheral system and that these cell receptors and 
other mechanism may not identical to those cells in vivo. Several studies have 
demonstrated a redistribution of channels and receptors in cultured DRG neurons not 
normally found in intact DRG. (Baccaglini and Hogan, 1983; Cesare and 
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McNaughton, 1997). Thus, while cultured primary sensory neurons are convenient 
and cost effective, they can not replace in vivo animal studies.  
 
 
 
2.1.1.2 Culturing DRG neurons 
 
 
I employed DRG cultures prepared from wild-type and TRPV1 knock-out 
adult mice to assess whether DMSO is able to activate native TRPV1 cells (see 
Chapter Four).   
 
 Three wild-type C57BL6/J mice and three knock-out TRPV1 C57BL6/J mice 
were terminally anaesthetised with an overdose of isoflurane according to the UK 
Home Office Animal Licensing Laws. Surgical instruments such as forceps, scissors 
and dissection knives were washed in soap and rinsed in ddH20, before being 
sprayed with 70% ethanol. Following decapitation, the entire spinal cord was 
dissected removing as much tissue as possible and pinned to a dissecting board with 
the dorsal surface facing upwards.  
 
Using a microscope, two longitudinal cuts were made on each side of the spinous 
process of the vertebra, making it possible to remove the dorsal strip from the spinal 
column, revealing the meninges which envelop and protect the spinal cord. The 
meninges consist of three thin layers of tissues: the dura mater, the arachnoid mater 
and the pia mater (Fig 2.1). 
 
 The dura mater and the arachnoid layers where then carefully removed to expose the 
spinal cord and the DRG with their attached spinal nerves, dorsal and ventral roots. 
The DRG neurons from the first cervical to the first sacral spinal segments on both 
sides were carefully dissected out, using a fine pair of tweezers and a pair of 
microsurgery scissors, under aseptic conditions and collected in a petri dish 
containing growth medium (Fig. 2.2). 
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Figure 2.1. Cross-section of the spinal cord and surrounding structures. Each spinal 
nerve is formed by dorsal (sensory) and ventral (motor) roots which merge with the 
spinal cord. The dorsal root is a bundle of sensory axons which carries impulses into 
the spinal cord via a DRG, a small node that contains a collection of cell bodies of 
the sensory neurons. (Figure taken and adapted from Wingėrd and Stein, 1988) 
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Figure 2.2. The spinal segments of a mouse. There are 34 pairs of spinal nerves that 
are separated into five regions from which they arise: 8 cervical (C1-8), 13 thoracic 
(T1-13), 6 lumber (L1-6), 4 sacral (S1-4) and 3 caudal. (Figure taken and adapted 
from Winger, 1988) 
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The growth medium which I used contained: Ham‟s Nutrient Mixture F12 (Sigma) 
supplemented with 1 mM L-glutamine (Invitrogen), antibiotics (50 units/ml 
penicillin and 5 µg/ml streptomycin; Invitrogen) and 4% Ultroser G (serum 
substitute; BioSepra). After collection of the DRGs which were trimmed of excess 
nerves and roots, the medium was gently removed and replaced with growth medium 
containing 0.125 % collagenase Type IV (200 units/ml; Sigma or Worthington 
Biochemical Corporation) for 3 hours in an atmosphere of 95% air and 5% CO2 at 37 
°C. Collagenases are enzymes that break down peptide bonds in collagen, the main 
protein in connective tissue, allowing the DRGs to soften to permit gentle trituration. 
Subsequently, the DRGs were washed three times with growth medium to remove 
traces of collagenase. To minimise the risk of DRGs being removed with the 
supernatant, in each wash the growth medium was added and the suspension allowed 
to stand, until the DRGs settled to the bottom and the supernatant was then removed.  
To achieve a DRGs suspension, mechanical trituration was carried out with a fire-
polished (removes sharp edges) Pasteur pipette. The processes of these sensory 
neurons are removed during this procedure, making the cells appear round in shape. 
Following addition of nerve growth factor 50 ng ml
−1
 (NGF: Promega, Southampton, 
UK) the cells were plated on poly-DL-ornithine coated coverslips and cultured for 
two days  at 37°C, 95% air and at 5% CO2. Each culture contained cells from only 
one animal. Cells from each animal were plated on 8 coverslips. Cells were used two 
days after plating. 
 
Prior to plating the cells, the glass coverslips were first coated with adhesion 
molecules, such as poly-DL-ornithine (Sigma). This organic substrate contains 
electrically charged poly-amino acids, which by electrostatic interaction favour cell 
anchoring on the glass coverslips (Ariano et al., 2005). This allows the cells to 
survive, adhere and maintain their electrical properties, including ion channel 
availability. Furthermore, the cells must adhere to the coverslip sufficiently to 
prevent their being washed away during experimental procedures. Coverslips were 
therefore coated with poly-DL-ornithine by placing them into 0.5 mg/ml poly-DL-
ornithine in ddH20 and placing them on a rotor shaker to agitate the coverslips for 2 
hours at room temperature. This allowed the organic substrate to be deposited as a 
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thin layer on the coverslips. The coverslips were then washed several times with 
ddH2O to remove excess poly-DL-ornithine (toxic to cells) and covered with growth 
medium until use. 
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2.1.2 Cell culture of HEK293 cells 
 
2.1.2.1 Theory of technique 
 
     The HEK293 cell line is a clone of standardised cells which has proved to be 
particularly accommodating for reliably expressing DNA which has been artificially 
introduced into the cell in a process called transfection.  The HEK293 cell line is 
derived from HEK293 cells which were transformed by exposing human embryonic 
kidney cells to sheared fragments of adenovirus type 5 (Ad5) DNA (Graham et al., 
1977); and the human-viral junctions of integrated adenovirus type 5 DNA in 
HEK293 cells have been cloned and sequenced (Louis et al., 1997).  Remarkably, it 
has been found that these cells express significant amounts of protein and mRNA for 
the neurofilament (NF) subunits NF-M, NF-L, and alpha-internexin, three of the four 
major NF proteins, with, in addition, small amounts of NF-H, the fourth NF subunit. 
Subject to very few, apparently aberrant, exceptions, each of these NF proteins is 
found only in neurons.  Hence, the presence of all of these proteins in HEK293 cells 
is highly suggestive that these cell lines belong to the neuronal lineage (Shaw et al., 
2002).  It has been suggested that the most likely explanation for this phenomenon is 
that Ad5 preferentially transforms rare neuronal lineage cells present in human and 
rodent kidney cultures.  It has also been observed that the use of these cells as a non-
neuronal control line in transfection studies is inappropriate given their many 
attributes of developing neurons and neuronal progenitor cells (Shaw et al., 2002). 
 
 An important variant of the HEK293 cell line is the HEK293T cell line which 
provides longer temporal expression of the desired gene product. HEK293T cells 
stably express an SV40 temperature-sensitive T-antigen. Plasmids containing the 
SV40 insert are able to replicate copy numbers between 400-1000 plasmids per cell 
and therefore express higher levels of recombinant proteins. HEK293T cells were the 
cell line used in this PhD project. However, for simplicity, these cells are simple 
referred to as HEK293 cells in this thesis.  
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       HEK293 cells have limitations when employed as a model to examine the 
functioning of various cell types since they are essentially in a category of their own.  
However, they are highly efficient in expressing a reliable transient transfection.  
Moreover, they are relatively easy to manage and sustain in culture.  They are, 
therefore, useful where the behaviour of the cell itself is not the subject of study, but 
rather the protein which is expressed by the transfected DNA.   Repeated passaging 
of these cells results in variations from their original characteristics (Thomas and 
Smart, 2002; Park et al., 2004, Lee et al., 2001).  Therefore, cells passaged >20 times 
were discarded. 
 
      
2.1.2.2 Culturing HEK293 cells 
 
 HEK293 cells obtained from Dr John B. Davis at GlaxoSmithKline and the 
European Collection of Cell Cultures (ECACC) were routinely grown as monolayers 
in growth medium on plastic tissue culture grade T75 flasks for culturing, and on 
plastic tissue culture grade petri dishes for transfection (Nalg Nunc International), in 
an atmosphere of 95% air and 5% CO2 equilibrated at 37 °C.  
 
All cell culture procedures were done under clean and sterile conditions. Glassware 
and pipette tips were sterilised by autoclaving before use, to remove any 
contaminating microorganisms, because if left unchecked, these would grow in the 
culture media and become infected. Autoclaving is carried out using pressurised 
steam at 121 
o
C under 105 kPa for 20 minutes which will destroy microorganisms 
such as bacteria, viruses, fungi and spores (Wilson and Walker, 2005). Sterile 
plastic-ware, which is commercially available, was also used (Nalg Nunc 
International). All procedures were performed under a cell culture hood, which 
generates a laminar flow of sterile filtered air.  
 
 The growth media consisted of minimum essential medium (MEM), 2 mM L-
glutamine, MEM non-essential amino acids, 10% foetal bovine serum (FBS), 
antibiotics (50 units/ml penicillin and 5 µg/ml streptomycin). MEM is patterned after 
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Eagle's Media and is well suited for the growth of a broad spectrum of mammalian 
cells. It contains essential amino acids (arginine hydrochloride, cystine, histidine 
hydrochloride, isoleucine, leucine, lysine hydrochloride, methionine, phenylalanine, 
threonine, tryptophan, tyrosine and valine), vitamins (choline chloride, calcium 
pantothenate, folic acid, niacinamide, pyridoxal hydrochloride, riboflavin, thiamine 
hydrochloride and inositol), inorganic salts (calcium chloride, magnesium sulphate, 
potassium chloride, sodium bicarbonate, sodium chloride, and sodium phosphate) 
and glucose. Glutamine is added to the media, as MEM is formulated without this 
essential amino acid due to its unstable characteristic during long-term storage. The 
primary function of glutamine in cell culture is to provide a reservoir of nitrogen 
atoms to synthesise proteins, nucleic acids and other nitrogenous compounds.  These, 
in turn, produce nucleotides, amino acids and vitamins which are necessary for the 
survival of cells. Glutamine also supports the growth of cells which have high energy 
demands, as it is also able to function as an alternative energy source for rapidly 
dividing cells in vitro and for cells that use glucose insufficiently (Conrad, 2008).  
MEM non-essential amino acids (glycine, alanine, asparagines, aspartic acid, 
glutamic acid, praline and serine)  stimulate growth, prolong the viability of cells in 
culture, and reduce the biosynthetic burden on cells in vitro. FBS is rich in albumin, 
hormones and growth factors which stimulate cellular growth and proliferation. 
Antibiotics inhibit bacterial growth by inhibiting bacterial protein synthesis, thus 
ensuring the survival of cells in culture. All of the products described in this 
paragraph were sourced from Invitrogen U.K. 
 
  Sub-confluent cells (70-80%) were obtained after 3–4 days and were 
harvested using 0.05% trypsin containing 0.53 mM ethylenediaminetetraacetic acid-
tetrasodium (EDTA-4Na). EDTA chelates calcium and magnesium ions from 
intracellular bridges and desmosomes and potentiates the action of trypsin which 
helps to dissociate the cells from each other and from the flask. Therefore, the cells 
were briefly washed with 1x Dulbecco's Phosphate Buffered Saline (D-PBS) and 
treated with trypsin-EDTA (5 minutes at room temperature). Trypsin was inactivated 
by adding equal amounts of growth media, since bovine serum has a rich source of 
trypsin inhibitors. Cells were then centrifuged (200g for 5 minutes, at room 
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temperature) and resuspended in fresh growth medium (to remove any traces of 
trypsin-EDTA as EDTA has growth inhibitory properties at even low concentrations) 
before plating into T75 flasks and/or Petri dishes.  
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2.2  Transfection 
 
2.2.1  Background to the purpose of transfection 
 
One of the major achievements of biological research is the development of cell 
culture technology and the molecular cloning of genes. These developments have put 
the investigation of ion channel physiology onto new qualitative level. First, cell 
culture of cell lines obtained from a single cell produces unlimited supply of cells 
with uniform properties that can be grown ex vivo. Second, molecular cloning of 
genes has allowed them to express exogenous ion channel proteins, via a transfection, 
at levels much higher than native cells do. It is therefore possible to investigate ion 
channel properties under much “cleaner” conditions.  
 
2.2.1.1  Cloning of DNA  
 
 
 DNA may be cloned by first obtaining a fragment of DNA which contains the 
gene of interest. In our experiments this was the hTRPV1 gene. This DNA is then 
inserted into the purified DNA genome of a self-replicating genetic element –
generally a virus or a plasmid. Plasmids are self-replicating extra-chromosomal 
circular DNA molecules, distinct from the normal bacterial genome. The term 
"recombinant DNA technology", refers to the process of the transferring of a DNA 
fragment of interest from one organism to a self-replicating genetic element, such as 
a bacterial plasmid. The DNA of interest can then be propagated in a foreign host 
cell. To "clone a gene," a DNA fragment containing the gene of interest is isolated 
from chromosomal DNA using restriction enzymes and then united with a plasmid 
that has been cut with the same restriction enzymes. When the fragment of 
chromosomal DNA is joined with its cloning vector in the laboratory, it is called a 
"recombinant DNA molecule." Following introduction into suitable host cells, the 
recombinant DNA can then be reproduced along with the host cell DNA (Alberts et 
al., 2004).  
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Plasmids are self-replicating extra-chromosomal circular DNA molecules because 
they contain an origin of replication, which allows replication in the host cell 
independently of the chromosome. Plasmids can carry up to 20,000 bp of foreign 
DNA. In addition to bacterial plasmids, some other cloning vectors include viruses, 
bacteria artificial chromosomes (BACs), and yeast artificial chromosomes (YACs). 
Cosmids are artificially constructed cloning vectors that carry up to 45 kb of foreign 
DNA and can be packaged in lambda phage particles for infection into E. coli cells. 
BACs utilize the naturally occurring F-factor plasmid found in E. coli to carry 100 to 
300 kb DNA inserts. A YAC is a functional chromosome derived from yeast that can 
carry up to 1 MB of foreign DNA. Bacteria are most often used as the host cells for 
recombinant DNA molecules, but yeast and mammalian cells also are used (Human 
Genome Project Information, 2008). 
 
In the present study, wild-type hTRPV1 cDNA had been inserted into the 
plasmid, pcDNA3.1v5-HIs-TOPO by Hayes and co-worker (Invitrogen, Hayes et al., 
2004; see Fig 2.3).  
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Figure 2.3. Map of pcDNA3.1v5-HIs-TOPO vector. The vector contains key 
components for cloning. F1 ORI insert is the replication origin (ORI) for replication 
in the host cell. SV40 ori (origin), SV40 pa (polyadenylation), pUC and T7 inserts 
enable high levels of replicate copy numbers. CMV or cytomegalovirus promoter 
insert also achieves high levels of expression. Neomycin resistance gene and 
ampicillin resistance gene inserts for selective amplification. To clone a DNA 
sample, the same restriction enzyme must be used to cut both the vector and the 
DNA sample. The expanded area above contains a poly-linker region, which is able 
to recognise several different restriction enzymes. This enables the vector to be used 
for cloning for a variety of DNA samples. The poly-linker region also contains a 
section into which the wild-type hTRPV1 cDNA can be inserted, (indicated here as 
PCR Product). (Taken from  http://tools.invitrogen.com/content/sfs/vectors/pc 
dna3.1v5 histopo_map.pdf.) 
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2.2.1.2 Theory of transfection  
 
Transfection is the transfer of recombinant genes into cultured mammalian 
cells. Typically, it involves opening transient pores in the cell plasma membrane to 
allow the uptake of material.  Genetic material (such as supercoiled plasmid DNA or 
siRNA constructs), or even proteins, such as antibodies, may be transfected.  This 
technique is an important tool for investigating how genetic variations affect the 
functioning of certain genes. Transfections may be stable (permanant) or transient. A 
stable transfection requires that the transfected gene should remain in the genome of 
the cell transfected and its daughter cells. To achieve a stable transfection, another 
gene must be co-transfected which gives the host cells some selection advantage, 
such as resistance to a certain toxin to their genome.  Addition of the toxin, to which 
the transfected gene offers resistance, results in only those few cells being able to 
proliferate, while the others perish.  Repeated application of this selection procedure 
results in only the cells with a stable transfection remaining for further passages. 
Transient transfections do not require the foreign DNA to be introduced into the 
nuclear genome. This results in the foreign DNA being lost at the later stage, when 
the cells undergo mitosis. Typically, expression of the transfected gene can be 
analysed between 1 and 4 days after induction of the DNA (Felgner et al., 1987).   
 
In the case of my project, transient transfection was the most appropriate 
method for producing functional human TRPV1 (hTRPV1) polymorphs, in order to 
assess differences, if any, in their sensitivity to several known activators of TRPV1. 
The use of transient transfection has it disadvantages because it involves the use of 
costly transfection reagents and the need to transfect cells each time a clone is 
required to be expressed. Nevertheless, this method avoids the laborious and time 
consuming process of establishing stable transfection of several clones.  
 
There are several methods which have been developed for introducing cloned 
DNA into cultured cells. These include transfection with: (i) calcium phosphate or 
DEAE-dextran (Pari and Keown, 1997.); (ii) polybrene (Kawai and Nishizawa, 1984; 
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Chaney et al., 1986); (ii) protoplast fusion (Schaffner, 1980; Rassoulzadegan et al., 
1982); (iv) electroporation (Neumann et al., 1982; Zimmermann, 1982); (v) direct 
microinjection into the nuclei (Capecchi, 1980); and (vi) liposomes (Felgner et al, 
1987). However, regardless of the method used to introduce DNA into cells, the 
efficiency of transfection is dependent on the cell type. Different cultured cell lines 
vary in their ability to take up and express foreign DNA. Certain cell types and lines 
are intrinsically easier to transfect than others, although the reason for this is 
currently unknown (Nikcevic et al., 2003) 
 
I chose the HEK293 cell line to express hTRPV1 as these cells have been 
extensively used in transfection and have become the mammalian expression system 
of choice for studying a variety of membrane proteins (Thomas and Smart 2005). 
Furthermore, HEK293 cells transiently transfected with TRPV1 are routinely used by 
a large number of laboratories (Caterina et al., 1997; Davis et al., 2000; Jordt et al., 
2000; Voets et al., 2004). Hence, transfection of these cells by liposomes was chosen 
due to its simplicity and high efficiency of transfection to adherent cells 
(Lipofectamine™ 2000 Transfection Reagent product sheet; Graham Smith, personal 
communication). 
 
 
Liposomes are small vesicles made up of phospholipids which consist of 
hydrophilic heads and lipophilic tails. These vesicles are not only used to deliver 
foreign DNA to mammalian cells but are also widely used for drug delivery. 
Liposome-mediated transfection involves the synthetic cationic (positively charged) 
lipid, N-[1-(2,3-dioleyloxy)propyl]-N,N,N-trimethylammonium chloride (DOTMA; 
Felgner et al., 1987). Liposomes that contain DOTMA have an overall positive 
charge, which consequently interact spontaneously with negatively charged nucleic 
acid molecules, to form lipid-DNA complexes. These complexes, in turn bind 
strongly to the plasma membrane of the cell due to favourable charge interactions. 
And with the aid of DOTMA, these complexes facilitate fusion with the plasma 
membrane of the cell, as both are made up of phospholipid bilayer. This results in 
both the uptake and expression of the foreign DNA. These synthetic liposomes were 
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first introduced in 1987 by Felgner and colleagues (Felgner et al., 1987).  
Consequently, a number and variety of commercially available forms are available, 
such as Lipofectamine.    
 
Lipofectamine
TM
 (Invitrogen U.K.) is a cationic liposome based reagent that 
provides high transfection efficiency and high levels of gene expression in a range of 
mammalian cell types in vitro. Optimum transfection efficiency and subsequent cell 
viability depend on a number of experimental variables, such as cell density, 
liposome and DNA concentrations, liposome-DNA complexing time, and the 
presence, or absence, of media components, such as antibiotics and serum  (Dalby et 
al., 2004). PLUS
TM
 reagent by Invitrogen can also be used in conjunction with 
Lipofectamine to boost the efficiency of transfection. This reagent enhances the 
cationic lipid-mediated DNA transfection by assisting in the stage where DNA is 
„complexed‟ to the lipids. 
 
Other methods of transfection all suffer from one, or more, problems relating 
to either cellular toxicity, poor reproducibility, insufficiency of DNA delivery, is 
simple, highly reproducible, low toxicity, effective for both transient and stable 
expression of transfected DNA.  
 
However, Lipofectamine does have a number of disadvantages. First, an 
additional preparation of antibiotic-free and serum-free media is required. The 
presence of antibiotics in the media during transfection causes cell death. The 
presence of serum in the media inhibits cationic lipid-mediated transfection 
(Lipofectamine™ 2000 Transfection Reagent product sheet). Second, the gene of 
interest must be inserted into a plasmid, prior to transfection.  
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2.2.1.3 Transient transfection 
 
HEK293 cells expressing hTRPV1 were obtained by transient transfection of 
subconfluent HEK293 cells using PLUS
TM
 reagent and Lipofectamine
TM
 2000 
reagent (Invitrogen).  The hTRPV1111 cDNA was cloned in pcDNA3.1/V5-His-TOP 
vector. The cells were also transfected with a plasmid DNA encoding the Green 
Fluorescent Protein (GFP), a reporter gene which, when expressed fluoresces green. 
The co-transfection of cells with the two vectors (TRPV1 and GFP) were carried out 
to allow efficient selection of cells expressing the transfected genes.  
 
The green fluorescent protein (GFP) is a 27 kDa polypeptide which converts 
the blue chemiluminescence of the Ca
2+
-sensitive photo-protein, aequorin, into green 
light (Chalfie, 1994; Cody et al., 1993). GFP was originally discovered from the 
Aequoria Victoria jellyfish (Shimomoura et al., 1962). The gene for GFP has been 
cloned (Prasher et al., 1992) and linked/fused with other genes to produce chimeric 
proteins when translated, thereby acting as a fluorescent protein tag (Chalfie et al., 
1994; Inouye and Tsuji et al., 1994). This technique is a powerful tool in 
biochemistry and cell biology, because it functions as a non-invasive fluorescent 
marker in living cells. It has been used in a wide range of applications because it has 
the ability to function as a cell lineage tracer, a reporter of gene expression, or a 
measure of protein-protein interactions. Typically, naturally occurring GFP has an 
absorbance/excitation peak at 395 nm with a minor peak at 475 nm. The emission 
peak is at 508 nm. The main advantages of using GFP as a gene expression maker 
are: (i) it can be used in all organisms; (ii) it can be used to target a specific tissue, 
cell, organelle or protein; (iii) it has good optical properties (visible excitation); and 
(iv) it is cheap to replicate. In this case, GFP was used as a transfection marker to 
increase the efficiency of identifying cells to patch-clamp and test for TRPV1 
activity. The disadvantages of using GFP as a marker of gene expression are: (i) gene 
transfection is required; and (ii) strong promoters are needed for sufficient expression 
for detection, especially in mammalian cells (Tsien, 1998).  
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The transfection method used has previously been optimised for high 
efficiency of transfection by GlaxoSmithKline. HEK293 cells were typsinised 1 day 
before transfection and plated on a 90 mm-diameter plastic Petri dish so that they 
were 50-70% confluent by the next day when transfection was carried out. On the 
day of transfection, 0.15 µg of GFP cDNA and 1.5 µg of hTRPV1 cDNA were 
diluted in serum-free and antibiotic-free Dulbecco‟s Modified Eagle Medium (D-
MEM; Invitrogen) containing Plus
TM
 reagent and were incubated for 15 minutes at 
room temperature in order to pre-complex DNA with Plus reagent. The reason for 
transfecting in a 1:10 ratio of GFP to TRPV1 is because cells expressing the green 
fluorescence under a fluorescent microscope are also more likely to express the gene 
of interest, TRPV1. However, the expression cassette of a pIRES which contains an 
internal ribosome entry site with two open reading frames enabling one to translate 
two genes of interest simultaneously, could be used as an alternative method of cell 
selection (Trouet et al., 1997). Diluted Lipofectamine reagent was then added to the 
pre-complexed DNA and incubated for a further 15 minutes at room temperature.  
 
Cells were briefly washed with D-MEM to remove traces of growth medium 
containing serum and then D-MEM was added to the dish. This was followed by the 
addition of DNA-Lipofectamine-Plus reagent complexes (final concentration: ~8.7 
µg/ml of Lipofectamine reagent and ~8.5 µg/ml of Plus reagent). These were gently 
which was gently mixed into the medium and incubated at 37°C at 5% CO2 for 3 
hours. After incubation, the transfection medium was removed and replaced with 
growth medium containing serum and antibiotics and incubated for a further 1 hour.  
 
Transiently transfected cells were typsinised and then plated onto 13-mm 
poly-DL-ornithine coated glass coverslips as the recording chamber of the 
electrophysiology machine is of this size.   
 
hTRPV1-tranfected HEK293 cells were used after 24 hours of plating 
because, being a cationic-mediated transfection, a negative charge forms around the 
cells, making whole-cell recordings very difficult (Thomas and Smart, 2005).  
Transfected cells were not used after 72 hours because the culture becomes too 
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confluent making it difficult to record from a single cell and it has been reported that 
peak transient expression is generally seen 24-72 hours following transfection (Dalby 
et al., 2004).  
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2.3 Site-directed mutagenesis 
 
2.3.1 Theory behind site-directed mutagenesis 
 
Site-directed mutagenesis (SDM) or oligonucleotide-mediated mutagenesis is used to 
add, delete, or substitute, a nucleotide in a region of DNA with known sequence 
using synthetic oligonucleotide primers containing the desired mutation. SDM is an 
invaluable technique for studying gene expression and the protein structure-function 
relationship of mutated DNA at key residues. It has revolutionised molecular genetic 
research.  This technique was discovered by independent work carried out by Karry 
B. Mullis (Mullis and Faloona, 1987) and Michael Smith (Gillam et al., 1980; Zoller 
and Smith, 1983), who later shared the Nobel Prize in 1993 for their contribution to 
the development of methods within DNA-based chemistry.  
 
The polymerase chain reaction (PCR) is a technique used for amplifying 
specific segments of DNA. The PCR method was first developed in 1987 by Mullis 
and co-workers (Mullis and Faloona, 1987; Mullis, 1987; Mullis et al., 1987). The 
PCR technique derives its name from a key component of the reaction, namely, a 
heat-stable DNA polymerase, which is an enzyme that is not denatured by the 
repeated heat treatments involved in the reaction. The most widely used enzyme is 
Taq DNA polymerase, an enzyme first isolated from Thermus aquaticus (Taq), a 
bacterium which lives in hot springs and which can tolerate high temperatures 
(optimum temperature 72-74 
o
C; Brock and Freeze, 1969). The other essential 
components of the PCR reaction are: (i) a DNA template that contains the nucleotide 
target to be amplified; (ii) a pair of primers (synthetic DNA oligonucleotides) that 
anneal with the flanking sequences of the specific target which are complementary to 
each strand of the DNA double helix thus determining the boundaries of the 
amplified product; (iii) dNTPs; and (iv) buffer solution containing Mg
2+
, which 
provides a suitable environment for optimum activity and stability of the reaction. 
Mg
2+
 is used to stabilise dsDNA and contributes to the specificity of primer 
annealing (Alberts et al., 2004). 
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A PCR mixture is then placed in a thermal cycler, which is pre-programmed with the 
following PCR steps:  
 
1. Denaturation or strand separation. The parental dsDNA template is 
separated by a brief heat treatment of the reaction, usually 96°C for 30 
seconds. 
2. Annealing of primers. The reaction is then cooled to the melting 
temperature of the primers, usually between 55 °C to 60 °C and typically 
1 minute is required for every 1kb of DNA to be amplified to anneal to 
complementary sequences within the DNA template.  
3. Elongation or DNA synthesis. The reaction is then heated to the optimum 
temperature of the Taq DNA polymerase, usually 72 °C for 3 minutes. 
This allows the DNA polymerase to elongate both primers downstream of 
the target DNA sequence as synthesis is in the 5‟ to 3‟ direction.  
 
These three steps are then repeated several times, so that, in addition to the parental 
DNA molecule, the newly synthesised fragment serves also as a template. Thus, for 
every cycle the amount of DNA synthesised is doubled. Usually 30 cycles of the 
reaction are required for detectable DNA amplification.   
 
PCR technique has several limitations and disadvantages. First, the target 
DNA sequence must be known. The region of interest must be previously 
characterised in order to design specific primers. However, this can be overcome by 
using degenerate primers if a related gene member has previously been sequenced. 
Many genes are highly conserved among different species. By aligning the sequences 
from a number of previously determined related DNA sequences, whose protein 
products have similar functions (homology), conserved regions can be observed. 
These conserved regions provide the starting point for designing degenerate PCR 
primers to unidentified members of the family, instead of using specific PCR primers 
with a given sequence. Second, product size is short. Typically, PCR product is 
approximately between 0.1 - 5 kb, compared to cell-based DNA cloning where the 
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sizes of the cloned fragment is able to reach 2 Mb. Third, amounts of product are 
limited. A single PCR reaction produces very small amounts of product when 
compared to cell-based DNA cloning where “scale-up” is possible. Finally, there 
may be infidelity of DNA replication. DNA replicated in vitro has higher copying 
error rate when compared to DNA replication in vivo because of the lack of proof-
reading mechanisms of the polymerase. The commonly used Taq DNA polymerase 
has no associated 3‟-to-5‟ exonuclease which has the function of proof-reading. This 
may result in mis-incorporation during DNA replication. However, an alternative 
polymerase, such as Pyrococcus furiosus (Pfu) DNA polymerase, which has 
associated 3‟-to-5‟ exonuclease activity, can be used (Cline et al., 1996).  
 
Nevertheless, PCR technique has major advantages. First, the speed and ease 
of use of the method and a complete reaction can be performed in only a few hours. 
Initially some time is required to: (a) design and synthesize the primers; and (b) 
optimise the conditions for the PCR reaction which usually involves altering the 
annealing temperature for the primers to anneal to the DNA template. Once these 
two issues have been dealt with, the reaction is quick and simple. For these reasons 
PCR has revolutionised molecular genetics by allowing rapid cloning and analysis of 
DNA. Thus, this technique is widely used for the diagnosis of genetic diseases, as 
well as in basic and clinical research. PCR technique is able to detect a single DNA 
molecule in a sample and is even able to amplify from a single cell (Li et al., 1988). 
This technique has been exploited in many applications of forensic science, genetic 
linkage analysis and molecular palaeontology studies. Futhermore, this technique is 
able to use degraded and fixed DNA samples, making it suitable for anthropological 
and palaeontological studies (Strachan and Read, 1999). In addition, PCR has been 
adapted into other techniques such as DNA sequencing and in vitro site directed 
mutagenesis.   
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Smith discovered that even if one of the bases of the oligonucleotide primer 
was incorrect/mis-matched, the primer will still anneal at the correct position of the 
DNA template and generate an altered/mutated DNA sequence which, in turn, can 
produce a modified protein (Gillam et al., 1980; Zoller and Smith, 1983).  
 
Previously, SDM required ssDNA as a template to achieve efficient mutagenesis 
which meant that this was often technically difficult and intensive procedure 
(Kunkel, 1985; Sugimoto et al., 1989; Taylor et al., 1985; Vandeyar et al., 1988). 
However, Braman and colleagues in 1996 developed a new method in which they 
allowed dsDNA to be the starting template for SDM (Braman et al., 1996). The 
QuikChange SDM kit from Stratagene, utilises this principle (Papworth et al., 1996). 
The key steps used in this kit are as follows.  
 
1. Mutagenesis reaction. The plasmid dsDNA of the gene of interest is first 
placed into a standard PCR reaction mixture (DNA polymerase, dNTPs, 
and buffer-containing Mg
2+
) with the mutagenic oligonucleotide primers. 
These are primers which are complementary to the DNA target sequence 
except for a base, or a few bases, which will produce either a point 
mutation, a switch in amino acids, an insertion or a deletion of single or 
multiple amino acids. The mixture is placed into a thermal cycler set to 
standard PCR cycle. This involves: (i) denaturation to separate the 
dsDNA; (ii) annealing to allow the mutagenic primers to anneal to the 
imperfectly matched DNA strands; and (iii) elongation to allow 
amplification of the entire plasmid DNA. Two kinds of DNA products 
result. Half will contain the desired mutated DNA sequence containing 
staggered nicks (dsDNA break that produces 3‟ or 5‟ protruding ends). 
The other half will contain the wild-type DNA sequence (Papworth et al., 
1996).  
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2. Dpn I digestion. dsDNA template naturally contains methylated strands. 
Thus incorporation of the mutated primers to the dsDNA template results 
in unmethylated ssDNA and dsDNA products. The Dpn I endonuclease 
specifically digest parental methylated non-mutated dsDNA and 
hemimethylated DNA (where only one of the two strands are methylated), 
leaving unmethylated dsDNA-containing the desired mutation with 
staggered nicked ends (Nelson et al., 1992). 
 
3. Transformation. The unmethylated dsDNA-containing the desired 
mutation is then transformed into „competent cells‟, which not only 
repairs the staggered nicked ends but results in the amplification of the 
plasmid DNA with the desired mutation. „Competent cells‟, such as E. 
coli, are bacterial cells which possess cell walls that are easily altered 
when treated with calcium chloride followed by a brief heat shock (Cohen 
et al., 1972; Mandel and Higa, 1970). This allows the cells to be not only 
transiently permeable to DNA but also results in genomic incorporation 
of the foreign DNA. 
 
DNA must be cloned and then inserted into a plasmid. In the present 
study, wild-type hTRPV1 cDNA has already been inserted into the 
plasmid vector, pcDNA3.1v5-HIs-TOPO, which carries genes resistance 
for the antibiotic, ampicillin. This plasmid can then be propagated by 
transformation in a bacterial cell in the presence of ampicillin, and left to 
grow on a nutrient agar plate. Thus, only the bacteria which contain 
plasmids will survive and replicate into a colony of identical cells. This 
colony appears as a white plaque on the agar plate. Inoculation of a single 
colony into culture medium is then carried out. This produces a large 
number of identical plasmid DNA molecules so that detectable amounts 
of DNA can be purified for sequencing. Typically a small starter culture 
of 1.5 mls is sufficient. 
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4. Purification of plasmid DNA and sequencing. The bacteria containing 
plasmid DNA molecules are then separated from each other using an 
alkaline lysis extraction method.  
 
The purified plasmid DNA is then amplified using PCR with primers that 
flank the region of interest and sequenced to verify that the desired DNA 
mutation has been achieved. 
 
 Once a specific colony has been verified to contain the desired DNA 
mutation, the plasmid can be re-transformed to produce larger amounts of DNA for 
transient transfection, thereby allowing investigative analysis of the protein arising 
from the mutated DNA. 
 
The four step procedure generates mutants with greater than 80% efficiency 
(Papworth et al., 1996). Furthermore, the use of dsDNA as a template makes this 
technique a simple, rapid and reliable method, eliminating the need for the time 
consuming procedure of subcloning into M13-based bacteriophage plasmids 
(Sambrook et al., 1989).  
 
However, there are disadvantages to this technique. Many of these are similar to the 
limitations of PCR. First, the design of mutant oligonucleotide primers is critical to 
the efficiency of the reaction and consequently the target DNA sequence must be 
known. The length of the mutant oligonucleotide primers is usually more than 25 
bases as the primer must be long enough to hybridise to the target DNA sequence. 
The degree of similarity must be 100% over 10-15 bases at both the 3‟ and 5‟ ends, 
usually the target base/bases are found in the middle of the primer. The sequence of 
the mutant primer should not generate secondary structures which will inhibit 
annealing of the primers to subsequent amplification cycles.  
 
The use of the QuikChange Primer Design Programme has made designing 
mutagenic primers quick and simple. Second, the lack of 3‟-to-5‟ exonuclease 
associated with the DNA polymerase, such as Taq DNA polymerase, increases the 
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risk of introducing random mutagenesis due to the lack of proofreading activity. 
However, the QuikChange SDM kit is supplied with an enhanced version of Pfu 
DNA polymerase with associated 3‟-to-5‟ exonuclease activity, PfuTurbo® DNA 
polymerase. This enzyme has a 6-fold higher fidelity in DNA than Taq DNA 
polymerase and is able to amplify plasmid DNA targets up to 15 kb in length 
(Hogrefe et al., 1997). 
 
2.3.2 Site-directed mutagenesis: practical approach 
 
Originally, I was supplied by Davis and colleagues with five haplotypes: 
hTRPV1111, hTRPV1222, hTRPV1211, hTRPV1121, and hTRPV1112. Due to the initial 
outcome of my data, I made two additional haplotypes, hTRPV1121-S and 
hTRPV1121A (Table 2.1). 
 
 
 
 
Amino Acid 
 
Code name. 
Position  
315 
Position  
469 
Position  
585 
1 hTRPV1111  I T V 
2 hTRPV1211 M T V 
3 hTRPV1121 I I V 
4 hTRPV1112 I T I 
5 hTRPV1222 M I I 
6 hTRPV1121-S I S V 
7 hTRPV1121-A I A V 
 
Table 2.1 Seven haplotypes of hTRPV1. Haplotypes 1-5 were 
made by Davis and co-workers. Haplotypes 6-7 were made by me.  
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Two mutants were made in order to verify whether codon 469 plays an 
important role in TRPV1-mediated sensitivity. These changed the wild-type codon, 
by altering the polar amino acid, threonine, to either a non-polar amino acid, alanine 
(T469A), or another polar amino acid, serine (T469S) (see Fig. 5.2). The hTRPV1111 
gene was cloned in the mammalian expression plasmid vector pcDNA3.1v5-HIs-
TOPO (7.7 Kb).  Site directed mutagenesis of codon 469 (bases 1406-1408) of this 
gene was then performed using the QuikChange XL Site-Directed Mutagenesis kit in 
accordance with the manufacturer‟s instruction (Strategene, La Jolla, CA).  
 
The primer pairs used for mutagenesis were designed by the QuikChange 
Primer Design Programme (www.stratagene.com) and ordered from MWG Biotech, 
Ebersberg, Germany. The primer pairs were as follows (bases in bold indicate the 
desired mutation which differs from wild-type sequence; Fig 2.4): TRPV1-T469A, 
5‟-C TTG CCT CCC TTT AAG ATG GAA AAA GCT GGA GAC TAT TTC-3‟ 
(sense,) and 5‟- GAA ATA GTC TCC AGC TTT TTC CAT CTT AAA GGG AGG 
CAA G-3‟ (antisense); TRPV1-T469S, 5‟-C TTG CCT CCC TTT AAG ATG GAA 
AAA TCT GGA GAC TAT TTC-3‟ (sense), and 5‟-GAA ATA GTC TCC AGA 
TTT TTC CAT CTT AAA GGG AGG CAA G-3‟ (antisense).  
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Figure 2.4. Location of mutagenic primers for site-directed mutagenesis of codon 469 on the hTRPV1 gene. (a) Wild-type hTRPV1. Sense and 
anti-sense cDNA sequences between bases 1392-1418 of the open reading frame of hTRPV1 gene and the corresponding in-frame translated 
amino acids are shown. Note: the anti-sense sequence is shown upside down, to illustrate how the sequences complement each other. Bases 1406-
1408 which correspond to codon 469 are shown in bold. Codon 469 on the hTRPV1 gene, originally a polar threonine amino acid is altered using 
SDM to: (b) the non-polar amino acid, alanine (T469A); and (c) another polar amino acid, serine, (T469S). Sense and anti-sense strands are 
shown with the corresponding mutagenic sense and anti-sense primers (mutagenic bases are shown in red) to produce the desired mutant product 
resulting in a change of amino acid at codon 469 (shown in blue).Arrows indicate direction of amplification during PCR. Note: both primers 
contained the desired mutation and anneal to the same sequence on opposite strands. Also, the desired mutation on the nucleotide is situated in 
the middle of the primers with ~10-15 bases of the correct sequence on both sides.  
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Each mutagenesis reaction contained: QuikChange reaction buffer; 
QuikSolution; dsDNA template (10 ng); primer pair (125ng); dNTP mix; and 
PfuTurbo DNA polymerase (2.5 U/ul). The reaction mixture was placed in a thermal 
cycler (Gene Amp PCR System 9700, PE Applied Biosystems) producing mutated 
plasmid containing staggered nicks. The cycling parameters were as follows: an 
initial 1 minute incubation
 
at 95°C for 30 seconds prior to the addition of polymerase 
to hot start the mixture. Then 18 cycles of each of the following steps were 
performed, namely: 95°C for 30 seconds; 60°C for 1 minute;
 
and 65°C for 8 minutes 
(the plasmid DNA is ~7.7 kb). Dpn I digestion of the amplification products was 
then carried out using Dpn I restriction endonuclease (10 U/ul; Strategene, La Jolla, 
CA) at 37 
o
C for 1 hour to digest methylated non-mutated parental dsDNA template. 
The unmethylated mutated dsDNA was then transformed into XL1-Blue 
Supercompetent cells (Strategene, La Jolla, CA) by incubating the cells with Dpn I-
treated DNA on ice for 30 minutes, and then heat pulsed at 42 
o
C for 45 sec. The 
mixture was further incubated on ice for a further two minutes. XL-1 blue competent 
cells were purchased pre-treated with calcium chloride, ready for transformation. The 
heat pulse enables uptake of DNA into competent cells. The length of the heat pulse 
and the temperature of the water bath are critical in obtaining optimal transformation 
as efficiency decreases sharply when cells are heat-pulsed for <45 seconds or for >60 
seconds. LB broth was added to the reaction and incubated at 37 
o
C for 1 hour, with 
shaking, before plating of 10 µl, 100 µl, and 200 µl of the reaction medium onto agar 
plates containing ampicillin (100 ug/ml) which were left overnight (>16 hours) at 37 
o
C.  
 
In order to increase the chances of identifying, and producing, the correct 
mutation, a total of 10 colonies from each reaction were picked from a selective plate 
and placed into 1.5 ml Terrific Broth containing ampicillin. The inoculated cultures 
were incubated for >12 hours with shaking. To isolate and purify sequencing grade 
plasmid DNA from bacterial cells QuickLyse Miniprep kit (Quigen) was used, as 
described by the manufacturer. The kit is optimised to isolated plasmid DNA from 
1.5-3 ml of inoculated culture.    
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All site-directed mutated constructs were confirmed by DNA sequencing 
using 3.2 pmol/L of the following primers (MWG Biotech, Ebersberg, Germany) 5‟-
GCA GGA CAA GTG GGA CAG AT-3‟ (sense), and 5‟-GCT GTC CAC AAA 
CAG GGT CT-3‟ (antisense; Fig 2.5). The primer set was designed to flank the DNA 
region of interest (between 1270-1531 bp of the hTRPV1 gene; see Fig), generating 
~260 bp of PCR product. Sequencing was performed at the Sequencing Facility of 
the MRC-CSC Genetics Core Facility (Imperial College, Hammersmith Campus, 
London, United Kingdom). 
 
 
 
 
 
 
Figure 2.5. Complementary DNA sequence between bases 1021-1660 of the open 
reading frame of the human TRPV1 and the location of the primer pair flanking the 
region of site directed mutation. *Nucleotides ACT (bases 1406-1408, shown 
underlined) correspond to codon 469, which is the desired region of site-directed 
mutation. The sense primer and anti-sense primer were designed to flank bases 1406-
1408. Arrows indicate direction of amplification.  
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After identifying the culture with the desired mutation, the DNA was re-
transformed into DH5alpha competent cells and grown in 200 ml Terrific Broth 
containing ampicillin, thus allowing relatively large amounts to be obtained which 
were used for transient transfection. Quigen Plasmid Maxi Kit (Quigen) was used to 
purify plasmid from bacterial cells. The Maxi kit is able to isolate plasmid DNA 
from an inoculated culture volume of 100-500 mls. The plasmid DNA was then re-
sequenced to confirm that the correct mutation had been achieved (Fig 2.6). 
 
 
Figure 2.6. Sequencing data of site directed mutation of codon 469 of the human 
TRPV1 gene. Codon 469 (bases 1406-1408, shown in bold) of the open reading 
frame encoding the hTRPV1 gene was subjected to site directed mutagenesis. Two 
mutants were made, changing the wild-type codon encoding threonine, to either 
alanine (T469A), or serine (T469S). The numbering of nucleotides and codons shown 
above the wild-type sequence is taken from the open reading frame of the TRPV1 
transcript and encompasses bases 1381-1441. The equivalent coding region for each 
of the two mutants, together with their in-frame translation products, is shown below 
this. Bases changed by site directed mutagenesis are shown in bold capitals and the 
resulting amino acid changes are underlined in bold. 
 
 
Once the haplotypes were made, whole-cell patch-clamp recordings were carried out 
during applications of various TRPV1 activators to see whether the change in a 
single amino acid could result in change in agonist-evoked TRPV1-mediated 
activity.  
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2.4  Agonist-activated cobalt uptake  
 
2.4.1 Theory of agonist-activated cobalt uptake 
 
 The agonist-activated cobalt uptake technique is a method of quantitatively 
analysing the extent of non-selective cation channel activation in neurons and other 
cells. The cells are placed in cobalt in solution with expectation, that their 
extracellular environment includes divalent cobalt cations (Co
2+
). When the cobalt-
permeable cation channels, are opened upon being stimulated by an agonist, these 
extracellular cobalt ions are drawn by their concentration and electrical gradients 
within the cell.  
 
Intracellular Co
2+
 ions may be precipitated by exposure to sulphide ions to form 
cobalt sulphide (CoS) by application of ammonium polysulphide ((NH4)2S) or 
mercaptoethanol (HSCH2CH2OH) solution. The extent of the resulting intracellular 
staining offers a measure of the extent to which the ion channels in question have 
been activated by the agonist, or putative agonist. The intracellular staining can be 
assessed visually, using a microscope, which is adequate where the technique is 
employed only to determine whether there has been agonist activation of the 
channels under investigation. Hence, it can be used as a histology technique in whole 
cell tissue sections in vitro to localise cobalt-permeable ion channels (Anderson and 
Josephson, 1983; Pruss et al., 1991; Williams et al., 1992; Yin et al., 1994; Nagy et 
al. 1994; Zhou et al., 1995; Toomim and Millington, 1998; Borbély et al., 2009). 
However, such visual assessment is inadequate where one seeks to investigate the 
existence of gradations in staining, i.e., this method can not be used to quantify the 
level of response in individuals cell (all or nothing approach). Hence, the 
development of a computer programme which measures on an arbitrary scale the 
extent to which individual cells absorb light (i.e., are discoloured). While the scale is 
arbitrary, it is, nevertheless, relative which is all that is required since the enquiry 
relates to the extent of comparative, rather than absolute, staining by precipitated 
cobalt ions.  
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 This technique was developed by Hogan then applied by Winter who showed 
the characterisation of capsaicin-sensitive neurones in the adult rat DRG cultures 
using cobalt-uptake staining (Hogan, 1983; Winter, 1987). The specificity of 
TRPV1-mediated cobalt-uptake is well established in DRG neurons (Winter, 1987; 
Wood et al., 1988; Nagy et al., 1993; Marin-Burgin et al., 2000; Sathianathan et al., 
2003; Wach et al., 2003; Singh Tahim et al., 2005). The selective and specific 
TRPV1 antagonist, capsazepine (Bevan et al., 1992), has also been shown to 
completely block the number of capsaicin-mediated cobalt labelled cells, which 
suggest that the cobalt entry into the cells is mediated through TRPV1 (Mahmud et 
al., 2009; Sathianathan et al., 2003; Singh Tahim et al., 2005). Furthermore, DRG 
neurons obtained from TRPV1 knockout mice fail to show cobalt labelling in the 
presence of capsaicin application (unpublished data from our laboratory, see Chapter 
Four). Cobalt ions that enter DRG neurons do not occur via voltage-gated channels, 
as potassium-evoked depolarisation in these channels does not result in cobalt influx 
(Nagy et al., 1993; Reichling et al, 1997).  
 
Subsequently, other cobalt permeable ion channels have also been identified. These 
include: the N-methyl-D-aspartate (NMDA) channel, some of the alpha-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) channel; and the non-NMDA 
kainate receptors of the ionotropic glutamate family (Chung et al., 2005; Malva et al., 
2003; Kim et al., 2001; Smeraski et al., 2001; Zhou et al., 1997; Simmons et al., 
1994; Pruss et al., 1991). Pruss and co-workers first showed that activation of kainate 
receptors causes Co
2+
 influx into neurons, type-2 astrocytes, and O-2A progenitor 
cells.  Based on the pattern of responses to kainate, glutamate, and quisqualte, it was 
possible to discriminate between three functionally different kainate-activated ion 
channels using this cobalt-uptake technique (Pruss et al., 1991). In the presence of 
the competitive non-NMDA glutamate receptor antagonist CNQX, the number of 
cobalt-stained cells was significantly reduced in taste cells (Chung et al., 2005). 
 
The TRPV1 ion channel is potently activated by capsaicin which is typically 
employed as an agonist to activate this channel. Therefore, the extent of capsaicin 
activation of these ion channels in the presence, and absence, of various substances 
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can be assessed using this technique. The standard protocol for cobalt labelling 
involves rinsing the cells twice for 2 minutes in a buffer without Co
2+
 followed by 
incubation for 5 minutes of the cells in buffer-containing cobalt, to which there has 
previously been added, sufficient capsaicin to allow for activation by capsaicin  of 
TRPV1 expressed by the cells.  The result is that the capsaicin activates these ion 
channels expressed in the cells in the presence of extracellular cobalt ions in solution.  
These cobalt ions thereby gain access to the cells, via the opened TRPV1 ion channel 
pores, where they discolour the cytoplasm when they are precipitated in the presence 
of sulphide ions.  The cells most discoloured are usually referred to as having been 
"labelled" as TRPV1-activated cells.  The precipitation is achieved after a brief 
rinsing of the cells in standard buffer followed by 1 minute incubation in ammonium 
polysulphide or mercaptoethanol solution. 
 
The extent to which TRPV1 ion channels are activated when challenged with 
different concentrations of capsaicin can be determined by examining the uptake of 
cobalt by individual cells as evidenced by the discolouration of the cells when seen 
with by a light microscope attached to a charge coupled device (CCD) camera (Leica) 
and a PC running the QWin software package (Leitz, Wetzlar, Germany). A CCD 
camera is designed to convert optical brightness into electrical amplitude signals and 
then reproduce the image of a subject using the electric signals. Following 
background subtraction, the area of the cells and their optical density, measured on 
an arbitrary scale between 0 and 255, are measured in 100-150 randomly 
systematically chosen neurons on each coverslip. With these settings, greater optical 
intensity values represent light, labelled cells, while smaller optical intensity values 
represent dark, non-labelled cells.  
 
Two buffers are necessary for cobalt-uptake. One buffer, named here as 
„Buffer A‟ contains (in mM): 57.5 NaCl, 5 KCl, 2 MgCl2, 10 HEPES, 12 glucose, 
139 sucrose, buffered to pH 7.4. The second buffer, named here as „Buffer B‟, 
consists of the same components as in Buffer A plus 5 mM of CoCl. The main 
concerns with the use of the cobalt uptake technique arise from the fact that the 
extracellular solution is not a physiological solution. In particular, it does not 
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comprise Ca
2+
; and, moreover, the concentration of sucrose in the buffer creates a 
hypertonic extracellular solution.  
 
The buffers first composed by Hogan (1983), which excluded Ca
2+
 ions to prevent 
these ions from competing with Co
2+
 for entry. Of course TRPV1 responses are 
affected by calcium, as calcium entry into the cell results in desensitisation/ 
tachyphlaxis (Koplas et al., 1997; Mohapatra et al., 2003). Therefore, in the absence 
of calcium no desensitisation/ tachyphlaxis occurs, hence during a 5 minute 
application of capsaicin in the absence of calcium, we assume no reduction of cobalt 
influx should occur. Furthermore, there is no known data on whether cobalt is able to 
induce any desensitisation or tachyphlaxis. Previous data show that cobalt used as a 
track tracer accumulates in the mitochondria (Székely et al., 1983). Similar 
mitochondria accumulation of cobalt could be observed after using cobalt uptake in 
neurons (Nagy, unpublished; Tanaka et al., 2004). This may suggest that cobalt may 
have significant effect of cell function/survival at longer incubation times. However 
within the five minutes of continuous application of cobalt-buffer to the cells, we 
assume no adverse effect occurs. In addition, it has been shown that cells activated 
by capsaicin for the first time in the absence of calcium, produce a larger current than 
in the presence of calcium (Docherty et al. 1996; Liu & Simon, 1996). This 
potentiation could not be explained purely to the lack of tachyphlaxis, because it 
needs time to develop (Schwarz et al., 2000). Therefore, the lack of competition from 
calcium could also contribute to an increased response. Docherty and co-workers 
studied the effect of capsaicin-induced Co
2+
 currents in DRG cells using whole-cell 
patch-clamp recordings. The experimental design consisted of a control I-V curve 
with Ca
2+ 
in the solution, which was then replaced with Co
2+
. Capsaicin was then 
applied in the presence of Co
2+
 to produce a test I-V curve. Their data showed that in 
Co
2+ 
solution capsaicin produced an inward current at -90 mV and an outwardly 
rectifying increase in membrane conductance. When capsaicin was washed out and 
Co
2+ 
was replaced with Ca
2+
, there was no recovery of the calcium current. 
Moreover, when Co
2+
 was used to substitute for Ca
2+
 in control experiments and 
capsaicin was not applied, then the current recovered 70% (Docherty et al., 1991). 
However, the effect of Ca
2+ 
and Co
2+ 
in varying ratios to test the effect of Co
2+
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current was not investigated. Hence, we cannot conclude whether there is any effect 
on calcium on cobalt entry. Nevertheless, since cobalt uptake here is used to find the 
proportion of responding cells, a putative increase in the cobalt entry in the absence 
of calcium, may be of benefit as it is easier to identify responding cells.   
 
 
It has been found that this (139 mM) amount of sucrose employed is necessary to 
maintain the cells in the buffer in a healthy condition (Winter, 1987). However, the 
nature of the extracellular buffer may be such as to activate mechanoreceptors 
resulting in influx of Co
2+
 via these channels. However, when the cells are ultimately 
visualised under the microscope, there is no evidence of cell lysis – a finding which 
has been consistently made in all of the experiments performed in this and other 
laboratory (Lever et al., 2009; Baiou, et al; 2007; Santhianata et al, 2003; Singh et al., 
2005; Sathianathan et al., 2003). Moreover, a 45 minute incubation of HEK cells in 
the Buffer A does not change the proportion of hTRPV1-expressing HEK cells 
responding to 10 nM-1 uM capsaicin (White et al., 2008). Furthermore, previous 
findings showed that the diameter of capsaicin-responding cultured DRG neurons 
measured by cobalt uptake is not different from that of TRPV1-expressing cultured 
and native DRG neurons (Lever et al., 2009; Baiou, et al; 2007; Santhianata et al, 
2003). This suggests that the ionic composition of the cobalt buffers were within the 
isosmotic (pressure of the fluid is equal to cell) range as the cells did not show 
shrinkage or swelling.  
 
If the buffers were indeed hypotonic or hypertonic the intracellular pressure may 
change and therefore might activate mechanoreceptors. While this is a possibility 
such activation does not affect my results because, when no capsaicin is added to the 
Buffer A which does not contain Co
2+
, the proportion of labelled cells is negligible. 
However a low proportion of cells are seen in controlled experiments when no 
agonist is applied, (Fig 2.7). This could be due to several factors. First, the labelled 
cells could represent unhealthy cells with leaking membranes. Second, cobalt in 
these cells could enter through to TRPV1, due to an increase open probability with 
unknown reason. Finally, if mechanoreceptors are cobalt permeable these cells could 
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represent mechano-sensitive cells. However, cobalt staining is abolished in the 
presence of a capsaicin selective antagonist (Singh et al., 2005; Sathianathan et al., 
2003) and no capsaicin-evoked cobalt-labelling occur in DRG cultures obtained from 
TRPV1-knock out mice (unpublished data, see Chapter Four).  
 
Agonist-activated cobalt-uptake technique is cheap, efficient, and entirely suitable 
for the limited purpose for which it has been employed in our experiments. This 
technique is able to study the number, in terms of a percentage of responding cells to 
stimuli of the ion channel. This method can not be used to quantify the level of 
response in individual cells. Thus, cobalt-uptake technique is inferior to calcium 
imaging, where intracellular calcium status of a cell can be analysed in real time. 
Nevertheless, an advantage of using this technique over calcium imaging when 
studying cultured cells is that a large field of cells can be examined at once. The 
technique can also be applied to cells in culture or slices, or to tissue explants, and 
allows the use of additional pharmacological agents as controls (Lee et al., 1998). 
Furthermore, cobalt-uptake technique can be combined with immunocytochemistry 
to provide a powerful tool to study the morphology and distribution of cells 
expressing receptors with ligand-gated Ca
2+
 channels (Winter et al., 1987; Nagy et 
al., 1994; Carriedo et al., 1995; Yoshimura et al., 1998; Yoon et al., 1999; Chung et 
al., 2005; Ikenaga et al., 2006; Huesa et al., 2008). 
 
 
2.4.2 Practical application of agonist-activated cobalt-uptake 
 
Cobalt-uptake assay was used on hTRPV1-transfected HEK293 cells and 
DRG cultures to assess functional TRPV1 activity in those cells. Two buffers were, 
referred to here as Buffer A and Buffer B.  Buffer A contained in mM: NaCl, 57.5; 
KCl, 5; MgCl2, 2; HEPES, 10; glucose, 12; sucrose, 139; pH 7.4). Buffer B 
contained Buffer A components plus the addition of 5 mM CoCl2. The standard 
protocol for cobalt-uptake assay involved rinsing the cells twice for two minutes at 
37 
o
C in Buffer A, to remove growth medium and extracellular Ca
2+
 ions. The cells 
where then incubated the cells in cobalt-uptake Buffer B either alone, or in the 
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presence of a TRPV1 activator, for 5 minutes at 37
o
C. TRPV1 expressed in the cells 
were activated upon addition of an agonist, thereby inducing channel opening. Cobalt 
ions in the buffer entered the cell via the open pore.  Following one further brief 
washes for two minutes at 37
o
C in Buffer A to wash out cobalt from the extracellular 
fluid, the water-soluble cobalt taken up by the cells was precipitated by 0.4 % 
mercaptoethanol (Sigma) dissolved in Buffer A for 1 minute (see Fig. 2.7). This 
resulted in the formation of dark, water-insoluble cobalt-sulphide in the cytoplasm of 
activated cells. The cells were then fixed in 70% ethanol and mounted on glass slides 
using glycerol for analysis.  
 
 
Figure 2.7 General procedure when carrying out cobalt-uptake assay to investigate 
functional TRPV1 activity in TRPV1-expressing cells. 
 
 
2.4.2.1 Data analysis of agonist-activated cobalt-uptake 
 
 The analysis of cobalt-uptake was performed as described by Singh Tahim 
and colleagues (2005) using a Leica light microscope attached to a CCD camera 
(Hamamatsu, Japan) and a PC running the QWin software package (Leica, Wetzlar, 
Germany). A charge coupled device (CCD) camera is designed to convert optical 
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brightness into electrical amplitude signals and then reproduce the image of the 
subject using the electric signals.  This analysis is based on measuring the optical 
density of defined pixels of digitised grey scale images and using a statistical 
approach to differentiate the sub-population with different optical intensity. Using 
this approach meant bias and error due to miss recognition of lightly labelled cells as 
cobalt-responding cells were avoided. Background subtraction must be performed to 
avoid errors due to differences in the illumination of various parts of the visual field 
produced by possible misalignment of the optical axis of the microscope. These 
differences due to misalignment could be as big as 5 arbitrary units on a 0-255 scale. 
This background subtraction results in an inverted image, with unlabelled cells 
having a dark appearance while labelled cells having a white appearance. The 
software package is able to measure the darkness and lightness (shade) of pixels on a 
0-255 scale. In order to obtain quality inverted images, the light intensity of the 
visual field before the background subtraction was set around 200 arbitrary units. 
The condenser was lowered in order to see unlabelled cells. After the background 
subtraction, minor adjustments of the illumination were sometimes necessary to 
obtain a quality picture on the computer screen attached to the microscope. The 
setting of the illumination and position of the condenser was kept constant for the 
duration of analysis of each of the culture. Visual fields were randomly and 
systematically chosen and images were taken. Images were stored on the hard disk 
and analysed off line. In each coverslip the light intensity of at least 100 cells was 
measured.  
 
 The light intensity data were copied into Origin statistical software 
programme, where the frequency distribution of the light intensity values was 
computed.  The agonist-activated cobalt-uptake assay was employed on hTRPV1-
transfected cells and mouse DRG cultures neurons. Identical analyses were 
conducted, except cultured DRG neurons light intensity frequency distribution graph 
were fitted with three Gaussian curves when an agonist was present in cobalt-
containing Buffer B, while hTRPV1-transfected cells were only fitted with two 
curves.  
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2.4.2.1.1 Data analysis for hTRPV1-transfected HEK293 cells 
 
For each round of hTRPV1-transfected HEK293 cells, the frequency distribution of 
the optical intensities in the negative control (absence of TRPV1 activators) 
experiments was generated. The histogram of the HEK293 cells in these negative 
experiments were symmetrical bell-shaped with one peak, thereby suggesting that 
these cells have a normal distribution. This distribution could be fitted with one 
Gaussian curve (r
2
>0.95) using the Origin software package (Fig. 2.8C), which 
confirmed that the distribution was normal. These were unlabelled cells. The 
histogram of the optical intensities of the cells incubated in the presence of a TRPV1 
activator (capsaicin, proton or heat, i.e. positive control) showed a distinct bimodal 
distribution.  I found that in the case of HEK293 cell the light intensity of labelled 
cell could be fitted with two Gaussian curves (Fig. 2.8D).  
 
The cut off optical intensity value which distinguished between labelled and non-
labelled cells was determined in experiments. In normally distributed variables the 
average ± 2 standard deviation of the population covers 95% of the total number of 
the population. Thus, this establishes the cut-off value between the labelled and 
unlabelled cells, with a 5% error. (For further detail, see Chapter Two: Statistical 
Analysis).The mean optical intensity values
 
for cobalt-labelled cells were higher than 
the mean optical intensity values
 
for unlabelled cells. After determining the 
percentage of cobalt-labelled cells in each treatment, the mean value for each 
protocol was calculated from experiments performed on at least 3 independent 
different cell passages.  
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Figure 2.8. Analysis of cobalt-uptake assay on hTRPV1-transfected HEK293 cells. 
(A) Inverse image of cells incubated in the presence of CoCl2 alone shows very few 
labelled cells. (B) Inverse image of cells incubated in the presence of 500 nM 
capsaicin and CoCl2 shows cobalt-labelling in a large number of cells. (C) An 
example of the distribution of optical intensities on hTRPV1111-transfected cells 
incubated with only CoCl2 buffer. The graph is fitted with one Gaussian curve 
indicating the presence of only one population of cells with a normal distribution of 
optical intensities (r
2
>0.95). (D) The distribution of optical intensities incubated in 
CoCl2 buffer and 500 nM capsaicin. The frequency distribution of optical intensities 
is fitted with two Gaussian curves indicating the presence of 2 populations with a 
normal distribution of optical intensities (r
2
>0.95). The dash line on (D) represents 
the cut-off optical intensity which discriminates between labelled and non-labelled 
cells.  Scale bars represent 50 µm in figure (A) and (B). 
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2.4.2.1.2 Data analysis for mouse DRG culture 
 
 In each mouse DRG culture, the frequency distribution of the optical 
intensities in the negative control experiments (absence of TRPV1 activators) were 
created and fitted with two Gaussian curves, indicating the presence of two sub-
populations of cells (Fig. 2.9A and B). The reason for the presence of these sub-
populations regarding the optical intensity of the neurons is not clear. Histological 
staining of DRG cells differentiates light large and dark small cells in DRG sections 
(Lieberman 1976; Winter, 1987; Kitao et al., 1996). However, analysis of the cell 
size in the unlabelled subpopulation did not reveal a correlation between cell size and 
optical intensity (Sathianathan et al., 2003). 
 
The distribution of the optical intensities of the positive control (capsaicin) could be 
fitted with three Gaussian curves, where the third population represented the cobalt-
labelled cells (Fig. 2.9C and D). The mean optical intensity values for cells in the 
third subpopulation were higher than those for the two other subpopulations in both 
experiments and represented labelled cells. The cut-off optical intensity value which 
distinguished between labelled and unlabelled cells was determined on the positive 
control as the lower range of a 95% confidence interval for the third Gaussian curve 
(labelled cells). This value was employed in all coverslips from the respective 
cultures. The percentage of cobalt-labelled cells for each protocol was calculated 
from experiments performed on at least three different rodents. 
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Figure 2.9 Analysis of cobalt-uptake assay on mouse DRG cells. (A) Incubation of 
cells in the presence of 5 mM CoCl2 results in none or very few labelled cells. (B) 
The distribution of optical intensities of neurons incubated in the presence of 5 mM 
CoCl2 shows the presence of two, largely overlapping, sub-populations of neurons, 
with only very few labelled cells (circled). (C) Image of neurons incubated with the 
addition of 500 nM capsaicin to the 5 mM CoCl2-containing buffer results in dark 
cobalt-labelling in a proportion of cells. The arrow indicates a labelled cell. (D) The 
distribution of the optical intensities of cells incubated in the presence of 500 nM 
capsaicin and 5 mM CoCl2 shows the presence of three populations; two, largely 
overlapping sub-populations, and a third, separate sub-population representing 
labelled cells. Dashed line on (D) indicates the cut-off optical intensity that 
differentiates between labelled and non-labelled neurons. 
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2.5  Whole-cell patch-clamp recordings 
 
 
2.5.1 Introduction to whole-cell patch-clamp recording 
 
 
Whole-cell patch-clamp recording is a technique which is routinely used by 
electrophysiologists to study the properties of ion channels in living cells. The patch 
clamping technique is a derived technique from the voltage-clamp configuration. 
During voltage-clamp recordings, currents necessary to maintain a defined 
membrane potential is measured. This current, if there are no leakage currents, is 
equal to the currents flowing through ion-permeable membrane pores. Since the 
membrane is maintained, this current is directly proportional to the membrane 
conductance of the channel. Gating of ion channels, whether through voltage- or 
ligand-dependence, results in changes in the membrane conductance. 
 
The voltage-clamp technique was introduced initially by Cole in the late 
1930's and was further developed by Hodgkin & Huxley (1952). They first described 
a two-electrode voltage-clamp set-up to study the ionic conductances of the giant 
squid axon. For this, one electrode functioned as a voltage sensor to record the 
transmembrane, whilst the second electrode served as a current source to pass current 
to the cell. Sharp electrodes (open tip diameter of 0.2-0.5 µm) are inserted into a cell 
and are connected through a feedback amplifier whereby any change in the 
membrane potential detected by the voltage electrode result in a current injection by 
the current electrode to maintain the voltage at a constant level (Fig. 2.10). In 
response the circuit produces a current injection equal and opposite to the ionic 
current. This can be measured. It is assumed that the current flow through the current 
electrode is the exclusive flow across the membrane.  
 
A major disadvantage of this set-up is the requirement that two electrodes be placed 
within a cell, which often result in leakage of the intracellular fluid and a large 
electrical conductance across the plasma membrane. Furthermore, its application is 
limited to large cells of > 20 µm and to the study of cells embedded in tissue; 
therefore this technique is unfeasible (Sontheimer and Ransom, 2002). 
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Figure 2.10 The main components of a two-electrode voltage-clamp set-up. The 
output of the left amplifier is the difference in potential between the bath and the cell 
electrodes (Taken from Stuhmer, 1997). 
 
A single-electrode voltage-clamp was developed in an attempt to solve this 
problem. This allows the use of one sharp electrode to serve as the current and 
voltage electrode, in an alternating manner. However, this set-up is limited by time 
its time resolution as a result of the switching between the two modes (Sontheimer 
and Ransom, 2002).  
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The patch-clamp technique also uses one electrode to continuously measure 
the membrane potential and inject current to clamp the voltage at a constant level 
(Fig 2.11: Hamill et al., 1981; Neher and Sakmann, 1976). To measure small 
membrane currents using this technique requires a low-noise recording set-up. This 
is achieved by tightly sealing a glass electrode, referred to as patch electrode, on to 
the plasma membrane of an intact cell. Patch electrodes have relatively blunt but 
smooth ends (open tip diameter of 1-2 µm). The tip of the electrode is pressed 
against a plasma membrane and suction is applied to pull the membrane inside the tip 
of the electrode. The suction results in a tight seal between the patch electrode and 
the plasma membrane. These tight seals have an electrical resistance in the range of 
giga-ohms (10
9
 ohms), and are referred to as either a gigaseal or a gigaohmseal. 
 
  
Figure 2.11 Diagram of the main components of a patch-clamp configuration using 
one electrode. The patch electrode is filled with saline (intracellular) solution and 
inserted over silver-chloride coated silver wire. The patch electrode forms a gigaseal 
with the plasma membrane of the cell, which not only prevents leak currents flowing 
between the patch electrode and the reference ground electrode, but also inhibits 
flooding of the cell with the bath solution. This configuration is referred to as cell-
attached patch, where a single ion channel‟s membrane current can be recorded. The 
signal input refers to the ground electrode which is placed in the superfusing 
extracellular solution. The ground electrode is made from silver-chloride coated 
silver wire. Both the patch and ground electrode are connected to a feedback 
amplifier, which allow the small signal from the cell to be detected. The patch-clamp 
output of the amplifier is the difference in potential between the patch and the bath 
electrodes. (Taken from Aidley and Stanfield, 1996).  
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Ag/AgCl electrode 
 
It is important to note that the patch electrode is not an electrode, per se. The 
electrode is a solid electric conductor, typically made from a silver-chloride coated 
silver (Ag/AgCl) wire, referred to as Ag/AgCl electrode. The patch electrode filled 
with intracellular solution covers the wire. The Ag/AgCl electrode enables electrical 
current to leave and enter the set-up (Fig 2.12). 
 
 
  
 
 
Figure 2.12 The Ag/AgCl electrode. Currents are able to flow in both direction of 
the electrode. (Taken from Axon Guide, 2008).  
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Due to the robust nature of a gigaseal, different configurations of the plasma 
membrane in relation to the patch electrode are achievable. These include: (i) cell-
attached; (ii) inside-out; (iii) whole-cell patch-clamp; and (iv) outside-out 
configuration (Fig 2.13). 
 
 
 
 
 
 
Figure 2.13 Four configurations of patch-clamp technique. (A) Cell-attached is a 
result of a tight seal between the patch electrode and the plasma membrane. (B) 
Inside-out patch is achieved by retracting the patch electrode in cell-attached mode, 
which causes a small piece of the membrane to remain attached to the electrode. The 
internal membrane surface is exposed to the extracellular bath solution, whilst the 
external membrane surface faces the intracellular pipette solution. This configuration 
is useful when studying channels that are activated by intracellular ligands. (C) 
Whole-cell patch configuration is obtained if the membrane patch within the patch 
electrode is ruptured in cell-attached mode by a brief suction (by mouth or with a 
syringe). This results in the interior solution of the patch electrode becoming 
continuous with the cytoplasm of the cell.  (D) Outside-out patch is achieved by 
retracting the patch electrode in whole-cell mode. This causes a small piece of the 
membrane to remain attached to the electrode. The patch of membrane will be 
oriented with the internal membrane surface exposed to the intracellular pipette 
solution, the external membrane surface is submerged with extracellular bath 
solution. This set-up allows the study of ion channels isolated from the cell, which is 
particularly useful when investigating channel activity influenced by extracellular 
chemical signals. Taken and adapted from Fulton, 2000 and Purves et al., 2000.   
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Cell-attached patch-clamp configuration enables recordings of membrane currents 
flowing through a single ion channel, known as single-channel recording. Access to 
the cytoplasm of the cell is obtained as the membrane within the patch selected is 
perforated. This configuration allows the measurement of membrane currents from 
the entire cell and therefore is referred to as whole-cell patch-clamp recording. In my 
experiments whole-cell patch -clamp was used. 
 
 
2.5.2 Biophysics of whole-cell patch-clamp technique  
 
In order to understand the basis of whole-cell clamped membrane currents 
and data obtained by the whole-cell patch-clamp technique one must first understand 
the electrical properties of excitable cells and some principles of electricity. The 
electrical properties of an excitable cell are derived primarily from (i) the ion 
channels in the plasma membrane; (ii) the lipid bilayer of the plasma membrane; and 
(iii) the ionic composition of the intracellular and extracellular solution on either side 
of the plasma membrane.   
 
2.5.2.1 Ion channels 
 
Ion channels are large membrane proteins, with several subunits which contain 
amino acid chains that move back and forth across the membrane. Ion channels form 
transient pores which connect the interior and exterior side of the lipid membrane. 
The transient pore forming property of ion channels permit transit of ions across the 
plasma membrane according to theconcentration and electrochemical gradient. In 
many channels part of this protein forms a molecular gate that opens and closes the 
channel in response to stimuli. Hence these channels are referred to as gated 
channels. There are hundreds of different ion channels and they are distinguished on 
the basis of their sequence similarity, ion selectivity (Na
+
 selective, K
+
 selective, 
Ca
2+
 selective, Cl
-
 selective and non-selective), and gating mechanism. Ion channels 
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maybe gated by one or more, of the following, namely: voltage, ligand, pH, 
mechanical pressure, or temperature.  
 
Since ion channels form transient pores which allow ions to cross the membrane 
when opened they can be regarded as conductors. Their conductance changes from 0 
(in closed state) to a characteristic value (in open state). Conductors allow free 
movement of charged particles and therefore allow flow of ion currents. Charged 
particles, such as electrons, are moved along a conductor by the potential difference 
existing between the two ends of the conductor. The potential difference is created 
by the separation of the positive and negative charges.  
 
The relationship between the current of the charged particles, the potential difference 
and the ability of the conductors to allow the current to flow is described by Ohm’s 
law (Fig 2.14). 
 
V = I x R 
 
where I is the electric current (the flow of electric charge measured in amperes); V is 
the voltage or the potential difference (the difference of electrical potential between 
two points of an electrical circuit measured in volts) and R is the resistance of the 
conductor (the property which restricts the flow of electric current measured in 
ohms). 
 
Hence, R is inversely proportional to conductance G (the ease of flow of current 
between two points along an electrical circuit, measured in siemens).  
 
Thus: 
 
G = 1/R = I/V 
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Figure 2.14 Ohm‟s law. Ohm‟s law states that there is a linear relationship between 
current I and voltage V. This law also specifies that the conductance G is constant.  
Hence the slope of the line yields the conductance. Conductance is the reciprocal of 
resistance R. When currents are measured across a membrane, by convention: an 
outward current is the flow of positive ions from the inside of the cell to the outside; 
and an inward current is the flow of positive ions from the outside of the cell to the 
inside. The reversal potential Vr is the membrane potential where there is no net 
current, the outward and inward are the same (Adapted from Golan et al., 2007). 
        
 
As already mentioned ion channels can be regarded as conductors/ resistors 
and their resistance/conductance alters between two values. Ion channels are either 
(a) in a zero conductance and indefinite resistance state, called the „closed state‟, or 
(b) in a maximal conductance and minimal resistance state, called the „open state‟ 
(Fig 2.15). The probability of being in an open or close state is described by the open 
probability Po. The Po is 0 if the channel is in a closed state at all times and Po is 1 if 
the channel is in open state at all times. 
Inward current 
Outward current 
Positive potentials Negative potentials 
 
I 
 
Vr 
 
 
 
 
V 
R= V/I 
 
G= I/V 
 
G= 1/R 
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Figure 2.15 Schematic diagram of an idealised single channel recording. A channel 
opens and closes in a stochastic (random) manner. Each opening of the channel 
results in a current influx of the same amplitude. When the channel goes from a 
closed to an open state, a step change in the current indicates a single channel current 
(i). Taken from Levitan and Kaczmarek, 1986. 
 
 
Furthermore, in whole-cell recording, when all the ion channels on a plasma 
membrane are activated or opened, the whole-cell total conductance Gtotal is the 
product of the number of ion channels N, and the single-channel conductance g, (see 
Fig 2.16 ).  
  
G total  =  N g 
 
 
 
Figure 2.16 Ion channels as a parallel circuit. Ion channels on a membrane may act 
as parallel conductors hence the total conductance Gtotal of a cell can be calculated by 
adding all the single ion channel conductances g (Adapted from Axon guide, 2008). 
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A single-channel conductance is a measure of the current that flows through an open 
channel in response to a given electrochemical driving force. The electrochemical 
driving force, ΔV, is the electrical and chemical driving force that moves ions. The 
electrical driving force depends on the electrical potential difference across the 
membrane. The chemical driving force depends on the concentration gradients of 
specific ions across the membrane. The electrochemical driving force is defined as 
the difference between reversal potential Vr and the membrane potential Vm.   
 
ΔV= Vm - Vr 
 
As ion channels open and close, the conductance changes and so does the current. 
The current that flows through all the open channels can further be defined as: 
 
I = N g (Em – Vr) 
 
Therefore, the whole-cell current is proportional to the number of open channels at 
any given time and each open channel can be considered as an increase in 
conductance.  
 
The plasma membrane expresses thousands of channels of the same type. 
While the open probability during activation is similar, their opening and closing is 
not synchronised. As a result, the whole-cell conductance or resistance produced by 
the activity of the same type of ion channel cannot be described by a two state model, 
i.e. open and close state.  
I = pN g (Em – Vr) 
 
Since p is the open probability which follows Boltzmann distribution, the 
whole cell conductance must follow it.  
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The Boltzmann distribution function is defined as: 
 
 
 
where G is the whole-cell conductance which can be defined between two values: (i) 
the minimum value which is the result of P=0; and (ii) the maximum value which is 
the result of P=1.  Gmax is the maximum conductance with a minimal resistance; Gmin 
is the minimum conductance with an indefinite resistance; and A1/2 is the strength of 
activator which produces half maximal conductance which is in between Gmin and 
Gmax; Vm is the membrane potential; and slope is the steepness of the curve.  
 
2.5.2.2 Lipid bilayer  
 
Ion channels are situated in the lipid bilayer. The lipid bilayer of the plasma 
membrane is not permeable to ions. Hence, it is a poor conductor of ionic current. 
The lipid bilayer behaves like an insulator which strongly resists the flow of ionic 
current.  
 
2.5.2.2.1 Compensating the capacitive transients 
 
It should be taken into account that during whole-cell patch-clamp recordings, whilst 
the cell is at rest, the electrical properties of the cell do not change with time. As long 
as the membrane potential remains constant, the lipid bilayer‟s capacitance is 
negligible. If the voltage changes as a result of ion channel opening, steady-state 
0 
1 
A1/2 
Strength of Activator  
G/Gmax 
g = 
G max  - G min 
1 + exp ((A1/2 - A )/ slope) 
+  G min 
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currents in addition to transient capacitive currents, pass through the open channels. 
These capacitive currents must there for be compensated. 
 
 
A capacitor is an electrical device able to store charge. Capacitance is a measure of a 
capacitor‟s ability to store charge in an electrical field. The amount of charge 
(measured in coulombs, symbol Q) stored by a capacitor is given by: 
 
Q (coulombs) = C (farads) x V (volts) 
 
The presence of capacitance at the amplifier input originates from several 
sources. These include: (i) the capacitance across the glass wall of the electrode 
immersed in solution; (ii) the stray capacitance from the rest of the electrode to 
nearby grounded surfaces; (iii) the stray capacitance from the electrode holder; and 
(iv) the capacitance to the ground at the input of the buffer (Axon Guide, 2008). The 
capacitance from these sources needs to be compensated for because otherwise the 
recording bandwidth is reduced. The bandwidth describes the difference between the 
highest and lowest frequency of the recording. The difference between the bandwidth 
and the frequency is referred to as the frequency of sampling. Reduced bandwidth 
therefore reduces the frequency of sampling, making it difficult to measure rapid 
currents during voltage steps or ramp protocols. Typically, during whole-cell 
recordings the capacitive current was compensated between 70 and 90 %. 
 
 
2.5.2.3 Ionic distribution  
 
An electrical potential difference („membrane potential‟) exists between the 
interior and exterior of the plasma membrane, as no single ion species is distributed 
equally on both sides of the membrane of the cell. At rest, an excitable cell has an 
electrical charge as the outside of the membrane is positively charged, whilst the 
inside of the membrane is negatively charged. This is because the outside of the cell 
contains an excess of Na
+
 and the inside of the cell contains excess of K
+
 and A
- 
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(organic anions). Large organic anions are negatively charged proteins and nucleic 
acid molecules which inhabit the cell but are unable to permeate the cell membrane; 
hence the inside of the cell is more negative when compared to the outside. This 
separation of charges is maintained because of the properties of lipid bilayer of the 
membrane which prevents the diffusion of ions across the membrane and carrier 
molecules. Carrier molecules are essential, as without them the membrane potential 
would not be maintained.   
 
The resting membrane potential describes a steady-state condition where there is no 
net flow of electrical currents across the membrane. The resting membrane potential 
is determined by the intracellular and extracellular concentration of ions to which the 
membrane is permeable and is also affected by the osmotic pressure and electrostatic 
forces. 
 
The voltage/electrical potential of a cell membrane required to oppose the flow of 
any given ion X is called the equilibrium potential (EX) and maybe calculated by the 
Nernst equation which is as follows: 
 
EX =  
RT
/zF  In 
[X]o
/[X]i 
 
where R is the gas constant (8.3143 J/mol/K), T is the temperature in Kelvin, z is the 
valence of the ion, F is the Faraday constant (9.65 x 104 coulombs per mol) and [X]o 
and [X]i are the concentrations of  ions outside and inside the cell.                                                                                                                                                                                                                                                                               
 
 
The Nernst equation is applicable in situations where only one ionic species flows 
across the plasma membrane. However, many cells contain several different ion-
selective channels all of which contribute to the overall resting membrane potential. 
The resting or equilibrium potential is influenced by each species of ions. The 
movement of each species of ions is governed by its concentration on the inside and 
outside of the cell and by the permeability of the membrane to that ion type. The 
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Goldman-Hodgkin-Katz equation describes this relationship between ion species and 
the cell membrane. The equation below refers only to monovalent ions 
 
 
 
where Erp is the resting membrane potential, R is the gas constant, T is the 
temperature in Kelvin, z is the valence of the ion, F is the Faraday constant,  PX is the 
membrane permeability of ion X, [X]o and [X]i are the concentrations of the ion 
outside and inside of the cell.  This equation generally states that the higher the 
concentration of a specific ion type, the greater its membrane permeability, the 
greater its role in determining the membrane potential. Thus, when an ion-selective 
channel opens the membrane potential is driven toward the Nernst potential for that 
specific ion.  
 
In practice, during electrophysiology recordings the ionic compositions of the 
intracellular and extracellular solution in vitro in which the cells are placed are 
controlled.  The ionic compositions of my normal electrophysiology solutions used in 
this study were the following: extracellular solution consisted of (mM): NaCl, 130; 
KCl, 5; CaCl2, 2; MgCl2, 2, adjusted to pH 7.4. Intracellular solution consisted of 
(mM): NaCl, 5; KCl, 130; MgCl2, 1.26. Using the Goldman-Hodgkin-Katz equation, 
the resting membrane potential for HEK293 cells maintained in these solutions was 
~-60 mV. 
 
In whole-cell voltage clamp experiments, the membrane potential of the cell was 
clamped or held at a pre-determined level. In these experiments the Vm was held at – 
60 mV and the transmembrane current required to maintaining this voltage was 
measured.  
 
Erp  = 
RT
/F In 
PK [K
+
]i PNa [Na
+
]i PCl [Cl
-
]o + +  
PK [K
+
]o PNa [Na
+
]o PCl [Cl
-
]i  + +  
117 
Due to the electrical properties of the plasma membrane of the cell, the plasma 
membrane can be modelled in terms of an electrical circuit containing resistors and 
capacitors, as shown in Fig 2.17. 
 
 
 
 
Figure 2.17 A single membrane ion channel as circuit.  The cell membrane can be 
modelled as an electric circuit containing a resistor and a capacitor. Ion channels 
function as resistor (identical to conductors), through which ions flow down their 
electrochemical gradient. This RC (resistor-capacitor) circuit changes the timing 
between the flow of current and changes the voltage because of the lipid bilayer 
which acts as a capacitor as it stores some of the charge that passes across the 
membrane (Adapted from Axon guide, 2008). 
 
 
2.5.2.3.1  Compensating for series resistance  
  
Another issue that should be noted when using the whole-cell patch-clamp technique 
is the series-resistance of the configuration. That is, only one patch electrode is used 
for both voltage recording and current passing.  
 
Series- resistance is the sum total of the resistance of the resistors in a series in an 
electrical circuit. The total resistance (Rtotal) of a series circuit where the electric 
current flows through a single path can be defined as the sum of each individual 
resistance (R) of each component in the circuit: 
Lipid bilayer Ion channel 
Outside 
Inside 
+ + + + + + + + + + + 
- - - - - - - - - - - - - - - 
Lipid bilayer 
Resistor /conductor 
(ion channel) 
Outside 
++++++ 
 - - - - - - 
+ 
- 
- 60 mV 
Capacitor 
(lipid bilayer) 
Inside 
Battery 
(electrochemical force) 
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Rtotal = R1 + R2 + R3 …… + Rn 
 
 
In an ideal configuration, the resistance of the patch electrode in whole-cell 
recordings will equal 0 ohm. However, due to time resolution for measuring current 
and altering the membrane potential, to maintain resting holding potential is limited 
to the speed of the electronics in the configuration. Series-resistance compensation 
reduces the patch-clamp error due to the voltage drop across the resistance of the 
electrode, thus reducing the effect of the pipette resistance. However, compensation 
is never perfect due to practical applications (Axon Guide, 2008). Typically, during 
whole-cell recordings the series resistance was compensated between 70 and 90 %. 
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2.5.3  Practical components of whole-cell patch-clamp recordings 
 
Briefly, TRPV1-mediated currents were measured using the conventional 
whole-cell patch-clamp technique with an Axopatch 200 B amplifier (Axon 
Intruments, Inc. Fig 2.18) and the pClampex 8 software package with a laboratory 
PC for storing and evaluating data. All experiments were performed at physiological 
temperature of 36-37 
o
C using a temperature controller (Wavelength Electronics). 
The membrane potential was held at - 60 mV. Data was collected using the 
pClampex 8 software package and analysed using the Clampfit data analysis 
programme (Axon Instruments Ltd). If the membrane current following the 
establishment of whole-cell configuration was more than -0.5 nA the cell was 
discarded.  
 
 
 
 
 
Figure 2.18 The main components of a patch-clamp set-up. The patch electrode is 
attached to the amplifier headstage. (Aidley and Stanfield, 1996) 
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2.5.3.1 Solutions 
 
The normal extracellular buffer for patch clamp consisted of (mM): NaCl, 
130; KCl, 5; CaCl2, 2; MgCl2, 2; glucose, 10; HEPES, 10; adjusted to pH 7.4.  
 
Patch electrodes were filled with normal intracellular buffer for patch clamp 
which consisted of (mM): NaCl, 5; KCl, 130; MgCl2, 1.26; HEPES, 10; adjusted to 
pH 7.4.  
 
2.5.3.2 Patch Electrodes 
Patch electrodes were pulled from borosilicate glass capillaries (1.5 mm outer 
diameter and 0.86 mm inner diameter: Harvard Apparatus Ltd, Kent, UK) by a two 
stage-puller using a DMZ-Universal 2-Stage Puller (DMZ, München, Germany; see 
Fig 2.19). For whole-cell patch-clamp recordings, the patch electrodes were pulled to 
have relatively blunt ends (1-2 µm: see figure e) with low-resistance of 4-6 Mohm in 
order to achieve and maintain mechanically stable electrode-membrane gigaseal 
(Sontheimer and Ransom, 2002). 
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Figure 2.19 Schematic diagram of the fabrication of patch electrodes using a two-
stage vertical puller. (a) A glass capillary is placed between the two clamps on the 
puller, so that it is roughly in the middle. (b) The pre-programmed automatic system 
is initiated. The right and left clamp closes, clamping the capillary into place. The 
puller pulls the capillary apart, as the heated metal filament starts to melt the glass. A 
two-stage puller mechanism is used. The first pull softens the glass and pulls it a 
short distance to thin the capillary, after which the second pull breaks the capillary, 
thus producing two patch electrodes (c) and (d) (Penner, 1995).  Before each of the 
electrodes were removed from the puller and placed into a electrode holder, a final 
heat polishing step is used to smooth the edges of the tip.  (e) An unpolished 27 µm 
giant patch electrode. (f) A polished patch electrode with smaller tip end. (Taken 
from www.dagan.com/puller.htm). 
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 Prior to use, each electrode was filled, with standard intracellular buffer using 
a syringe and a fine needle (diameter less than 0.86 mm), making sure that no air 
bubbles were present. If air bubbles remain at the tip, the electrode resistance will be 
extremely high. The electrode was then inserted over the silver-chloride coated silver 
wire, into the electrode holder of the Axon headstage (Axon Instruments), making 
sure the wire is in contact with the solution inside electrode. The electrode was 
tightly screwed to fix into position, forming an  air-tight seal. The electrode holder is 
attached to a tube connected to a syringe which is used as a suction line to aid in 
forming a gigaseal. The headstage sends the signal recorded by the electrode to the 
amplifier. The headstage unit is attached to 3D moveable platform (micro-
manipulator) that can be controlled manually, for macro-movements and 
electronically, for micro-adjustments. 
 
2.5.3.3 Perfusion system and drug application  
 
For drug application, a system designed the enable to exchange of solutions, 
as well as to control the temperature of the superfusate, was used (Fig. 2.20). It 
consisted of a manifold, connected to the outlets of 6 solenoid valves. The perfusion 
system also contained a heat exchanger unit, which was able to heat, or cool, the 
superfusate to a specific temperature and was able to produce heat ramps at a desired 
range. The heat exchanger unit contained a semi-conductor thermoelectric device 
which works on the Peltier effect: when supplied with a suitable electric current, it 
pumps thermal energy from one side to the other which means that one side of the 
device is heated up, while the other is cooled down. One side of the thermal electric 
device was fitted with a silver heat exchanger block which contained a channel 
through which the superfusate flowed. The inlet of the heat exchanger block was 
connected to the outlet of the manifold. The outlet of the heat exchanger block was 
connected to a small delivery tube of 250 µm inner diameter. The end of this delivery 
tube was positioned at ~100 µm from the cell from which the recording was made. 
The valves were switched through a controller which was connected to the PC. The 
delivery tube contained a miniature thermocouple which was connected to an 
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electronic thermometer with an analogue output. The analogue output of the 
thermometer was connected to the PC through an AD interface, so that the 
temperature of the superfusate during the time of the recording can be traced. Each of 
the 6 tubes were connected to a reservoir containing solution separated from the tube 
by a valve that was closed under resting conditions. This arrangement allowed 
automated drug applications, and temperature-ramp applications, all of which was 
controlled by the Clampex 8 software package. The heat exchanger block was fitted 
with a thermocouple connected to the controller unit (Wavelength Electronics). A 
low-noise recording set-up was achieved by placing the parts of rig, particularly the 
microscope and the headstage, on top an anti-vibration table surrounded by a Faraday 
cage to minimise such interference from microscopic movements and vibrations, and 
to prevent environmental electromagnetic noise from entering the circuit. The anti-
vibration table (Newport Corporation) works on the basis that pressurised gas has far 
superior vibration isolation properties compared to any sold material. Thus, the 
tabletop of the anti-vibration table is kept afloat by air cushions in the table legs from 
a pressurised gas source (Molleman, 2002).    
 
 
 
 
A 
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 Figure 2.20  
 
Figure 2.20 Perfusion system of the electrophysiology set-up. (A) The ends of tubes 
A are placed in test tubes containing buffer or drug solution. The tubes go through a 
peristaltic pump and are subsequently linked to connection B. The peristaltic pump 
controls the flow of the fluid circulating in the perfusion system at a smooth and 
constant flow at constant pressure. (B) Connection B is linked to 5 ml syringes 
reducing the bubbles entering the rest of the perfusion set-up. The cylinders are 
linked to connection C. (C) Connection C is connected to electromagnetic (solenoid) 
valves which control drug application automated by the PC. The end of the valves is 
linked to a manifold which connects 6 tubes to one tube which then enters the heat 
exchanger unit. The heat exchanger heats the buffer to the required temperature, 
before the superfusate enters the recording chamber. Waste is removed via 
connection E by another peristaltic pump. (D) The electromagnetic valves have two 
configurations: (i) The solution from connection C enters the manifold then the heat 
exchanger unit, before entering the recording chamber; (ii) The solution from 
connection C is linked to connection D which is placed back to the test tube 
containing buffer or drug solution, so unused fluids are recycled. Parts of the 
perfusion set up (figures (B) and (C)) are placed on top of an anti-vibration table 
surrounded by a Faraday cage which acts as a shield to prevent the environmental 
electromagnetic noise from entering the circuit. 
 
D 
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2.5.3.4 Obtaining whole-cell patch-clamp configuration 
 
 
A coverslip containing HEK293 cells transfected with hTRPV1 and GFP was 
removed from the tissue culture incubator and placed into the recording perfusion 
chamber fixed on top of the inverted fluorescent microscope. Positive cells were 
identified by GFP expression emission under the inverted fluorescent microscope 
(Nikon). With the use of the microscope, the superfusion tube outlet was positioned 
so as to be in the centre of visual field, a few micrometers above the cells. The patch 
electrode was inserted to the electrode holder of the headstage. The tip of the patch 
electrode was then gently placed into the extracellular buffer solution superfusing the 
recording chamber. Once this was achieved, the external command located in the 
“whole cell parameters” in the amplifier was turned turned off. The seal test in the 
computer usually read between 3-5 Mohm. The external command was then turned 
on. The external command was held at holding potential of –60 mV.  A 5 mV test 
impulse was then applied; this evoked current steps as seen on the seal test window 
on the computer.  
 
After compensating for the offsets of the amplifier, the patch electrode was further 
lowered onto the membrane of a GFP single cell membrane using the manipulator.  
Seal formation was monitored by observing the electrode current on an oscilloscope 
while applying 5 mV test pulses to the electrode. Before the electrode was placed 
into the bath solution, a flat current trace was observed. Upon entering the 
extracellular bath solution, the 5 mV test pulses resulted in current of 10-15 nA to 
flow in a 2-5 Mohm patch electrode. As the electrode approached the cell membrane, 
a slight decrease in current (2-5 nA) occurs reflecting an increase in the electrode 
resistance (10-15 Mohm), until the formation of a gigaseal For whole-cell 
configuration, the membrane patch was broken with additional suction. The 
additional suction was achieved via the suction line attached to a syringe, where 1-2 
mls was adequate to break the membrane. Once the configuration of a whole-cell 
was obtained with the cell, the configuration was ready to record the responses of 
activator-induced membrane currents. 
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2.5.4  Recording protocols and data analysis 
 
All data were recorded using the pClampex 8 software package.  and analysed using 
the Clampfit data analysis programme (Axon Instruments Ltd). All experiments were 
performed at physiological temperature of 36-37 
o
C. 
 
2.5.5   Capsaicin-evoked activation  
 
To investigate the effect of capsaicin-evoked responses, stock solution of 50 mM 
(E)-capsaicin (Tocris) was prepared by dissolving the compound in 100% DMSO. 
Capsaicin was dissolved in standard extracellular buffer to various concentrations 
ranging between 10 nM and 100 µM.  As a result of my finding that DMSO activates 
TRPV1 (see Chapter Three), capsaicin solutions were made to contain ≤ 0.05% 
DMSO content. The application of capsaicin for 10 seconds was controlled by the 
automated perfusion system controlled by the pClampex 8 software package, with 
only one application of capsaicin per cell.  Normal extracellular and intracellular 
solutions were used. The membrane potential was held at - 60 mV 
 
Capsaicin-evoked membrane currents were assessed using the Clampfit data analysis 
programme. In order to measure the peak amplitude of the current in response to 
agonist activation, two cursors were placed on the recording as responses were 
normalised to baseline current. The first cursor was placed over the baseline 
membrane current, which was defined as 1 second prior to application of the agonist.  
The second cursor was fitted over the peak of the current where the maximum 
amplitude was seen. The corresponding current amplitudes were then copied into an 
Excel spreadsheet. The maximum current amplitude was subtracted from the current 
seen at baseline.  
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To plot a capsaicin-concentration response curve, the data was placed into either 
Origin or Graphpad statistical analysis software. The data was then fitted with a 
sigmoidal dose-response curve (see Statistical Analysis section for further detail).  
 
2.5.6 Anandamide-evoked activation 
 
 
To investigate the effect of anandamide-evoked response, stock solution of 30 
mM arachidonyl ethanolamide (anandamide; Tocris) supplied in a water soluble 
emulsion Tocrisolve (Tocris) was used. Anandamide was dissolved in standard 
extracellular buffer to various concentrations, namely: 1 µM, 3 µM and 10 µM. 
Since stock solution of anandamide was used, the percentage of Tocrisolve in these 
solutions were, namely: 0.03%, 0.01% and 0.003%, respectively.  Application of 
anandamide for 50 seconds was controlled by the automated perfusion system 
controlled by the pClampex 8 software package.  As a control, 0.03% Tocrisolve was 
also investigated. Normal extracellular and intracellular solutions were used. The 
membrane potential was held at -60 mV. 
 
Anandamide-evoked membrane currents were assessed by subtracting the peak 
current of the response from the baseline current for each individual recording. This 
was done using Clampfit data analysis programme and Excel.  
 
 
2.5.7  Proton-evoked activation 
 
To investigate the effect of proton-evoked response, normal extracellular buffer was 
adjusted to a specific pH. Extracellular solutions were adjusted to specific pH, 
ranging from pH 4-7.  
 
Solutions adjusted to pH 7.0, pH 6.5 and pH 6.0 were made by adjusting the pH of 
the normal extracellular buffer used in patch-clamp studies, using a pH meter. 
Normal extracellular buffer was used for this range of solutions because the 
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buffering agent HEPES buffering capacity was within this range. The buffering 
capacity of buffering salts is a measure of the resistance of a buffer solution to pH 
change on addition of H
+
 ions. However, solutions adjusted to pH 4,  pH 4.5, pH 5 
and pH 5.5 were made by adjusting normal extracellular buffer containing 10 mM 2-
(N-Morpholin) ethanesulfonic acid sodium (MES) buffering agent instead of HEPES, 
due to its lower range buffering capacity of pH ≤5.  
  
Amiloride was added to these buffers to inhibit endogenous acid sensing ion channel 
in HEK293 cells. Stock solution of amiloride (Sigma) was made ddH20.  30 µM 
amiloride solution was added to the extracellular buffer. 30 µM amiloride solution 
was chosen as this concentration almost completely blocks the ASIC conductance in 
HEK293 cells (Gunthorpe et al., 2001).  
 
Normal intracellular solutions were used. The membrane potential was held at -60 
mV.   
 
pH-evoked membrane currents were assessed by subtracting peak current of the 
response from the baseline current for each individual recording using Clampfit data 
analysis programme and Excel.  
 
For pH-dose response curve, the data was placed into either Origin or Graphpad 
statistical analysis software. The data was then fitted with a sigmoidal dose-response 
curve. 
 
2.5.8 Heat-evoked activation   
 
To investigate the effect of temperature normal extracellular solution was 
passed through the heat exchanger unit. The heat exchanger unit is able to heat the 
passing solutions to a chosen constant temperature (37
o
C), but could produce a rapid 
temperature-ramp at ~1.4 
o
C in 1 sec. Normal extracellular and intracellular solutions 
were used. The membrane potential was held at -60 mV. 
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2.5.8.1 Analysis of heat-sensitivity  
 
2.5.8.2 Biophysics of heat-sensitivity 
 
 Detection of environmental temperatures is mediated by specialised 
molecules in the great majority of living organisms. In mammals, these molecules 
are ion channels which transduce thermal energy into electrical energy by 
temperature-induced transient changes in the permeability of the channels. Primary 
sensory neurons express a series of temperature-sensitive ion channels, suggesting 
that these cells, in addition to transmitting nociceptive information, can also detect 
various ranges of temperatures and transduce heat energy into electrical signals. The 
great majority of heat-sensitive ion channels belong to the transient receptor potential 
ion channel (TRP) family. These ion channels are referred to as thermo-TRP 
channels (see Fig 2.21). They include the “heat-sensitive” vanilloid type 1 (TRPV1), 
vanilloid type 2 (TRPV2), vanilloid type 3 (TRPV3), and vanilloid type 4 (TRPV4) 
and the “cold-sensitive” melastatin type 8 (TRPM8) and ankyrin type 1 (TRPA1) 
(Caterina et al., 1997; Caterina 1999, Xu et al., 2002; Guler et al., 2002McKemy, 
2002; Story et al., 2003).  
 
 
 
 
 
Figure 2.21 Thermo-TRP channels respond to a wide range of temperatures. The 
thermal threshold (below) and the range of temperatures to which they respond 
(above) are indicated for each channel. (Taken and adapted from Jordt et al., 2003) 
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Gating of thermo-TRP channels is controlled by temperature. As previously 
mentioned, gating of ion channels involves conformational changes of certain parts 
of the channel. The reaction rate constant between the transitions from open and 
close states are temperature-dependent. A reaction rate constant quantifies the speed 
of a chemical reaction. The temperature dependence of the rate constant can be 
defined by the Arrhenius relationship. The Arrhenius relationship is based on the 
collision theory which suggests the particles must collide with the correct orientation 
and with sufficient kinetic energy, in order for any physiological process to proceed. 
Furthermore, only a small proportion of particles have the ability to collide in the 
correct orientation and with sufficient kinetic energy to activate the physiological 
process, which is governed by the Boltzmann probability distribution: 
 
-Ea/RT 
 
where Ea is the activation energy, R is the gas constant and  T is the absolute 
temperature in Kelvins. 
 
 
 Thus, the Arrhenius equation is:  
 
 
 
where k is the rate constant, A exp is the pre-exponential factor, and -Ea/RT is the 
Boltzmann probability distribution (Arrhenius, 1889). The pre-exponential factor is a 
temperature-independent factor and is defined as:  
 
A = pZ 
 
where p is steric factor and Z is the collision rate. The „steric factor‟ represents the 
probability of molecules colliding in the correct orientation to activate the reaction.  
k = A exp 
Ea  
RT  
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Typically, the Arrhenius equation is written in logarithmic form which states that the 
logarithm of the rate constant is proportional to the reciprocal of the absolute 
temperature: 
 
 
Consequently an Arrhenius plot of the natural log of k (lnk) against the inverse of the 
absolute temperature (1/T) generates a linear relationship between the two variables 
(see Fig 2.22).  
 
 
Figure 2.22 Schematic diagram of a typical Arrhenius plot. The Arrhenius plot 
shows the logarithm of a rate (lnk) against the reciprocal of the absolute temperature 
(1/T). Note: The activation energy (Ea) can be extrapolated from the gradient (b). 
Taken and adapted from Keusch, 2009). 
 
 
 Arrhenius plots have been used to identify temperature-induced changes in 
processes. A dramatic change in the slope, or a deviation from the straight line of an 
Arrhenius plot, suggests that the activation energy is different above and below the 
point of deviation. In thermo-TRP channels, a sudden deviation from the straight line 
can be defined as the thermal threshold of activation, where the channel‟s rate 
constant, i.e. the open probability, suddenly shows a great change. For example, the 
sudden appearance of a steeper slope means that the channel‟s rate constant at that 
temperature becomes greater; hence the open probability becomes higher.  
 
lnk =              +  lnA 
Ea 
RT  
lnk 
1/T 
y = - a+b*x 
Key: 
x = 1/T 
y = lnk 
a = lnA  
b = -Ea/R 
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 Q10 is a measure used to describe the factor by which the rate (R) of reaction 
increases for every 10 
o
C rise in the temperature (T). R may represent any measure of 
the progress of a process. Typically, R is measured at two different temperatures, T1 
and T2 (where T2 > T1), where the rate measurement R1 (measured at T1) and R2 
(measured at T2), are obtained, respectively. The Q10 equation is then: 
 
 
 
(Note that, the difference between T1 and T2 does not need to be exactly10 
o
C to 
permit the use this equation). A conductance of an open channel with a Q10 of 1.2-1.5 
is considered to be relatively temperature insensitive, which can be accounted for by 
the temperature dependence of ionic diffusion and chemical reactions in general 
(Hille, 2001). Most ion channels and enzymes have a gating Q10 of 2-5 and are 
regarded as being highly temperature-dependent (Hille, 2001; Clapham, 2003). 
Thermo-sensing TRP channels are known to have high Q10 values (see Table 2.2).   
 
Ion channel Q10 Reference 
TRPV1 27 
29.5 
25.6 
17.8 
20.6 
Liu et al., 2003 
Ni et al., 2006 
Vlachova et al.,  2003 
Vyklicky et al., 1999 
Welch et al., 2000 
TRPV2 ~100 Leffler et al., 2007 
TRPV3 25 
6.6 
Xu et al., 2002 
Peier et al., 2002 
TRPV4 9.9 
19.1 
Guler et al., 2002 
Benham et al., 2003 
TRPM8 -23 
-35 
Brauchi et al., 2004 
Andersson et al., 2004 
TRPA1  No published data 
 
Table 2.2 TRP channels and their Q10 values as found in various studies. Note: Ion 
channels that are activated by heat or by an increase in temperature have a positive 
Q10 value, whereas channels that are activated by cold or a decrease in temperature 
have a negative Q10 value. 
(   ) Q10   = 
10 
T2 - T1  (     ) 
R2 
R1  
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2.5.8.3 Analysis of heat-induced response 
  
When analysing heat-induced response of hTRPV1, the current amplitude at a 
particular temperature, the Q10 value, the heat threshold of activation, and the 
activation energy are each calculated.  
 
To determine the amplitude of the current at 48 
o
C two cursors were placed 
on the heat-induced membrane current using Clampfit 8.2 data analysis programme 
(Axon Instrument, Inc). The first cursor was placed over the baseline membrane 
current, which was defined as 1 second before the application of the heat ramp. The 
second cursor was fitted over the first instance that the temperature of the 
extracellular solution reached 48 
o
C. The corresponding current amplitudes were then 
copied into an Excel spreadsheet. The current amplitude detected at 48 
o
C was 
subtracted from the current amplitude obtained at baseline (37 
o
C). 
 
To determine the Q10 of a heat-induced response, the Q10 equation was used 
(Saucr et al., 2001; Leffler et al., 2007): 
 
 
 
where I1 (measured at T1)  and I2 (measured at T2)  represent the whole-cell currents 
conducted through the cell at two different temperatures T1 and T2 (where T2 > T1). 
 
 The first analysis of the heat-evoked currents in hTRPV1-transfected cells, 
the heat threshold of activation was determined by manually placing two lines at the 
two linear parts of the Arrhenius plot, as shown by the example in Fig 2.23 and 
published by Sutton (2005) and Vyklicky (1999). This was done by transferring the 
rising phase of the temperature ramp data from Clampfit 8.2 as a text file to Excel. 
Due to the high resolution of the data sampled during the whole-cell recording, the 
(   ) Q10   = 
10 
T2 - T1  (     ) 
I2 
I1  
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data was reduced by calculating the average of every 5th data point to form an 
average data set. The common logarithm of normalised current at 37 
o
C and the 
reciprocal of the absolute temperature were calculated. The Arrhenius plot was then 
constructed using Origin statistical analysis software. Due to the nature of the heat-
induced currents, the Arrhenius plot showed a curved line; in which (at least) two 
lines with different slopes are needed to adequately describe the relationship (Cesare 
and McNaughton, 1996; Vyklicky et al., 1999; Caterina et al., 1999).  Two manual 
lines were then fitted on the plot. The first line was manually placed across the points 
between 37-42 
o
C. The second line was place across the steeper points on the plot, 
typically through 45-51 
o
C. From the intersection of these two lines, the threshold 
temperature for heat activation was established. However, the manual fit raised an 
issue relating to the reliability of the data. Therefore, a more valid and reliable 
approach was employed.   
 
 
 
Figure 2.23 Arrhenius plot of heat-induced response in hTRPV1-transfected cells. 
The common logarithm of normalised current to 37 oC was plotted against the 
reciprocal of the absolute temperature (Arrhenius plot). The heat threshold was 
established from the intersection of these two lines fitted on the two linear parts of 
the graph. In this example the heat threshold was 44.6 
o
C (arrow). 
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During this analysis, recordings from untransfected HEK293 cells during 
application of a heat ramp were first analysed. Visual inspection showed no current 
increase with an increase in the temperature (see Fig. 1A). Consequently, the average 
amplitude at 48 
o
C was -63 ± 28 pA (n=7). This can be described as a non-specific 
heat-induced current. Current-temperature plots showed that there was only a 
moderate steady increase in membrane current with an increase in the temperature 
37-51 
o
C (Fig. 2.24). Consequently, an Arrhenius plot was constructed and a linear 
regression was fitted across. All untransfected HEK293 cells showed a nearly 
horizontal line, indicating no linear relationship between the two variables (Fig. 
2.24B). The Q10 for the rising phase of the temperature ramp (37-51 
o
C) was then 
calculated to be 1.12 ± 0.03 (n=7; Fig 2.24C), which corresponds to the non-specific 
effects of temperature on membrane properties. This suggests that untransfected cells 
showed no heat-evoked response. 
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Figure 2.24 Whole-cell membrane current induced by heat ramp and its Q10 in an 
untransfected HEK293 cell. (A) A current trace at a membrane potential of -60 mV 
recorded using the whole-cell patch clamp technique. A heat ramp 37-51 
o
C was used 
to stimulate the cell. A very small heat-evoked response was seen in this cell. (B) 
Relationship between the membrane current and temperature using every 5th data 
value of the trace on A. A very small was seen with an increase in the temperature. 
(C) The common logarithm of normalised current to 37 
o
C was plotted against the 
reciprocal of the absolute temperature (Arrhenius plot). The temperature scale in 
degrees centigrade is shown below the scale of the reciprocal of the absolute 
temperature. The scatter plot was fitted with a linear regression. A linear regression 
was fitted, where the Q10 (37-51 
o
C) was calculated to be 1.1. This implies that the 
trace in A is temperature insensitive.   
 
 
 
Recordings from TRPV1-transfected HEK293 cells during application of a 
heat ramp were then analysed. Inspection of a recording showed a large inward 
membrane current, as a result of an increase in the temperature of the solution 
superfusing the cell (for example see Fig 2.25A). By generating a current-
temperature plot, the activation of the current was seen to be initiated at temperatures 
> 45 
o
C, which resulted in a distinct change in the gradient of the slope (Fig. 2.25B). 
The Arrhenius relationship was then constructed. Similar to the original analysis, two 
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lines were fitted on the plot, however, instead of a manual fit, the linear regression 
function in Origin software was used. The software produced a summary output 
detailing the equation of the linear regression and the correlation coefficient r value 
(see Chapter Two: Statistics for further detail). The linear regression was then 
extrapolated.The lines representing the Arrhenius plot can then be superimposed on 
to the graph and the temperature of the intersection of the two lines can be calculated 
as the heat threshold of activation (Fig 2.25C). 
 
Often, the Arrhenius plot was not best represented with two lines at different slopes 
(for example Fig 2.25C). Original analysis of the temperature threshold of activation 
utilised only two lines at different slopes as, typically, a slow rising phase in the 
temperature range of ~37-42 
o
C was seen, followed by a fast rising phase between 
46-51 
o
C. However, a third slope with a different gradient to the other two, could be 
fitted through 43-45 
o
C data points, which is the range of TRPV1 threshold of 
activation (Cesare and McNaughton, 1996; Vyklicky et al., 1999; Caterina et al., 
1999; Sutton et al., 2005).   
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Figure 2.25 A whole-cell membrane current induced by a heat ramp and its Q10 in 
TRPV1-transfected HEK293 cell. (A) A current trace at a membrane potential of -60 
mV recorded using the whole-cell patch clamp configuration. (B) Membrane current-
temperature scatter plot using the mean of every 5th data value of the trace on A. To 
best represent the relationship of the trace, three manually fitted lines with different 
slopes were extrapolated on the plot.  The current increased with temperature above 
44 °C. Hence the estimated heat threshold for this example was 44 °C.  (C) The 
common logarithm of normalised current to 37 
o
C was plotted against the reciprocal 
of the absolute temperature (Arrhenius plot). The temperature scale in degrees 
centigrade is shown below the scale of the reciprocal of the absolute temperature. 
The plot was fitted with three linear regressions using OriginLab 7 software. The 
first line was fitted across the points between 37-43 
o
C (red line, r = 0.2). The second 
line was fitted across the points between 45-47 
o
C (green line, r >0.95). The third line 
was fitted across the points between 45-51 
o
C (blue line, r >0.95). An r > 0.95 
suggests a strong relationship between an increase in temperature and membrane 
current for the trace in A. The heat threshold was established from the intersection of 
the three lines fitted on the two linear sections of the plot. In this example, two heat 
thresholds of activation were calculated. The intersection between red line and green 
line showed a threshold of 44.1 
o
C whilst the intersection between red line and blue 
line exhibited a threshold of 45.2 
o
C. The temperature which was interpolated 
between the red and green line was accepted as the heat activation threshold, if the 
value was < 0.37 
o
C of the estimated value. The temperature which was interpolated 
between the red line and blue line illustrates that a linear fit between 45-51 
o
C was 
unreliable, as the value was > 0.37 
o
C of the estimated value.  
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 Having a regard to the considerations stated above, each recording was 
subjected to a second analysis, in order to obtain a more reliable heat activation 
threshold of hTRPV1-transfected HEK293 cells. The protocol for the second analysis 
is as follows: 
(i) Transfer the rising phase of the temperature ramp to a text file, which 
should include the membrane current of the cell be tested. 
(ii) Calculate the current amplitude at 48 oC of the recording by subtracting 
the current at 48 
o
C from the current seen at 37 
o
C one second before the 
heat ramp (baseline) is initiated. Due to the non-specific heat-induced 
current in untransfected cells during application of the heat ramp, current 
traces with an amplitude of < 63 pA were excluded, whilst current 
amplitude >  63 pA, which was the amplitude of current at 48 
o
C in 
untransfected HEK293 cells,  progressed to the next step.  
(iii) Calculate the Q10 value for the rising phase of the temperature ramp (37-
51 
o
C). Current traces with a Q10 of <1.1 were excluded while current 
values Q10 of >1.1 progressed to the next step, due to the characteristics of 
untransfected cells during a heat ramp. 
(iv) Construct a current-temperature plot in Origin. Manually fit a line through 
the points at 37-40 
o
C, which is below the temperature range for wild-type 
TRPV1 activation. Estimate heat threshold of activation by placing a 
cursor at point which the current membrane deviates from the manually 
fitted line, for example ~44 
o
C. This was referred to as the estimated 
value.  
(v) Construct the Arrhenius relationship. To be included in the next step, the 
plot must show a curved line which can be fitted with a least two lines. If 
the plot is best represented by one line, exclude data. 
(vi) Compute a linear regression from 37 oC to the estimated threshold minus 
1 
o
C, for example 44 - 1 = 43 
o
C. Compute another linear regression, this 
time from the estimated threshold plus 1 
o
C (i.e., 45 
o
C) to two degree 
centigrade from the estimated threshold (i.e., 45-47 
o
C). The latter linear 
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fit must have coefficient correlation of r > 0.95 to be included in the next 
step, while an r < 0.95 is excluded. The +1 
o
C or -1 
o
C from the estimated 
threshold were eliminated from the linear regression fit, to reduce the 
possibility of forcing the linear regression through these points. Thus, 
reducing biased heat activation threshold analysis.  
(vii) Extrapolate the lines representing the equation for both of the linear 
regression. Work out the temperature threshold of activation at which the 
two lines intercept and compare this with the estimated threshold. Accept 
threshold if < 0.37
 o
C of the estimated value and reject if it is > 0.37
 o
C. A 
difference of 0.37
 o
C was chosen as the critical value because the lowest 
temperature threshold of activation cannot be lower than the baseline 
temperature of 37
 o
C.  Thus, 1 % of 37
 o
C is 0.37
 o
C using 99 % 
confidence level (See Chapter 2: Statistical analysis for further detail on 
confidence level. A confidence level of 95 % was not chosen, as this 
relates to a critical value of 1.85
 o
C, which can consequently result in a 
huge error in estimating the temperature threshold of activation.       
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 To determine the activation energy (Ea) for specific parts, that is, the slow 
rising phase and the fast rising phase, of the heat-induced response, the Arrhenius 
relationship is plotted in Origin and a linear regression is computed. As a result, 
values a and b from the linear regression equation (y = - a + b * x) are determined. 
The gradient of the line, represented as b, is equal to –Ea/R, where R is the gas 
constant (8.3145 J mol 
-1
 K
-1
). Hence, the activation energy can be calculated (Lewis 
and Evans, 2006).  
 
For example, the linear regression equation for the fast rising phase (between 46-51 
o
C), in Fig 2.25 C was determined to be: 
 
y = 42.6 + -13564.8 * x 
 
According to the equation, the slope is -13564.8 Kelvin. The minus sign of the slope 
is a mathematical convention, indicating that the graph slopes from right to left.  
 
Thus, 
-13564.8 K = –Ea/R 
 
Hence, the activation energy for this example is:  
 
Ea = 13564.8 K x 8.3145 J mol 
-1
 K
-1 
= 112777.9 J mol 
-1 
or 112.8 kJ mol 
-1
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2.5.8.4 Comparison of analysing heat-induced responses by the two methods  
 
 In this section of my thesis I compare results obtained by analysing TRPV1-
mediated heat-responses in hTRPV111-transfected HEK293 cells. Since the amino 
acid sequence of TRPV1 which was used to transfect cells has no importance, here I 
refere to this polymorph as TRPV1.  
 
Increasing the temperature of the superfusing solution induced an increasing inward 
membrane current in hTRPV1-transfected cells in the range of 44-51 
o
C (Fig 2.25A). 
Untransfected HEK293 cells showed very small but visible heat-induced response 
during application of a heat ramp (Fig. 2.24A). Consequently, the amplitude at 48 
o
C 
of the hTRPV1-transfected cell was 419 ± 38 pA (n=8) which was significantly 
higher than that of the untransfected cells which was 63 ± 18 pA (n=7), (Fig 2.26). 
 
 
 
 
Figure 2.26 Current at 48 
o
C from untransfected HEK293 cells and hTRPV1-
transfected HEK293 cells. Each data point represents the mean ± SEM. Both the f-
test and the normality test showed a p-value of >0.05, High probability of equal 
variance and normal distribution. The statistical difference between the means was 
assessed using the Student t-test (two-tail distribution and two-sample equal 
variance). (*) Differences were regarded as being statistically significant at p<0.05. 
Note that comparisons between the means showed a significant difference. 
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Both the membrane current-temperature graph and the corresponding Arrhenius plot 
showed a notable change in the gradient in hTRPV1-transfected cells (Fig 2.25B-C). 
Untransfected cells showed a near horizontal line, when compared to that of the 
upper part (Fig 2.24B-C).  
The Q10 of the rising phase of the temperature heat ramp (37-51 
o
C) for untransfected 
cells was 1.1 ± 0.04 pA (n=8), while the Q10 (37-51 
o
C) for hTRPV1-transfected cells 
was 3.75 ± 0. 28 pA (n=8), (see Fig 2.27). These values were significantly different 
from each other.  
 
 
 
 
 
 
 
Figure 2.27 Q10 values of untransfected HEK293 cells and hTRPV1-transfected 
HEK293 cells between 37-51 
o
C. Each data point represents mean ± SEM. Both the 
f-test and the normality test (Shapiro-Wilk) showed p-values of >0.05, indicating 
high probability of equal variance and normal distribution. The statistical 
significance of the difference in the means was assessed using the Student t-test 
(two-tail distribution and two-sample equal variance). Differences were regarded as 
being statistically significant at *p<0.05. Note that comparisons between the means 
showed a significant difference. 
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In hTRPV1-transfected cells, two straight lines of different gradients could be 
distinguished in the Arrhenius plot, which were further characterised by their Q10 
and their activation energy. The slow rising phase which was calculated in the range 
of 37-43 
o
C showed a  Q10 of 1.5 ± 0. 12 pA (n=8), corresponding to Ea = 10.4 ± 2.1 
kJ mol 
-1 
(n=8)). The fast rising slope in the range of ~46-51 
o
C had a Q10  of 14.1 ± 
2.0 pA (n=8), relating to Ea = 10.4 ± 2.1 kJ mol 
-1 
(n=8)).  Both the Q10 and the 
activation energy were significantly higher in the fast rising phase when compared to 
the slow rising phase of heat-induced membrane currents (see Fig 2.26). The Q10  for 
~46-51 
o
C is slightly lower that the value of previously published data, which ranges 
from 18-30 (Liu et al., 2003, Ni et al., 2006; Vlachova et al., 2003; Vyklicky et al., 
1999).   
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Figure 2.28 Q10 values and activation energy the slow rising phase (37-43 
o
C) and 
the fast (46-51 
o
C) from hTRPV1-transfected HEK293 cells. Each data point 
represents mean ± SEM. Both the f-test and the normality test (Shapiro-Wilk) 
showed p-values of >0.05, indicating equal variance and normal distribution. The 
statistical significance of the difference in the means was assessed using Student t-
test (two-tail distribution and two-sample equal variance). (*) Differences were 
regarded as being statistically significant at p<0.05. Note that comparisons between 
the means showed a significant difference. 
 
 The heat threshold of activation of the first analysis of hTRPV1-transfected 
cells was 45.9 ± 0.45 
o
C (n=8). Two heat thresholds of activation were calculated 
from the second type of analysis of data which included analysis criteria and 
exclusion criteria. The first was obtained from the estimation of the temperature 
threshold of activation value from the deviation of the manually fitted line through 
data points 37-40 
o
C, which was 45.0 ± 0.36 
o
C (n=8).  The second was constructed 
by intercept of the two linear lines extrapolated from the linear regressions, which 
was 44.8 ± 0.31 
o
C (n=8). Note that, there is less than 0.37 
o
C difference between the 
second analysis estimated value and second analysis value obtained from the 
intercepting the two lines, indicating that the estimation was of a good fit. Although 
the temperature threshold of activation obtained from the first analysis is higher than 
that of the second analysis, the difference was not statistically significant. 
Nevertheless, the second type of analysis was essential in order to obtain a more 
reliable heat activation threshold. Henceforth, all heat activation data presented were 
analysed using the second type of analysis. 
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Figure 2.29 Heat activation threshold of first and second analysis of data. The 
difference between relevant groups was assessed by 1-ANOVA. Both the Bartlett‟s 
test for equal variance and the normality test (Shapiro-Wilk) showed p-values of 
>0.05, indicating equal variance and normal distribution. The statistical significance 
of the difference in the means was assessed using 1-ANOVA. A post hoc test was 
not computed as the overall p-value was >0.05. Note that comparisons between the 
means showed no significant difference. 
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2.5.9.1 Current-voltage relationship of the TRPV1 agonist-evoked responses 
 
Ion channels, including TRPV1 frequently exhibit non-linear current-voltage 
relationship.  This phenomenon is called rectification. TRPV1 shows outward 
rectification in both single channel and whole cell measurements (Nagy and Rang, 
1999; Hayes et al., 2000). Regardless of the lack of linear relationship, TRPV1-
mediated currents, like the great majority of other currents, show zero current at a 
certain membrane potential. This membrane potential is called the reversal potential. 
For TRPV1, at physiological ionic concentrations, the reversal potential is around 0 
mV. The reversal potential measured in the presence of one permeable ion species 
gives an important clue to the ion selectivity of the ion channel (see Goldman-
Hodgkin-Katz equation). For TRPV1 expressed in primary sensory neurons, the 
permeabilities of Na
+
 and Ca
2+
 relative to the permeability of Cs
+
 are between ~1-2 
(Nagy and Rang, 1999). 
  
 
Data in the literature showed that the capacitance of HEK293 cells is <50 
pico Farad (Pelucci et al., 2006) while the membrane resistance is < 10 megaOhms 
(Zhu et al., 1998). Hence, the tau () is 500 µsec. With time =5x (2.5 milliseconds), 
the desired voltage value is reached to 99.66%. Thus, in order to establish the 
current-voltage relationship of the TRPV1-mediated responses in HEK293 cells, a 
ramp was designed from -100 to +40 mV in 340 milliseconds (0.38 mV/ms). This 
value is comparable to previously reported (0.14 mv/ms: Hayes et al., 2004) when 
obtaining IV relationship in HEK cells expressing various channels including TRP 
channels.  
 
To establish the I-V relationship of agonist-induced currents normal 
extracellular and intracellular solutions were used (extracellular buffer (mM): NaCl, 
130; KCl, 5; CaCl2, 2; MgCl2, 2; glucose, 10; Hepes, 10; intracellular buffer NaCl, 
5; KCl, 130; MgCl2, 1.26; Hepes, 10; adjusted to pH 7.4.). The membrane potential 
was held at -60 mV and the series resistance was compensated by 50-90 %. The 
residual uncompensated series resistance was 2.2 ± 0.2 MΩ (n = 55), which would 
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produce an expected error of 2.2 mV for an agonist-induced current of 1 nA at a 
holding potential of - 60 mV. The membrane patch was ruptured and a waiting 
period of at least 1 min was allowed for equilibration of the electrode solution with 
the contents of the cell. Agonists were applied to cells using the automated system. 
Only one recording was performed on any coverslip of cells to ensure that recordings 
were not made from cells which had been inadvertently exposed to any agonist. In 
order to study the current-voltage relationship of the agonist-evoked responses, a 
voltage ramp between -100mV to +40mV for 340 milliseconds was applied before 
(control curve) and during the 10 second agonist application (test curve) in hTRPV1-
tranfected cells.  
 
Current–voltage relationship was then established by subtracting the control curve 
from the test curve. The reversal potential was then interpolated from the zero 
current intercept of the fitted line of the current-voltage curve to 0 mV. Interpolation 
was achieved by plotting the two data points below and above the 0 nA and fitting 
them with a simple linear regression. The linear equation for the linear regression 
was noted and the reversal potential was then calculated. 
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2.5.10   Voltage-dependence  
 
2.5.10.1 Biophysics of voltage-dependence 
 
Voltage-gated ion channels open and close in response to changes in the membrane 
potential of the cell. The membrane potential is the voltage difference between the 
interior and exterior of the cell. Neurons contain voltage-gated ion channels and use 
changes in the membrane potential as a communication signal for receiving and 
sending information. A change in the membrane potential is caused by anything that 
alters the membrane permeability to any ion, or anything that alters the ion 
concentration on either side of the plasma membrane.  
 
Hodgkin and Huxley suggested a simple model that could explain the voltage-
dependence of ion channels. The model presumes that individual ion channels, each 
having a small ionic conductance, influences the activity of the whole membrane. As 
previously mentioned each ion channel has two conducting states: (i) an open state 
(O) where the gate is open allowing ions to travel across the membrane; and (ii) a 
closed state (C) where the gate is closed. 
 
The transition from C to O is a conformational change that moves the gating charge 
of valence, z, from the inner membrane surface to the outer side. The symbols α and 
β are the rate constants for channel opening and closing, respectively. Both rate 
constants are highly temperature- and voltage- dependent (Hille, 2004; Sigworth. 
1994). For voltage-gated ion channels, these rate constants reflect the response of the 
charge particles on the voltage sensor, to the electrical potential. Altering the 
membrane potential changes the probability that a channel is in the open conducting 
state, referred to as the open probability. Consequently, this increases the percentage 
of the total population of channels to be in the open state and hence increases the 
total membrane conductance. The maximum conductance is achieved when all the 
channels are open, where further depolarisation has negligible effect (Hodgkin and 
Huxley, 1952).  
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In order to calculate the overall open probability of voltage-dependent activation of 
an ion channel in a cell, a protocol was designed to obtain data on the amplitude of 
the current and the current‟s dependence on voltage.  Typically, the membrane 
potential is stepped or changed from the holding potential to a range of potentials in a 
sequence, usually by 10-15 mV increments, at a given frequency. Maximum current 
at the beginning of each step and the current at the end of each step (steady-state 
current) can then be plotted to obtain the current-voltage curves (Guia et al., 2001). 
Tail current measurements are initiated with a membrane potential at which the 
channels have been fully active (open), and which is followed by successive voltage 
steps with potentials more negative and more positive of the reversal potential. 
Steady state current is the residual current that is seen after the channels have been 
fully activated or closed at the given the membrane potential.  
 
The open probability can then be obtained by, first fitting the tail current amplitudes 
with a sigmoid Boltzmann distribution:  
 
Itail = Imax / (1+ exp (- (V – V1/2) s)) 
  
where Itail is the tail current, Imax  is the maximum current amplitude, V is the 
membrane potential, V1/2 is half-maximal activation potential, and s is RT/zF (R is 
the gas constant, and T is the temperature, z is the valence of the gating charge and F 
is the Faraday constant). Secondly, normalising the tail current to maximum current 
amplitude (Nilius et al., 2005):  
 
Po = Itail / Imax = 1 / (1+ exp (- (V – V1/2) s)) 
 
The Boltzmann distribution determines the probability that a channel is open by 
voltage-dependent gating which is derived from the Boltzmann equilibrium. The 
Boltzmann equilibrium illustrates the ratio of the probability to be in one of the two 
conducting states, C and O, which is governed by free energy. The sigmoid 
relationship between the ionic conductance and the membrane potential is due to the 
physical principle for the movement of charged particles under an electrical field of 
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the plasma membrane. The steepness of the rise of the curve is governed by the 
valence of the gating charge: the larger the z becomes, the steeper the rise of the open 
probability in response to depolarisation (Matthews, 2000). Voltage-gated sodium 
and potassium ion channels are highly dependent on the membrane potential for 
activation which suggests that the gating charge has a large valence and activation 
which occurs in a relatively narrow range. For example, the potassium channel 
containing the shaker mutation has a z value of 12-13 (Schoppa  et al., 1992; 
Aggarwal and Mackinnon, 1996) and the bacterial sodium channel, has gating charge 
of 15 (Kuzmenkin et al., 2004). 
 
TRPV1 is a voltage-dependent ion channel which can be activated by depolarisation 
(Voets et al., 2004). The voltage dependence of TRPV1 can be established by 
studying the relationship between the membrane potential and the whole-cell 
conductance produced by TRPV1 normalised to the maximum whole-cell 
conductance due to TRPV1 activity. Maximum whole-cell current produced by 
TRPV1 could be achieved if the Po of TRPV1 is at maximum. Since TRPV1 
responds to various activators, in theory the maximum Po (Po max) could be produced 
in several ways. Previously, depolarisation was used in an attempt to achieve Po max 
(Voets et al., 2004). However, as mentioned before, depolarisation cannot achieve Po 
max, as it is only a partial activator (Matta and Ahern, 2007). The other possibility 
mechanisms to achieve Po max  includes activation by heat, pH, or capsaicin. However 
the application of heat affects the activity of multiple components of a cell and not 
just TRPV1. Again, the affect of pH are mediated also by acid sensing ion channels 
(ASICs) as well as TRPV1. Capsaicin is a specific and selective activator of TRPV1. 
Hence, capsaicin application to TRPV1 provides an appropriate mechanism for 
achieving Po max. The capsaicin-concentration curve fitted with a sigmoidal curve for 
hTRPV1 based on my data (see chapter 5), together with the results of published 
work, justified the assumption that a saturating concentration of 10 uM induced Po 
max (Voets et al., 2004; Hayes et al., 2000; Matta and Ahern; 2007).  
 
Establishing that TRPV1 is voltage-dependent in transfected HEK293 cells 
can be achieved provided these cells do not express any voltage-gated ion channels. 
155 
However, previous findings have shown that several voltage-gated ion channels are 
constitutively expressed in HEK293 cells. Several endogenous voltage-gated 
potassium (Yu and Kerchner, 1998; Perez-Garcia et al., 1999; Mohapatra and 
Trimmer, 2006) and calcium (Berjukow et al., 1996) channels are expressed in these 
cells. The presence of these endogenous channels results in the generation of small 
currents (several hundred picoamps) at various membrane potentials (Yu and 
Kerchner et al., 1998). Therefore, prior to studying TRPV1 voltage-dependence, I 
examined whether untransfected HEK293 cells respond to changes in whole-cell 
membrane potentials. If they were to respond, then the activity of these endogenous 
voltage-gated ion channels would effect the membrane potential, which would effect 
whole-cell currents in TRPV1-transfected cells, thus distort TRPV1-mediated 
currents. 
 
2.5.10.2 Untransfected HEK293 cells and  voltage-dependene 
2.5.10.2.1 Study design and practical application 
 
I used voltage steps in these experiments as this method is better suited for 
analysing time- and voltage-dependent features of ion channels (Nilius et al., 2005). 
The ionic compositions of the bath and pipette solutions to study voltage-dependent 
activation were designed so that the only permeable ion was Na
+
.  
 
Na
+
 was chosen because TRPV1 is permeable to this ion (Caterina et al., 
2001; Cesare and McNaughton 1996; Nagy and Rang 1999). In addition, while 
HEK293 cells express endogenous K
+
 and Ca
+
 channels, they are not known to 
express Na
+
 channels (Thomas and Smart, 2005; Berjukow et al., 1996; Cummins et 
al., 2003; Yu & Kerchner, 1998). I used symmetrical Na
+ 
concentration in these 
experiments because any small deviation from the theoretical 0 mV reversal potential 
due to errors, such as error in offsetting, can easily be compensated for during 
analysis.  Thus, in these experiments, both the bath and pipette solutions consisted of 
the following (mM): NaCl, 150; MgCl2, 2; Hepes, 10; EGTA, 0.1; glucose, 10 (bath 
solution only); adjusted to pH 7.4. The voltage step protocol involved holding the 
membrane potential at 0 mV due to the symmetrical ionic composition followed by  
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voltage steps from +155 mV to -130 mV in 15 mV step intervals, of 100 
milliseconds duration, before returning back to the holding potential of 0 mV (Fig. 
2.30a). The ambient temperature of the recordings in these experiments was 37ºC. To 
improve voltage control during the voltage steps, the series resistance and 
capacitance were compensated between 50 and 70 %.  
 
Conductance curves were then constructed by using the following description: 
 
First, the current-voltage curve from each cell was generated by measuring 
the amplitude of the steady-state current at the end of the voltage-step (i.e. 1 
millisecond before returning back to the holding potential of 0 mV), and 
analysed individually.  
Due to the symmetrical ionic composition the reversal potential should be 0 
mV. Therefore, in the second step, if the reversal potential was not at zero, it 
was interpolated to 0 mV. Interpolation was achieved by plotting the two data 
points below and above the 0 nA and fitting them with a simple linear 
regression. The linear equation for the linear regression was noted and the 
reversal potential was then calculated. 
Thirdly, the conductance of the steady-state current from the untransfected 
cells was then calculated as follows: 
 
 
where G is conductance; Iss is the steady-state current; Em is the membrane potential; 
and Vr is the reversal potential. Finally, the conductance-voltage curve was 
constructed and fitted with the Boltzmann function and the half activation potential 
(V1/2), was analysed. 
 
(Em – Vr) 
Iss  
 G  =  
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2.5.10.2.2 Response of untransfected cell to changing the membrane potential 
 
I examined the current-voltage relationship of changing the membrane 
potential by using voltage steps from + 155 mV to -130 mV in 15 mV step intervals 
with 100 milliseconds before returning back to the holding potential of 0 mV (Fig. 
30a). The current-voltage curve for untransfected HEK293 cells showed a near linear 
relationship between -130 mV to +100 mV. However, from + 100 mV to +155 mV, 
the curve deviates from the linear part with a faster outward current. The reversal 
potential of untransfected cells was calculated individually and averaged to be - 0.33 
± 1.23 mV (n=14).   
 
Figure 2.30d, shows a plot of average peak conductance versus membrane 
potential. The smooth curve is best fit to a Boltzmann function used to calculate 
minimal conductance Gmin, maximal conductance Gmax, and voltage for half-maximal 
activation V1/2 of the graph (r
2
> 0.95). The Gmin and Gmax for untransfected cells were 
28.17 ± 1.57 nS (n=14) and 78.87 ± 16.6 nS (n=14), respectively. The conductance-
voltage curve for untransfected HEK293 cells showed a near constant conductance 
relationship between -130 mV to +100 mV. Furthermore, a constant conductance 
with a Gmin of 28.17 ± 1.57 nS (n=14) is present at this range, which indicate that the 
current is flowing through the cell at all times. Conversely, from + 100 mV to +155 
mV, the curve deviates from the near constants part with a larger conductance, and a 
Gmax of 78.87 ± 16.6 nS (n=14). The V1/2 was calculated to be 117.38 ± 16.0 mV 
(n=14). 
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Figure 2.30 Response of untransfected cell to changing the membrane potential. (a) 
Voltage step protocol used in untransfected cells; (b) a typical trace measured using 
symmetrical Na
+ 
(150 mM); (c) current-voltage relationship; and (d) conductance-
voltage relationship of the steady-state current of untransfected cells fitted with a 
Boltzmann function (OriginLab software analysis).  Note that each data point 
represents mean ± SEM (n=14).  
 
 
 
2.5.10.3 TRPV1-transfected HEK293 cells and voltage-dependent activity 
 
2.5.10.3.1 Study design 
 
Since untransfected HEK293 cells respond to changes in membrane potential 
with whole-cell currents (Fig. 2.30) voltage-dependence of TRPV1 could be only 
estimated. Therefore, I had to consider the most appropriate way to do that 
estimation. In order to do that I considered the following:  
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Any current recorded from the transfected cells contains both the HEK293 
cell-generated non-specific background current and the TRPV1-mediated current, if 
there is any. Therefore, the total current (Itotal) of HEK293 cells transfected with 
TRPV1 is 
 
1. I total  = I TRPV1  + I non-specific 
 
where ITRPV1 is the voltage-activated current flowing through TRPV1 and  Inon-specific is 
the non-specific voltage-activated current produced by HEK293 cells.  
 
The Po can be determined as follows. 
 
2. Po = G/Gmax 
 
Gmax and Gcan be determined respectively, by measuring the current flowing through 
TRPV1 with a maximum open probability (ITRPV1 max) and with an open probability 
determined by the membrane potential (I TRPV1 Va). However, because of the presence 
of the non-specific current in HEK293 cells, any whole-cell recordings, in addition to 
the TRPV1-mediated maximum and variable current contain this non-specific current 
(Inon-specific).Therefore, the current flowing  through the membrane of HEK293 cells 
transfected with TRPV1 which has a maximum open probability (Itotal max) can be 
described as follows: 
 
3. I total max   =    I TRPV1 max   +   I non-specific 
 
Furthermore, the current flowing through the membrane of HEK293 cells transfected 
with TRPV1 which has an open probability between minimum (0) and maximum (1) 
determined by the membrane potential can be described as follows, where ITRPV1 Va is 
the  voltage-activated current flowing through TRPV1.  
4. I total Va   =   I TRPV1 Va    +   I non-specific Va 
 
In general, whole-cell current produced by one particular type of ion channels is:  
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5. I   =   N g Po ΔV 
where N is the total number of functional channels in the plasma membrane; g is the 
single channel conductance; Po is the open probability of the channels; ΔV is the 
electrochemical driving force which is defined as  
6. ΔV   =   Vm  -  Vr 
 
where Vm is the membrane potential; and Vr is the reversal potential of the
 
ionic 
current. 
Therefore:  
7. I TRPV1 max   =   N g   Po max ( Vm  -  Vr) 
where ITRPV1 max  is the voltage-activated current flowing through TRPV1 at maximum 
open probability; and g  is the single channel conductance.  
8. I TRPV1 Va   =   N g  Po Va ( Vm  -  Vr) 
where Itotal Va is the total voltage-activated current evoked by HEK293 cells 
transfected with TRPV1.  
 
Therefore 
9. I total Va   =   N gPo Va (Vm-Vr)   +   I non-specific  
10. I total max   =   N gPo max (Vm-Vr)   +   I non-specific 
 
Hence, the Po Va and Po max  can be defined as: 
 
 
 
The open probability can be defined as: 
 
12.          Po max  = 
N g  (Vm – Vr) 
I Total max– I non-specific 
11.          Po Va    = 
I  Total Va  – I non-specific  
VV  
Po Va  
Po max 
= 
I total Va   – I non-specific 
Va 
N g max (Vm – Vr) 
x 
N g Va (Vm – Vr) 
I max – I non-specific Va 
13. 
Va 
N g  (Vm – Vr) 
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Or 
 
 
Whole-cell current is defined as  
15. I = G ΔV 
 
Based on these considerations, the total conductance of HEK293 cells transfected 
with TRPV1 is as follows: 
 16. 
 
 
Therefore, 
 
 17. 
 
 
Based on my finding that untransfected HEK cells do not respond to 
capsaicin, I considered the values of Gnon-specific in the numerator and in the dominator 
to be the same. Thus, any difference in the value Po Va / Po max of the different clones 
must be due to the changes in the voltage dependence of TRPV1. Therefore, by 
Po Va  
Po max 
= 
G total Va   -  G non-specific   
G total max   -  G non-specific  
Po Va  
Po max 
= 
(G total Va ΔV )  -  (G non-specific ΔV )   
(G total max ΔV )  -  (G non-specific ΔV )   
Po Va  
Po max 
= 
I max – I non-specific Va 
14. 
I Total Va   – I non-specific  
N g (Vm – Vr) Po Va  
Po max I Total max – I non-specific 
N g (Vm – Vr) 
= 
13. 
I Total Va   – I non-specific  
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measuring whole-cell currents to which TRPV1 contributes with maximum open 
probability and whole-cell currents to which TRPV1 contributes with less than 
maximum open probability due to voltage-dependent activation, I can determine 
changes in TRPV1 voltage-dependence attributed to the differences in the 
haplotypes. 
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2.5.10.3.2 Practical application  
 
In order to study voltage-sensitivity, compensation was made for the 
capacitance and series resistance between 50 and 70 %. A voltage protocol was then 
applied. In these experiments both the bath and pipette solutions consisted of the 
following (mM): NaCl, 150; MgCl2, 2; Hepes, 10; EGTA, 0.1; glucose, 10 (bath 
solution only); adjusted to pH 7.4.  
 
Two methods were initially considered to be capable of inducing Po max. The 
first method was based on work done by Voets et al (2004), who showed that the 
channel reached Po max at + 155 mV. This involved depolarisation of the membrane 
by holding the cell at + 155 mV for 100 milliseconds to induce Po max (Fig. 2.31). 
This was then followed by voltage steps from +155 mV to -130 mV, in 15 mV step 
intervals, of 100 milliseconds duration, to evoke tail-currents followed by steady-
state currents produced by voltage-dependent activation, before returning back to the 
holding potential of 0 mV (Fig. 2.31). There are two problems with this voltage step 
protocol: (i) due to fast gating, tail currents could be difficult to measure precisely; 
(ii) +155 mV may not open all the TRPV1 channels on the membrane (Matta and 
Ahern, 2007).  
 
The second method involved application of 10 µM capsaicin to the cell to 
induce Imax at holding potential of + 60 mV to allow visual indication of whether the 
cell responded to capsaicin (i.e. produces an outward current, see capsaicin-
concentration response curve for hTRPV1111). The holding potential was then 
changed to 0 mV, which was followed by voltage steps + 155 mV to -130 mV, in 15 
mV step intervals, of 100 milliseconds duration.  
 
2.5.10.3.3 Response of TRPV1-transfected cell to voltage-dependence 
 
In the majority of cells, both methods of inducing maximum TRPV1 open 
probability produced a linear I-V relationship (r>0.95). The I-V curves of the steady 
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state currents were different from the I-V curves of currents measured at maximum 
TRPV1 current. In each cell, the steady state current was smaller than the maximum 
TRPV1 current, produced by capsaicin at each membrane potential. This is in 
agreement with data published recently by Matta and Ahern (2007), that voltage is a 
partial activator of TRPV1.  Due to reservations regarding the reliability of 
measuring tail currents, in the analysis, I decided to use the I-V relationship of the 
current flowing through the channel opened with 10 µM capsaicin to produce 
maximum TRPV1 current. 
 
The V-G (voltage-conductance) and the G/Gmax curves were then 
constructed by using the following description. For each cell, two I-V curves were 
generated and analysed. 
 
In the presence of 10 uM capsaicin, the I-V relationship of the current 
flowing through the channels was constructed by measuring the amplitude of the 
steady-state current at the end of the voltage-step (i.e. 1 millisecond before returning 
back to the holding potential of 0 mV). It was expected that the steady-state current 
produced during capsaicin application showed a linear I-V relationship because if the 
channel has an open probability which is not changed by the membrane potential, 
then the I-V curve should show ohmic relationship change not true.  However, I-V 
curves of capsaicin-induced currents showed a small outward rectification below 0 
mV. A reasonable explanation for the lack of linear I-V relationship could be that 
hyperpolarisation reduced the open probability slightly at 10 uM capsaicin. 
 
 
 In the absence of capsaicin, the I-V relationship of the current flowing 
through the channels with Po Va was constructed using the same steps, as mentioned 
above.  
 
In theory, the voltage-activated current should be 0 nA, or near zero below 
certain negative membrane potentials. This is because at –60 mV membrane 
potential TRPV1 does not show single channel activity (Nagy and Rang., 1999; 
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Matta and Ahern., 2007; Raisinghani et al., 2005; Voets et al., 2004). On the other 
hand above a certain membrane potential, when TRPV1 reached Po max, the I-V 
relationship should be linear. 
 
In contrast to these expectations, I never managed to obtain a recording which 
had no current flowing through the cell at negative membrane potentials. This 
indicated that some current was present even if TRPV1 was closed at negative 
membrane potentials. This is in agreement with my findings made in untransfected 
HEK293 cells.  
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Figure 2.31. Data analysis of voltage-dependence of hTRPV1-mediated response.  
(A) Upper trace: Voltage protocol to evoke tail-currents and steady state currents. 
Lower trace: A typical recording using depolarisation to induce maximal opening 
probability measured at symmetrical Na+ (150 mM). (B) Upper trace: Current 
protocol during capsaicin-evoked activation. Lower trace: A typical recording using 
10 µM capsaicin to induce maximal opening of the ion channel. (C) Current-voltage 
relationships of tail-current, steady-state current during voltage-dependent activation 
and steady-state current during capsaicin application.  
 
The reversal potential was interpolated from the zero current intercept by plotting the 
two data points below and above 0 nA and fitting them with a simple linear 
regression. The linear equation for the linear regression was noted and the reversal 
potential was then calculated. The conductance GVa of the steady-state current during 
voltage-dependent activation of the whole-cell Iss Va and maximum conductance Gmax 
of the steady-state current during capsaicin application Iss cap of the whole-cell was 
calculated as follows: 
 
 
 GVa  =  
(Em – Vr) 
Iss Va 1. 
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An example of a corresponding conductance-voltage graph of the Gva and Gmax can 
be seen in figure below (Fig. 2.32). 
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Figure 2.32 GVa was calculated from the steady-state current during voltage-
dependent activation whilst the Gmax curve was constructed from the steady-state 
current during capsaicin application at the end of the voltage pulse. Note that Gmax is 
constant between ~0 and -130 mV. Above ~+60 mV it showed an increase. This 
increase corresponds with the voltage-dependence of non-specific current in 
untransfected cell (n=1). Note also that Gva showed increase between -120 mV and -
40 mV and above 0 mV.  
 
 
Then the G/Gmax was analysed to obtain the open probability.   
 
 
 
 
The points were fitted with the Boltzmann function. However, the result of the 
Boltzmann function showed a poor fit with an r
2 
<0.95 (Fig 2.33).  
Po Va  
Po max 
= 
G total Va   -  G non-specific   
G total max   -  G non-specific  
 Gmax   =  
(Em – Vr) 
Iss cap 2. 
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Figure 2.33 V-G/Gmax relationship of conductances. The relationship was fitted with 
one Boltzmann function (r2<0.95) through all data points, from -130 to +155 mV 
(n=1). Note the poor fit.  
 
A close inspection of the V-G/Gmax relationship showed that two Boltzmann 
functions could be fitted instead of one, to best represent the data points (Fig 2.34). 
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Figure 2.34 V-G/Gmax relationship showed on fig 2.32, fitted with two Boltzmann 
functions. One sigmoid curve was fitted through data points from -130 mV to +5 mV 
(r
2
>0.95), whilst another sigmoid curve was fitted through data points from -25 mV to 
+155 mV (r
2
>0.95) (n=1). Note the high correlation coefficients of the fits. 
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The high correlation coefficients of the two fits, suggested the presence of two 
separate voltage-dependent currents in this cell: (i) between -25 mV and -130 mV; 
(ii) between -50 mV and +155 mV. Since untransfected cells exhibited only one 
voltage-dependent current, above ~0mV, these data suggest that the voltage-
dependent current below 0 mV, in the transfected cells should be due to the presence 
and voltage-sensitivity of TRPV1.   
 
Visual comparison of the average V-G relationships of voltage-activated currents in 
untransfected and hTRPV1 transfected cells (Fig. 2.35, and V-G/Gmax relationships 
of voltage-activated currents in hTRPV1 transfected cells confirmed that 
conductances in both hTRPV1111- and hTRPV1222- transfected had two components. 
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Figure 2.35 V-G relationship of voltage-activated current in untransfected cell and 
hTRPV1-transfected cell (n=1).   
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Figure 2.36 Average V-G/Gmax relationship of hTRPV1111 and hTRPV222. Capsaicin 
was used to induce maximum opening. Lines represent Boltzmann functions fitted to 
the data. Point represents n=1.  
 
 
The transfection-associated appearance of a conductance at negative potentials 
together with the presence of a conductance at positive potentials both in 
untransfected and TRPV1-transfected cells suggested that while the conductance at 
negative potentials was very likely produced by voltage-dependent activation of 
TRPV1, the conductance at positive potentials was produced by an unidentified 
voltage-gated channel(s) expressed by HEK293 cells constitutively. However, 
comparison of the V-G relationship of the average conductance in untransfected cells 
to that of the TRPV1 transfected cells showed that the constitutive conductance 
could be affected by the transfection; in other words the two conductances might not 
be separated.  
 
Therefore, proper characterisation of the voltage-dependence of TRPV1 could not be 
provided, i.e., the precise V1/2 of TRPV1 polymorphs alone could not be 
deteremined, it could only be estimated. Nevertheless, this estimation might reveal 
differences in voltage-dependence of the various polymoprhs if the differences are 
relatively large.   
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2.6  Statistical analysis  
 
Statistical analysis is conveniently divided into two categories: (i) descriptive 
statistics; and (ii) inferential statistics.  
 
2.6.1 Descriptive statistics 
 
Descriptive statistics are used to quantitatively describe the basic features of 
the data sampled.  Quantitative description is obtained by univariate analysis, which 
examines data from one group separately, in terms of central tendency, variability 
and distribution.  
 
2.6.1.1  Central tendency 
 
Central tendency is the value in a group of values which is the most typical 
for the group, or is a measure of the centre of distribution of values. There are three 
types of measures of central tendency: mean, median and mode.  The description 
here is based on accounts given by Hinton (2004) and Coolican (2005). 
 
The mean is the most commonly used measure of central tendency. The mean is the 
sum of observations divided by the number of observations. In most cases, the mean 
is not the same value as any values in the group. An advantage of using the mean is 
that all data values are used in the calculations and can be used in inferential 
statistics. However, the mean is more susceptible to extreme values in a data group. 
A single extreme value in one direction (an outlier) can distort the mean, whereas 
extreme values in both directions tend to cancel each other out (Coolican, 1995; 
Hinton, 2004). 
 
The median is the value halfway through a range of numbers that are arranged in 
numerically order: ranked in ascending or descending order.  If the data set has an 
odd number of values, the median is the central value of the ordered set. However, if 
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the data set has an even number of values the mean of the two central values is the 
median.  
 
The mode is the value that occurs most often in a set of data. Data with one mode is 
referred to as unimodal distribution.  However, there may be more than one mode 
from a set of data:  hence, bi-modal (two modes) distribution or multimodal (several 
modes) distribution. An advantage of using the median and the mode is that they are 
not affected by extreme values in a set of data (Keeping, 1995). 
 
For all data sets, the mean (X) was computed as the sum of all scores (∑x) divided 
by the total number of scores (N) 
 
 
The mean of a group of data was calculated in Excel, where the function was 
performed by the formula where Array1 is the data set being analysed: 
 
= AVERAGE(Array1) 
 
 
2.6.1.2   Variability  
 
Variability, or dispersion, of data refers to the spread of the values from the 
mean and can be expressed by the range, variance or standard deviation.  
 
The range is the maximum value minus the minimum value from a group of data. 
The range is greatly affected by extreme values in one direction and does not include 
all values from a group. 
 
Standard deviation refers to the relationship between the variability of the data from 
a group to the mean of the group. For example, the standard deviation is small if the 
values from a group are similar to the mean (standard deviation is zero when the data 
     ∑ X 
N 
X 
= 
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are equal to the mean). The standard deviation is large if the values are distant from 
the mean.  Standard deviation (s) is the root mean square deviation of values from 
the mean of a group.  
 
 
 
The variance is the sum of squared deviations from the mean divided by the number 
of observations. Hence, standard deviation is the square root of the variance or the 
variance is the standard deviation squared.  
 
Variance = S
2
 
 
Standard deviation is easier to interpret in terms of the range of data from a group 
than the variance, thus it is the most common measure of variability. The main 
advantages of using standard deviation instead of the range are that: (i) standard 
deviation considers all data in a group; (ii) is able to illustrate variation above and 
below the mean; and (iii) is able to identify outliers from a group of values 
(Coolican, 1995;  Hinton, 2004). 
 
I calculated the standard deviation of a group of data was calculated in Excel, where 
the function was performed by the formula:  
 
= STDEV(Array1) 
 
where Array1 is the data set being analysed. 
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2.6.1.3  Distribution 
 
The distribution is a summary of the frequency of individual values from a 
group of data, usually represented in a histogram or bar chart. There are three main 
characteristics to describe the frequency distribution histogram of a set of data: 
modality, skewness and kurtosis. 
 
The modality describes the number of modes (distinct humps) in a distribution. The 
modality of distribution can be unimodal (one mode), biomodal (two modes), or 
multimodal (more than 2 modes).   
 
The skewness is a measure of the asymmetry of the distribution, i.e., a symmetrical 
distribution exhibits no skewness and has a numerical value of zero. In a symmetrical 
unimodal distribution, all three central tendencies are located at the same point and 
hence, are equal to each other. An asymmetric frequency distribution can be either 
positively skewed or negatively skewed. A distribution is positively (right) skewed if 
the scores cluster around the lower end of the scale (i.e., smaller values), with 
progressively fewer scores at the upper end of the scale (i.e., larger values). In 
positively skewed distributions, the mean is larger than the median and has a 
numerical positive value. A distribution is negatively (left) skewed if the scores 
cluster around the upper end of the scale, with progressively fewer scores at the 
lower end of the scale. In negatively skewed distributions, the mean is smaller than 
the median and has a numerical negative value. 
 
The kurtosis characterises the „peakness‟ of a histogram, i.e., a normal distribution  
(see below) exhibits no kurtosis and exhibits a numerical value of zero. Kurtosis 
describes the extent to which the frequency distribution of scores is concentrated 
around the mode of the distribution. If a distribution is more peaked than a normal 
distribution, the kurtosis has a numerical negative value and is referred to as 
“leptokurtic”.  However, if a distribution is flatter than a normal distribution, the 
kurtosis has a numerical positive value and referred to as “platytkurtic”. 
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In many natural processes, random variation conforms to a particular probability 
distribution known as the normal distribution. Normal distribution, also referred to as 
Gaussian distribution, is a theoretical frequency distribution for a set of variable data 
and can be explained by the Central Limit Theorem (CLT; Hinton, 2004). The CLT 
states, that regardless of the distribution of the data from a group, the distribution of 
the means of the random values approaches a normal distribution. Normal 
distribution is usually represented as a symmetrical bell-shaped density curve, with a 
single peak at the centre of the distribution. The single peak represents the mean, 
mode and median of the distribution. The spread of data or the girth of the bell curve 
represents the standard deviation.  
 
Normal distribution can be transformed to standard normal distribution, by 
subtracting the mean of the group from the individual raw data and then dividing the 
difference by the standard deviation of the group. This conversion process will 
normalise data. Standard normal distribution, also referred to as z distribution, has a 
mean of zero and a standard deviation of 1, but the original symmetry or shape of the 
distribution remains unchanged. A z score indicates the number of standard deviation 
above or below the mean. All standard normal distributions satisfy the Empirical 
Rule, which provides that: (i) ~ 68% of all values fall within 1 standard deviation of 
the mean; (ii) ~ 95% of all values fall within 2 standard deviations of the mean; and 
(iii) ~ 99.7% of all values fall within 3 standard deviations of the mean (Fig 2.37). 
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Figure 2.37 Normal distribution curve and the Empirical Rule. The curve is bell-
shaped, where the mean, median, and mode are equal and are located at the centre of 
the distribution. The curve is symmetric to the mean (both sides of a vertical dashed 
line passing through the centre). The curve is continuous, that is, there are no gaps or 
holes. The curve never touches the x axis. The total area under a normal distribution 
curve is equal to 100%. The standard deviation (s) around the mean (x) is presented 
as the width. The Empirical Rule for normal distribution states that almost all data 
will fall within three standard deviations of the mean. (Taken and adapted from 
http://rchsbowman.wordpress.com/2009/09/08/statistics-notes-%E2%80%94-
interpreting-standard-deviation-%E2%80%94-the-empirical-rule-68-95-997-rule/.) 
 
 
 
2.6.1.4  Sampling distribution of the mean 
 
The sampling distribution of the mean must also be considered as part of the 
descriptive analysis of data as it is used to construct confidence intervals and in 
significance testing (see later). The sampling distribution of the mean states that in a 
population with a mean and a standard deviation, the sampling distribution of the 
mean has mean and a standard deviation. The standard deviation of the sampling 
distribution of a mean is referred to as the standard error of the mean (SEM; Fig 
2.38).   
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Figure 2.38 The spread of the sampling distribution of the mean. Note that as the 
number of sample sizes increases the spread of the sampling distribution decreases. 
However, the mean of the distribution is not affected by sample size.  (Taken from 
Lane, 2009). 
 
 
SEM is calculated by dividing the standard deviation by the square root of the 
number of samples (n) from a group. Hence, SEM is always smaller than standard 
deviation.  
 
 
where SM is SEM, S is the standard deviation, √ is the square root, and N is sample 
size.  
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The main advantage of using SEM is that it takes into account, the standard deviation 
and the sample size of the group. SEM gets smaller as the number of samples 
increase.  
 
I calculated the SEM of group of data was calculated in Excel, where the function 
was performed by the formula: 
 
=STDEV(Array1)/SQRT(COUNT(Array1)) 
 
where Array1 is the data set being analysed: 
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2.6.2 Inferential statistics 
 
Inferential statistics are used to make predictions about a population based on 
the data collected from small sample taken from that population. These statistics are 
dependent on the use of random sampling which ensures that a sample is 
representative of the population.  
 
The two main methods used in inferential statistics: estimation statistics and 
hypothesis testing. 
 
2.6.2.1 Estimation statistics   
 
Estimation statistics are used to make estimates about the population based on 
the sampled data. In estimation statistics, the sample is used to estimate a parameter 
and a confidence interval about the estimate is calculated.  
 
2.6.2.1.1 Parameter estimation  
 
Parameter estimation statistics are used to determine the values of parameters based 
on the sampled data. Parameter estimation statistic tests include the linear regression 
model and the non-linear regression mode.  
2.6.2.1.1.1 Linear regression model 
 A linear relationship between two variables (i.e., x and y, where y is a 
function of x) is usually first assessed by drawing a straight line through the points 
using a scatter plot. The line is drawn as near possible to the various points so as to 
best represent the trend and is referred to as the line of best fit or trend line.  Linear 
regression line finds the best fit of a linear relationship between two variables and 
analyses these values with a correlation coefficient. The linear regression model was 
used by me when analysing the heat threshold of activation of hTRPV1-transfected 
cells during an application of a heat ramp (37-50 
o
C). 
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The linear regression equation is:  
y = A + B  * x  
where y is the dependent variable, A is y intercept, B is the gradient of the slope and 
x is the independent variable  
 
 2.6.2.1.1.2a  Correlation coefficient of a linear regression 
 Correlation analysis is a statistical test for measuring the relationship between 
data from two variables. Correlation coefficient (r) quantifies the strength of the 
linear regression between the variables and ranges from -1 to +1. (In comparison, r
2 
quantifies the strength of the nonlinear regression between the variables). A positive 
coefficient indicates a direct relationship, where the variables change in the same 
direction, whilst a negative coefficient indicates an inverse relationship where one 
variable increases while the other decreases (Jones et al., 2007). A coefficient of zero 
implies that the two variables show no linear relationship; whilst an r value of -1 or 
+1 indicates that all points lie exactly on the line with no scatter. The Pearson‟s 
correlation coefficient is used, if the variables are normally distributed (parametric). 
If the data are not normally distributed (non-parametric), the Spearman‟s correlation 
coefficient is used (Sonnergaard, 2006). 
 
Fitting a linear regression line   
 
The simplest method of assessing linear regression is to plot the two variables, 
independent (x) and dependent (y) variable and fit a linear regression line to the 
points.  All linear regression lines were done with the fit linear tool in Origin 
statistical analysis software; the r value and the values A and B from the linear 
regression equation were calculated.  
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2.6.2.1.1.2 Non-linear regression model 
 
Non-linear regression models employed as part of my work included: the Gaussian 
distribution, the sigmoidal dose response and the Boltzmann sigmoidal  
 
2.6.2.1.1.2a Gaussian distribution 
 
The Gaussian distribution is a bell-shaped distribution of results from a normal 
sample population. Gaussian distribution was used when analysing agonist-evoked 
cobalt-labelling light intensity data.  
 
The Gaussian equation is defined as:  
 
Y=Amplitude*exp(-0.5*((X-Mean)/SD)^2 
 
where Amplitude is the height of the centre of the distribution in Y units, Mean is the 
X value at the centre of the distribution. SD or standard deviation is a measure of the 
width of the distribution, in the same units as X (Motulsky, 2007). 
 
Fitting a Gaussian curve to a histogram  
 
The simplest method of assessing normal distribution or normality is to plot 
the frequency distribution histogram of the data and to fit a Gaussian curve to the 
histogram. All Gaussian curve fitting was performed by me with a curve fit tool in 
Origin statistical software analysis (OriginLab Corp). 
 
First the raw data for a range of values was highlighted, and then under Descriptive 
Statistics, frequency count was selected. Frequency count is the number of events of 
a particular sort. This function opens the Count dialog box, in which the minimum 
and maximum values and the step size increments are specified. The programme then 
creates a set of bins, beginning at the minimum value and based on the step size 
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specified. The number of times a value is encountered which falls within the several 
bins is recorded. This function returns the result in the form of a worksheet: the first 
column shows the mid-point value in each bin and the second column displays the 
number of hits observed for each bin. A histogram can then be constructed with these 
values (OriginLab, 2007). 
 
If the histogram appeared to visually display the presence of one bell-shaped curve 
with a single peak at the centre of the distribution, one normal distribution curve was 
fitted by selecting Fit Gaussian, under Analysis tab.  If the histogram appeared to 
visually display the presence of two or more distinct peaks, multiple normal 
distribution curves were fitted by selecting Fit Multiple-peaks and Gaussian. This 
function opened a Number of Peak dialog box, in which the number can be entered. 
Using the cursor, the peak of each distribution was selected. The programme then fits 
a Gaussian curve or curves onto the histogram and a data dialog box appears with an 
r
2
 value and confidence intervals which describes the relationship between the fitted 
curve and the histogram. The fitted parameters in terms of width, maximum 
amplitude, areas of the curve with SEM, are also computed.  
 
 
2.6.2.1.1.2b Sigmoid curve 
 
The sigmoid curve is an S-shaped curve, which is common curve in biological 
distributions as it describes the relationship between the amount of dose of a 
substance and the resulting response (Fig 2.39). Thus, it is referred to as the 
sigmoidal dose-response curve. Two assumptions are made when using this function: 
(i) that there is almost always a dose below where no response can be measured; and 
(ii) that once a maximum response is reached any further increases in the dose will 
not result in any increased effect.  Sigmoidal dose-response curve was used to 
contract capsaicin- and pH-evoked hTRPV1-activated current 
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The equation for a dose-response curve is:  
 
 
where the variable Bottom is the Y value at the bottom region; Top is the Y value at 
the top region, and LogEC50 is the X value when the response is halfway between 
Bottom and Top. LogEC50 is the logarithm of the EC50 (effective concentration, 
50%). This equation assumes a standard slope, where the response goes from 10% to 
90% of maximal as X increases over about two log units. All sigmoidal dose-
response curves were fitted using either Origin or Graphpad Prism statistical analysis 
software, were EC50 and maximal amplitude response, in this case current (Imax) 
response were computed with a SEM. r
2
 value and confidence intervals were also 
shown (see later). 
 
 
Figure 2.39 Sigmoidal dose response curve. The response is shown as a function of 
the logarithm of concentration. X is the logarithm of agonist concentration and Y is 
the response. (Taken from Graphpad Software Inc, 2007). 
 Statistical comparisons between two dose-response curves were analysed using 
Graphpad Prism statistical analysis software. EC50 and the Imax values were 
compared using Student t-test (two-tailed test, equal variance) to compare best fit 
variables of the non-linear regression used (see later).   
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2.6.2.1.1.2c Boltzmann curve 
 
The Boltzmann curve can describe the voltage dependent activation of ion channels.  
 
The equation for the Boltzmann fit 
 
where the conductance varies from Bottom to Top. V50 is the potential at which 
conductance is halfway between Bottom and Top (Fig. 2.40). Slope describes the 
steepness of the curve, with a larger value denoting a shallow curve. Slope is 
expressed in units of potential, usually mV, and is positive for channels that activate 
upon depolarization. Under appropriate experimental conditions, the Slope is used to 
calculate the valence (charge) of the ion moving across the channel. Slope equals 
RT/zF where R is the universal gas constant, T is temperature in °K, F is the Faraday 
constant, and z is the valence. Since RT/F » -26 mV at 25°C, z = -26/SLOPE. Bottom 
is commonly made a constant equal to 0.0. If the Top is a constant equal to 1.0, then 
Y can be viewed as the fraction of channels that are activated (Graphpad Software 
Inc, 2007). All Boltzmann curves were fitted with Graphpad Prism statistical analysis 
software (Graphpad Software, Inc). 
 
Figure 2.40 Boltzmann curve. The fit describes voltage dependent activation of ion 
channels.  It describes conductance (Y) as a function of the membrane potential (X).  
(Taken from Graphpad Software Inc, 2007). 
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Statistical comparisons between two Boltzmann curves were analysed using 
Graphpad Prism statistical analysis software. V50 of the two curves were compared 
using Student t-test (two-tailed test, equal variance) to compare best fit variables of 
the non-linear regression used (see later).   
 
 
2.6.2.1.1.3  The goodness of fit of nonlinear regression 
 
The goodness of fit of nonlinear regression or r
2 
quantifies the strength of the 
nonlinear regression between the variable and ranges from 0 to 1. An r
2 
value of zero 
implies that the two variables show no relationship, whilst an r
2
 value of 1 indicates 
that all points lie exactly on the curve with no scatter. r
2
 is computed from the sum of 
the squared values of the distances of the points from the best-fit curve determined 
by nonlinear regression. 
 
2.6.2.1.1.4 Confidence intervals 
 
Confidence interval is a measure of the accuracy of an estimated value. The interval 
represents a range of values, consistent with data that has a generally high probability 
of capturing the true population value. Confidence level, expressed as a percentage 
or a probability, is the likelihood that the confidence interval will contain the true 
population parameter. Confidence intervals are therefore defined in terms of 
confidence levels. Confidence intervals can be constructed from any level of 
confidence level. The most common levels are 90 %, 95 % and 99 %.  
 
For example, selecting 95 % confidence level means that there is a 0.95 probability - 
that the specified interval will include the true population parameter.  
 
186 
 
2.6.2.2  Hypothesis testing  
 
Hypothesis testing uses statistical data analysis to make statistical conclusions 
about whether or not the sample data supports a particular hypothesis. Thus, in 
statistics, a hypothesis is a predication of a relationship between data to be measured. 
Hypothesis testing uses statistics to determine if the hypothesis is not true with a high 
probability. Hypothesis testing consists of the following steps:  
 
(i) Formulation of hypotheses: Two hypotheses are initially stated. The null 
hypothesis (H0) states that one group of data is not different from another 
group of data.  
H0 :  µ1  =  µ2 
where µ1 is population l mean, and  µ2 is a population 2 mean.  The 
alternative hypothesis (HA) is a statement which is true if the null 
hypothesis false, that is the refusal of H0.  
 
HA :  µ1  ≠ µ2 
 
where ≠ is not equal. Furthermore, the HA can either one-tailed or two-
tailed. One-tailed alternative hypothesis includes the direction of the 
effect according to the null hypothesis.   
H0 :  µ1  =  µ2 
HA :  µ1  < µ2   or  HA :  µ1  > µ2 
 
 
A two-tailed alternative hypothesis predicts no direction of the result 
corresponding to the null hypothesis.   
H0 :  µ1  =  µ2 
HA :  µ1  ≠ µ2 
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(ii) Setting the critical p-value or statistical significance level: The probability 
value, also referred to as the p-value, is the probability that the value 
obtained in a statistical test is due to chance, rather than a true 
relationship between the groups being compared.  
 
A critical value is the value that a statistical test must exceed in order for 
the null hypothesis to be rejected. Thus, significance level is the fixed 
critical p-value, to determine whether or not the null hypothesis is 
rejected. The most universally accepted level of statistical significance is 
0.05 or 5%, also written as p = 0.05. This means that there is 5% chance 
that the null hypothesis is rejected, even though it is true. 
 
(iii) Identify the appropriate statistical test to calculate critical value: To assess 
the truth of the null hypothesis a suitable statistic test is used to calculate 
the p-value. The critical value is compared with the set significance level 
of the statistical test used. The critical value is always calculated 
assuming the null hypothesis is true.  
 
2.6.2.2a Statistical errors: type I and type II error 
 
In any hypothesis statistical test one can never be 100% certain that one has to reject 
(or accept) the null hypothesis. There is, therefore, the possibility of making an error. 
There are two types of statistical errors associated with hypothesis testing: Type I 
error and Type II error (Fig 2.41).   
 
Type I error relates to the incidence of a false positive result.  It refers to the situation 
where the null hypothesis is incorrectly rejected, when it should be accepted. To 
reduce the possibility of making a type I error, one must assign small p-values (p 
≤0.05) (Columb and Stevens, 2008). 
 
Type II error relates to the incidence of a false negative result. It refers to the 
situation when the null hypothesis is accepted incorrectly. The “power” of a 
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statistical test refers to the probability of detecting a true positive result, That is, it 
rejects the null hypothesis when it is true. Thus the power of the hypothesis test is the 
probability of not committing a type II error and is estimated by subtracting the 
probability of making a type II error from 1 (Columb and Stevens, 2008). The most 
universally accepted power of an experimental study is 0.8 or greater i.e. there is at 
least an 80% chance of correctly detecting a difference. Power analysis can be used 
to reduce the risk for Type II errors by estimating in advance how big a sample is 
needed (Hinton, 2004). 
 
Figure 2.41 Types of statistical errors associated with hypothesis testing.  
(Taken from http://www.microbiologybytes.com/maths/1011-20.html). 
 
  2.6.2.2b  Power analysis  
 
Power analysis estimates in advance how big a sample is needed prior to the study to 
obtain a significant result. There are four components in a power analysis: 
 
1. The significance criterion: The more stringent this criterion is, the lower the 
power. 
2. The sample size. As the sample size increase, the power increases.  
3. The effect size:  The effect size is an estimate of how wrong the null hypothesis 
is, i.e, how the strength of the relationship between the variables is in the 
population 
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4. Power. This is the probability of falsely rejecting the null hypothesis, when in 
fact its true. 
5. Typically, the critical value of power is equal 0.8, that is there is a 20% risk of 
committing a type II error. Although this percentage is high, a value of >0.8 
requires much larger sample size, which is economically unaffordable (Polit and 
Beck, 2008). 
 
A number of assumptions must be made when using power analysis.  An 
estimation of what is relatively important difference may not always be clear and in 
studies where small differences are important, inaccuracies may be magnified. 
Standard deviation estimations from pilot studies may not be representative of the 
population as the samples are often small. Nevertheless, the power analysis provides 
at least some guidance with a scientific basis (Columb and Stevens, 2008). A power 
analysis was not calculated prior to my investigations. It was taken that value of 3, 
was the minimum size for each data point, as this was the minimum sample size 
required to calculate a standard deviation.  However, when a means comparison test 
showed significant difference between the two groups or more in the Student t-test or 
1-ANOVA, respectively (see later), where n=3, the power was calculated in 
conjunction with the parametric test employed. A critical value was set to 0.8. If the 
power calculated was >0.8, the null hypothesis for the means comparison test, was 
rejected.  
 
2.6.2.2.1 Parametric tests 
 
 
Prior to using a parametric test, the normality of the distribution of data must be 
assessed, using a normality test. Furthermore, the standard deviation between the 
groups of data must also be assessed for variance, as parametric tests assume equal 
variance between the samples being compared.  
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2.6.2.2.1a Test for normality of the distribution  
 
A normality test is a statistical test used to determine whether the data 
sampled are from a population which is normally distributed. A normality test is 
useful because other statistical tests, such as t-test and ANOVA, assume that the data 
is from a normally distributed population. There are several tests available to analyse 
the homogeneity of variance, one of which is the Shapiro-Wilk W test. 
 
The Shapiro-Wilk W test is used to test for normality. It tests whether the null 
hypothesis (i.e., that the data are normally distributed) is true. The Shapiro-Wilk W 
test is the preferred the test for normality because it possesses good power properties 
when compared to alternative tests, such as the Kolmogorov-Smirnov test and the 
Lilliefors Test (StatSoft, Inc. 2001). The null hypothesis for all normality tests is that 
the data set is similar to the normal distribution. Therefore, a sufficiently small p-
value indicates non-normal data. 
 
Performing a normality test 
 
The normality test was used to investigate the probability of accepting the null 
hypothesis, that the distribution is normal and was performed using an Origin 
statistical analysis programme. In the Origin statistical analysis programme, the data 
being analysed was highlighted and under Descriptive Statistics, the Normality Test 
(Shapiro-Wilk) was selected. The function returns the result of the normality test 
under the assumption that the null hypothesis is true. The function calculates the W-
value, the p-value and the decision whether the data is normal at 0.05 level. If the 
resulting p-value is smaller than or equal to the pre-determined significance level (p 
≤0.05), this suggests that the data is not normally distributed. However, if the p-value 
value is larger than the significance level (p >0.05), this indicates that the data 
distribution is normal.  
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2.6.2.2.1b  Test for equal variance 
 
Equal variance across groups, or homogeneity of variance, is assumed when 
using parametric tests. There are several tests available to analyse the homogeneity 
of variance: the F-test; the Bartlett‟s test; and the Levene‟s test. 
 
The F-test or Fisher test is used to investigate whether the variances of two groups 
are equal by comparing the ratio of two variances. Since variance is the standard 
deviation squared, the F-test formula is calculated by dividing the variance of the 
first sample by the variance of the second sample 
 
F = S 1 
2
/ S 2 
2 
 
where S1
2  
is standard deviation squared of Group 1 and S2
2
 is standard deviation 
squared of Group 2. The larger of the two variances was placed as the  numerator, in 
order for the F-value to exceed 1.  If the variances are exactly the same between the 
two groups, the ratio of the variances has an F-value of 1. The F-test for significance 
indicates whether, given the sample sizes of the groups, the F-value is significant 
(Dever, 1991).  
 
The Bartlett‟s test and the Levene‟s test are equal variance tests used to investigate 
the homogeneity of variances of three or more groups. The Bartlett‟s test analyses 
the equality of variance in populations having normal distributions. Thus, this test is 
sensitive to departures from normality. If the samples obtained are not normally 
distributed, the Bartlett‟s test may be used to test for non-normality. Levene‟s test is 
an alternative to the Bartlett‟s test as it is less sensitive to departures from normality 
and should be used if the data are not normally distributed (e-Handbook of Statistical 
Methods). For this reason, Levene‟s test was the preferred equal of variance test for 
three or more groups. 
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The null hypothesis for the variance test states that there are no differences between 
the variances of two groups or more, i.e., the variances are equal between the groups 
tested. Whilst, the alternative hypothesis for the variance test states that there are 
differences between the variances of two or more groups. Furthermore, the HA can be 
either one-tailed or two-tailed: one-tailed test states the direction of the variance of 
the groups being compared to be less than, or more than, each other, whilst the two-
tailed test does not state the direction of the variance.   
 
Performing a test for equal variance  
 
The F-test was used to investigate the probability of accepting the null hypothesis, 
that the variances of two groups are equal.  An F-test was performed using an Origin 
statistical analysis programme. In the Origin statistical analysis programme, the data 
being analysed was highlighted and under Statistics, Hypothesis Testing was 
selected. Under Hypothesis Testing, Fit Comparison was selected. This function 
compares two data sets by fitting the same function to the data. The value of 0.05 
was selected for significance level for comparison with the p-value for F-test. As a 
result, a decision rule was shown as a statement whether or not the population means 
were significantly different at a 0.05 level 
 
Levene‟s equal variance test was used to assess the equality of variance of three or 
more groups, in terms of probability.  A Levene‟s test was carried out in 
conjunctions with the analysis of variance test (see later) using the Origin statistical 
analysis programme (see 1-ANOVA).   
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2.6.2.2.1.1 Comparing the means of data 
 
The Student‟s t-test and analysis of variance (ANOVA) are widely used statistical 
tools used to compare the means of data.  
 
2.6.2.2.1.1 (a)  Student t-test 
 
Student‟s t-test is used to compare the means of two groups and assess 
whether the means of the two groups are statistically different from each other. The t-
test assumes that the data analysed within each group are normally distributed and 
that the variances are equal.  
 
The t-test is a comparison between two group means, which takes into considerations 
the difference in group variation and group size of the two samples.  
 
The t-test formula states: 
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The numerator is the difference between the means. The t-value gets larger as the 
means of the groups get further apart. The denominator is the standard error of the 
difference between the means. The probability of getting the t-value under the null 
hypothesis is calculated using the t-distribution. The t-distribution is a probability 
distribution that arises in the problem of estimating the mean of a normally 
distributed population when the sample size is small. Thus the t-test function returns 
the probability value that the t-value equals a desired value, assuming a t-distribution 
(McDonald, 2009).  
 
 
Performing a   Student t-test  
 
The Student t-test was used to find the probability of rejecting the null 
hypothesis, that the means of two groups are statistically different from each other. A 
t-test was performed using an Origin statistical analysis programme. In the Origin 
statistical analysis programme, the data being analysed was highlighted and under 
Statistics, Descriptive Statistics was selected. Under Statistics was selected two 
sample t-test. This function opened a two sample t-test dialog box, where certain 
parameterswere chosen, such as the type of test, hypothesis and power analysis. 
 
In types of test two could be selected: (i) paired test; or (ii) independent test. A paired 
t-test was applied when the two sets of data were from the same sample and had the 
same sample size. Independent t-test was used when the two sets of date were from 
independent samples. This test may also be used even if the sample sizes are not 
equal. The appropriate type of test was selected.  
 
In hypothesis, under the null hypothesis, the value of 0 was entered as the estimated 
difference of the sample mean, indicating no mean difference between the groups. In 
hypothesis, under alternate hypotheses two different types of tails could be selected: 
two-tailed test or one tailed test. A two-tailed test was used for all Student t-tests as 
no assumption was made prior to the treatment used.  The value of 0.05 was selected 
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for significance level for comparison with the p-value for t-test. The power analysis 
function was also selected.  
 
Once all the parameters were chosen, the Compute button was selected. The function 
returned the result of the t-test which was shown in the Results Log Table where the 
t-value, the p-value and a decision whether the data was normal at 0.05 levels, was 
shown. A decision rule was shown as a statement whether or not the population 
means were significantly different at a 0.05 level. The result of power analysis was 
also shown.  
 
2.6.2.2.11(b) ANOVA 
 
Analysis of variance (ANOVA) is used to simultaneously compare the means 
of more than two groups of data and assess whether the means of the groups are 
statistically different from each other. The name is derived from that fact that in 
order to assess statistical significance between the mean values of data, the variances 
between groups are analysed. There are lots of different experimental designs that 
can be analyzed with different kinds of ANOVA.   
 
One-way ANOVA is used to test for differences among two or more independent 
groups with dependent variable. The independent variable is the variable being 
manipulated or changed. The dependent variable is the observed result of the 
independent variable being manipulated. 1-ANOVA for repeated measures is used 
when the groups are subjected to repeated measures. Factorial ANOVA is used when 
the experimental design studies the effects of two or more treatment variables. 
Multivariate analysis of variance (MANOVA) is used when there is more than one 
dependent variable (Hinton, 2004).  
 
Due to the experimental design of my studies, only 1-ANOVA was used to compare 
the mean of more than two groups. 
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1-ANOVA 
 
Before using 1-ANOVA, there are three criteria which must be met: (i) the 
population from which the samples are obtained must be normally distributed; (ii) 
the samples must be independent of each other; and (iii) the variances of the 
population must be equal. The null hypothesis will be that all population means are 
equal. Thus, the alternative hypothesis is that at least one mean is different.  
 
1-ANOVA, calculates the mean of each group being tested and then compares the 
variance among these means to the average variance within each group. Thus, 1-
ANOVA is expressed as a ratio, referred to as the F-ratio: the variance determined 
between-group differences divided by the variance determined within-group 
differences, also referred to as error term.  The error term provides a measure of the 
variance due to chance. When the null hypothesis is true, the error term measures the 
same value of variance as the numerator of the F-ratioso that, as the means get 
further apart, the variance among the means increases (McDonald, 2009).  
 
The F ratio is calculated under the assumption of equal population variance (f-
distribution), as variation within each of the groups can be combined to form one 
estimate of the variation due to error. The F-distribution is a continuous probability 
distribution which is used to calculate the probability of getting a ratio which equals 
a desired value. Thus, when the probability is p≤0.05, the ratio is considered to be 
statistically significant. 
 
 1-ANOVA calculates the average difference between the group means. As a 
consequence of comparing the means of three or more groups, a relatively large 
mean difference between these group means may be determined even if two of the 
three or more group means are identical. Thus, a statistically significant F-ratio 
indicates that there is a statistical difference between the mean of at least two of the 
groups being compared. It does not indicate which groups differ from each other 
significantly. Therefore, a post hoc test is required to indicate where the differences 
lie (Urden, 2005).  
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2.6.2.2.1.1(c) Post hoc tests 
 
Post-hoc tests are used at the second stage of ANOVA, if the null hypothesis 
is rejected, i.e., if there is a statistical significance between the means of at least two 
groups. There are a wide variety of post hoc tests available to analyse data. Each of 
these tests has advantages and disadvantages. However, all post-hoc tests use the 
same basic principle of comparing the differences between two means (pair-wise) 
against the critical difference (similar to critical value) required for significance. If 
the differences between two means are more than or equal to the critical difference, 
the difference is significant. If the differences between two means are less than the 
critical difference, there is no significant difference between the pairs being 
compared. The critical difference required to call a pair of means significantly 
different, is what differentiates all pair-wise tests from each other. 
 
The Fisher's least significant difference (LSD),  Tukey’s honestly significant 
difference (HSD) and  Scheffe’s test are the most widely used tests employed to find 
where the differences between means lie when the Analysis of Variance indicates the 
means are not all equal. The Fisher's LSD test explores all possible pair-wise 
comparisons of means using the equivalent of multiple Student t-tests. Tukey‟s HSD 
test computes a single value which determines the minimum difference between the 
two means that is necessary for significance. If the mean difference is more than 
Tukey‟s HSD, the difference is considered to be statistically significant. The Tukey 
test is generally used when the sample sizes are all the same (McDonald, 2009; Kau 
and Green, 2008).  Scheffe‟s test uses the F-ratio obtained from 1-ANOVA to test for 
a significant difference between any two means.  The critical value for the Scheffe‟s 
test is the same as the F-ratio from the overall ANOVA. The Scheffe‟s' test is 
generally used when the sample sizes are different (McDonald, 2009; Kau and 
Green, 2008).   
 
As there are substantial differences among these post hoc tests, there are advantages 
and disadvantages to each. Thus careful consideration as to the appropriate test 
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should be given in each experimental investigation. Fisher‟s LSD test is the least 
rigorous of post hoc tests and is most likely to result in a type I error. Tukey‟s HSD 
is similar to Fisher‟s LSD but is less likely to result in a type I error. Scheffe‟s test is 
one of the safest or conservative post hoc tests, as it uses an extremely cautious 
method for reducing the risk of a type I error. In many experimental investigations, 
different post-hoc tests may lead to the same conclusions and which of the above 
tests is actually used is often a matter of fashion or personal taste (Hilton and 
Armstrong, 2006).  
 
An acceptable way of deciding which post hoc test to use is to consider the purpose 
of the experimental investigation. If the purpose of the investigation is to decide 
which of a group of treatments is likely to have an effect, it is justifiable to use the 
more liberal Fisher‟s LSD test. This is because it is better not to overlook a possible 
effect.  In comparison, if the purpose of the investigation is to establish that a 
particular treatment does have an effect; it is better to use the more conservative 
Scheffe‟s and Tukey‟s HSD test (Hilton and Armstrong, 2006). 
 
Performing 1-ANOVA 
 
1-ANOVA was used to investigate whether the mean data of three or more groups 
were statistically different from each other was carried out using Origin statistical 
analysis programme. In Origin, the data being analysed was highlighted, where each 
column presented raw data of one group. Under Statistics, 1-ANOVA was selected. 
This function opened the 1-ANOVA dialog box, where certain parameters were 
chosen, such as the significance level, means comparison test and equal variance 
test.  The value of 0.05 was selected for significance level for comparison with the p-
value when making the statistical decision. The means comparison test was chosen 
on the basis of the experimental design. If the purpose of the investigation was to 
decide which of a group of treatments was likely to have an effect, the Fisher‟s LSD 
test was used. If the purpose of the investigation was to establish that a particular 
treatment did have an effect, the Scheffe‟s of Tukey‟s HSD test were used. 
Furthermore, if the sample size were different from each other, the Scheffe‟s' test 
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was selected. However, if the sample sizes were equal to each other, the Tukey‟s test 
was selected. Levene‟s test was selected to test for equal variance of the data. Once 
all the parameters were chosen, the Compute button was selected.  The function 
returned the results of the 1-ANOVA under the assumption that the null hypothesis is 
true. Summary Statistics dialog box (including the Null and Alternative hypotheses), 
an ANOVA table, and a decision rule were shown in the Results Log. Similar results 
for Levene's test for equal variance were also disclosed.   
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Chapter 3 
 
 
DMSO ACTIVATES TRPV1 
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3.1  Introduction 
 
In order to ascertain that the dimethyl sulfoxide (DMSO) employed to dissolve 
capsaicin did not activate or inhibit TRPV1, the DMSO-evoked effects both in 
untransfected and hTRPV1-transfected cells were studied. In addition, the DMSO-
evoked effect was also investigated in cultured DRG neurons prepared from wild-
type mice and TRPV1 knock-out mice.   
 
3.2  Methods 
 
The following techniques were employed in this section, namely: cell culture of 
HEK293 cells; primary culture of DRG neurons, transient transfection, cobalt-uptake 
and whole-cell patch clamp-technique. For further detail, see Chapter Two: Materials 
and Methods. The wild-type hTRPV1111 haplotype was used in this investigation to 
assess the effect of DMSO in TRPV1-transfected HEK293 cells. For, simplicity this 
haplotype will be referred to as hTRPV1. 
 
3.2.1 Whole-cell patch-clamp recordings 
 
Whole-cell patch-clamp recordings were taken from hTRPV1-transfected and 
untransfected HEK293 cells in order to assess whether DMSO is able to induce 
currents. For further details on whole-cell patch-clamp technique, see Chapter Two.   
 
Briefly, DMSO-mediated currents were measured using the conventional whole-cell 
patch-clamp technique with an Axopatch 200 B amplifier (Axon Intruments, Inc.) 
and the pClampex 8 software package with a laboratory PC for storing and 
evaluating data. All experiments were performed at a physiological temperature of 
36-37 
o
C using a temperature controller (Wavelength Electronics). The membrane 
potential was held at -60 mV. Data was collected using the pClampex 8.2 data 
analysis programme (Axon Instruments, Inc). The cell was discarded if the 
membrane current following the establishment of whole-cell configuration was 
below -0.5 nA.  
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Solutions 
 
Normal extracellular buffer consisted of (mM): NaCl, 130; KCl, 5; CaCl2, 2; MgCl2, 
2; glucose, 10; HEPES, 10; adjusted to pH 7.4.  
 
Patch electrodes were filled with normal intracellular buffer (mM): NaCl, 5; KCl, 
130; MgCl2, 1.26; HEPES, 10; adjusted to pH 7.4.  
 
A stock solution of capsaicin (Tocris, UK) and capsazepine (Tocris Bioscience, 
Avonmouth, UK) was dissolved in 100 % DMSO (Sigma). All further capsaicin and 
DMSO dilutions were made using normal extracellular buffer. In these experiments 
100 nM, 500 nM capsaicin and 5 µM capsazepine solutions containing 0.006% 
DMSO were used. A stock solution of allyl isothiocyanate (Aldrich) was dissolved in 
100% mineral oil (Aldrich Chemical, Tokyo). 
 
Dimethylsulfoxide (DMSO) is routinely used in laboratories to dissolve lipophilic 
compounds and it is totally soluble in water. DMSO has a molecular weight of 78.12 
g/mol, density of 1.101 g/ml and a purity of 99.7%.  The DMSO concentration and 
percentage in solution was calculated by reference to the dilution factor used in the 
experiments (Table 3.1).  
 
DMSO dilution factor DMSO % in solution DMSO concentration 
1 in 200 0.5% 70 mM 
1 in 500 0.2 % 28 mM 
1 in 1000 0.1 % 14 mM 
1 in 2000 0.05 % 7 mM 
1 in 4000 0.025 3.5 mM 
1 in 16,000 0.006 0.9 mM 
 
Table 3.1 DMSO in terms of dilution factor, percentage in solution and 
concentration. 
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3.2.1.1  Application of 0.2% DMSO 
 
To investigate the effect of DMSO in transfected and untransfected cells, DMSO was 
dissolved in normal extracellular buffer in the following percentages, namely: 0.2%, 
0. 1 %, 0.05 %, 0.025 % and 0.006 % (see Table 5.1). Application of DMSO for 10 
seconds was controlled by an automated system which was itself controlled by 
pClampex 8 software. As a control the effect of 500 nM capsaicin was also 
investigated. 500 nM capsaicin was made so that the DMSO in solution was 0.006%. 
A concentration of 500 nM was chosen to investigate TRPV1-mediated response 
because it is approximately the EC50 value of capsaicin to TRPV1-expressing cells 
(Caterina et al., 1997; Welch et al., 2000; Hayes et al., 2000; Ahern et al., 2006).  
 
Data were then analysed by measuring the maximum amplitude of the responses 
using the pClampfit 8.2 software. The maximum amplitude of both the capsaicin- 
and DMSO-evoked responses were established.  
 
3.2.1.2  Application of 0.2% DMSO  in the presence of capsazepine 
 
Whole-cell recordings were also used to investigate the effect of the competitive 
TRPV1 antagonist capsazepine on the DMSO-evoked currents in hTRPV1-
transfected HEK293 cells. In these experiments cells were continuously perfused 
(minimum period of 2 minutes) with 5 µM capsazepine (DMSO content 0.006%) 
before applying 0.2 % DMSO for 10 seconds. As a control for the antagonistic effect 
of capsazepine, the effect of 500 nM capsaicin (0.006%) was also investigated in this 
condition. The maximum amplitudes of the responses were also established.   
 
 
The effect of 0.006% and 0.012% DMSO, which was the percentage of DMSO in 
capsaicin and capsazepine alone, and when applied at the same time, respectively, 
was not investigated (Table 4.2). This is because; whole-cell patch-clamp 
experiments showed no membrane current when 0.05 % DMSO was applied on to 
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hTRPV1-transfected cells (see results). Hence, we assumed that DMSO of less than 
0.05% in solution will not evoke TRPV1-mediated membrane current. The effect of 
0.206 % DMSO when 0.2% DMSO was simultaneously applied with capsazepine 
was not investigated as we assume that an increase of 0.006% DMSO was 
undetectable due to the sensitivity of the whole-cell patch-clamp configuration (noise 
of the set-up contributed ~15-20 pA). 
 
 
3.2.2 Cobalt-uptake of hTRPV1-transfected HEK293 cells  
 
Cobalt-uptake assay was performed on TRPV1-transfected and on untransfected 
HEK293 cells in order to assess the effect of DMSO.   
 
Solutions 
 
Buffer A contained (in mM): 57.5 NaCl, 5 KCl, 2 MgCl2, 10 HEPES, 12 glucose, 
139 sucrose, adjusted to pH 7.4. Cobalt-containing Buffer B consisted of Buffer A 
plus the addition of 5 mM of CoCl. 
 
In these experiments 500 nM capsaicin and 5 µM capsazepine solutions containing 
0.006% DMSO were used. 
 
3.2.2.1  0.2% DMSO application  
 
The cobalt-uptake assay was carried out in: (i) hTRPV1-transfected HEK293 cells; 
and (ii) untransfected cultures, to assess whether DMSO is able to induce cobalt-
labelling.  
 
Cells were washed in Buffer A twice and then incubated for 5 minutes at 37
o
C in 
either:  (i) drug-free cobalt-containing Buffer B; (ii) cobalt-containing Buffer B  plus 
500 nM capsaicin (DMSO content 0.006 %); or (iii) cobalt-containing Buffer B  plus 
0.2 % DMSO. The cells were then briefly washed before precipitating the cobalt with 
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0.4 % mercaptoethanol for 1 minute. Cells were fixed in 70% ethanol, mounted in 
glycerol on slides and analysed. This was carried out in at least three independent 
cultures of HEK293 cells.  
 
 
3.2.2.2   0.2% DMSO application in the presence of capsazepine   
 
In order to investigate the effect of the competitive TRPV1 antagonist, capsazepine, 
on the DMSO-evoked cobalt-labelling of hTRPV1-transfected HEK293 cells the 
following protocols steps were carried out, see table 3.1.  
 
Six cover-slips containing transfected cells were washed twice in Buffer A. They 
were then pre-incubated for 5 minutes at 37
o
C in the respective treatment group 
indicated in table 3.1 under the heading of “pre-incubation for 5 minutes” containing 
either drug-free Buffer A or Buffer A containing  5 uM capsazepine (DMSO content 
of 0.006 %). A pre-incubation step was used to allow the antagonist to occupy the 
binding sites of the receptor without interference from the agonist. The cells were 
then incubated in cobalt buffer for a further 5 minutes at 37
o
C in shown in Table 4.2, 
under the heading of “incubation for 5 minutes” in Buffer B containing cobalt ions, 
where 0.2 % DMSO and 500 nM capsaicin (DMSO content 0.006 %) were used. The 
cells were then briefly washed before precipitating the cobalt with 0.4% 
mercaptoethanol for 1 minute. Cells were then fixed in 70% ethanol, mounted in 
glycerol on slides and analysed. This was carried out in at least three independent 
cultures of HEK293 cells.  
 
We have been using capsazepine in our laboratory as a capsaicin receptor 
antagonist for studying TRPV1-mediated responses. Although at first capsazepine 
was shown to be a selective and specific inhibitor of capsaicin-evoked currents in 
primary sensory neurons (Bevan et al., 1991, 1992; Dickenson and Dray, 1991; Dray 
et al., 1991), later it was found to inhibit patch-gated calcium currents with an IC50 
of 7.7 uM (Docherty et al., 1997). Therefore, we have been using 5µM capsazepine 
routinely in our laboratory. We used the same concentration of capsazepine in these 
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experiments, although using higher capsazepine concentration in studying TRPV1-
mediated responses either by whole-cell patch-clamp recordings or cobalt uptake 
should not have any non-specific effect. During whole-cell recordings the membrane 
potential is kept at -60 mV constantly therefore we do not activate patch-gated 
calcium channels. Due to the low Na+ concentration in the cobalt uptake buffer it is 
very unlikely that patch-gated Ca2+ channels are activated. Further, cobalt cannot 
pass through voltage-gated calcium channels (Llinás and Sugimori, 1980; Toomim et 
al., 1992; Shen, 2006; Nagy et al., 1993). 
 
 
Protocol Pre-incubation treatment for 5 mins Incubation treatment for 5 mins % DMSO in
incubation treatment
A Buffer A Buffer B 0
B Buffer A Buffer B + Capsaicin 500 nM 0.05
C Buffer A Buffer B + 0.002% DMSO 0.20
D Buffer A + Cpz 5 µM Buffer B + Cpz 5 µM 0.05
E Buffer A + Cpz 5 µM Buffer B + Cpz 5 µM + Capsaicin 500 nM 0.10
F Buffer A + Cpz 5 µM Buffer B + Cpz 5 µM + 0.002% DMSO 0.206  
 
Table 3.2. Protocols of cobalt-uptake assay to investigate the effect of capsazepine 
(Cpz) on capsaicin-evoked and DMSO-evoked cobalt-labelling. The percentages of 
DMSO in the incubation treatment step were calculated.  
 
 
Figure 3.1 Sequence of treatment steps performed to investigate capsazepine on 
capsaicin-evoked and DMSO-evoked capsaicin-evoked cobalt-labelling. 
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3.2.2.3 Repeated applications of capsaicin and DMSO in the presence and absence 
 of calcium ions.  
 
Cobalt-uptake was also used to investigate the effect of repeated applications of 
capsaicin and DMSO in the absence and presence of calcium ions as desensitisation 
is calcium-dependent (Koplas et al., 1997; Mohapatra et al., 2003).  
 
Buffer A and Buffer B was first composed by Hogan 1983, which excluded Ca
2+
 
ions, to prevent these ions from competing with cobalt ions for entry. Of course, 
TRPV1 responses are affected by calcium, as calcium entry into the cell results in 
desensitisation/ tachyphlaxis (Koplas et al., 1997; Mohapatra et al., 2003). Therefore, 
in the absence of calcium, no desensitisation/ tachyphlaxis occurs. Furthermore, 
during successive application of capsaicin in the absence of calcium no reduction of 
cobalt influx should occur (Mandadi et al., 2003).  The effect of two successive 
applications of capsaicin and DMSO in the presence and absence of 2 mM CaCl2 
were investigated. This was carried out on at least three independent cultures of mice 
DRG. 
 
Since the original solutions used in the cobalt-uptake technique were made without 
CaCl2 the effect of repeated application in the absence of Ca
2+
 was first investigated. 
Nine cover-slips containing hTRPV1-transfected cells were washed twice in Buffer 
A and then pre-incubated for 5 minutes at 37 
o
C as indicated in the table below 
(Table 3.3) under the heading, “pre-incubation for 5 minutes”. The cells were washed 
again twice with Buffer A. The cells were then incubated in a cobalt-buffer for a 
further 5 minutes at 37 
o
C as described in the table below under the heading, 
“incubation for 5 minutes”. The cells were then briefly washed once before 
precipitating the cobalt with 0.4 % mercaptoethanol (Fig. 3.2). Cells were fixed in 
70% ethanol, mounted in glycerol on slides and analysed.  
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Next the effect of repeated application in the presence of Ca
2+
 was investigated. 
Since the original solutions used in the cobalt-uptake technique were made without 
CaCl2, two additional buffers were made: Buffer A containing 2 mM CaCl; and 
Buffer B containing 2 mM CaCl. This was carried out in at least three independent 
cultures of HEK293 cells.  
 
 
Protocol Pre-incubation for 5 mins Incubation for 5 mins
A Buffer A Buffer B 
B Buffer A Buffer B + Capsaicin 500 nM
C Buffer A Buffer B + 0.2 % DMSO 
D Buffer A + Capsaicin 500 nM Buffer B 
E Buffer A + Capsaicin 500 nM Buffer B + Capsaicin 500 nM
F Buffer A + Capsaicin 500 nM Buffer B + 0.2 % DMSO  
G Buffer A + 0.2 % DMSO Buffer B 
H Buffer A + 0.2% DMSO Buffer B  + Capsaicin 500 nM
I Buffer A + 0.2% DMSO Buffer B  +  0.2 % DMSO   
 
Table 3.3 Protocols of cobalt-uptake assay to investigate the effect of repeated 
applications of capsaicin and DMSO. 
 
 
Figure 3.2 Sequence of treatments steps investigates the effect of successive 
applications of capsaicin and DMSO. 
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3.2.2.4 Application of capsaicin dissolved in varying percentages of DMSO  
  
I also used the cobalt-uptake assay in order to assess whether the DMSO content in a 
capsaicin solution had any effect in mediating the responses of hTRPV1 activation to 
the capsaicin. 
 
Six cover-slips containing transfected cells were washed twice in Buffer A. The cells 
were then incubated in Buffer B containing 100 nM capsaicin dissolved in various 
percentages of DMSO, namely: 0.1 %, 0.05 %, 0.012%, 0.025 % and 0.006 % for 5 
minutes at 37
o
C (refer to Table 3.1). As a control, the sixth coverslip was only 
incubated in drug-free cobalt-containing Buffer B. The cells were then briefly 
washed before precipitating the cobalt with 0.4 % mercaptoethanol. Cells were fixed 
in 70% ethanol, mounted in glycerol on slides and analysed. This was carried out in 
at least three independent cultures of HEK293 cells.  
 
 
3.2.2.5  Cobalt-uptake on cultured DRG neurons  
 
The cobalt-uptake assay was also used in DRG cultures obtained from wild-type and 
TRPV1-knock-out mice to assess whether DMSO is able to induce cobalt-labelling 
through native TRPV1 ion channels. See “Chapter Two: Cell culture of DRG 
neurons” for further details. 
 
In these experiments cells were washed in buffer A twice and then incubated for 5 
minutes at 37 
o
C in either: (i) drug-free cobalt-containing Buffer B; (ii) Buffer B 
containing 500 nM capsaicin (DMSO content 0.006%); (iii) Buffer B containing 
0.2 % DMSO;  and (iv) cobalt buffer containing 60 µM mustard oil (positive control 
for cobalt-uptake on DRG neurons obtained from TRPV1 knock-out mice). The cells 
were then briefly washed before precipitating the cobalt with 0.4% mercaptoethanol. 
Cells were then fixed in 70% ethanol, mounted with glycerol on slides and analysed.  
This was carried out in at least three independent DRG neuronal cultures. 
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Mustard powder was dissolved in 100 % mineral oil so that the solution contained 
0.05 % mineral oil. Although the effect of 60 µM mustard oil cobalt-labelling may be 
due to either the mustard oil alone or the mineral oil which the mustard oil was 
dissolved in or a combination of the two, the effect of 0.05% mineral oil was not 
investigated. This is because the purpose of using mustard oil was used to investigate 
whether the DRG neurons obtained from knock-out mice were healthy and could 
respond to agonist-evoked cobalt-labelling other than capsaicin-evoked labelling. 
 
 
3.2.3 Statistical analysis  
  
  
Differences between the variances were analysed by the F-test or the Levene‟s test, 
as appropriate. The normality test (Shapiro-Wilk) was used to investigate whether 
the data was normally distributed. Differences between the averaged values were 
analysed by 1-ANOVA or an independent two-sample t-test, as appropriate. 
Following ANOVA, Fisher‟s LSD test was used to establish the statistical 
significance of the differences. Differences were regarded as being statistically 
significant at p<0.05.  
 
In whole-cell recordings, the data are presented as mean ± standard error of means of 
the maximum amplitude of the current from different cell and n refers to the number 
of cells on which a given treatment was repeated. In cobalt uptake studies, the data 
are presented as mean ± standard error of means is the number of cobalt-labelled 
cells. In cobalt uptake studies, n refers to the number of independent cultures on 
which a given treatment was repeated.  
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3.3  Results 
 
3.3.1  Properties of DMSO-evoked hTRPV1-mediated currents  
 
As part of my control studies I investigated whether DMSO used to dissolve 
capsaicin could alone activate TRPV1 in transfected cells during whole-cell patch 
clamp recordings.  I investigated the following DMSO percentage, namely: 0.5%, 
0.2%, 0.1%, and 0.05%. These were the percentages of DMSO routinely used in my 
laboratory to dissolve lipophilic compounds. I used 500 nM capsaicin (0.006% 
DMSO) application to activate hTRPV1 as a positive control in order to check 
whether the cells responded to TRPV1 activation.  
 
Application of 500 nM capsaicin to hTRPV1-transfected cells produced an inward 
current (-1.43±0.3 nA, n=7; Fig 3.3). Application of 0.5% DMSO to transfected cells 
caused the cells to initially swell and then rupture resulting in loss of the whole-cell 
configuration (n=5). Application of 0.2 % DMSO produced an inward current in the 
hTRPV1-transfected cells (-261 ± 5.1 pA, n=10; Fig 3.3). Application of 0.1% 
DMSO produced an inward current (-189 ± 24.4 pA, n=13; Fig 3.3). Decreasing the 
percentage of DMSO to 0.05% failed to produce any response (-20 ± 10 pA, n=4; Fig 
3.3) as the noise of the whole-cell patch-clamp configuration contributed to ~15-20 
pA; Fig 3.3).  
 
In comparison, I found that application of capsaicin to untransfected HEK293 cells 
failed to produce any currents (not shown) and that 0.2% DMSO also failed to elicit 
any response in these cells (-21 ± 6.3 pA, n=7; noise of the set-up contributed ~15-20 
pA; Fig 3.3).  However, application of 0.5% DMSO also resulted in the loss of 
whole-cell configuration (n=5; data not shown).  
 
0.006% DMSO was not tested; it was assumed that DMSO of less than 0.05% in 
solution will not evoke TRPV1-mediated membrane current. 
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Figure 3.3. DMSO-evoked responses in untransfected cells and hTRPV1-transfected 
cells using whole-cell patch-clamp recordings. (A) Currents produced by hTRPV1 
during application of DMSO at varying percentages.  The whole-cell configuration 
could not be maintained during the application of 0.5% DMSO, as the cell lyses. 
However, 0.2% DMSO and 0.1% DMSO elicited a small inward current. No 
response was seen during the application 0.05% DMSO. (B) No inward current was 
seen during an application of 0.2% DMSO to untransfected cells.  (C) Average 
amplitudes of DMSO-evoked currents in untransfected cells and hTRPV1-
transfected cells. Each data point represents the mean ± SEM of the maximum 
amplitude of the current from different cells. The n represents the number of cells on 
which a given treatment was repeated. Both the Levene‟s test for equal variance and 
the Shapiro-Wilk normality test showed p-values of >0.05, indicating equal variance 
and normal distribution. The statistical significance of the difference in the means 
between untransfected and transfected cells was assessed using Student‟s t-test (two-
tail distribution and two-sample equal variance). The statistical difference between 
the means with varying percentages of DMSO for transfected cells was assessed 
using 1-ANOVA. Whether the differences found were significant was established 
using Fisher LSD post-hoc. (* and 
#
) Differences were regarded as being statistically 
significant at p<0.05. (*) A statistical significance was seen between the 
untransfected and hTRPV1-transfected cells. (
#
) 0.2 % and 0.1 % DMSO were 
statistical different from 0.05 % DMSO in TRPV1-transfected cells.  
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To investigate this DMSO-evoked TRPV1 activation, I then studied the effect of 
capsazepine, a selective TRPV1 antagonist (Bevan et al., 1991, 1992; Dickenson and 
Dray, 1991; Dray et al., 1991; Walpole et al, 1994).  Here I studied the effect of this 
TRPV1 antagonist on 0.2% DMSO-evoked current. The effect of this antagonist on 
capsaicin-evoked response was also investigated.  
 
I found in this study that continuous perfusion of capsazepine significantly reduced 
the capsaicin-mediated currents from – 1.43 ± 0.31 nA (n=7; Fig 3.4A and C) to - 
0.44 ± 0.21 nA (n=7; Fig 3.4B and C), a reduction of ~ 70 %. Consequently, 
capsazepine significantly reduced the DMSO-mediated currents from - 261 ± 51 pA 
(n=10; Fig 3.5A and C) to - 48 ± 0.21 nA (n=6; Fig 3.5B and C), a reduction of ~ 
80%. 
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Figure 3.4 The effect of capsazepine on capsaicin-evoked activation of hTRPV1-
transfected cells using whole-cell recordings. Whole-cell currents during application 
of: (A) 500 nM capsaicin; and (B) continuous perfusion (minimum period of 2 
minutes) of 5 µM capsazepine and 500 nM capsaicin in hTRPV1-transfected cells. 
(C) Capsazepine significantly reduced capsaicin-induced current. Each data point 
represents the mean ± SEM of the maximum amplitude of the current from different 
cells. The n represents the number of cells on which a given treatment was repeated. 
Both the f-test and the normality test (Shapiro-Wilk) showed p-values of >0.05 
indicating equal variance and normal distribution. The statistical difference between 
the means was assessed using Student‟s t-test (two-tail distribution and two-sample 
equal variance). (*) Differences were regarded as being statistically significant at 
p<0.05.   
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Figure 3.5 The effect of capsazepine on 0.2% DMSO-evoked currents in hTRPV1-
transfected cells using whole-cell recordings. Whole-cell currents during application 
of (A) DMSO in 1:500, and (B) continuous perfusion of 5 µM capsazepine and 
DMSO in 1:500 in hTRPV1-transfected cells. (C) Capsazepine significantly reduces 
DMSO-induced currents. Each data point represents the mean ± SEM of the 
maximum amplitude of the current from different cells. The n represent the number 
of number of cells on which a given treatment was repeated. . The f-test showed 
unequal variance of the data, while, the normality test (Shapiro-Wilk) showed a 
normal distribution. The statistical difference between the means was assessed using 
the Student‟s t-test (two-tail distribution and two-sample unequal variance). (*) 
Differences were regarded as being statistically significant at p<0.05. 
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3.3.2 The effect of DMSO on cobalt-uptake 
 
 Next, I studied DMSO-evoked effects on hTRPV1. The cobalt-uptake 
technique was used on hTRPV1-transfected HEK293 cells and untransfected 
HEK293 cells. 
 
 I found in these experiments that untransfected cells did not respond to  drug-
free cBuffer B, 500 nM capsaicin or to 0.2 % DMSO (Fig 3.6).  
 
 
 
Figure 3.6 Grey scale images of cells following cobalt-uptake assay of untransfected 
cells in response to 500 nM capsaicin and 0.2% DMSO application. (A) drug-free 
cobalt-containing Buffer B, (B) Buffer B with 500 nM capsaicin and (C) Buffer B 
with 0.2% DMSO showed no cobalt-labelling. Bar indicates 50 µM.. 
 
 
In comparison, 500 nM capsaicin induced cobalt labelling in 59.9 ± 2.3 % (n=3) of 
the hTRPV1-transfected cells. This proportion of labelled cells was significantly 
greater than that produced by the drug-free cobalt-containing buffer in the hTRPV1-
transfected cells (4.4 ± 1.4 %, n=3). Surprisingly, application of DMSO in 0.2% 
(30µM) produced cobalt labelling in 24.2 ± 5.2 % (n=3) of the transfected cells. This 
proportion of labelled hTRPV1-transfected cells by DMSO was significantly greater 
than that produced by drug-free cobalt-containing buffer (4.4 ± 1.4 %, n=3), and was 
significantly less than that produced by 500 nM capsaicin.  
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Figure 3.7 Grey scale images of cells following cobalt-uptake assay Cobalt-uptake 
images of hTRPV1-transfected cells in response to 500 nM capsaicin and 0.2% 
DMSO application. (A) Inverse image of cells incubated in the presence of drug-free 
cobalt-containing buffer shows very few labelled cells (arrows). (B) Inverse image of 
cells incubated in the presence of 500 nM capsaicin and CoCl2 shows cobalt-
labelling in a large number of cells. (C) Inverse image of cells incubated in the 
presence of 0.2% DMSO and CoCl2 shows more cobalt-labelled cells than in image 
A. Bar indicates 50 µM.. 
 
To investigate whether DMSO indeed induced the cobalt-uptake through 
TRPV1, I next studied the effect of the TRPV1 antagonist capsazepine on the 
DMSO-evoked cobalt-uptake. I found that 5 µM capsazepine (DMSO content 
0.006%) alone did not produce cobalt-entry in a significantly higher proportion of 
hTRPV1 transfected cells (5.1± 1.4 %, n=3) than that produced by drug-free cobalt-
containing buffer (4.0 ± 0.7 %, n=6). I also found that capsazepine (0.006% DMSO) 
significantly reduced the percentage of labelled cells produced by capsaicin from 
58.9 ± 3.5 % (n=6) to 32.5 ± 2.3 % (n=3), a reduction of 55%.  Capsazepine had a 
similar inhibitory effect on DMSO-evoked cobalt-uptake. It reduced the labelling 
from 14.3 ± 1.7 % (n=6) to 8.5 ± 1.6% (n=3), a reduction of ~ 65 %, which indicated 
that the capsaicin-evoked responses are indeed mediated through TRPV1 (Fig 3.8). 
  
These findings together indicated that DMSO can activate hTRPV1 in a heterologous 
system. In subsequent experiments, DMSO-evoked TRPV1 activation was 
characterised and its characteristics were compared to the characteristics of 
capsaicin-evoked TRPV1 activation.   
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Figure 3.8 The effect of capsaicin (500nM), capsazepine (5µM) and DMSO (0.2 %) 
on hTRPV1-transfected cells using cobalt-uptake. Data show that both applications 
of capsaicin and DMSO in the presence CoCl2 significantly increased the number of 
labelled cells when compared to control (*).  Labelling is significantly reduced (
#
) in 
the presence of capsazepine. Each data point represents the mean ± SEM of the 
number of cobalt-labelled cells. n represent the number of independent cultures on 
which a given treatment was repeated. Both the Levene‟s test for equal variance and 
the normality test (Shapiro-Wilk) showed p-values of >0.05, indicating equal 
variance and normal distribution. The statistical significance of the difference in the 
means was assessed using 1-ANOVA. Comparisons of means were computed using 
Fisher‟s LSD post-hoc test. Power test showed a value of >0.95. (* and #) 
Differences were regarded as being statistically significant at p<0.05. 
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3.3.3 DMSO-evoked desensitisation in the presence of calcium ions. 
 
 Repeated activation of TRPV1 by many of its ligands, including capsaicin, 
results in the characteristic of desensitisation. Cobalt-uptake was used to investigate 
the effect of repeated applications of capsaicin and DMSO. Also, I wanted to 
compare the effect of repeated application of capsaicin and DMSO in the absence 
and presence of Ca
2+
 to find out how the presence of Ca
2+
 affects desensitisation. 
(Koplas et al, 1997; Mohapatra et al, 2003; Mandadi et al., 2003). 
 
 
Responses in absence of  Ca
2+
  
 
In control experiments, cells were pre-incubated in drug-free buffer A for 5 
minutes, followed by incubation in drug-free or drug-containing Buffer B. Incubation 
of cells in the drug-free Buffer produced labelling in 3.8  ± 1.8% (n=3) of the cells. 
Addition of capsaicin to Buffer B resulted in labelling in 58.4 ± 6.7 % (n=3) of the 
cells. Addition of DMSO to Buffer B resulted in labelling of 28.4 ±3.6 % (n=3). The 
proportion of the cells produced by capsaicin and DMSO was statistically different 
from the control (Fig 3.9B).  
 
Next, I studied the effect of pre-incubating the cells in capsaicin for 5 minutes 
in Buffer A on drug-free capsaicin-evoked cobalt uptake. Unexpectedly, incubation 
of cells in drug-free cobalt-containing buffer after pre-incubation in capsaicin 
resulted in labelling of 41.7 ± 3.9% (n=3) of the cells. Buffer B in the presence of 
capsaicin   produced labelling in 53.0 ± 4.0 % (n=3) of the cells. Statistical analysis 
showed that pre-incubation of the cells in capsaicin for 5 minutes significantly 
increased the number of cobalt labelled cells produced by drug-free Buffer B. 
However, it had no significant effect on the capsaicin-induced cobalt labelling (Fig 
3.9B).  
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In addition, I studied the effect of pre-incubating the cells in DMSO for 5 
minutes in Buffer A before incubating the cells in drug-free, DMSO-containing 
Buffer B. Here, the drug-free Buffer B produced labelling in 11.0 ± 1.2 % (n=3) of 
the cells, while addition of DMSO to Buffer B produced labelling in 13.4 ± 0.2 % 
(n=3) of the cells. Statistical analysis revealed that the pre-incubation of cells in 
DMSO did not significantly increase the number of cells produced by drug-free 
buffer B. In addition, it had no significant effect on the DMSO-induced cobalt 
labelling (Fig 3.9B). 
 
Responses in the presence of Ca
2+
 
 
In control experiments, cells were pre-incubated in drug-free Buffer A for 5 
minutes, followed by incubation in drug free or drug-containing buffer B. Incubation 
of cells in the drug-free Buffer B produced labelling in 2.8 ± 0.9% (n=3) of the cells. 
Addition of capsaicin to Buffer B resulted in labelling in 44.3 ± 3.5 % (n=3) of the 
cells. Addition of DMSO to Buffer B resulted in labelling of 17.1 ± 1.3 % (n=3). The 
proportion of the cells produced by capsaicin and DMSO was statistically different 
from the control (Fig 3.9C).  
 
Next, I studied the effect of pre-incubating the cells in capsaicin for 5 minutes 
in Buffer A on drug-free- capsaicin-evoked cobalt uptake. Incubation of cells in 
drug-free Buffer B after pre-incubation in capsaicin resulted in labelling of 11.4 ± 
2.4% (n=3) of the cells. Capsaicin application to the Buffer B produced labelling in 
15.4 ± 2.2 % (n=3) of the cells. Statistical analysis showed that pre-incubation of the 
cells in capsaicin for 5 minutes had no significant effect on the number of cobalt 
labelled cells produced by drug-free buffer B. In addition, it had no significant effect 
on the capsaicin-induced cobalt labelling (Fig 3.9C). 
 
Subsequently, I studied the effect of pre-incubating the cells in DMSO for 5 
minutes in buffer A before incubating the cells in drug-free or DMSO-containing 
Buffer B. Here, the drug-free Buffer B produced labelling in 15.3 ± 1.1 % (n=3) of 
the cells. Addition of DMSO to Buffer B produced labelling in 3.7 ± 3.1 % (n=3) of 
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the cells. Statistical analysis revealed that the difference in the number of labelled- 
cells found with or without pre-incubating the cells in DMSO was significantly 
different. However, pre-incubating cells in DMSO had no significant effect on the 
DMSO-induced cobalt labelling (Fig 3.9C). 
 
I then analysed the effect between the respective treatment groups of the 
absence and presence of Ca
2+
. I found that while, the percentage of cobalt-labelling 
obtained in the absence of Ca
2+
 were somewhat lower than in presence of Ca
2+
 the 
differences were not significant, with the exceptions of 
 
three treatment groups. I 
found that repeated application of capsaicin and DMSO was significantly lower in 
the presence of Ca
2+
. Furthermore pre-incubation of capsaicin, followed by 
incubation of drug free Buffer B was significantly lower in the presence of Ca
2+
 (Fig 
3.9D). 
 
In summary, I found that, in the absence of Ca
2+
, repeated application of 
either DMSO or capsaicin did not result in a reduction of cobalt-labelled cells. 
Instead, pre-incubation with capsaicin, but not DMSO, had a sensitising effect in the 
absence of Ca
2+
. However, in the presence of Ca
2+
, DMSO, like capsaicin, produced 
desensitisation.  
                A 
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Figure 3.9 Repeated application of capsaicin and DMSO in hTRPV1-transfected 
cells in the presence, and absence, of 2 mM CaCl2 using the cobalt-uptake assay.  (A) 
Protocols of cobalt-uptake assay to investigate the effect of repeated applications of 
capsaicin and DMSO. (B) Cobalt-labelling in the absence of Ca
2+
. (C) Cobalt-
labelling in the presence of Ca 
2+
. (D) Cobalt-labelling in the absence and presence of 
Ca
2+ 
in their respective treatment groups. Each data point represents mean ± SEM (n= 
3).  Both the Levene‟s test for equal variance and the Shapiro-Wilk normality test 
showed p-values of >0.05, equal variance and normal distribution.  The statistical 
difference between the means of the various treatments within a group was assessed 
using 1-ANOVA. Whether the differences found were significant was established 
using Fisher LSD post-hoc. The statistical difference between the means in the 
respective treatment groups was assessed using Student‟s t-test (two-tail distribution 
and two-sample equal variance; data not shown). Differences were regarded as being 
statistically significant at p<0.05. (
#
) Significant increase was seen in drug-free pre-
incubation and pre-incubation with capsaicin in the absence of CaCl (Fig 3.9 B). (*) 
Repeated application in the presence of Ca
2+,
 were significant different higher than in 
the absence of Ca
2+
 (Fig 3.9 D).  
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3.3.4 Effect of  DMSO on the capsaicin-evoked hTRPV1 activation 
 
 The data obtained so far clearly showed that 0.2% DMSO, like capsaicin, 
activates TRPV1. Since TRPV1 is a stimulus integrator (Tominaga et al., 1998) it 
could be that the amount of DMSO used to dissolve capsaicin, above 0.1% DMSO, 
may modify the effect of capsaicin. Therefore, it was also necessary to assess 
whether the DMSO content in a capsaicin solution has any effect on hTRPV1-
mediated responses.  
 
 Using the cobalt-uptake technique, I found that 100 nM capsaicin dissolved 
in various percentage of DMSO, namely: 0.1 %; 0.05 %; 0.025 %; and 0.006 %, 
produced labelling in a similar number of cells (48.1 ± 8.0%, n=3; 41.3 ± 5.7%, n=3; 
42.3 ± 1.6%, n=3; 47.6 ± 3.6%, n=3; and 40.0 ± 2.2%, n=3; respectively; Fig 3.10). 
Furthermore, there were no statistical differences between the means of values. 
These relative numbers of labelled cells were all significantly different from control 
where no DMSO was added to the solution (3.1 ± 1.0%, n=3). 
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Figure 3.10 The effect of the percentage of DMSO content in capsaicin on hTRPV1-
mediated capsaicin responses assessed by the cobalt-uptake assay. The relative 
number of cobalt-labelled cells induced by 100 nM capsaicin was similar in all tested 
DMSO contents.  Each data point represents the mean proportion of labelled cells ± 
SEM (n= 3). Both the Levene‟s test for equal variance and the Shapiro-Wilk 
normality test showed p-values of >0.05, indicating equal variance and normal 
distribution. The statistical difference between the means was assessed using 1-
ANOVA. Whether the differences found were significant was established using 
Fisher‟s LSD post-hoc test. (*) Differences were regarded as being statistically 
significant at p<0.05. Note that comparisons between the means showed no 
significant difference. 
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3.3.5 DMSO-evoked responses in DRG cultures 
 
 The data obtained on hTRPV1-transfected HEK293 cells showed that DMSO 
activates hTRPV1. Although that activation resembles that produced by capsaicin, it 
is possible that this effect can be observed only in heterologous systems, or that other 
TRP channels are also activated by DMSO. In order to study these possibilities, I 
next studied DMSO-evoked cobalt-uptake in DRG neurons taken from wild-type, 
and TRPV1 knock-out, mice.  
 
 I found that application of drug-free Buffer B produced none, or very few, 
labelled cells in prepared from wild-type, and TRPV1 knock-out mice (1.9 ± 0.4 % 
(n=3), 1.2 ± 0.4 % (n=3), respectively; Fig 3.9). Addition of 0.2% DMSO into Buffer 
B resulted in a significant increase of cobalt-labelled neurons to 8.6 ± 1.0 % (n=3; 
Fig 3.9) in DRG cultures prepared from wild-type animals. However, in cultures 
prepared from TRPV1 knock-out mice there was no significant increase in the 
proportion of cobalt-labelled cells by the addition of 0.2% DMSO to the cobalt-
containing buffer (0.9 ± 0.6 %, n=3; Fig 3.9). In addition, this value was not 
significantly different from drug-free Buffer B in TRPV1 knock-out mice (Fig 3.11). 
 
 To confirm that the mice used were from TRPV1 knock-out mice, I incubated 
these cells in the presence of TRPV1 agonists, 500 nM capsaicin and Buffer B. Both 
wild-type and TRPV1 knock-out mice were investigated.  In these experiments, I 
found that capsaicin significantly increased the proportion of cobalt-labelled cells in 
wild-type mice in comparison to TRPV1 knock-out mice (from 1.2 ± 0.6 % (n=3) to 
14.6 ± 1.5 %, n=3; Fig 3.11). In addition, there was no significant difference between 
drug-free Buffer B and Buffer B containing capsaicin, in TRPV1 knock-out mice. 
 
As the TRPV1 knock-out mice did not respond to capsaicin-evoked cobalt-labelling, 
this confirmed that the mice used were knock-out animals. To confirm that the 
failure of DMSO to produce cobalt-uptake in cells collected from TRPV1 knock out 
mice was not due to a general unresponsiveness of the cells, I incubated these cells in 
the presence of the TRPA1 agonist (Jordt et al., 2004), mustard oil (60 µM), and 
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cobalt-containing Buffer B.  In these experiments, I found that mustard oil 
significantly increased the proportion of cobalt-labelled cells in comparison to drug-
free cobalt-containing Buffer B (14.6 ± 3.5 %, n=3; Fig 3.11). 
 
 
 
 
 
 
 
 
Figure 3.11 The effect of 0.2% DMSO in DRG cultures prepared from wild-type, 
and TRPV1 knock-out mice using the cobalt-uptake technique. (*) In the presence of 
DMSO, the relative number of cobalt-labelled cells obtained from wild-type mice 
was significantly higher those neurons prepared from TRPV1 knock-out mice. 
Similar effect was seen for capsaicin-evoked labelling. (
#
) 60 µM mustard oil 
induced labelling in a significant number of cells when compared to control, from 
neurons obtained from knock-out mice. Each data point represents the mean 
proportion of labelled cells ± SEM (n=3). Both the Levene‟s test for equal variance 
and the Shapiro-Wilk normality test showed p-values of >0.05, indicating equal 
variance and normal distribution. The statistical difference between the means of a 
group was assessed using 1-ANOVA. Whether the differences found were significant 
was established using Fisher LSD post-hoc. Differences were regarded as being 
statistically significant at p<0.05.  
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In summary, these data confirmed that DMSO indeed produced cationic influx into 
hTRPV1-transfected HEK293 cells through hTRPV1, and that the DMSO-evoked 
effect is concentration-dependent between 28 mM and 14 mM, which were 0.2% and 
0.1%, respectively. In addition, the effect of 0.2% DMSO was inhibited by 
capsazepine, both in whole-cell patch-clamp recording (Fig 3.5) and in cobalt-uptake 
assay (Fig 3.8). A further finding showed that in the presence of calcium, DMSO is 
able to desensitise TRPV1.  
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3.4  Discussion 
 
 Data from these experiments indicate that DMSO concentration-dependently 
activates TRPV1. To the best of my knowledge, this is the first time that this effect 
of DMSO on this specific ion channel has been demonstrated. I found that, while 
untransfected cells did not, hTRPV1-tranfected cells did, respond to DMSO, and that 
this response was reduced by capsazepine. 
 
 A comparison of DMSO-evoked responses obtained in cobalt-uptake assay 
and whole-cell recordings to those evoked by capsaicin showed that, DMSO has a 
lower potency and efficacy as an activator than capsaicin. The finding that 5 µM 
capsazepine, a competitive TRPV1 antagonist, reduced the DMSO-evoked responses 
may suggest that DMSO may interact with the capsaicin binding site. However, 
results from a recent study by Matta and Ahern (2007) indicate that capsazepine 
might act as an inverse agonist because capsazepine is capable of reducing TRPV1 
activity induced by activators other than capsaicin. To expand on this, in addition to 
capsazepine and other competitive inhibitors of capsaicin, these compounds are able, 
with varying degrees, to inhibit heat, protons, cations (Tominaga et al., 1998; Ahern 
et al., 2005.   Therefore, DMSO may interact with TRPV1 at a site different from the 
capsaicin binding site.  
 
 
 I also found in these experiments that, while application of DMSO to neurons 
collected from wild-type animals produced cobalt-labelling, a similar application did 
not evoke a similar response in neurons collected from TRPV1 knock-out mice. 
These data indicate that, in addition to heterologous TRPV1, native TRPV1 
expressed in primary sensory neurons also respond to DMSO.  
  
While DMSO did not produce responses from TRPV1 knock-out mice, I found that 
mustard oil induced cobalt-labelling in these cells. Mustard oil selectively activates 
another TRP channel, the cold-sensitive transient receptor potential ankyrin type 1 
(TRPA1; Jordt et al., 2004; Macpherson et al., 2005; Bautista et al., 2005). TRPA1 
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has been shown to be co-expressed with TRPV1 on a subset of sensory neurons in 
DRG (Story et al., 2003; Kobayashi et al., 2005). The mustard oil-evoked cobalt-
uptake on primary sensory neurons confirms that the absence of DMSO-evoked 
cobalt labelling in neurons collected from knock-out animals was not due to 
unresponsiveness of cells. Furthermore, these data also indicate that, in addition to 
TRPV1, other temperature sensitive ion channels, such as TRPA1, are also 
permeable to Co
2+
.  
 
  Having confirmed the excitatory effect of DMSO on TRPV1 in both 
heterologous and native systems, I compared various other aspects of the DMSO-
evoked response to the response evoked by the archetypical TRPV1 activator, 
capsaicin. Sensitisation and desensitisation are two of the main characteristics of 
TRPV1. TRPV1 is essential for the development of inflammatory heat hyperalgesia 
(Davis et al., 2000; Caterina et al., 2000). During inflammation, TRPV1 mediated 
responses are increased due to a process, called sensitisation. Sensitisation involves 
phosphorylation of the receptor by multiple pathways involving PKA and PKC  
(Premkumar and Ahern, 2000; Numazaki et al., 2002; Ahern et al., 2005; Morenill-
Palao et al., 2004; Lee et al., 2005). For example, PKA is able to phosphorylate 
TRPV1, which results in decreased desensitisation and increased sensitivity to each 
of anandamide, capsaicin, protons and heat (Di Marzo et al., 2002). Increased protein 
kinase activities are induced by various inflammatory mediators, including nerve 
growth factor, prostaglandin, and bradykinin (Cesare et al., 1996; Chuang et al., 
2001; Zhuang et al., 2004; Moriyama et al., 2005; Rukwied et al.,2007; Fischer and 
Reeh, 2007 ). 
 
 Desensitisation of TRPV1 is a calcium dependent process (Koplas et al., 
1997; Mohapatra et al., 2003). In the presence of an inhibitor of calcineurin, a Ca
2+
- 
and calmodulin-dependent protein phosphatase 2B, the desensitisation effect of 
capsaicin is reduced (Docherty et al., 1996). Moreover, Ca
2+-
dependent 
phosphorylation, and dephosphorylation, of PKA and of PKC have been shown to 
also modulate desensitisation of TRPV1 (Liu et al., 2004; Mohapatra and Nau, 2003; 
Mohapatra and Nau, 2005; Mandadi et al., 2004). It is well documented that 
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repeated, or prolonged, application of capsaicin induces profound desensitisation of 
TRPV1 (Jancsó and Jancsó-Gabor, 1949; Jancsó, 1968). 
 
Thus, in order to investigate this effect, I repeated applications of capsaicin and 
DMSO, in the presence and absence of CaCl, and used cobalt-uptake assay. As the 
standard cobalt-uptake buffer does not contain Ca
2+
, the first experiments were done 
in the absence of extracellular Ca
2+
. In this condition, I found that pre-incubation 
with capsaicin but not DSMO, sensitised hTRPV1, as the number of labelled cells 
induced by agonist-free cobalt-buffer was increased. This effect could not be due to 
capsaicin remaining in the buffer, as the cells were washed once with 300 µl of 
buffer, which should have removed all traces of capsaicin. A plausible explanation of 
this sensitising effect is that pre-incubation of the cells with capsaicin reduce the heat 
threshold from ~44 
o
C to below 37 
o
C for a duration that was long enough to allow 
the 5 minute incubation in drug-free cobalt-containing buffer to produce labelling.  
 
Repeated application of DMSO treatments did not have any significant effects on the 
number of labelled cells. Similar findings were seen for successive application of 
capsaicin.   The failure of DMSO to induce sensitisation may be due to differences in 
cellular responses evoked by capsaicin and by DMSO.  The absence of sensitisation 
to successive application of capsaicin may be due to the saturation of cobalt-labelling 
by capsaicin. Capsaicin, at a concentration of 500 nM, may have induced maximal 
cobalt-labelling rendering additional exposure to capsaicin redundant. It may be that 
efficacy of the transfection was approximately the same as the number of cobalt-
labelled cells evoked by 500 nM capsaicin. 
 
 
 In the presence of Ca
2+
, the experimental paradigms described above 
produced desensitisation. Both successive application of capsaicin or DMSO resulted 
in the reduction of cobalt-labelled cells. The same protocol, in the presence of Ca
2+
, 
failed to increase the number of labelled cells, in contrast to the increase in the 
number of cobalt-labelled cells following pre-incubation of cells in capsaicin or 
DMSO followed by incubation of the cells in drug-free cobalt-uptake in the absence 
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of Ca
2+
. The number of cobalt-labelled cells induced in the Ca
2+
-containing cobalt-
buffer in the presence of capsaicin, or DMSO, without pre-incubation, was slightly 
lower than the number of cobalt-labelled cells in the absence of Ca
2+ 
in the 
comparable experiments. This could be explained by the presence of Ca
2+
.
  
 Both 
Co
2+
 ions and Ca
2+
 ions are capable of permeating certain non-selective, ligand-gated 
ion channels, including TRPV1. Thus, Co
2 + 
ions may have competed with Ca
2+
 ions 
for entry into the cell, when TRPV1 was activated. As Ca
2+
 is likely to have a higher 
permeability than Co
2+ 
 through TRPV1, due to calcium‟s smaller size, more Ca2+ 
could have entered than Co
2+
, thereby reducing the number of cobalt-labelled cells. 
 
 Collectively, this finding suggests that, although there are differences in the 
characteristics of DMSO-evoked, and capsaicin-evoked, responses, DMSO behave 
like a typical TRPV1 ligand, and is capable of inducing desensitisation. Moreover, in 
agreement with previously published data, these findings confirmed that TRPV1 
desensitisation indeed depends on calcium (Koplas et al, 1997; Mohapatra et al, 
2003).  
 
 It has been demonstrated that TRPV1 activators, such as heat, protons, and 
post-translational modification, respectively, potentiate the responses of other 
TRPV1 agonists (Caterina et al., 1997; Tominaga et al., 1998, Tominaga et al., 2005, 
Cesare et al., 1996; Chuang et al., 2001; Baumann & Martenson, 2000; McLatchie & 
Bevan, 2001; Ryu et al., 2003). Thus, it may be that concentrations of DMSO, which 
could not open the channel on their own, may modify the effect of other agonists e.g. 
capsaicin dissolved in DMSO. Thus, DMSO may be able to potentiate the response 
of TRPV1 to an agonist. The effect of 100 nM capsaicin dissolved in various 
dilutions of DMSO on TRPV1 was next studied, using the cobalt-uptake assay. A 
capsaicin concentration of 100 nM was chosen instead of the typical 500 nM on the 
basis of the latter being able to induce maximal cobalt-labelling, hence precluding 
the DMSO-induced potentiation. Data from these experiments showed that 100 nM 
capsaicin dissolved varying percentages of DMSO, namely: 0.1 %, 0.05 %, 0.025 %; 
0.012% and 0.006 %. DMSO resulted in similar, but varying, relative numbers of 
cobalt-labelled cells. These findings were unexpected as 0.1% DMSO activated 
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TRPV1 on it own. Hence, a combination of 0.1% DMSO and 100 nM capsaicin was 
expected to produce higher labelling than 100 nM capsaicin in combination with 
DMSO in lower percentages. The reason for the absence of this expected effect may 
reside in the limited sensitivity of the cobalt-uptake assay. While the amount of 
cobalt that entered the cells during incubation of the culture in various DMSO 
contents in the capsaicin solutions might have varied, the analysis of the labelling 
could not have reliably recognised that variability. Only whole-cell recordings could 
determine whether the content of DMSO has any effect on the capsaicin-evoked 
responses. Another plausible explanation is that DMSO may be a partial agonist. 
Nevertheless, results of these experiments suggest that DMSO dilution in solutions 
intended to be used on TRPV1-expressing cells should be kept below 0.05 % 
because DMSO is able to activate TRPV1 and may potentiate the effect of other 
TRPV1-activators. It is also important that the DMSO concentration should be kept 
constant in order to avoid the possible variability of the responses due to the possible 
interference of DMSO in some other TRPV1 activator-induced response. 
 
In conclusion, these data show that the DMSO content of solutions must be taken 
into consideration. Consequently, as a result of these findings, the DMSO content of 
capsaicin when used by me in subsequent experiments was ≤0.05% DMSO. 
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Chapter 4 
 
 
CONSTITUTIVE ACID SENSITIVITY OF HEK293 CELLS 
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4.1  Introduction 
  
 HEK293 cell lines are routinely used in laboratories as an expression system 
for recombinant proteins including ion channels. Their popularity is due to their 
ability to produce highly reliable and efficient transfection and protein production. 
However, HEK293 cells express their own receptors and ion channels on their 
plasma membranes which may compromise studies on heterologously expressed 
membrane molecules. HEK293 cells, specifically, have been reported to express 
acid-sensing ion channels (ASIC; Hayes et al., 2000; Gunthorpe et al., 2001). ASIC 
channels belong to the degenerin type of sodium channels (Waldmann et a., 1997) 
and, like TRPV1, they can be activated by acids. In order to determine how these 
endogenously expressed, proton-responding ion channels effect the proton-evoked 
responses of hTRPV1, I have studied pH-activated whole-cell currents on 
untransfected cells.  
 
4.2  Methods 
 
Cell culture of HEK293 cells, cultured DRG neurons, transient transfection, cobalt-
uptake and whole-cell patch clamp technique were used in this section.  For further 
detail, see Chapter Two: Materials and Methods. The wild-type hTRPV1111 
haplotype was used in this investigation to assess the effect of DMSO in TRPV1-
transfected HEK293 cells. For, simplicity this haplotypes will be referred to as 
hTRPV1. 
 
 
4.2.1  Whole-cell patch-clamp recordings of hTRPV1-transfected HEK293 cells 
 
Whole-cell patch-clamp recordings were performed on hTRPV1-transfected 
and on untransfected HEK293 cells in order to assess the effect of endogenously 
expressed acid-sensing ion channels (Hayes et al., 2000; Gunthorpe et al., 2001) on 
TRPV1-mediated responses induced by protons, capsaicin and heat application.  
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Briefly, TRPV1-mediated responses were measured using the conventional whole-
cell patch-clamp technique with an Axopatch 200 B amplifier (Axon Intruments, 
Inc.) and the pClampex 8 software package with a laboratory PC for storing and 
evaluating data. All experiments were performed at physiological temperature of 36-
37 
o
C using a temperature controller (Wavelength Electronics). The membrane 
potential was held at -60 mV. Data were collected using the pClampex 8.2 data 
analysis programme (Axon Instruments). If the membrane current following the 
establishment of whole-cell configuration was more than -0.5 nA the cell was 
discarded. 
 
Solutions 
 
The normal extracellular buffer consisted of (mM): NaCl, 130; KCl, 5; CaCl2, 2; 
MgCl2, 2; glucose, 10; Hepes, 10; adjusted to pH 7.4.  
 
Patch electrodes were filled with normal intracellular buffer (mM): NaCl, 5; KCl, 
130; MgCl2, 1.26; Hepes, 10; adjusted to pH 7.4.  
 
Solution adjusted to pH 7.0, pH 6.5 and pH 6.0 were made by adjusting the pH of the 
normal extracellular buffer used in patch-clamp studies, using a pH meter. Normal 
extracellular buffer was used for this range of solutions because the buffering agent 
HEPES buffering capacity was within this range. The buffering capacity of buffering 
salts is a measure of the resistance of a buffer solution to pH change on addition H
+
 
ions. However, solutions adjusted to pH 4,  pH 4.5, pH 5 pH 5.5 were made by 
adjusting normal extracellular buffer containing 10 mM 2-(N-Morpholin) 
ethanesulfonic acid sodium (MES) buffering agent instead of HEPES due to its lower 
buffering capacity of pH ≤5.  
 
Amiloride-containing extracellular buffer was made from normal extracellular buffer 
used for patch clamp with the addition of 30 µM amiloride solutions. A stock 
solution of amiloride (Sigma) was made is ddH20. 30 µM amiloride solution was 
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chosen as this concentration almost completely blocks the ASIC conductance in 
HEK293 cells (Gunthorpe et al., 2001).  
 
Stock solution of capsaicin (Tocris, UK) was dissolved in 100 % DMSO (Sigma). 
All further capsaicin and DMSO dilutions were made with normal extracellular 
buffer. In these experiments capsaicin within the concentration ranges between 10 
nM and 10 µM were used. As a result of my previous finding (Chapter Four: DMSO 
activates TRPV1), where feasible, capsaicin solutions were made to contain 0.006%. 
However, due to the stock solution of capsaicin, higher concentrations of capsaicin 
(3-10 µM) were made to contain ≤ 0.05% DMSO content, as 0.006% DMSO was 
unachievable. 
 
4.2.1.1   Proton application in the absence and presence of amiloride 
 
 To investigate the effect of proton application (pH 5) in untransfected cells, 
the pH of 10 mM 2 MES salt containing standard buffer was adjusted to pH 5 and 
applied for 10 seconds. The application was controlled by an automated system 
driven by the pClampex 8 package.  
 
 To investigate the effect of 30 µM amiloride on proton application (pH 5) in 
untransfected cells, the cells were continuously perfused (minimum period of 2 
minutes) with 30 µM amiloride before applying pH 5 bath solution for 10 seconds. 
Data were analysed by measuring the maximum amplitudes of the responses using 
the pClampfit 8.2 software package.  
 
These experiments were repeated on hTRPV1-transfected cells to investigate the 
effect of amiloride on hTRPV1-mediated responses evoked by pH 5. In addition to 
establishing the maximum amplitude, the activation time (10-90%) and inactivation 
time (90-10%) of proton-evoked responses in the absence or presence of amiloride 
were also calculated.  
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The kinetics of proton-evoked currents in the absence or presence of amiloride were 
analysed by measuring the activation and deactivation time for the inward current.   
Activation time was measured as the time taken for the response to activate from 10 
% to 90% of its maximum amplitude. Deactivation time was measured as the time 
taken for the response to deactivate from 90 % to 10% of its maximum amplitude. 
 
 The effect of 30 µM amiloride on the proton response relationship of 
hTRPV1-transfected cells was also assessed by applying protons between the range 
of pH 5 to pH 7.4 for 10 seconds, in the presence or absence of this agent. Cells were 
continuously perfused for a minimum period of 2 minutes with amiloride before each 
proton application. Buffering salts in the bath solution consisted of 10 mM HEPES 
(pH 7.0, pH 6.5 and pH 6.0) or 10 mM MES (pH 5.5 and pH 5.0). Data were 
analysed by measuring the maximum amplitudes of the responses using the 
pClampfit 8.2 software package.  
 
4.2.1.2   Capsaicin application in the absence and presence of amiloride 
 
 I investigated the effect of 30 µM amiloride on the capsaicin-response 
relationship using 10 seconds application of capsaicin within the concentration range 
10 nM to 10 µM on hTRPV1-transfected cells. This was carried out in the absence 
and presence of amiloride.  DMSO content ≤0.05 %. Cells were continuously 
perfused for a minimum period of 2 minutes with amiloride before each capsaicin 
application. The maximum amplitude was then established for each recording.  
   
4.2.1.3   Heat application in the absence and presence of amiloride 
 
The effect of 30 µM amiloride on heat-evoked responses in hTRPV1-
transfected cells was assessed by applying a heat ramp between 37-50 
o
C. This was 
done in the absence and presence of this agent. Cells were continuously perfused for 
a minimum period of 2 minutes with amiloride. The heat activation threshold and the 
amplitude of the current produced at 48 
o
C were both established. For further details 
on determining the heat activation threshold, see section 2.2.9.2.  
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4.2.2 Statistical analysis 
 
The mean and standard error of the mean (SEM) of corresponding data were 
calculated. The f-test and the normality test (Shapiro-Wilk) were also used to analyse 
variance and normality of data. The significance of difference between two groups 
was established by the Student‟s t-test (2-tailed distribution, two-sample equal). 
Statistical comparisons between two concentration-response curves were analysed 
using Student‟s t-test (two-tailed test, equal variance) to compare best fit variables 
(EC50 and Imax). Differences were regarded as being statistically significant at 
p<0.05. Data are presented as mean ± standard error of means of the maximum 
amplitude of the current from different cells.  n refers to the number of cells 
recorded. 
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4.3 Results 
4.3.1 Proton-evoked responses in untransfected HEK293 cells  
 
 In agreement with a previous report (Gunthorpe et al., 2001), application of 
an acidic extracellular solution (pH 5.0) to untransfected cells produced an inward 
current. Responses of all cells had two components, namely, a fast activating and 
inactivating response followed by a slowly activating and inactivating current. A 
fundamental characteristic of ASICs is their marked sensitivity to amiloride, a 
sodium channel blocker diuretic agent. The effect of amiloride on proton-evoked 
responses on untransfected HEK293 cells was therefore explored. In agreement with 
published data 30 µM amiloride significantly reduced the fast activating and 
inactivating current (from -1.18 ± 0.36 nA (n=4) to -0.22 ± 0.09 nA (n=3); an 82 % 
reduction: Fig 4.1) as well as the slower component (from -1.78 ± 0.46 nA (n=4) to -
0.20 ± 0.16 nA (n=3); an 88 % reduction: Fig. 4.1) of the proton-activated responses 
(Gunthorpe et al., 2001). These findings confirmed that ASIC channels are 
constitutively expressed on HEK293 cells and suggested that, in order to assess the 
proton-evoked responses of hTRPV1, the superfusate should contain 30µM 
amiloride. 
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Figure 4.1 Untransfected HEK293 cells constitutively express proton-responding ion 
channels. Whole-cell patch-clamp recordings from untransfected HEK293 cells 
reveal proton-activated responses. (A) A typical inward current activated with a 
superfusate of pH5. The response has fast and slowly activating and inactivating 
components. (B) Pre-incubation of cells in 30µM amiloride for a minimum period of 
2 minutes reduces both components of the proton-activated current. (C) Average 
maximum amplitude of proton-evoked responses with and without 30µM amiloride. 
Note that amiloride significantly reduces the maximum amplitudes of both 
components. Each data point represents the mean ± SEM (n=3). Significance was p < 
0.05. Both the f-test and the normality test (Shapiro-Wilk) showed p-values of >0.05, 
indicating equal variance and normal distribution. The statistical significance of the 
difference in the means was assessed using Student‟s t-test (two-tail distribution and 
two-sample equal variance). (*) Differences were regarded as being statistically 
significant at p<0.05. 
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4.3.2 The effect of amiloride on hTRPV1-mediated responses in hTRPV1-     
  transfected cells  
 
 
Since amiloride may not only affect the ASICs but also TRPV1, it was 
necessary to study the affect of amiloride on TRPV1. Therefore, I studied the effect 
of 30 µM amiloride on TRPV1-evoked responses.  
 
 
4.3.2.1    The effect of amiloride on proton-evoked responses  
 
First, I compared the proton-evoked responses in hTRPV1-transfected cells in 
the absence and presence of 30µM amiloride. hTRPV1-transfected cells responded to 
application of an acidic extracellular solution (pH 4.0). Application of pH 4 in the 
presence of amiloride elicited smaller currents than in standard buffer (- 4.20 ± 0.60 
nA (n=6) and - 2.47 ± 0.59 nA (n=5) (Fig. 4.2). These values were significantly 
different from each other. Interestingly, the proton concentration–response curves in 
standard buffer, or in the presence of 30 µM amiloride, showed that the half-maximal 
pH (pH0.5) for channel activation was pH 6.03 ± 0.2.18, and pH 5.8 ± 0.25, 
respectively (Fig 4.3). These values were not significantly different from each other. 
However, the Imax for pH evoked activation was significantly lower in the presence of 
30 µM amiloride than in standard buffer (2.54 ± 0.30 nA and 4.0 ± 0.28 nA, 
respectively) (Fig. 4.3). 
 
 
Figure 4.2 
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Figure 4.2 Whole-cell patch-clamp recordings of hTRPV1-mediated response to 
protons (pH 4.0) in the absence and presence of amiloride. (A) Current trace in 
standard buffer. (B) Current trace in amiloride buffer. (C) Bar chart showing mean 
peak amplitudes in the presence and absence of amiloride. Both the f-test and the 
normality test (Shapiro-Wilk) showed p-values of >0.05, indicating equal variance 
and normal distribution. The statistical significance of the difference in the means 
was assessed using Student‟s t-test (two-tail distribution and two-sample equal 
variance). (*) Differences were regarded as being statistically significant at p<0.05. 
Note that comparisons between the means showed a significant difference. 
 
 
 
Figure 4.3 Proton concentration–response curve of hTRPV1-transfected HEK293 
cells in the absence and presence of amiloride. Note that Imax is higher in the 
presence of amiloride. Each data point represents mean ± SEM (n≥5). Both the 
Levene‟s test for equal variance and the normality test (Shapiro-Wilk) showed p-
values of >0.05, indicating equal variance and normal distribution.  The pH-response 
was fitted with a sigmoidal dose-response curve (Graphpad Prism, r2 ≥0.95). 
Statistical comparisons between two dose-response curves were analysed using 
Student t-test (two-tailed test, equal variance). There was a significant difference 
between the Imaxs  but not the EC50s of the two solutions. 
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4.3.2.2    The effect of amiloride on capsaicin-evoked responses  
 
 Next, I studied the effect of amiloride on capsaicin-evoked responses. The 
capsaicin concentration-response curves were established both in the absence and 
presence of 30 µM amiloride. Application of 10 µM capsaicin in the presence of 
amiloride elicited larger currents than in standard buffer (-7.54 ± 0.86 nA (n=6) and -
5.81 ± 0.32 nA (n=5) indicating that amiloride sensitises TRPV1. However, these 
values were not significantly different from each other (Fig. 4.4). Interestingly, the 
EC50 of capsaicin in the presence of amiloride was somewhat higher (817.61 ± 148 
nM) than in the absence of this blocker (734 ± 255 nM) (Fig. 4.5). However, this 
difference was not significant. The curve fitting also revealed that the Imax for the 
capsaicin evoked TRPV1-activation in the standard buffer, or in the presence of 30 
µM amiloride were 5.39 ± 0.34 nA or 6.36 ± 0.45 nA, respectively (Fig 4.5).  These 
values were not significantly different from each other. 
 
 
 
 
Figure 4.4 
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Figure 4.4 Whole-cell patch-clamp recordings of hTRPV1-mediated responses to 10 
µM capsaicin in the absence and presence of amiloride buffer.  (A) Current trace in 
standard buffer. (B) Current trace in amiloride buffer. (C) Bar chart showing mean 
peak amplitudes. Each data point represents mean ± SEM (n≥5).  Both the f-test and 
the normality test (Shapiro-Wilk) showed p-values of >0.05, indicating equal 
variance and normal distribution. The statistical significance of the difference in the 
means was assessed using Student‟s t-test (two-tail distribution and two-sample 
equal variance). Note that comparisons between the means showed no significant 
difference. 
 
 
 
 
Figure 4.5 Concentration response curves of hTRPV1 to capsaicin in the absence 
and presence of 30 µM amiloride. Each data point represents mean ± SEM (n≥5). 
Both the Levene‟s test for equal variance and the normality test (Shapiro-Wilk) 
showed p-values of >0.05, indicating equal variance and normal distribution. The 
capsaicin-response was fitted with a sigmoidal dose-response curve (Graphpad 
Prism, r2 ≥0.95). Statistical comparisons between the two dose-response curves were 
done using Student‟s t-test (two-tailed test, equal variance). There was no significant 
difference between the EC50s and the Imaxs  of the two solutions. 
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4.3.2.3    The effect of amiloride on heat-evoked responses 
 
 Finally, I also compared the heat evoked responses in the absence and 
presence of amiloride. Increasing the temperature of the superfusing solution induced 
an increasing inward membrane current in hTRPV1-transfected cells in the range of 
44-51 
o
C both in absence and presence of amiloride buffer (Fig 4.6A+B). The inward 
current elicited at 48 
o
C in the presence of amiloride was significantly higher when 
compared to that measured in the standard buffer (-957 ± 159 pA, (n=5) and - 419 ± 
38 pA (n=8), respectively (Fig. 4.6 and Fig. 4.7 A). However, there was no 
significant difference between the heat thresholds of activation in standard and 
amiloride buffer (44.8 ± 0.31 
o
C (n=8) and 45.20 ± 0.74 
o
C (n=5), respectively: Fig. 
4.5 and Fig. 4.6 B).  
 
Recordings from untransfected HEK293 cells during application of a heat ramp in 
standard buffer were also analysed. Untransfected HEK293 cells showed very small 
but visible heat-induced response during application of a heat ramp (Fig. 4.6). The 
average amplitude of untransfected cells at 48 
o
C was -63 ± 28 pA (n=7), which was 
significantly lower than that of the TRPV1-transfected cells (Fig. 4.7A). 
Consequently, untransfected cells in amiloride buffer during application of a heat 
ramp were not investigated, as the responses of these cells in standard buffer were 
non-specific heat-induced currents. 
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Figure 4.6 Heat-evoked response of untransfected cell in standard buffer. Upper 
trace: Whole-cell patch-clamp recording of untransfected cell in response to heat 
ramp (37 to 52 
o
C) in standard buffer. Lower trace: temperature of the superfusate 
from ~100µm from the cell from which the recording was done. 
 
 
 
Figure 4.7 Heat-evoked responses of hTRPV1-transfected and untransfected cells in 
the absence and presence of amiloride (Part II). (A) Amiloride buffer significantly 
increases the amplitude of currents seen at 48 
o
C when compared to the response 
measured in the standard buffer (*). Transfecting HEK293 cells with TRPV1 
significantly increases the current seen at 48 
o
C when compared to the response of 
untransfected cells in standard buffer (#). (B) Amiloride does not affect the heat 
activation threshold of hTRPV1. Each data point represents the mean ± SEM. Both 
the f-test and the normality (Shapiro-Wilk) test showed p-value of >0.05, indicating 
equal variance and normal distribution. The statistical significance of the difference 
in the means was assessed using the Student‟s t-test (two-tail distribution and two-
sample equal variance). (* and #) Differences were regarded as being statistically 
significant at p<0.05. 
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Taken together, the results of these experiments showed that amiloride reduced the 
proton-activated current mediated through the constitutively expressed ASIC 
channels, and has a sensitising effect on TRPV1-mediated heat-evoked responses. 
However, amiloride does not affect TRPV1-mediated capsaicin -evoked responses.   
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4.4  Discussion 
 
 ASICs and TRPV1 are ion channels which are gated by protons. The 
presence of proton-responding ASIC channels in untransfected HEK293 cells 
suggests that these constitutively expressed ASICs should be taken into account in 
experimental design of subsequent experiments relating to TRPV1 (Hayes et al., 
2000; Tominaga et al., 1998; Gunthorpe et al., 2001). My findings are in agreement 
with previously published data showing functional expression of hASIC in HEK293 
cells, and a reduction of sensitivity to protons in the presence of amiloride, a sodium 
channel blocker.  Interestingly, in addition to reducing ASIC-mediated responses, 
amiloride increased the TRPV1-mediated capsaicin-, and heat-evoked responses. 
 
 Whole-cell patch-clamp recordings of untransfected HEK293 cells showed 
that proton-evoked (pH 5.0) responses exhibited a fast activating and inactivating 
component followed by a slow activating and inactivating component. The fast 
activating and inactivating component of the response is similar to the rapidly 
desensitising ASIC-mediated response identified previously (Waldmann et al., 1997; 
Gunthorpe et al., 2001). However, the slow activating and inactivating component 
has not been reported by previous authors. One possible explanation for this 
difference may be that proton application was longer in this study than in previous 
studies. Application of protons for a longer period seems to activate an unidentified 
response which may even be mediated by a receptor other than hASIC. Interestingly, 
amiloride was also able to reduce the slow activating and inactivating component of 
the response, as well as the fast component. Further studies are required in order to 
elucidate the molecular basis of this response. Nevertheless, these data show that 
constitutive expression of hASIC contributes to proton-evoked currents in TRPV1-
transfected HEK293 cells.   
 
 Initial inspection of the recordings during application of pH 4.0 in the 
presence and absence of amiloride to hTRPV1-transfected HEK293 cells showed a 
noticeable difference. In the presence of amiloride a larger current was seen. Initial 
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inspection of the recordings during application of pH 4.0 in the presence and absence 
of amiloride to hTRPV1-transfected HEK293 cells showed a noticeable difference. 
In the presence of amiloride a larger current was seen. Interestingly, the currents 
produced by TRPV1-transfected HEK293 cells in the absence of amiloride in this 
study are different from those found in previous reports. Hayes and colleagues 
(2000) reported a clearly visible, fast proton-gated current elicited by endogenous 
ASICs, which was shortly followed by a slower proton-gated current mediated by 
TRPV1. In the present study I did not find these two distinct currents. The reason for 
this difference could be that all the present recordings were made at 37
o
C, while 
Hayes and colleagues recorded at room temperature. Due to the heat-sensitivity of 
TRPV1 (Caterina et al., 1997; Tominaga et al., 1998; Davis et al., 2000), the TRPV1-
mediated component of the proton-induced response in these cells could appear 
earlier. Thus, the TRPV1-mediated response to protons may be merged with the 
response mediated by the activity of endogenously expressed receptors. The proton 
concentration–response curve of hTRPV1-transfected HEK293 cells in the presence 
of amiloride showed pH0.5 response at pH 5.6 which is close to that reported for both 
human and rat TRPV1 (Hayes et al., 2000; Tominaga et al., 1998). In the absence of 
amiloride, the pH0.5 was at pH 6.2, which reflects the combination of the ASIC and 
TRPV1 receptors found in hTRPV1-transfected HEK293 cells. These data therefore 
suggest that in order to distinguish the difference between ASIC- and TRPV1-
mediated proton-evoked current, it is essential to inhibit the endogenously expressed 
ASIC when studying heterologously expressed TRPV1 in HEK293 cells, at least at 
37 
o
C. 
 
There are no data available on the possible effect of amiloride on TRPV1-
mediated responses evoked by heat and capsaicin. Accordingly, I investigated the 
effect of amiloride on TRPV1-mediated capsaicin-evoked, and heat-evoked, 
responses in hTRPV1-transfected HEK293 cells.  
 
Although 10 µM capsaicin produced a larger response in the presence of 
amiloride, this difference was not significant. Furthermore, I found that the capsaicin 
concentration response curve in the presence of amiloride was not different from that 
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found in the absence of the sodium channel blocker. These data suggest that 
amiloride does not affect TRPV1 responses to capsaicin-induced activation.  
 
Interestingly, the heat evoked responses in the presence and absence of 
amiloride were different. Although the heat threshold of activation in the presence of 
amiloride was not significantly different from that measured in the standard buffer, 
the amplitude of the current elicited at 48
o
C, in the presence of amiloride, was 
significantly larger than that found in absence of this agent. These data indicated that 
heat-induced currents were affected by amiloride but not capsaicin-induced currents.  
The underlying mechanism of this effect is not clear and requires further 
investigation. However, given the complex effect of amiloride on the TRPV1-evoked 
responses, it may be that amiloride affects the integration mechanism of the channel.  
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Chapter 5 
 
 
NATURALLY OCCURRING POLYMORPHISM IN HUMAN 
TRPV1 GENE ALTERS THE SENSITIVITY OF THE ION 
CHANNEL. 
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5.1  Introduction 
 
 The human TRPV1 ion channel exhibits several naturally occurring polymorphisms 
To investigate whether the ethnic differences in heat-sensitivity are due to mutations 
in  TRPV1 five haplotypes were made containing SNP. hTRPV1111 and hTRPV1222 
were chosen for the first comparison as, if there were any differences in the 
responses, it would be apparent in these two haplotypes, because they show the 
greatest genetic variability. To elucidate whether these mutations produce any 
functional differences, whole-cell patch-clamp recordings were done during 
application of each of capsaicin, anandamide, protons and heat, and voltage 
activation.  
  
 
 
Amino Acid 
Code name. 
Position  
315 
Position  
469 
Position  
585 
hTRPV1 111  I T V 
hTRPV1211 M T V 
hTRPV1121 I I V 
hTRPV1112 I T I 
hTRPV1222 M I I 
 
Table 5.1. Table showing 5 haplotypes of hTRPV1, where 
isoleucine (I), threonine (T) and valine (V) are substituted by a 
different amino acid within a specified position. 
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5.2  Methods 
Cell culture of HEK293 cells, transient transfection, and whole-cell patch clamp 
technique were used in this section.  For further detail, see Chapter Two: Materials 
and Methods. 
 
5.3 Results 
5.3.1 Comparative analysis of hTRPV1111-, and hTRPV1222 - mediated 
responses to various activators 
 
 I studied the issue of whether naturally occurring mutations in hTRPV1 have 
functional effects by analysing the differences in whole-cell currents produced by 
hTRPV1111 and mutant hTRPV1s to various TRPV1 agonists. Responses were 
elicited by application of: capsaicin; anandamide; protons; and heat; or alterations in 
the membrane potential.  
 
 Four different mutants were available for comparative analysis. One of these 
mutants (hTRPV1222) possessed all of the mutations found individually in the other 
three mutants. Therefore, I decided to use this mutant (hTRPV1222) for the initial 
comparative analysis with hTRPV1111.  
 
5.3.1.1    Comparison of responses to capsaicin  
 
Capsaicin is the archetypical activator of TRPV1. Therefore, first I compared 
capsaicin-activated currents produced by hTRPV1111 and hTRPV1222 using normal 
electrophysiology bath and pipette solutions. The membrane potential was held at -
60 mV. All experiments were performed at physiological temperature of 36-37 
o
C. 
 
 I found in this experiment that capsaicin evoked concentration-dependent responses 
in cells transfected by either of the clones (Fig. 5.1 A and B). The EC50s of capsaicin 
in hTRPV1111-transfected, and TRPV1222-transfected cells were 817.61 ± 148 nM 
and 89.64 ± 64 nM, respectively, which were significantly different from each other 
(Fig. 5.1C). There was no significant difference between Imax of capsaicin in 
hTRPV1111-transfected, and TRPV1222-transfected cells (6.36 ± 0.45 nA and 5.84 ± 
256 
0.89 nA, respectively ) (Fig. 5.1D). Untransfected HEK293 cells failed to elicit 
responses, during application of 10 µM capsaicin (not shown). 
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Figure 5.1. Capsaicin-evoked responses of hTRPV1111-transfected, and hTRPV1222-
transfected, HEK293 cells. Normal extracellular and intracellular solutions were 
used. (A) Whole-cell patch-clamp recordings of hTRPV1111-mediated responses 
evoked. Note the concentration-dependence of the peak amplitudes. (B) Pooled 
normalised concentration response curves of hTRPV1111 and hTRPV1222 to 
capsaicin. (C) E50 of capsaicin in hTRPV1111-transfected and hTRPV1222-
transfected, cells. (D) Imax of capsaicin in hTRPV1111-transfected and hTRPV1222-
transfected, cells. Data obtained from each cell were normalised to the cell‟s 
response of hTRPV1111 at 10 µM capsaicin. Each data point represents mean ± SEM 
(n≥5). Both the Levene‟s test for equal variance and the normality test (Shapiro-
Wilk) showed p-values of >0.05, indicating equal variance and normal distribution. 
The capsaicin-response was fitted with a sigmoidal dose-response curve (Graphpad 
Prism, r2 ≥0.95). Statistical comparisons between two dose-response curves were 
analysed using Student‟s t-test (two-tailed test, equal variance). Note that 
comparisons between the EC50s showed a significant difference but not Imaxs of the 
two clones. 
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I next studied the current-voltage relationship of the 1 µM capsaicin-evoked 
currents in standard electrophysiology bath and pipette solutions, using voltage 
ramps between -100mV and +40mV (340 milliseconds). The current-voltage curves 
for both hTRPV1111 and hTRPV1222 showed similar outward rectification (Fig. 5.4). 
The reversal potential of hTRPV1111 and hTRPV1222 were 10.1 ± 6.1 mV (n=5) and 
5.3 ± 4.2 mV (n=5), respectively. These data showed that the mutations in 
hTRPV1222 did not have any effect on the efficacy of capsaicin or on the ion 
selectivity of the channel. 
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Figure 5.4. Current-voltage relationship of 1 µM capsaicin-evoked current of 
hTRPV1111 and hTRPV1222. Normal extracellular and intracellular solution was used. 
(A) I-V relationship of capsaicin-evoked currents. (B) Reversal potential of capsaicin-
evoked currents. Note that currents produced by either clones show similar outward 
rectification and reversal potentials. Each data point represents mean ± SEM (n ≥ 5). 
Each data point represents mean ± SEM. Both the f-test and the normality test 
(Shapiro-Wilk) showed p-values of >0.05, indicating high probability of equal 
variance and normal distribution. The statistical difference in the means was assessed 
using the Student t-test (two-tail distribution and two-sample equal variance). Note 
that there were no statistical differences between the reversal potentials of the two 
clones. 
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5.3.1.2    Comparison of responses to anandamide 
 
Previous findings indicated that the endogenous lipid, anandamide, may be 
one of the most important endogenous TRPV1 activators under certain conditions 
(Zygmunt et al., 1999; Smart et al., 2000; Dinis et al., 2004; Olah et al., 2001; Singh 
Tahim et al., 2005). In order to find out whether the hTRPV1111 and hTRPV1222 
clones respond to anandamide differently, I compared the anandamide–evoked 
response of hTRPV1111-transfected and hTRPV1222-transfected cells, using normal 
electrophysiology bath and pipette solutions. The membrane potential was held at -
60 mV. All experiments were performed at physiological temperature of 36-37 
o
C. 
 
 I found that anandamide in Tocrisolve produced concentration-dependent 
responses in both clones (Fig. 5.3 A and B). The mean peak current during 1 µM, 3 
µM and 10 µM anandamide during 50 seconds application to hTRPV1111 were 83.13 
± 48.92 pA (n=5), 166.25 ± 28.12 pA (n=5), 181.30 ± 71.90 pA (n=5), respectively, 
and hTRPV1222 were 117.15 ± 27.77 pA (n=5), 160.75 ± 53.24 pA (n=5), 183.17 ± 
36.23 (n=5), respectively. Moreover, 0.03 % Tocrisolve failed to evoke a response 
when applied to hTRPV1111-transfected cells (data not shown). There were no 
significant differences between both clones from any of the three concentrations of 
anandamide tested. These data indicated that those mutations in hTRPV1222 did not 
have any effect on the anandamide-mediated current when compared to hTRPV1111. 
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Figure 5.3. Anandamide-evoked responses in hTRPV1111-transfected, and 
hTRPV1222-transfected, HEK293 cells. Normal extracellular and intracellular 
solutions were used. (A) Whole-cell patch-clamp recordings of hTRPV1111-mediated 
responses to anandamide using normal extracellular and intracellular solution. (B) 
Pooled normalised concentration response curves of hTRPV1111 and hTRPV1222 to 
anandamide. Each data point represents mean ± SEM (n = 5). Both the Levene‟s test 
for equal variance and the Shapiro-Wilk normality test showed p-values of >0.05, 
equal variance and normal distribution.  The statistical difference between the means 
of the various treatments within a group was assessed using 1-ANOVA. Whether the 
differences found were significant was established using Fisher LSD post-hoc test. 
The statistical difference between the means in the respective treatment groups was 
assessed using Student‟s t-test (two-tail distribution and two-sample equal variance). 
A post hoc test was not computed as the overall p-value was >0.05.  Note: the means 
of each group were not statistically different from each other.  
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5.3.1.3    Comparison of responses to protons 
 
Protons are potent activators of the TRPV1 (Caterina et al., 1998; Jordt et al., 
2000; Ryu et al., 2003). Therefore, I next studied proton-activated currents in 
hTRPV1111-transfected and hTRPV1222-transfected, cells. Having regard to previous 
reports (Jordt et al., 2000; Ryu et al., 2003) and my finding that HEK293 cells 
constitutively express proton-responding ion channels, the superfusate contained 30 
µM amiloride (see chapter 4).  
 
In these experiments, I found that protons produced concentration-dependent 
responses in both clones (Fig. 5.4 A and B). The half-maximal pH (pH50) for channel 
activation for hTRPV1111 and hTRPV1222 were pH 5.80 ± 0.14 and pH 5.77 ± 0.19, 
respectively (Fig. 5.4 C). The maximal effect of pH (pHmax) for channel activation 
for hTRPV1111 and hTRPV1222 were 2.54 ± 0.30 nA and 1.80 ± 0.125, respectively 
(Fig. 5.4 D).   
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Figure 5.4. Proton-evoked responses of hTRPV1111-transfected and hTRPV1222-
transfected, HEK293 cells. Extracellular solution containing amiloride and normal 
intracellular solutions were used. (A) Whole-cell patch-clamp recordings of 
hTRPV1111-evoked response to protons using extracellular solution containing 
amiloride and normal intracellular solution. (B) Pooled normalised concentration 
response curves of hTRPV1111 and hTRPV1222 to protons. Data obtained from each 
cell were normalised to the cell‟s response of hTRPV1111 to pH 5. Each data point 
represents mean ± SEM (n≥5). Data points fitted with sigmoidal curve function 
(Graphpad Prism statistical analysis programme). (C) pH50 of protons in hTRPV1111-
transfected and hTRPV1222-transfected, cells. (D) pHmax of protons in hTRPV1111-
transfected and hTRPV1222-transfected, cells. Both the Levene‟s test for equal 
variance and the normality test (Shapiro-Wilk) showed p-values of >0.05, indicating 
equal variance and normal distribution.  The pH-response was fitted with a sigmoidal 
dose-response curve (Graphpad Prism, r2 ≥0.95). Statistical comparisons between 
two dose-response curves were analysed using Student t-test (two-tailed test, equal 
variance). Note, there was no statistical difference between pH50 and pHmax. The 
current was normalised to pH5-mediated hTRPV1111-activation. 
 
 
 
I next examined the current-voltage relationship of pH 5-evoked currents in standard 
electrophysiology bath and pipette solutions using voltage ramps between -100 mV 
and +40mV (340 milliseconds). The current-voltage curve for hTRPV1111 and 
hTRPV1222 showed similar outward rectification (Fig. 5.7). The reversal potential of 
hTRPV1111 and hTRPV1222 using physiological bath and pipette solutions were 18.7 
± 7.1 mV (n=5) and 22.18 ± 2.5 mV (n=4), respectively. These values were not 
significantly different from each other. These data indicated that either those 
mutations in hTRPV1222 did not have any effect on the potency and efficacy of 
protons on hTRPV1111, and the ion selectivity of the channel or, alternatively, the 
change produced by the mutations compensated for each other‟s effects. 
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Figure 5.7. Current-voltage relationship of pH 5-evoked currents of hTRPV1111 and 
hTRPV1222  using normal extracellular and intracellular solution.  (A) I-V relationship 
of pH 5-evoked currents. Both clones show similar outward rectification and reversal 
potentials (B) Reversal poten ial of of pH 5-evoked currents. Each data point 
represents mean ± SEM (n≥5). The statistical difference in the means was assessed 
using the Student t-test (two-tail distribution and two-sample equal variance). Note 
that there were no statistical differences between the reversal potentials of the two 
clones. 
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5.3.1.4    Comparison of responses to heat 
 
 One of the most characteristic features of TRPV1 is its sensitivity to heat.  
TRPV1 at negative membrane potentials produces an inward current when activated 
by heat above ~ 44 
o
C (Caterina et al., 1998; Hayes et al., 2000; Smart et al., 2003).  
Hence, I next compared heat-activated currents in hTRPV1111-transfected, and 
hTRPV1222-transfected, cells by applying heat via a temperature ramp between 37- 
50 
o
C using standard electrophysiology bath and pipette solutions. 
 
 Using the Arhenius plots (Vyklicky et al, 1999), I found that hTRPV1111 and 
hTRPV1222 show a mean threshold of activation of 44.49 ± 0.31 
o
C (n=8), and 42.43 
± 0.44 oC (n=8), respectively (Fig. 5.6 A and B). These threshold values were 
significantly different from each other. The amplitude of the responses at 48 
o
C were 
also calculated and found to be -429 ± 34.6 pA (n=8) and -991 ± 226 pA (n=5), 
respectively (Fig. 5.6 A and B).  These values were also significantly different from 
each other.  
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Figure 5.6 Heat-evoked responses of hTRPV1111-transfected and hTRPV1222-
transfected, HEK293 cells. Normal extracellular and intracellular solutions were 
used. (A) Upper trace: hTRPV1111-mediated, and hTRPV1222-mediated, currents 
evoked by heat ramp (37 - 50
o
C). Lower trace: temperature of the superfusate from 
~100µm from the cell from which the recording was done. (B) Heat threshold of, and 
(C) amplitude of current at 48ºC mediated by, hTRPV1111 and hTRPV1222. Note that 
while the heat threshold is lower, the current measured at 48ºC is higher for the 
hTRPV1222-mediated current than for the hTRPV1111 mediated current. Each data 
point represents mean ± SEM (n ≥). The statistical difference in the means was 
assessed using the Student t-test (two-tail distribution and two-sample equal 
variance). (*) Differences were regarded as being statistically significant at p<0.05. 
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I then examined the current-voltage relationship of heat-evoked currents in 
the standard bath and pipette solutions using voltage ramps between -100mV and 
+40mV (340 milliseconds). The current-voltage curves for hTRPV1111 and 
hTRPV1222 in this experiment also showed similar outward rectification (Fig. 5.9). 
The reversal potentials of hTRPV1111 and hTRPV1222 were 9.15 ± 4.60 mV (n=10) 
and 19.26 ± 3.84 mV (n=5), respectively. The difference in the reversal potentials of 
hTRPV1222 and hTRPV1111 was not significant. 
 
-120 -100 -80 -60 -40 -20 20 40 60
-2
-1
1
2
I (nA)
hTRPV1111  
hTRPV1222
 I-V relationship of heat-evoked current 
V (mV)
A
 
 
 
 
 
Figure 5.9 Current-voltage relationships of heat-evoked currents of hTRPV1111 and 
hTRPV1222. Normal extracellular and intracellular solutions were used. (A) I-V 
relationship of heat-evoked currents. Note that both currents show similar outward 
rectification and reversal potentials.  (B) Reversal potential of heat-evoked currents.  
Each data point represents mean ± SEM (n ≥5). The statistical difference in the means 
was assessed using the Student t-test (two-tail distribution and two-sample equal 
variance). Note that there were no statistical differences between the reversal 
potentials of the two clones.  
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5.3.1.5    Comparison of responses to voltage-dependent activation 
TRPV1, in addition to being a ligand-, and temperature-, gated ion channel, is 
also a voltage-gated ion channel (Piper et al., 1999; Gunthorpe et al., 2000; Voets et 
al., 2004; Matta and Ahern, 2007). Therefore, I next, with limitations discussed in 
Chapter 2, investigated hTRPV1111-mediated, and hTRPV1222-mediated, responses to 
changes in membrane potentials. The voltage-dependent activation of the clones was 
established from the differential current of the current-voltage relationships of 
currents of the voltage-activated steady-state current and the current flowing through 
TRPV1 at maximum open probability. The maximum open probability was produced 
by the application 10 µM capsaicin. The currents were measured at symmetrical Na+ 
concentrations (130 mM).  
 
Since re-analysis of the conductances in hTRPV1111 and hTRPV1222 transfected cells 
showed the presence of two voltage-dependent conductances, the half activation 
potentials of these two conductances were established for each haplotype. In 
hTRPV1111  the lower and upper V1/2s were:  -87.2 ± 2.2 mV and  42.3 ± 10 mV, 
respectively (Fig. 5.8). In hTRPV1222  the lower and upper V1/2s were:  -1.5 ± 5.9 mV 
and  83.3 ± 10 mV, respectively (Fig. 5.8). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
270 
 
 
 
 
Figure 5.8 
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Figure 5.8 Voltage-evoked response of hTRPV1111-transfected, and hTRPV1222-
transfected HEK293 cells using symmetrical Na+ concentrations (130 mM). (A) 
Data points are fitted with a Boltzmann function through data points 130 mV to -10 
mV. (C) V1/2 of the corresponding Boltzmann function curves. Each data point 
represents mean ± SEM (n=5). Statistical comparisons of two dose-response curves 
were performed using Student t-test (two-tailed test, equal variance). (*) Differences 
were regarded as being statistically significant at p<0.05. Note that comparison 
between the V1/2s through points -25 mV to +155 mV showed a significant 
difference. 
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5.3.1.6    Summary of comparisons of responses of hTRPV1111 and hTRPV1222 to 
various to TRPV1 activators  
 
 The comparison of responses to various activators produced by hTRPV1111 
and hTRPV1222, respectively, demonstrated substantial differences (Table 5.2). The 
mutations in positions I315M, T469I and V585I, found in hTRPV1222 resulted in 
increased potency for capsaicin without affecting the efficacy of hTRPV1111. The 
mutations also increased the heat-sensitivity of the channel and reduced voltage-
sensitivity. However, I found that the mutations did not change the proton-
sensitivity, anandamide-sensitivity or the reversal potential obtained from current-
response curves evoked by various TRPV1 activators (Fig. 5.9).  
 
The mutations at positions I315M and V585I involved changes of neutral 
amino acids to other neutral amino acids. However, the mutation at position 469 
involved a change of a polar amino acid to a neutral, non-polar, amino acid. 
Therefore, I hypothesised that the mutation which may be responsible for the 
changes may be the one at position 469. 
 
  hTRPV1111 hTRPV1222 Sig. Diff 
Capsaicin EC50 817 ± 148 nM 89.6 ± 64.7 nM yes 
Capsaicin Imax 6.36 ± 0.45 nA 5.84 ± 0.89 nA no 
Anandamide no difference no difference n/a 
pH50 pH 5.80 ± 0.14 pH 5.77 ± 0.19 no 
pHmax 2.54 ± 0.30 nA 1.80 ± 0.25 nA no 
Heat threshold at -60 mV 44.5 ± 0.31ºC 42.3 ± 0.45 ºC yes 
Heat current at 48 
o
C 429 ± 34 pA 991 ± 229 pA yes 
V1/2 lower -87.2 ± 2.2 mV -71.5 ± 5.9 mV no 
V1/2 upper 42.3 ± 10 mV, 83.3 ± 10 mV yes 
 
Table 5.2. Summary of responses of hTRPV1111-transfected and hTRPV1222-
transfected, HEK293 cells evoked by various TRPV1 activators. Normal 
extracellular and intracellular solution was used, with the exception of V1/2 where 
recorded using symmetrical Na
+ 
(150 mM). 
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Figure 5.9. Summary of reversal potential obtained from current-response curves of 
hTRPV1111-transfected and hTRPV1222-transfected, HEK293 cells evoked by various 
TRPV1 activators. Normal extracellular and intracellular solutions were used. The 
statistical difference between the means of the various agonists within a group was 
assessed using 1-ANOVA. Whether the differences found were significant was 
established using Fisher LSD post-hoc test. The statistical difference between the 
means in the respective haplotype was assessed using Student‟s t-test (two-tail 
distribution and two-sample equal variance shown). Note that there is no statistical 
difference between the reversal potentials.  
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5.3.2   The relationship between heat and voltage for hTRPV1111 and hTRPV1222  
 
It has been shown that TRPV1 is a stimulus integrator (Tominaga et al., 1998; 
Davis et al., 2000; Caterina et a., 2000; Cortright et al., 2004; Tominaga et al., 2005). 
While the mechanism of stimulus integration has not been elucidated, currently there 
are two hypotheses regarding this mechanism. According to the first hypothesis, the 
heat sensor may play a central role in stimulus integration and channel gating 
because other activators, including capsaicin, protons, and post-translational 
modifications, all reduce the heat threshold of the receptor (Jordt et al., 2000; Liang 
et al., 2001; Babes et al., 2002; Sugiura et al., 2002; Petho et al., 2001; Chuang et al., 
2001; Prescott and Julius, 2003 Premkumar and Ahern, 2000; Tominaga et al., 2001).  
According to the second hypothesis, however, the ultimate activator of TRPV1 is 
depolarization, i.e., a shift of the activation threshold towards the resting membrane 
potential (Voets et al., 2004; Nilius et al., 2005). This latter hypothesis also 
postulates that the temperature sensitivity is tightly linked to voltage-dependent 
gating of TRPV1. This assumption is based on the findings that: (i) increasing the 
ambient temperature reduces the threshold of voltage-dependent gating of TRPV1; 
and (ii) depolarising the membrane reduces the heat threshold of TRPV1 (Voets et 
al., 2004). Therefore, I next studied the link between heat-sensitivity and voltage-
sensitivity in both hTPRV1111 and hTRPV1222. 
 
 
5.3.2.1    The heat threshold depends on the holding potential 
 
In the first experiment I measured heat-activated responses at different 
holding potentials. The heat activation threshold for hTRPV1111 at holding potentials 
of:  -20 mV, -40 mV, -60 mV and -80 mV were 43.42 ± 0.67 ºC (n=5), 44.49 ± 
0.31
º
C (n=8), 40.78 ± 0.88
º
C (n=5), and 40.01 ± 1.25 
o
C (n=5), respectively (Fig. 
5.11). The respective values for hTRPV1222 were as follows: 42.04 ± 0.80 
o
C (n=5), 
42.43 ± 0.44 
o
C (n=8), 38.00 ± 0.23 
o
C (n=5) and 39.44 ± 0.90 
o
C (n=5), (Fig. 5.11). 
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Overall, these data show that depolarising the membrane potential decreases 
the heat activation threshold (Fig. 5.10). The heat activation threshold for hTRPV1222 
at -20 mV and -40 mV were not significantly different from each other either. 
However, the heat activation threshold measured at -20 mV was significantly 
different from the threshold measured at -60 mV. In addition, the heat activation 
thresholds measured at both -20 mV and -40 mV were significantly different from 
that measured at -80 mV. The heat activation thresholds measured at holding 
potentials of - 60 mV and - 40 mV, were significantly lower for hTRPV1222 than 
hTRPV1111.  
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Figure 5.10. Heat activation threshold of hTRPV1111 and hTRPV1222 at four 
different holding potentials. Normal extracellular and intracellular solutions were 
used. Note that depolarization reduces the heat threshold for both clones. Note also 
that the heat activation threshold of hTRPV1222 is significantly lower that that of 
hTRPV1111 at each membrane potential. Each data point represents mean ± SEM 
(n= 5 or more). The statistical difference between the means of the various 
membrane potential within a group was assessed using 1-ANOVA. Whether the 
differences found were significant was established using Fisher LSD post-hoc. The 
statistical difference between the means in the respective membrane potential was 
assessed using Student‟s t-test (two-tail distribution and two-sample equal variance; 
data not shown). (*) Differences were regarded as being statistically significant at 
p<0.05 
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5.3.3 Comparative analysis of hTRPV1211- , hTRPV1121- and hTRPV1112-, 
mediated responses 
 
Given that the mutation at T469I (hTRPV1121) was the only mutation 
involving a change in the polarity of an amino acid in TRPV1222, it was considered 
that this mutation was the most likely to be responsible for the differences in 
responses to various activators found in hTRPV1111 and hTRPV1222. Thus, I 
examined the response of hTRPV1121 to heat and to voltage-dependent activation. To 
eliminate the involvement of the other SNPs found in hTRPV1222, namely, I315M 
(hTRPV1211) and V585I (hTRPV1112), both of these clones were also tested. I used 
heat and voltage-dependent activation as the activators in these experiments because 
only heat-, capsaicin-, and voltage-sensitivities were altered by the mutation. 
Furthermore, previous studies report that capsaicin and other ligands activate TRPV1 
either by reducing the heat-threshold or the V1/2.  In addition, I also examined the 
affect of heat activation thresholds during alterations in membrane potentials for all 
three clones. 
 
5.3.3.1    Responses of TRPV1211, hTRPV1121, and hTRPV1112  to heat 
 
 Firstly, I studied heat-evoked currents in hTRPV1211-, hTRPV1121-, and 
hTRPV1112-, transfected cells at a holding potential of -60 mV. Heat stimulation was 
done by the usual temperature ramp between 37 – 50 oC.  
 
Here, I found that the heat threshold of hTRPV1211, hTRPV1121 and 
hTRPV1112 were 44.47 ± 0.82 
o
C (n=4), 41.56 ± 0.56 ºC (n=6) and 44.19 ± 0.47 
o
C 
(n=5), respectively, (Fig. 5.11 A). Moreover, I found that the currents evoked at 48 
o
C were: - 422 ± 146 pA (n=5), - 941 ± 221 pA (n=7) and - 240 ± 80 pA (n=6), 
respectively, (Fig. 5.11 B).  Both the threshold and the amplitude of the hTRPV1121-
mediated heat-evoked responses were significantly different from those of 
hTRPV1111, hTRPV1211 and hTRPV1112, but were similar to the values obtained 
from hTRPV1222. These results confirmed the hypothesis that the mutation at 
position 469 altered the heat-sensitivity and heat-evoked responses of hTRPV1111. 
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Figure 5.11. Heat responses of hTRPV1111, hTRPV1222, hTRPV1121, hTRPV1211 and 
hTRPV1112. Normal extracellular and intracellular solutions were used. (A) Heat 
threshold, and (B) amplitude, of current at 48 
o
C all clones. Note that the heat 
activation threshold and current at 48 
o
C of hTRPV1222 and hTRPV1121 is 
significantly different than those of hTRPV1111, hTRPV1211 and hTRPV1112. Each 
data point represents mean ± SEM (n= 5 or more). The statistical difference 
between the means of the various membrane potential within a group was assessed 
using 1-ANOVA. Whether the differences found were significant was established 
using Fisher LSD post-hoc test. (*) Differences were regarded as being statistically 
significant at p<0.05. 
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5.3.3.2    Response of hTRPV1121 to voltage-dependent activation  
 
To further assess the validity of my hypothesis that the mutation which 
produced the alteration in hTRPV1 responsiveness was that found in hTRPV1121, I 
investigated the effect of alteration in membrane potential on the activation of 
hTRPV1121. The data were then compared to those obtained previously from 
hTRPV1111 and hTRPV1222.  
 
I found that the V1/2 of hTRPV1121, using depolarisation to achieve maximal 
open probability at 37 
o
C, was 85.38 ± 1.78 mV (n=5), which was similar to that of 
hTRPV1222 and significantly different from that of hTRPV1111 (Fig. 5.12 A and B). 
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Figure 5.12. Voltage-dependent activity of hTRPV1111, hTRPV1222, and 
hTRPV1121. (A) Voltage-dependent activation curves at 37 
o
C using depolarisation 
to open the channel with maximum open probability. Lines represent Boltzman 
functions fitted to the data. (B) V1/2 at 37 
o
C of hTRPV1111, hTRPV1222 and 
hTRPV1121 using depolarisation. Each data point represents mean ± SEM (n ≥ 3). 
Statistical comparisons between three Boltzmann curves were analysed using 
ANOVA (Graphpad Prism). Whether the differences found were significant was 
established using Fisher LSD post-hoc test. (*) Differences were regarded as being 
statistically significant at p<0.05. 
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5.3.4 Comparative analysis of hTRPV1 121-S and hTRPV1121-A mediated 
responses 
 
I have shown that the mutation at position 469 of TRPV1 involving the 
change from the polar amino acid, threonine, to the non-polar amino acid, isoleucine, 
found in hTRPV1121, is responsible for the difference in sensitivity in heat and 
voltage-dependent activation. I made twonon-natural mutants by site directed 
mutagenesis. This involved changing the wild-type amino acid encoding a polar 
threonine at position 469 in twofurther mutants. These were: a charge-conserving 
polar serine mutation (hTRPV1121-S mutant); and a charge-neutralising non-polar 
alanine mutation (hTRPV1121-A mutant). I then tested the sensitivity of these mutants 
to heat. The data obtained were then compared to the previous results from 
hTRPV1111, hTRPV1222 and hTRPV1121. 
 
5.3.4.1    Responses of mutants to heat 
 
Recordings were made on HEK293 cells transfected with one, or other, of 
these mutants while heating the bath solution from 37
o
C to 50
o
C. All mutants formed 
functional channels upon expression in HEK293 cells in response to heat. The heat 
activation thresholds for hTRPV1121-S, and hTRPV1121-A, transfected cells were: 
44.91 ± 0.77 
o
C (n=5); and 42.65 ± 0.23 
o
C (n=5), respectively, (Fig. 5.13 A). The 
currents evoked at 48 
o
C were: -688 ± 266 pA (n=5); and-1037 ± 253 pA (n=5), 
respectively (Fig. 5.13 A). Voltage-dependence could not be analysed because of 
quality issues. 
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Figure 5.13. Heat-activation thresholds of hTRPV1111, hTRPV1222, hTRPV1 121, 
hTRPV1121-S, and hTRPV1121-A. Normal extracellular and intracellular solutions were 
used.  Each data point represents mean ± SEM (n ≥5). * P < 0.05 from hTRPV1111. 
The statistical difference between the means of the various membrane potential 
within a group was assessed using 1-ANOVA. Whether the differences found were 
significant was established using Fisher LSD post-hoc test. (*) Differences were 
regarded as being statistically significant from hTRPV1111 at p<0.05. 
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Figure 5.14. Amplitude of currents at 48
o
C of hTRPV1111, hTRPV1222, hTRPV1 121, 
hTRPV1121-S, and hTRPV1121-A. Normal extracellular and intracellular solutions 
were used. (A) Amplitude of currents at 48
o
C, and (Each data point represents mean 
± SEM (n ≥5). The statistical difference between the means of the various 
membrane potential within a group was assessed using 1-ANOVA. Whether the 
differences found were significant was established using Fisher LSD post-hoc test. 
(*) Differences were regarded as being statistically significant at p<0.05 from 
hTRPV1111. 
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5.4 Discussion  
 
Several SNPs were found while cloning the hTRPV1 receptor. Davis and 
colleagues therefore searched for hTRPV1 missense SNPs in three ethnic groups 
(Caucasians, African-Americans and Asians) to investigate whether the previously 
reported ethnic differences in heat-sensitivity in these groups were due to mutations 
in their TRPV1 (Campbell et al., 2005). In total, only three non-synonymous SNPs in 
the hTRPV1 gene in Caucasians and African Americans were found to produce a 
frequency of more than 20%. Five clones were made; three clones contained single 
missense SNPs. These were hTRPV1211 (I315M), hTRPV1121 (T469I) and 
hTRPV1112 (V585I). Clone hTRPV1111 (I315/T469/V585) represented “wild-type” 
hTRPV1111, whereas hTRPV1222 (I315M/T469I/ V585I) had the combination of all 
three missense SNPs of hTRPV1 in one clone.  
 
A recent study by Campbell and colleagues compared the noxious heat-
evoked responses in Caucasians and in African-Americans and showed that, although 
the threshold of heat pain did not differ in these two groups, African-Americans 
exhibited significantly lower tolerance to heat-induced pain. Moreover, the intensity 
and unpleasantness of suprathreshold heat pain were rated higher in African-
Americans than in Caucasians (Campbell et al., 2005). It is well established that 
individual phenotypic variations, due to underlying genetic variations, are inherited 
(Morely et al., 2004; Schadt et al., 2003; Spielman et al., 2007). Consequently, it is 
reasonable to suggest that phenotypic variations in pain perception among 
individuals are controlled by gene expression and the level of gene products. Here, I 
postulate that the three non-synonymous SNPs in the hTRPV1 gene may explain 
these variations in sensitivity to noxious heat. They may also explain the variations 
found in TRPV1-dependent functional characteristics and in pathological conditions, 
such as visceral hyperreflexia and heat hyperalgesia following inflammation 
(Charrua et al., 2007; Dinis et al., 2004; Davis et al., 2000; Caterina et al., 2000) 
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Therefore, I aimed to investigate whether any of the three SNPs in hTRPV1 
would produce functional differences upon application of “classical” TRPV1 
activators (capsaicin, heat and protons) and voltage in hTRPV1 heterologously 
expressed in HEK293 cells. hTRPV1111-mediated and hTRPV1222-mediated 
responses were initially tested and compared to capsaicin, heat and protons. SNPs 
found in hTRPV1222  resulted in increased sensitivity to capsaicin (~ 10 fold) and 
heat (~ 2 
o
C lower threshold). However, no difference was seen in proton-evoked 
responses or in the ion selectivity of the receptors.  
 
Due to the existence of voltage-dependent conductances in native HEK293 
cells, establishing the voltage-dependent properties of hTRPV1 polymorphs properly 
was not possible. Nevertheless, here I was able to show: first, that transfecting 
HEK293 cells with hTRPV1 modified the voltage-dependent activation curve of the 
HEK293 cells, indicating that TRPV1 can indeed be activated by changing the 
membrane potential.  Second, I was also able to show that different polymorphs 
could have different voltage-dependency because transfecting HEK293 cells with 
various polymorphs modified the voltage-dependent activation curves differently.  
Results of these experiments suggest that TRPV1111 might be more significantly 
sensitive to depolarisation than TRPV1222. These data together suggested that SNPs 
found in hTRPV1 could indeed result in altered sensitivity of the molecule to some 
of the activators.  
 
The outward rectification of the I-V curve of TRPV1 seen at negative membrane 
potentials (Caterina et al., 1997) could be interpreted, by some, as a sign of voltage-
dependent reduction in the open probability of TRPV1. However, there is no 
apparent voltage-dependent change in the open probability in single channel 
recordings shown by Nagy and Rang (1999). Furthermore, the I-V curve of the single 
channel TRPV1-mediated currents showed outward rectification (Nagy and Rang, 
1999). These together indicate the existence of voltage-dependent change in the 
conductance of the ion channel. Therefore, the outward rectification shown in whole 
cell recordings could also be due to the voltage-dependence of channel conductance 
and not due to voltage-dependent change in the open probability.  
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It has also been reported that TRPV1 can be activated by depolarisation (Voets et al., 
2004; Matta and Ahern, 2007). Therefore our data do agree with these previous 
findings. However, while we found that voltage-activated currents are different in 
TRPV1-transfected and untransfected cells, the presence of voltage-activated 
currents in untransfected cells makes proper analysis of TRPV1 voltage-dependence 
impossible. The reasons for the difference in relation to constitutively expressed 
voltage-activated currents in HEK293 cells by the present and previous studies are 
not known (Thomas and Smart, 2005). Since the solutions used in the present study 
and by other previously are essentially identical, the only possibility could be in the 
HEK cells.  
 
Although voltage-sensitivity of TRPV1 has been shown by several groups (Voets et 
al., 2004; Matta and Ahern, 2007) still it may be regarded as a controversial issue. As 
discussed before, the current-voltage relationship of non-voltage-sensitive ion 
channels should follow Ohm‟s law, i.e., it should show a linear relationship. 
However, the I-V relationship of the majority of ion channels deviates from the 
linear regression at certain potential ranges. This indicates that the conductance of 
the channel is altered by the change of the membrane potential. The conductance of a 
channel is changed if its permeability is reduced or increased. There are at least two 
possibilities to change the conductance of an otherwise open ion channel: (i) a 
charged particle, an ion occupies the channel which cannot pass the pore; (ii) the 
pore exhibits a voltage-dependent change in its shape, diameter or properties of ion 
selectivity, which may result in an overall change in conductance. There are several 
examples for non-permeable ions occupying the pore including inward rectifier 
potassium channels and N-methyl-D-aspartate (NMDA) type of glutamate receptor 
channels (Tanaka and Tokimasa, 1999). Both of these channels have magnesium 
binding sites within their pore and depending on the membrane potential, magnesium 
ions enter the pore and block permeation of other ions. However, no such TRPV1 ion 
channel-occupying charged particle has been reported so far. On the contrary, 
Caterina and co-workers have shown recently that properties of the selectivity filter 
of TRPV1 depend on concentration and type of agonists (Caterina et al., 2008). The 
presence of outward rectification in the single channel I-V curve of TRPV1 suggests 
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that the membrane potential may also affect the selectivity filter. Taken together the 
currently available data indicate that membrane potential may have a complex effect 
on TRPV1. On the one hand, findings from Voets and co-workers (2004) and Matta 
and Ahern (2007) suggest that changes in membrane potential directly regulate the 
probability of channel opening; while on the other hand, changes in membrane 
potential may also affect ion selectivity of TRPV1. Elucidation of both of these 
possibilities requires further studies. 
 
Data obtained from hTRPV1111 were substantially similar to previously 
published data from „wild-type‟ hTRPV1. The EC50 of capsaicin for hTRPV1111-
tranfected HEK293 cells was ~ 861 nM, which is slightly higher than that of 640 nM 
reported by Hayes and colleagues (2000). The heat activation threshold for 
hTRPV1111 was ~ 45.6 
o
C which is higher than that reported at ~ 42
o
C by Smith and 
colleagues (2002). If we accept the assumption that the conductance at negative 
membrane potentials represents the majority of the conductance of TRPV1, and that 
the constitutive HEK293 cell conductance does not produce any major effect on that, 
then the V1/2s of both TRPV1111 and TRPV1222 established at 37
o
C were much more 
negative than that reported by Voets and co-workers (2004) where the V1/2 obtained 
at 35 
o
C was ~ +10 mV. The normalised G/Gmax values were also different. In my 
experiments they were between 0.1-and 0.2. While Voets and colleagues reported up 
to 1, Matta and Ahern (2007) found it to be 0.6. Thus, a comparison of the 
characteristics of hTRPV1111 to data previously reported on wild-type hTRPV1 
reveals differences in heat sensitivity and possibly voltage sensitivity. 
 
The difference between the heat threshold of hTRPV1111 in the present study 
and that found in previous studies on wild-type hTRPV1 may have been due to 
differences involved in measuring the temperature of the superfusate and establishing 
the threshold. Smith and colleagues (2002) activated the cells by superfusing the bath 
solution set to specific temperatures instead of using a heat ramp. In their report, they 
failed to mention measuring the temperature of the superfusate near the cells. 
Moreover, they established the heat threshold from simple current-temperature plots 
taken at every 2- 3 
o
C by finding the deviation of the plot of the hTRPV1 transfected 
cells from that of the untransfected cells. This method is obviously much less 
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accurate than the method used in this study, which involved applying a heat ramp 
and establishing the Arrhenius plot. In addition, the hTRPV1 used by Smith‟s group 
and the hTRPV1111 used in this study may have been different and this difference 
may well have resulted in different characteristics of the two channels.  
 
The difference in the V1/2 values could clearly be due to the presence of the 
constitutive voltage-activated currents in HEK293 cells. Since we do not know how 
this constitutive conductance affected TRPV1 conductance any discussion on the 
possible reasons for the differences would be mere speculation.  
 
The differences found between the functional characteristics of hTRPV1111 
and hTRPV1222 indicated that at least one of the three mutations had to be 
responsible for the changes observed in the properties of the ion channel. By 
analysing the individual mutations in hTRPV1222, it became apparent that the single 
missense SNP at T469I in hTRPV1 must have been responsible for this difference, as 
it was the only mutation which involved a change in polarity of an amino acid. It is 
well established that changes in the polarity of an amino acid in an ion channel, 
including TRPV1, often results in altered characteristics of the ion channel (Voets et 
al., 2007; Brauchi et al., 2006; Tombola et al., 2006;  Gavva et al., 2004) 
 
It has already been observed that TRPV1 ligands are able to reduce the heat 
threshold and the V1/2 of TRPV1 (Voets et al., 2004; Babes et al., 2002). It was 
therefore postulated that ligand-binding activates TRPV1 either through reducing the 
heat or the voltage-activation threshold. Thus, either the heat-sensor, or the voltage-
sensor, were postulated to be the ultimate activators of TRPV1 (Voets et al., 2004; 
Reeh and Petho, 2000). However, a recent publication has suggested that the voltage-
sensor is not the ultimate activator of this ion channel, as high concentrations of 
ligands are able to open the ion channel independently of the voltage sensor (Matta 
and Ahern, 2007). Notwithstanding this latter study, I decided to assess both the heat 
and the voltage sensitivity of hTRPV1121. 
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I found that the heat activation threshold of hTRPV1121, which contains only 
the T469I mutation, was similar to that of hTRPV1222 and significantly different 
from that of hTRPV1111.  Moreover, the voltage-sensitivity, for hTRPV1121 with 
observing all the limitations, was similar to that of hTRPV1222 and different from that 
of hTRPV1111. These data suggested that T469I may be responsible for the 
differences observed between hTRPV1111 and hTRPV1222. In order to verify the role 
of the T469I mutation in the generation of those changes, I also assessed the heat-
activated responses of hTRPV1211 and hTRPV1112. These studies showed that the 
heat activation threshold for hTRPV1211 and hTRPV1112 were similar to that of 
hTRPV1111 and significantly lower than those of hTRPV1222 and hTRPV1121, 
respectively.  These findings confirmed that the SNP, T469I, located in the 
extracellular loop between the first and second transmembrane domains is 
responsible for the increase in the sensitivity of the molecule to these activators. I 
postulated that the underlying mechanism of the changes associated with the T469I 
mutation likely to be the alteration of the charge distribution by this mutation. Since 
the voltage-sensitivity of voltage-gated ion channels, including the cold sensitive 
TRPM8, is known to depend on the distribution of charged amino acids (Voets et al., 
2007), the T469I mutation associated changes could involve changes in the 
sensitivity of the voltage sensor. However, the voltage sensor in voltage-gated ion 
channels is in the fourth transmembrane domain (Voets et al., 2007; Papazian et al., 
1991; Perez-Reyes, 2003; Stuhmer et al., 1989; Tombola et al., 2006), although the 
linker of the first and second transmembrane domains also contribute to voltage-
sensing in hyperpolarisation-activated cationic channels (Ishii et al., 2001). Charge 
distribution also affects the gating apparatus of voltage-gated ion channels (Lecar et 
al., 2003; Elinder and Århem, 1999). Hence, as an alternative, the T469I mutation 
may affect the gating apparatus, although according to the 2-dimensional putative 
membrane topology of the TRPV1, the T469I is far from the location of the gating 
apparatus, T670 and A680, suggested in a recent publication (Susankova et al., 2007)  
 
While the T469I mutation could result in an alteration in the voltage-
sensitivity or in the gating apparatus, it per se, is unlikely to be responsible for the 
altered heat-sensitivity of the molecule, because the temperature-sensing region in 
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temperature-sensitive TRP channels has been found to be located in the C-terminal 
domain of the molecule (Brauchi et al., 2006). Therefore, a more plausible 
explanation for the T469I mutation-associated reduction in heat-sensitivity may be 
that the T469I mutation acts through either the coupling mechanism predicted to link 
the voltage-sensor and the heat sensor (Brauchi et al., 2004; Brauchi et al., 2006; 
Lattore et al., 2007; Voets et al., 2004; Voets et al., 2007) or the gating apparatus.  
 
To further verify the role of the altered charge distribution in the T469I 
mutation-associated changes, I studied the heat threshold, and the V1/2, of 
hTRPV1121-S, and hTRPV1121-A, in which the polar threonine of hTRPV1111 at 
position 469 was changed to a polar serine, or non-polar alanine. Data from these 
mutants showed that, as expected, the threonine to serine amino acid change did not 
alter the heat threshold. Furthermore, these data also showed that, the heat threshold 
of hTRPV1121-A was similar to that of hTRPV1222 and hTRPV1121. These data on 
hTRPV1121-S and hTRPV1121-A are consistent with the predicted differential shift of 
the heat threshold of hTRPV1111, hTRPV1222 and hTRPV1121.  
 
 To further examine whether any of the mutations modify the hypothesised 
close link between the heat-sensitivity and the voltage-sensitivity of TRPV1, I 
studied the relationship between these properties in each of the five original clones. 
According to Voets and co-workers, depolarising the membrane to more positive 
potentials decreases the heat activation threshold. In fact, this relationship was seen 
in each of the 5 five clones. Furthermore, in agreement with the data that the T469I 
mutation results in lowering the heat threshold of hTRPV1, I found that hTRPV1222 
and hTRPV1121 showed significantly lower thresholds at all four holding potentials 
when compared to hTRPV1111, hTRPV1211, and hTRPV1112.   
 
The alterations in the sensitivity to heat and possibly to voltage, respectively, 
in opposite directions is surprising, since a close link between these two activation 
sites has been suggested in earlier studies (Voets et al., 2004; Brauchi et al., 2006). 
There has been an on going debate whether TRPV1 is ultimately gated by 
temperature-dependent regulation or by voltage-dependent regulation. Thus, Voets 
289 
and co-workers have proposed that: (a) the heat sensor is directly coupled to the 
voltage sensor; (b) ligand-binding mimics heat activation; and (c) all TRPV1 
activators activate this ion channel by shifting the voltage-dependence of channel 
activity from a physiologically non-relevant voltage range into a physiologically 
relevant one. However, other studies have shown that the temperature-sensor and the 
voltage-sensor are conserved in different modules and are able to modulate each 
others activity (Lattore et al., 2007). Furthermore, based on modelling and 
biophysical studies, it has been proposed that the stimulus integration occurs through 
an allosteric mechanism instead of by direct coupling. Subsequent studies by Matta 
and Ahern (2007) support this allosteric model as they show that voltage results in 
only a partial activation of TRPV1 and that a high concentration of capsaicin is able 
to elicit voltage-independent gating. These findings suggest that voltage does not 
constitute the ultimate gating mechanism of TRPV1 but is able to activate TRPV1 
independently, as well as being able to modulate the effect of other stimuli on 
channel activation. Data from this present work also support the allosteric model of 
TRPV1 activation, as our findings suggest that, while the heat-sensor and voltage-
sensor in TRPV1 are indeed coupled, that coupling may be indirect. Hence, the 
voltage-sensor is unlikely to be able to transmit all of the effects of each stimulus to 
the gating apparatus and it is also unlikely to be the main activator of TRPV1. The 
alterations in the sensitivity in opposing directions of TRPV1 for the heat-dependent 
and the voltage-dependent activation, respectively, in this study can therefore be 
explained by the temperature-sensor and the voltage-sensor being conserved in 
separate regions of the ion channel. Moreover, although they are linked, they may 
not necessarily shift in same direction due to a mutation. Interestingly, the acid-
sensitivity of hTRPV1111 was not changed by the mutations found in hTRPV1222 in 
spite of a shift in heat-sensitivity and capsaicin-sensitivity. This finding is in 
agreement with a putative allosteric link between the various sensors because, if the 
sensors are linked directly, then the proton sensitivity of hTRPV1222, should also be 
reduced since protons also mimic heat activation. (Voets et al., 2004; Jordt et al., 
2000;  Ryu et al., 2003).  
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Chapter 6 
 
SIMMARY OF RESULTS AND CONCLUSION 
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6.1 Summary 
The main findings of my research are as follows: 
 
(i) DMSO activates TRPV1; 
(ii) Amiloride affects TRPV1-mediated responses; 
(iii) Polymorphisms alter the sensitivity of hTRPV1 to various activators; and 
(iv) Polymorphisms induce differential changes in heat-sensitivity and  
      voltage-sensitivity of hTRPV1. 
 
Based on these results, it is considered that the following are the main 
conclusions of this thesis. First, the TRPV1 activating effect of DMSO should be 
observed when this lipophilic solvent is employed either in vivo, or in vitro, 
experiments. Second, amiloride may increase TRPV1-associated sensation in 
patients. Third, polymorphism(s) may underlie the differences in pain experience 
associated with TRPV1 activity reported by individuals. Finally, various sensors in 
TRPV1 are coupled allosterically, rather than directly.  
 
 
6.2 DMSO activates TRPV1 
 
As presented in Chapter Three, I found that DMSO concentration-dependently 
activates TRPV1 both in a heterologous system expressing human TRPV1 and in 
mouse primary sensory neurons. Further, I demonstrated that in the presence of Ca
2+
, 
DMSO, like capsaicin, produced desensitisation of hTRPV1.  
 
 DMSO is not only used in laboratories to dissolve lipophilic compounds, but has 
also been employed in clinics to treat different painful conditions, including 
interstitial cystitis and inflammation of peripheral organs (Sant et al., 1991 and 1987; 
Rossberger et al., 2005; Malek et al., 2002; Shiga et al., 2007). In urology, 
intravesical instillations of high concentrations of DMSO, for example, 50 %, have 
been shown to alleviate bladder hyperactivity and pain associated with interstitial 
inflammation (Melchior et al., 2003). Although controversial, DMSO up to 70% has 
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been shown to alleviate pain associated with inflammation of joints (Muir, 2001; 
Rosenstein, 1999; Santos and Tipping, 1994; Matsumoto, 1967).  However, the 
mechanism of these beneficial effects of DMSO has not yet been fully elucidated. 
Recently, Shiga and co-workers (2007) found that DMSO decreases calcium 
sensitivity of myo-filaments. Previously, Evans and co-workers (1993) showed that 
DMSO even at low concentration, for example, 5-7% could reduce nerve conduction 
in high threshold nociceptive C-fibers. As mentioned in the Introduction, the great 
majority of nociceptive C-fibers express TRPV1 (Caterina et al., 1997; Scotland et 
al., 2004; Christiansona et al., 2006; Avelino et al., 2002). Recent findings also show 
that TRPV1 is essential for the development of bladder hyper-reflexia and pain in 
cystitis and the development of heat hyperalgesia associated with inflammation 
(Charrua et al., 2007; Dinis et al., 2004; 2005; Davis et al., 2000; Caterina et al., 
2000). Results of the present study show that repeated application of 0.2% DMSO in 
cells expressing TRPV1 resulted in desensitsation. Therefore, it is reasonable to 
assume that, in addition to reducing calcium sensitivity of myo-filaments and 
reducing the conduction velocity of nerve impulses in nociceptive C-fibers, DMSO-
evoked TRPV1 desensitisation may also contribute to the beneficial effects of 
DMSO both in the urinary bladder and in joints. Thus my present finding may 
contribute to the elucidation of mechanisms through which DMSO used to control 
pain and bladder hyper-reflexia may occur. Of course, for a full elucidation, in vivo 
studies are needed. Our collaborator, Dr Antonio Avellino has started such studies by 
examining cFos expression in the spinal cord following intravesical application of 
DMSO.  
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6.3 Amiloride affects TRPV1-mediated responses 
 
 As presented in Chapter Four, I found that amiloride affects TRPV1-mediated 
responses. Amiloride is a prototypic inhibitor of epithelial sodium channels. It has 
also been shown that selected sodium channel mutations affect amiloride binding, 
provides critical clues towards defining sites within the channel that bind amiloride. 
Residues within the channel pore and within its extracellular domain participate in 
amiloride binding. These results suggest that sites that interact with amiloride within 
the channel's extracellular domain may be in close proximity to residues within the 
channel's pore (Katzman et al., 1988; Vidt, 1981). 
 
Amiloride hydrochloride is an orally administered, potassium-sparing diuretic with 
mild natriuretic properties. Its primary site of action is the distal tubule of the 
nephron where it selectively blocks sodium transport, thereby inhibiting sodium-
potassium exchange. The mechanism of action of amiloride is independent of 
aldosterone. It is excreted unmetabolized in the urine and faeces. Peak serum levels 
are seen at three hours, and the serum half-life is six hours. The drug can probably be 
safely administered to patients with hepatic dysfunction but should be used 
cautiously, if at all, in patients with renal insufficiency. Amiloride is well tolerated, 
and serious toxicity is rare. It should prove useful in edematous states and 
hypertension. When amiloride is used in fixed combination with a thiazide diuretic 
the risk of hypokalemia is minimal (Katzman et al., 1988; Vidt, 1981; Klayman et 
al., 1999). 
 
However, my present data suggest that when TRPV1 is sensitised and activated for 
example by inflammatory processes, this agent might induce adverse effects. As 
discussed, TRPV1 is involved in the development of visceral hyper-reflexia and 
visceral pain associated by inflammation of various organs, including cystitis and 
colitis (Dinis et al., 2004). Since amiloride is excreted with urine and faeces it might 
increase the activity of TRPV1 and increase visceral hyper-reflexia and pain. 
294 
Therefore, my findings should be taken into account when using amiloride in patients 
with inflammatory conditions, particularly cystitis or colitis.   
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6.4 Polymorphisms alter the sensitivity of hTRPV1 to various activators 
 
As presented in Chapter Five, I have found that certain naturally occurring TRPV1 
polymorphs show altered sensitivity to various activators, including capsaicin and 
heat and possibly voltage. These changes in TRPV1 sensitivity might have profound 
consequences both in the development of pain associated with various pathologies 
and in controlling those prolonged pain experiences in the development of which 
TRPV1 plays a pivotal role. It has been believed that TRPV1 is activated in vivo 
during pathological conditions by several activators, including endovanilloids and 
reduction in heat threshold (Walker et al., 2003). Therefore, altered sensitivity to 
capsaicin and probably other vanilloids, including endovanilloids (though 
anandamide-sensitivity was not affected) as well as altered heat threshold, which are 
both associated with certain naturally occurring mutations, may play an important 
role in the severity of pain experienced by patients. 
 
Several researchers have shown that ethnic differences influence the clinical 
appearance of pain experience (Riley et al., 2002; Rahim-Williams et al., 2007; 
Hastie et al., 2005), including the severity of pain associated with medical conditions 
such as arthritis (Creamer et al., 1999), postoperative pain (Faucett et al., 1994), joint 
pain (Rantanen et al., 1998), and the treatment of conditions such as low back pain 
(Taylor et al., 2005). Ethnic differences have also been seen in the responses to 
multiple experimental pain stimuli. For example, African Americans show 
significantly higher ratings in intensity and unpleasantness for supra-threshold heat 
stimuli than Caucasians (Campbell et al., 2005). A recent study has shown that ethnic 
identity predicts experimental pain sensitivity across multiple noxious stimuli 
(Rahim-Williams et al., 2007). The difference in pain perception experienced by 
various ethnic groups indicates that genetic factors may play a major role in the 
development of pain. 
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Data suitable for studying the correlation between ethnicity, allele frequency and 
pain ratings were not available during my PhD studies. However, given the heritable 
nature of SNPs and the ethnicity-associated pain-sensitivity, it is tempting to suggest 
that SNPs with possibly many other factors contribute to difference in the severity of 
pain experienced by people belonging to various ethnic groups. Although during my 
PhD studies I did not examine the effect of any of the novel TRPV1 antagonists, 
many of which are in clinical trials currently, on TRPV1-mediated responses, my 
findings regarding naturally occurring mutation-induced alterations of TRPV1 
sensitivity suggest that genotyping may increase the efficacy of controlling pain in 
the development of which TRPV1 plays a pivotal role.  
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